Effects of Dietary Dehydroepiandrosterone (DHEA) on Body Weight, Food Consumption, and Glucose-6-phosphate Dehydrogenase (G6PHD) Activity in Lethal Yellow (Ay/Aw) and White-bellied Agouti (Aw/Aw) Mice (strain 129/Sv) by Staber, Lisa DeEtte
South Dakota State University 
Open PRAIRIE: Open Public Research Access Institutional 
Repository and Information Exchange 
Electronic Theses and Dissertations 
1984 
Effects of Dietary Dehydroepiandrosterone (DHEA) on Body 
Weight, Food Consumption, and Glucose-6-phosphate 
Dehydrogenase (G6PHD) Activity in Lethal Yellow (Ay/Aw) and 
White-bellied Agouti (Aw/Aw) Mice (strain 129/Sv) 
Lisa DeEtte Staber 
Follow this and additional works at: https://openprairie.sdstate.edu/etd 
Recommended Citation 
Staber, Lisa DeEtte, "Effects of Dietary Dehydroepiandrosterone (DHEA) on Body Weight, Food 
Consumption, and Glucose-6-phosphate Dehydrogenase (G6PHD) Activity in Lethal Yellow (Ay/Aw) and 
White-bellied Agouti (Aw/Aw) Mice (strain 129/Sv)" (1984). Electronic Theses and Dissertations. 4237. 
https://openprairie.sdstate.edu/etd/4237 
This Thesis - Open Access is brought to you for free and open access by Open PRAIRIE: Open Public Research 
Access Institutional Repository and Information Exchange. It has been accepted for inclusion in Electronic Theses 
and Dissertations by an authorized administrator of Open PRAIRIE: Open Public Research Access Institutional 
Repository and Information Exchange. For more information, please contact michael.biondo@sdstate.edu. 
EFFECTS OF DIETARY DEHYDROEPIANDROSTERONE ( DHEA) 
ON BODY WEIGHT , FOOD CONSUMPTION , AND 
GLUCOSE-6-PHOSPHATE DEHYDROGENASE (G6PDH) 
ACTIVITY IN LETHAL YELLOW (AY/AW) AND WHITE-BELLIED 
AGOUTI ( AW/AW)  MICE ( STRAI N 129/ Sv ) 
by 
Lisa DeEtte S taber  
A thesis submi tted 
in part ial fulfi llment of the requirements for the 
degree Mas ter of Science , Major in 
Bio logy , South Dakota 
S tate Uni versi ty 
1984 
SOUTH y 
EFFECTS OF DIET ARY DE HYDROEPI ANDROSTERONE ( D HEA) 
ON BODY WEIG HT ,  FOOD CONSUMPTION , AND 
GLUCOSE-6-P HOSP HATE DE HYDROGENASE (G6PD H) 
ACTIVIT Y IN LET HAL YELLOW (AY/AW ) AND WHITE-BELLIED 
AGOUTI (AW/AW) HICE ( STRAIN 129/ S v) 
This thesis  is appro ved as a creditable and independent 
in vestigation by a candidate for the degree , Mas ter of Science , and is 
acceptable for meet ing the thesis  requirement s for thi s  degree . 
Acceptance of this thesis  does  not imply that the conclusi ons reached 
by the candidate are neces sarily the conclusions of the ma jor 
department . 
Thesis Ad viser Date 
Hea d, Bi�ogy Dep ��ent 
--l Date 
ACKNOWLEDGEMENTS 
These  past  three years of graduate school have been the mos t dif­
ficult time of my life -- without the support and encouragement of the 
following people I would not have finished and writ ten this thesis : 
Dr . Gerald Cizadlo , my undergraduate advisor at the College of 
S t . Scho las t ica , who gave me my first  tas te of biologica l 
resea rc h  and encouraging me to pursue graduate study at 
South Dakota S tate University . 
Dr . Nels G ra nholm, who advised and guided me through my graduate 
wor k. His financial support , knowledge , patience , and 
cheerfulness  were admirable and highly app reciated .  
D r .  Ernes t Hugghins , Dr . Peter Wil kin , and all the faculty , 
s taf f , and students in South Da kota S tate ' s  Biology 
Department , who ins t ructed , guided , supported me, and 
allowed me to gain teaching experience in the general 
bio logy and mammalian physiology laboratories . 
Dr . w. Lee Tucker , who statist ically analyz ed my data and had 
the pat ience to explain the results of thes e  analyses ; 
Dr . Hazel Shave , who allowed me to use the Coulter 
Counter and Hemoglobinometer and associated supplies in her 
Veterinary Science laboratory ; Dr . Ivan Palmer , who helped 
me wi th the use of t he Beckman D U  and le t me use it and 
the S ta tion B iochemis try laboratory in which it res ides . 
Kim w. Jeppeson , who did the photography , which can be seen 
within , and his help in the care of my mouse colony . 
Betty Pet it jean , Dr . Richard Luther , and all other faculty , staff , 
and students who worked in the Animal and Range S cience and 
S tat ion Biochemis t ry facilities in which I did  my res earch , 
who a llowed me to " invade " their space and helped me when I 
needed  assis tance . 
My fellow g raduate students and friends at SDSU , Mary Norri s, 
John Shultz ,  Kris Sletten , Diane Roggenbuc k ,  and numerous 
others , who lived with my inadequacies , moodines s ,  and 
problems , and still remained my friends . 
My other friends and family , who loved me and cared about me when 
I had li t t le time to do so for them. 
My mother , Avis  Palmer S taber , the one most important inf lue nce 
on my life  and wor k, who was my be s t  friend and guide . 
Her love and generosity are boundless . 
ABSTRACT 
Dehydroepiandrosterone (DHEA) is a non-competitive inhibitor in 
vitro of glucose-6-p hosphate dehydrogenase (G6PDH), the rate­
controlling enzyme in the pentose-p hosp hate shu nt. This pathway produ­
ces NADPH, a necessary co-factor for the synthesis of fatty acids and 
ribo- and deoxyribonucleotides. Some researchers believe that by 
decreasing G6PDH activity, DHEA prod uces an anti-obesity and anti­
carcinogenic effect in laboratory mice and rats genetically inclined 
toward obesity and cancer. It is DHEA's anti-obesity effect which 
lends it to the study of the yellow obese (AY/-) mouse with its pecu­
liar pleiotropic syndrome. 
Yellow obese AY/AW mice were found to be roore susceptible to 
dietary DHEA's effects than their agouti (AW/AW) littermates. They 
lost significantly more weight while consuming the same or greater 
amounts of food (P<0.01), their urinary output seemed to increase, and 
their G6PDH activities (U/1012 RBC) (P < 0.05) were significantly 
higher. G6PDH activity in red blood cell lysates at 340 nm also 
increased significantly (P < 0.01) in both mouse genotypes as the per­
cent of DHEA in the mouse chow increased. This increase in activity 
may be a compensatory effect in response to DHEA's actio n. However, 
this explanation neither explains the obser ved anti-obesity effects nor 
the differe ntial effects in G6 PDH activity between AY/AW a nd 
AW/AW littermates. 
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INTRODUCTION 
This research centered on the physiological and metabolic ef fects 
that the steroid dehydroepiandrosterone ( DHEA) has on the lethal yellow 
( AY/AW) mouse . The � allele is a genet ic mutation which is of par­
ticular intere s t  because of the multiple ef fects it produces in hetero­
zygotes ( AY/- ) . Homozygotes ( AY/AY) never  survive longer than the 
sixth day of ges tat ion ( Eaton and Green , 1 96 2 ) . Yellow heterozygotes 
display a yellow coat color , stimulation of normal body growth , obe­
sity , operat ion of unusual metabolic pathways ( i . e .  g reater  ef ficiency 
in the conversion of food to fat ) ,  sterility , d iabetes-like syndrome , 
and increas ed cancer susceptibility ( Silvers , 1 979 ) .  The obesity and 
the operation of unusual metabolic pathways were investigated in this 
research . 
Before discussing this research , however ,  it seems worthwhile to 
provide a general review of the available literature on the lethal 
yellow genotypic and phenotypic characteri stics , along with the 
research performed to dis cover reasons for these characteris tics , and 
suggest ions for future research int o  the � phenomenon . Following this 
dis cussion is a literature review pertaining specifically to my 
research and a discussion of the research itself , which included two 
separate experiments designed to tes t  the hypotheses that DHEA affects  
yellow obese  mice differently than their lean agouti li ttermates , and 
that defects in glucose-6-phosphate dehydrogenase metabolism may be 
responsible for one or more of the phenotypic abnormalities  observed in 
mice heterozygous for the lethal yellow gene ( AY/- ) .  
LITERATURE REVIEW 
There are 50 genet ic loc i  which inf luence the synthesis of mela­
nin in mice and there are over 1 30 different coat color mutations for 
.which they code . But , of these  loci , only two control  the "nature " of 
the pigment formed : the agouti and extension series of alle les . The 
agouti , or A ,  locus provides an extremely interesting model  for the 
cont rol of eumelanin ( black or brown pigment ) and phaeomelanin (yellow 
pigment ) synthesis . This complex locus , which is fo und on chromosome 2 
at linkage gro up V ,  acts  via the hair follicle . The individual  hairs 
of agouti animals are banded as the result of a swit ch from the synthe­
sis of phaeomela nin to eumelanin which occurs concurrent ly in every 
hair during the growth cycle . Non-agouti mutants , the number of which 
exceeds that recorded for any other locus concerned with the synthes is 
of melanin,  do not go through this cyclical switch in pigment synthe­
sis . Ins tead they create , in the simplest  genetic variat ions , solid 
brown , black , or yellow hairs . 
One of these  non-agouti mutants , the lethal yellow, or AY alle le 
represent s the dominant allele of the agouti series . It does not 
matter with which of the series � is heterozygous , the phenotype is 
either a ri ch yellow or orange color or , on some genetic  backgrounds , a 
" sooty yellow" or "sable " color . This allele ,  which represents an old 
mutant of the mouse fancy , was described as early as 1 883  by Lataste 
and in 1 905 by Cuenot . It was Cuenot who firs t recognized the fact 
that yellow mice are heterozygous for the dominant yellow allele and 
that the homozygote is le thal ( see also Cas t le and Lit t le ,  1 9 1 0 ;  Ibsen 
' 
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and S teigleder ,  1 9 1 7 ) . He came to this conclusion af ter observing that 
yellow mice never  bred  true -- they had both black and yellow progeny 
-- and these progeny had a 2 : 1  phenotypic ratio rather than the pre­
dicted heterozygous cross .3 : 1  rat io . 
However , while Cuenot believed that an AY-bearing egg could not 
be fertilized by an AY-bearing sperm to create AY/AY zygotes , this is 
not the case . jl/AY embryos are formed but disp lay characteris tic 
abnormalit ies at the mo rula or blastocyst stage ( Kirkham, 1 9 1 9 ; 
Robertson ,  1 942a ;  Brock and Granholm , 1 979 ; Cizadlo and Granholm , 1 9 78 ; 
Johnson and Granholm, 1 978 ) and die early on the sixth day of ges tat ion 
after the trophectoderm of the blas tocyst  has come int o  contact with 
the uterine epithelium ,  before imp lantation is comp lete  ( Eaton and 
Green ,  1 96 2 , 1 963 ; Eat on , 1 968 ; Pedersen , 1 974 ; Calarco and Pedersen , 
1 9 76 ; Johnson and Granholm, 1 978 ; Granholm and Johnson , 1 9 78 ) . 
A variety of experimental approaches have been used  in at tempts  
to identify �/AY embryos and to determine the mechanism of  le thality .· 
These incluqe hormone treatment , embryo culture , and chimera format ion 
(Eat on ,  1 968 ; Pede rsen , 1 974 ; Pedersen and Spindle , 1 9 76 , 1 98 1 ; Kelly , 
et  al . , 1 978 ; Granholm and Johnson , 1 978 ; Johnson and Granholm , 1 978 ; 
Papaioannou and Gardner , 1 976 , 1 979 ) . In general these  res earchers 
were able to conclude that morphological abnormalities are not adequate 
for ident ifying individual �/AY embryos . Howeve r, studies  by 
Papaiouannou and Gardner ( 1 976 , 1 979 ) suggest  that AY may be act ing 
different ially on trophectoderm cells of the early embryo . In 
cont ras t ,  data of Cizadlo and Granholm ( 1 978 ) and Granholm and S tevens 
( unpublished)  indicate that inner cell mass cells may in fact .be the 
primary target of AY exp ression in the blastocyst · 
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Although according to Eaton and Green ( 1 96 3 )  death is due to a 
lag in different iation of the trophoblast giant cells , preventing the 
normal interaction between embryo and endomet rium neces sary for suc­
cessful implantation ,  the primary lesion responsible for this fai lure 
of giant cells to different iate from the trophectoderm is not known . 
One sugges tion i s  faulty ce ll-to-cell  communication and int eraction in 
the trophectoderm, due to aberrant protein glycosylations in the cells 
(Holstein , et al . , 1 97 3 ) . 
Robertson ( 1 942b )  did provide some evidence that there may be 
some maternal influence on the development of .£.._ homozygotes . He 
demons t rated that AY/AY embryos which develop in a non-yellow mother ,  a 
feat . accomplished by mating a / �  females bearing AY/ � ovarian isografts 
with��  ma les , proceed to a somewhat more advanced  stage of  imp lan­
tation ,  attaining about twice the numbe r of cells , than AY homozygotes 
which develop in yellow mothers . This maternal inf luence may hold for 
_AY heterozygotes as well  (Wolff and Bartke , 1 966 ) . 
The� allele is not only of interes t because it causes a non­
agouti yellow coat color in heterozygotes and embryological abnor­
malit ies in homozygotes , but also because of its other multiple effects 
on mice heterozygous for the le thal yellow mutat ion . These  mice exhi­
bit a stimulat ion of normal body growth ( Danforth , 1 92 7 ; Cas t le , 1 94 1 ; 
and Heston and Vlahakis , 1 96 la ) ; obesity ( Cuenot , 1 905 ; Car penter and 
Mayer , 1 958 ) ; operat ion of unusual metabolic pathways ( Dickerson and 
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Gowen, 1 946 , 1 947 ; Gruneberg , 1 952 ) ; s terility ( M. c. Green , 1 96 6a ) ; a 
diabetes-like syndrome ( Hummel , et al . ,  1 9 72 ) ; increased cancer sus cep­
t ibility to both spontaneous and induced tumors ( Hes ton , 1 94 2 ; Hes ton 
and Deringer , 1 94 7 ; Hes ton and Vlahakis , 1 96 1a ,  Vlahakis and Hes ton , 
1 963 ; Deringer ,  1 970 ) ; inability of yellow males to induce es trous 
synchrony in females ( Wolff and Bartke , 1 966 ) ;  aberrant patterns of 
lipid and carbohydrate metabolism (Carpenter and Mayer , 1 958 ) ;  tem­
perature regulation problems ( Cizadlo , et al . ,  1 9 7 7 ) ;  and increased 
·breathing frequency ( Cizadlo , 1 97 6 ) . 
The fact that all of these pleiotropic effects are unique to 
AY , or  to animals of yellow genotypes , i . e . , these  ef fect s  are not 
ass ociated with any of the "non-yellow" agouti series alleles , is 
undoubtedly · significant both in terms of the structure of the agouti 
locus and it s mode of action . Indeed , the observation that � differs 
in so many ways from the other members of the series led S i r  Ronald 
Fisher to suggest  that it may represent a deletion covering more than · 
one locus ( Wallace , 1 954 ) .  
If .£ i s  a deletion ,  it could be possible to "rescue " lethal 
yellow homozygotes from early embryonic death or "cure " het erozygotes 
of their  defects by translocat ing a piece of ·another  chromosome into 
this deleted area , such as that done in Salome Glueksohn-Waelsch ' s  
experiment s with albino lethal homozygous mice a rid Cattanach ' s  flecked 
trans locat ion (1 979 ) .  Three reciprocal trans locat ions , T (1 ; 2 ) 5Ca , 
T (2 ; 8 ) 26H , and T (2 ; 1 1 ) 3 0H ,  have genetic breakpoints at or very close to 
the � locus (Searle et al ., 1 9 79 ) , and could be used in translocation-
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rescue experiments by breeding mice with these  trans locat ions to yellow 
mice . The basic  problem preventing such experimentation is the fact  
that the primary metabolic les ion caused by the probable AY dele t ion , 
and which , in tu rn, ca uses the yellow mouse ' s  numero us unique traits , 
is  unknown. Only after this lesion is fo und , either as a mis s ing 
s tructural  gene product or a deleted regulatory gene product necessary 
for cont rol of such a structural product , will scient ists  be able to 
tell if their  manipulations with the AY mutation are act ually changing 
the primary defect altering the yellow mo use ' s  metabolism. 
Many res earchers  have now turned to the endocrine glands and 
thei r hormonal product s  for the answer to the � les ion problem because 
of documentat ion of many endocrine dis turbances in the AY/- mouse . For 
example , Wolff ( 1 9 7 1 )  noted that serum insulin concent rat ion and body 
weight is greater in mott led  yellow (�/a ) mice than in their  black 
(a/a )  s iblings , while agouti (Avy /a ) mice paralle l black (!_/ �) mice in 
these characteristics . These  observations sugges t  that hair  color , as 
determined �y the agouti locus alleles , vis ibly expresses the metabolic 
condition of the mo use . Although Wolff ( 1 97 1 )  suggests  the ago ut i  
locus may alter the concent rat ion of a metabolic reg ulatory entity cru­
cial to many metabolic  pathways through mutat ion , he made no specula ­
t ion on the precise nature of this regulatory factor . 
A number of obese mice , including obese hyp -erglycemic and N ew 
Zealand obese mice , possess  an increased vo lume of pancreat ic is lets  
and an elevated blood sugar level . In an attempt to  elucidate the 
endocrine .pancreat ic funct ion in connection with the observed obes ity , 
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Hellerstrom and Hellman ( 1 963 )  compared the is lets  of Langerha ns in 
yellow obese mice with their  grey and lean lit termates . The blood 
sugar level of the yellow mice was more than twice that of their  lean 
lit termates . One hundred percent increase in total is let vo lume in the 
yellows , including considerable capillary dilatat ion with de granulation 
and increased nuclear size , was found and thought to be caused by 
hyperplas ia of the beta cell system. The values which indicated that 
hyperplas tic  is let tis sue volume was nearly doubled in the yellow obese  
mice were co mp·arable to those  previous ly found for  normal mice with 
obesity induced by goldthioglucose , ref lecting the adaptat ion of the 
beta cells to increased insulin demands . 
An earlier study was done on the is lets of yellow obese  mice 
which demonstrated is le t  hypertrophy ( Silberberg and S ilberberg , 1 957 ) .  
Interestingly , thes e  authors noted regress!  ve changes in the neurons of 
the thalamus , hypothalamus ,  and cerebellum, which led them to consider 
a hypothalamic dysfunctio n  as a probable cause of obesity . However , a 
regulat .ory obesity , characterized by an impairment of the hypothalamic 
" satiety center , "  has been ruled out by researchers since then ( Zomzely 
and Mayer , 1 959 ; Carpenter  and Mayer , 1 958 ;  Mayer , 1 960 ; Bray and York , 
1 9 79 ) . 
The occurrence of enlarged pancreat ic is lets  with considerable 
subcapsular adrenocortical hypertrophy was reported by Haus be rger and 
Hausberger ( 1 960 )  who also  stated that adrenalectomy can prevent all of 
these problems . In regard to the etiologic mechanism of obesity in 
yellow mi c.e ,  Haus berger  and Hausberger sugges ted oversecre t ion of the 
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adrenal cortex (hyperadrenocort icism ) as  the probable cause of obesity 
and enlarged  pancreat ic is lets  due to hypertrophy and hyperplasia of 
the beta cells , sugges ting accelerated release  of ins ulin . An excess  
o f  corticosteroids , such as the glucocorticoid cortisone , cannot , 
however , cause obe sity directly , since administration of cor­
ticos teroids which induces adiposity in control animals , fai ls to  do so 
in mildly alloxan diabetic  animals . 
Data on yellow mice indicate a high blood glucose  level 
(Carpenter and Mayer , 1 958 ; Hellerstrom and Hellman , 1 963 ) .  Carpenter  
and Mayer also  noted  an  insulin res is tance in yello.w mice . Both yellow 
and black mice were adminis tered the same amount of insulin , yet the 
effects produced in the black cont r ols were more pronounced than in the 
yellows since four out of eleven black mice died .  Findings that 
yellows did not have normal cont rol of their  blood sugar Levels and 
demons trated insulin resis tance were att ributed to metabolic  obes ity 
since mice with goldthioglucose  or electrolytic hypot halam-ic obesity 
exhibit nor�l insulin sensitivity . Hellers trom and Hellman concluded 
tha t  is let hyperplasia was not a primary defect but was most  likely a 
response to the observed hyperglycemia of the yellow mouse . 
Kas ten (1 952 ) s tudied the his tology of the adrena l glands of 
obese yellow mice . He observed no significant differences between the 
yellow and black mice examined and , therefore , d i d  not regard 
hyperadrenocorticism as a possible cause of obesity . This hypothesis 
has been questioned by Hausbe rger and Hausbe rger ( 1 960) who compared 
the adrenals of yellow mice at all weights and reported a more pro-
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nounced subcortical hypertrophy in obese yellow mice than i n  normal 
s iblings of yellow mice . As previous ly ment ioned ,  they sugges ted 
hyperadrenocort icism as a cause of both yellow obesity and enlarged 
pancreatic  is lets  in y "ellow obese mice . However ,  thei r  study l acked a 
comparison of obese  yellows to their normal lean lit te rmates .  
Hellerstrom and Hellman ( 1 963 )  also  compared the weights  of adrenal 
glands of male yellow obese animals and grey control animals and found 
no differences between the weights .  However a study by Marshall et al . 
( 1 957 ) demonstrated  significant increases in the adrenal weights of 
older obe s e-hyperglycemic mice . Jackson et al . ( 1 976 ) reported that 
adrenalect o my  "partially reduces the fat deposited in yellow mice but 
cannot be cons idered  the primary lesion in the development of obesity 
in this part icular gene t ic obe sity . " The changes noted in the his to­
logy of the adrenal gland appear to be a result of obes ity not a cause 
of it . 
In an at temp t  to show a possible hormonal cause for the yellow 
syndro ms, W�itze  ( 1 940 ) and Wolff ( 1 963 ) placed yellow and non-yellow 
lit termates  in parabiosis . A parabiotic union is es tablished when mice 
are surgica lly united in such a way that they share a common blood 
supply , much like S iamese twins . Weitze  hypothesized that adiposity 
was caused by a hormonal disorder , because yellow mice placed in p ara­
biosis with normal mice failed to become obese . However ,  the inves tiga­
tion by Wolff cont radicted these findings , since parabiotic  union of 
yellow and non-yellow mice h ad no ef fect on the rate of weight gain of 
either partne r .  Wolff  concluded that reciprocal physiological factors 
10 
were operative and postul ated that AY altered the effect iveness of spe­
cific hormones . He fai led  to speculate on the nature of these  hormones 
but hypothesized that "changes in the relative effect ive levels  of 
several hormones in the extracellular  fluid"  may aff ect cellular meta­
bolism. To su mmariz e , the failure of most  investigators to detect con­
sistent his tological and physiological abnormalities in the adrenal 
glands of  yellow mice seems to suggest  that adrenal malfunction is  not 
a primary ca use of yellow obesity . 
Reprod uctive funct ion of yellow (�/�) mice has also  been 
reported to be impai red .  Obese  yellow females show . decreased fertility 
comp ared to non-yellow mice ( Danforth ,  1 927 ) .  Kasten ( 1 952 ) examined 
the ovaries and tes tes  of yellow and black mice and observed differen­
ces only in the ovaries of the obese  yellow females ,  including few or 
no corpora lute a, high vas cularization , and the presence of darkly 
stained cells in the s urrounding fat tis sue . Kasten pos tulated that 
obesity resulting from a hormonal dysfunction dis rupt s  normal ovarian · 
funct ion and finally causes sterility . He did not re ject the possibi­
lity of the ovary itself be ing the site of a hormonal dis turbance . 
Although the tes tes posses sed normal spermatogenic states in yellow mice , 
tes tes of very obese  mice were not examined .  
Defective gonadal funct ion of ��  mice has been reported as an 
unimportant cause of obesity by various researche .rs . Kas ten ( 1 9 52 ) 
found no ovarian anoma _lies in mildly obese yellow mice and noted that 
obesity was expressed prior to sterility . Further evidence indicating 
that disturbed gonadal funct ion is probably not an important 
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determinant of yellow obe s ity was presented by Dickie and Wool ley 
(1 946 ) who demonstrated additive ef fects  on the amount of body fat 
caused by cas t ration of gj2_ mice . As concluded by Granholm and Brock 
(1 980 ) , " data which demonstrate • • •  characteris t ics of aberrant repro­
duction in yellow mice may represent secondary consequences of the obe­
sity itself not necessarily related to one or roore primary 
E. les ion (s ) . "  This is a ma jor problem with all studies dealing with 
AY, uncertainty of whether a specific observed abnormality represents  a 
cause or an effect of the yellow mouse ' s  obesity . Granholm and Brock 
pointed  out the need for caution in defining the relat ionship between 
the lethal yellow gene and reproductive dysfunction for this  reason .  
Yellow mice clearly demonstrate a high blood glucose level 
(Carpenter and Mayer , 1 958 ; Hellerstrom and Hellman , 1 963 ) and larger 
pancreat ic is lets  (Silberberg and S i lberberg , 1 957 ; Hausbe rger and 
Hausbe rger , 1 960 ; Hellerst rom and Hellman , 1 963 ) , but the relationship 
between these  and other endocrine-related abnormaliti es is not well 
understood • . Although work done previous ly (i . e . ,  parabiosis  experi­
ments and endocrine gland his tological studies ) sugges ts a hormonal 
disorder of some type , l i ttle is known about the natu re of these  
hormone (s ) ,  or  the role they may play in contributing to  yellow 
obesity . 
Dehydroepiandrosterone ( DHEA) , a steroid synthesized and s ecreted 
by the mammalian adrenal  glands , may be a key to unde rs tanding AY 
obesity and mammalian obe sity in general . In fact ,  DHEA is  already 
being sold in health food stores as a weight-reduction drug for humans , 
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although it has only been tes ted on small laboratory animals . DHEA has 
also been touted as an alleged ant i-aging drug (Butle r ,  1 98 1 )  because 
it undergoes the mo st marked age-related decline of any known steroid 
( Schwartz  and Tannen , 1 98 1 ) . After the second decade of life ,  the 
plasma concentration of this steroid declines , reaching levels in the 
very old of about 5% o f  its maximum value ( Schwartz ,  1 979 ) . In addi-
tion , it has been found to be effective in the treatment of age-related 
diseases such as · cancer ,  diabetes , and obesity , in small laboratory 
animals , studies  to be dis cussed later . 
DHEA and its sulfated form DHEA-sulfate are ma jor  secretory pro-
ducts of the adrenals ( Henderson et al . , 1 98 1 ) ;  DHEA-sulfate , next to 
cholesterol , is the mo s t  abundant steroid in humans ( Schwartz and 
Tannen ,  1 98 1 ) .  They are androgens formed by side chain cleavage from 
cholesterol in the zona fas ciculata and zona ret icularis of the adrena l 
cortex (Ganong , 1 979 ) .  DHEA ' s  biochemical formula is 3 -hydroxy-5 
androstan-1 7-one ( Raineri and Levy , 1 9 70) , and it s structure , both 
sulfated anq non-sulfated is : 
Figure 1 :  Figure 2 :  
t 
Although DHEA-sulfate is the main precursor of placental es t rogen and 
may be converted into act ive androgens in peripheral tis sue , there is 
no obvious biological  role for either DHEA or  DHEA-sulfate in the nor-
mal individual ( Schwartz and Tannen ,  1 981 ) . 
13 
Ret rospective studies have found that women with either  advanced 
or primary operable breas t  cancer have subnormal plasma levels of DHEA 
and DHEA-sulfate ( Wang et al . ,  1 974 ) . Also , long-term treatme nt of C3H 
mice with DHEA has been
. 
shown to suppres s spontaneous breas t cancer 
development , in addition to reducing weight gain without suppres sing 
appetite ( Schwartz , 1 979 ) . Coleman et al . ( 1 983 ) have done experime nts 
with genetically diabetic  ( db/db )  and obese ( ob/ob )  mice fed 0 . 1  to  
0 . 4% DHEA in the ir diet , finding that the 0 . 4% t reatment prevented 
hyperglycemia , is le t  atrophy , and the severe diabetes as sociated with 
these inbred strains of mice . Thei r  research also  suggests  that DHEA may 
act in insulin-resis tant mutant mice and in aging normal mice to 
increase the sensit ivity to insulin • Other researchers , particularly 
Yen et al . ( 1 9 77 ) , have reported that long-term treatment of genet i­
cally obese mice , such as the viable yellow��  mice , with DHEA pre­
vented  the development of obesity without suppressing food consumptio n .  
As stated in a Coleman et al . ( 1 982 ) paper , " chronic treatment with 
DHEA has many of the effects of caloric res t riction without actually 
decreasing the amount of food eaten . "  
DHEA presumably controls wei ght gain by inhibiting lipogenesis as 
a result of inhibition of mammalian glucose-6-phosphate dehydrogenase 
(G6PDH) , according to S chwartz and Tannen ( 1 981 ) . DHEA also inhibits  
carcinogen activation by reducing the rate of DNA synthesis  due to  this 
same inhibit ion of G6PDH ( Schwartz et al . ,  1 981 ) .  Ma rks and Banks 
( 1 960 ) demonst rated that DHEA is a potent non-compet i t ive inhibitor of 
G6PDH , the · rate-contr olli ng e nzyme in the pentose-phosphate shu nt .  
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This. pathway is a major source of extramitochondrial NADPH , a neces sary 
co-factor for ce rtain biosyntheses , including the synthesis  of fat ty 
acids and ribo- and deoxyribonucleotides (Marks and Banks , 1 960 ) , see 
Figure 1 .3 ( Dagley and Nicholson , 1 970 ) . 
The firs t  reaction of the oxidative port ion of the pentose­
phosphate pathway is the enzymatic dehydrogenation of 
glucose-6-phosphate by G 6PDH t o  form 6-phospho-D-gluconate . NADP+ i s  
the electron acceptor . The first  product is D-glucono-s;-lact one-6-
phosphate , which is hydrolyz ed to the free acid by a specific  lac­
tonase . In the next step 6-phospho-D-gluconate undergoes dehydrogenat ion 
and decarboxylation by 6-phospho-D-gluconate dehydrogenase to form the 
ketopent ose D-ribulose-5-phosphate , --a reaction that generates a second 
molecule of NADPH . Ribose  phosphate  and D-ribose-5-phosphate  ketal  
isomerases then convert D-ribulose int o its aldose isomer , D-ribose-5-
phosphate , which can be used in the biosynthesis of ribonucleotide $ and 
deoxyri bonucleotides . The net result is the production of NADPH for  
reductive bi _osynthetic  reactions in the extramitochondrial cytop lasm 
and the product ion of D-ribose-5-phosphate as a precursor for 
nucleotide synthesis . The overall equation of the oxidative part of 
the pentose-phosphate shunt is writ ten ( Lehninger , 1 982 ) : 
D-glucose-6-phosphate + 2 NADP+ + 2 H2 0 --� D-ribose-5-phosphate + 
C02 + 2 NADPH + H+ 
In red blood cells the production of NADPH via the pent ose­
phosphate pathway is necessary to maintain high levels  of reduced glu­
tathione ( G SH )  in these  cells . The G SH in turn is re quired to sustain 
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the structural integrity o f  the erythrocyte by prevent ing the oxidation  
of --S H-containing proteins and the oxidat ion of  membrane lipids 
(Bobinski , 1 979 ) .  If  G6PDH or  some other enzymes of the pent ose­
phosphate pathway are defective or inact ive ( as they are in a group of 
huma n genetic  def iciency diseases ) the red blood cells of the indivi­
duals af f licted with these  diseases will tend to undergo hemolysis , the 
loss  of hemoglobin through the damaged membrane , causing severe ane­
mia . When certain drugs are inges ted , part icularly the ant i -malarial 
drug primaquine , this condition is great ly worsened for the millions of 
people in Africa and Asia who have this genet ic def iciency ( Lehninger , 
1 9 82 ) . 
As has been stated previous ly , G6PDH is the rate-cont rolling 
enzyme in the oxidat ive portion of the pentose-phosphate pathway . 
There are at leas t  two dis tinct types of regulat ion of the pentose­
phosphate pathway dehydrogenases . In liver , the concent rat ions of both 
G6PDH and 6-phospho-D-gluconate dehydrogenase ( 6PDGDH) change dras ti­
cally with the nutrit ional state of the animal . The NADP+/ NADPH rat io 
also changes under these conditions and this ratio  has been shown to 
regulate the activity of G6PDH and 6PDGDH. Thus , both induction of 
enzymes and modulat ion of enzyme act ivity at the subs t rate level may be 
important in regulating the capacity of the pentose-phosphate pathway 
dehydrogenases to produce NADP H f or biosynthet ic reactions . The com­
binat ion of alterations in enzyme synthesis and NADP+/ NADPH ratios  with 
changes in the nutritional state of the animal appear to produce 
ef fects on both dehydrogenases which insure a balance i n  the capacity 
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of each to provide reducing equivalent s to meet the changing demands of 
the ce ll ( Holten et al . ,  1 97 6 ) . 
The mechanism and specificity by which DHEA inhibits G6PDH has 
been studied extensively , although the complete scheme has not been elu­
cidated as of yet . Several steroids , in addition to DHEA , have been 
shown to be potent inhibitors of G6PDH . This  inhibition requires the 
presence of a keto-group at C- 1 7  ( for andros tanes and es t ranes ) or at 
C-20 ( for pregnanes ) .  The bes t inhibitor tes ted , 5 -androstan-1 7-one , 
contains no other subst ituents and is characteriz ed by a la rge planar 
surface ( on the side )  which appears to play the dominant role in 
binding the steroid to the enzyme ( Raineri and Levy , 1 970 ) . 
Presumably this binding occurs-through hydrophobic interactions . 
Essentially all structural  alterat ions which dis rupt the planarity of 
the ring sys tem diminish inhibition . It could be inferred , that 
although the keto  group at C- 1 7  or C-20 is  es sential for inhibit ion , it 
plays no crucial role in binding . S tudies with steroid analogs 
possessing �rious port ions of the ring system sugges t  that the ent ire 
steroid structure , with the possible exception of port ions of ring D ,  
is requi red for inhibition .  The possible presence of two types of 
steroid binding sites  on G6PDH has also been suggested (Raineri and 
Levy, 1 970 ) . 
The general picture which emerges from structural  studies is that 
inhibitory steroids are bound to a hydrophobic pocket in the enzyme 
which has the approximate dimensions of 1 5  x 8 x 6 A. One side of this  
pocket. appears to be virtually planar under optimum condit ions of 
1 8  
binding , to permit very li ttle flexibility . Insufficient information 
i s  available on the shape of the opposite side of the pocket . The fact 
that various structural  altera tions on this side of the steroi d plane 
influence . inhibit ion , howeve r ,  does support the idea that the ste roid 
is  bound in a pocket and not just  via one plane . At one end of this 
pocket , corresponding to the position of the C- 1 7- or C-20-keto group 
of the bound steroid ,  there may be located an amino acid  with a polar 
group which can donate a hydrogen for hydrogen bonding with this keto 
group . The hydrogen may also be donated by a group on one of the bound 
substrates . The tight binding of the most  inhibitory steroids may be s t  
be at t ributed to the coopera t ive hydrophobic bonding af forded by the 
ent ire condensed ring system (Raineri and Levy , 1 970 ) . 
Present research doe s  not deal with further study of these mecha­
nisms of steroid binding and inhibition of G6PDH , although it is an 
interesting and important topi c .  Rather , G6PDH a ctivity was measured 
in red blood cell lysates us ing the first  reaction in the pentose­
phosphate pat.hway catalyzed by G6PDH ( see Figure 2 ) . Since the rate of 
NADPH format ion in this reaction is proport ional to the G6PDH activity 
( production of a second mola r equivalent of NADPH by 6 PDGDH , also pre­
sent in the red blood cells used , according to the second pentose­
phosphate pathway 6PDGDH) , and this rate can be determined spectropho­
tomet rically as an increase in absorbance at 340 nm, the change in 
absorbance per minute can be used to calcula te the uni ts  of G6PDH acti­
vity per 10 1 2  red blood cells ( S igma Technical Bulletin , No . 345-UV ) .  
The ob jectives of these studies were conce rned with di s covering 
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whether  there is a dif ference in erythrocyte G6PDH activity levels bet­
ween AY/AW and �/AW mice . Also , if inhibit ion does occur af ter DHEA 
treatment , how much inhibit ion is taking place and doe s  the level of 
that inhibition vary between genotypes ? If variation does exist  
in  G6PDH activity due to  the difference in genotypes , i t  may be caused 
by the � allele . In other words , any abnormal metabolic  activity of 
G6PDH could be the result of � and may in fact be a primary les ion . 
EXPERIMENT Ill 
EFFECTS OF DIETARY DEHYDROEPIANDROSTERONE 
ON BODY WEIGHT AND FOOD CONSUMPTION IN LETHAL 
YELLOW (AY/AW) AND WHITE-BELLIED AGOUTI ( AW/� ·- -- ..._ 
MICE ( STRAIN 129/Sv)  
The objective of  this  study was to tes t the ef fects  of DHEA on 
weight gain and food consumpt ion in le thal  yellow ( �/�) and white-
bellied agouti ( AW/AW) mice of the 1 29 / Sv strain . Four  genotype-sex 
combinations (AY/AW� AW/AWd AY/AW� and AW/AW�) were subjected to _ _  , _ _  , _ _ , - -
four dietary treatments ( cont rol -- 0. 0% DHEA , 0 . 1 % ,  0 . 2 % , and 0 . 4 %  
DHEA) . Thus the experimental design employed a four-by-four factorial 
model  having sixteen individual cages with five mice per cage . The 
dependent variables of changes in weight and amounts of food consumed 
were measured weekly for 10 weeks . 
There were signi f icant differences ( ANOVA) in wei ght · changes bet-
ween yellow males and agout i  males ( P  � 0 . 0 1 ) and between yellow females 
and agouti  females ( P  < 0 . 05 ) . Despite the fact that both agoutis 
and yellows los t  wei ght , yellows los t  significant ly more weight than 
agoutis . Overall , mice tended to lose  more weight with increasing 
levels of DHEA in the diet , indicat ing a probable dosage ef fect of the 
DHEA . With regard to the amount of food consumed , analysis of variance 
revealed no significant dif ferences ( P  < 0 . 0 5 ) be tween yellows and 
agoutis of either  sex. Males consumed significant ly more food (P < 
0 . 0 1 ) than females . 
In summary , DHEA causes a significant weight los s  in yellow as 
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compared to agouti control mice . Since there were no signif icant dif­
ferences in amount of food consumed between yellow and agouti mice , it 
appears that DHEA a lters pat terns of food uti lization rather than food 
intake . Apparently the AY-induced altered metabolism in AY/AW mice is 
more sus ceptible to the effects of DHEA than that of the homozygous 
agouti (�/AW) mouse .  
INTRODUCTION 
Lopez-S and Krehl ( 1 967 ) reported that obese individuals excrete 
les s  DHEA than the non-obese , and the urinary output of DHEA increases 
during weight los s . Thes e  observations have led to the hypothesis  pro­
posed by Sonka and Gregorova , as cited by Yen et al . ( 1 977 ) ,  that DHEA 
may play a regulatory role in obesity . Abnormally high concent rations 
of DHEA may decrease lipogenesis  by lowering the availability of NADPH 
through the inhibition of G6PDH . 
Yen et al . ( 1 9 7 7 )  reported that long-term treatment of viable 
yellow obese  ( Avy (a )  mice with DHEA ( 500 mg/kg PO or 1 0  mg/kg IP )  p re­
vented the animals from becoming obese  without affecting thei r  rate of 
food consumpt ion. The purpose of this study was to tes t  whether DHEA 
has the same ef fect on the le thal  yellow (AY/Aw) mouse of the 1 2 9 / Sv 
s train . S ince obesity has long been recognized as one of the primary 
phenotypic abnormalities of the lethal  yeilow gene ( AY ) ,  it is possible 
that , if inhibition of G6PDH affects obes ity , it may also affect or 
modify the expression of other phenotypic defects caused by the lethal 
yellow gene ( i . e . yellow coat color , stimulat ion of normal body growth , 
greater efficiency in the conversion of food to fat , etc . ) .  
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In  short , the abnormal metabolic activity of  G6PDH could be one 
primary lesion caused by AY .  I f  so , then we want to treat AY/Aw mice 
with DHEA and as ses s  the ef fects of this  treatment on traits  known to 
be classical  phenotypic  abnormalities of AY .  Prevention or signif icant 
modification of these  traits  would provide support for our hypothesis . 
MATERIALS AND METHODS 
DHEA was thoroughly mixed with ground mouse chow at four con­
cent rations , 0 . 0 ,  0 . 1 , 0 . 2 ,  and 0 . 4% . Glass dis t illed water  and 
molasses were then added to these  mixtures ( 60 ml . molasses and 400 ml . 
water per every 500 g .  meal mixture ) and patties  were formed and dried 
in an oven at sooc . 
These  pat t ies were then fed to four groups of mice , lethal yellow 
(AY/AW} males , white bellied agouti ( AW/AW) males , AY/AW females and 
AW/AW females . All these  mice were age-matched , inbred li t termates 
between 2 1  and 72 days of age at the beginning of the experiment . A 
cage of five mice from each group was placed in each of the following 
set s : one set of four cages  given 0 . 0% DHEA in their  food , one se t 
given 0 . 1 %  DHEA , one given 0 . 2% DHEA , and one given 0 . 4% DHEA. The 
weight of each mouse  was measured each week , as well  as the wei ght of 
the food consumed in each cage for 10 weeks . 
The main effects  between the genotype-sex compinat ions 1 and 2 
(AY/AW males and AW/AW males ) and between genotype-sex combinations 3 -
and 4 ( AY/AW females and AW/AW females ) were analyzed using leas t 
signif icant differences computations on the weight data collected 
during the ten-week period ( See Tables 1 and 2 ,  p .  2 6 ) . The 
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leas t squares means for that analysis are shown in Tables 3 and 4 ,  PP • 
27 and 29 . The data from which these  leas t  squares means were calcu­
lated can be found in Appendix Tables 1-5 , PP •  1 47- 15 1 . 
I t  should be noted from a review of these appendix tables that 
this experiment ' s  analysis  was hampered by the facts  that there were 
fewer mice in the 0 . 2% DHEA t reatment group than in the other groups and 
that several of the 0 . 4%  DHEA-fed mice died before the end of the ten­
week experimental period . Also , the weights of the 0 . 2 % and 0 .4 %  DHEA 
groups were not measured during the tenth week . All of the s e  problems 
increased the error in the analysis of variance . 
RE SULTS AND DISCUSSION 
Significant weight differences were found between AY/AW males and 
AW/AW males ( P  4.. 0 . 0 1 ) and between AY/AW females and AW/AW f emales ( P L  - - . 
0 . 05 ) . In other words , the AY/AW males los t  significant ly more weight 
than the AW/AW males , and the AY/AW females los t  significant ly more 
weight than the AW/AW females ( Tables 1 and 3 , PP • 2 6  and 27 ) .  
In order to view the genotype-t reatment interactions graphically , 
we plotted the weight least squares means versus the treatment levels  
(Figure 4 ,  p .  2 8 ) . The females of  both genotypes were affected simi-
larly , both losing weight in the same general pattern , but with the 
�/AW' s los ing singificant ly more . The same is true of the males . 
Genotype-sex combinations 1 and 2 did not interact with treatment level . 
Similarly , there was no interaction between genotype-sex combinat ions 3 
and 4 with treatment level . However , there was a significant interac-
tion when comparing combinat ions 1 and 2 with combinat ions 3 and 4 .  
With respect to the amount of food consumed , ANOVA showed a 
s ignificant dif ference between the genotypes in food consumption , but 
that includes the dif ference between sexes as well ( Table 2 , p .  2 6 ) .  
There is no significant dif ference between genotype-sex combinat ions 1 
and 2 nor between combinations 3 and 4 in regard to the amount of food 
they consumed weekly ( Table 4 ,  p. 2 9 ) .  In short , AY/AW males and 
AW/� males consumed about the same amount of food ; the same is true 
for the AY/AW females and AW/AW females . Both groups of female mice 
ate significant ly less  food than their  male counterpart s . 
A plot of food consumption least squares means versus treatment 
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levels ( Figure 5 ,  p . 3 0 ) , shows that interactions exi s t  between both 
combinations 1 and 2 and combinations 3 and 4 ,  but no such interact ions 
exist  between combinations 1 and 2 and combinations 3 and 4 ,  substan­
tiating what was stated above . 
In summary , DHEA causes a significant weight los s  in AY/AW as 
compared to AWJAW control mice . Since there was no significant dif­
ferences in the amount of food consumed be tween the two genotypes , this 
is a food utilizat ion rather than a food intake effect . Apparent ly , 
the Ay-induced altered metabolism in AY/Aw is  more sus ceptible to the 
ef fects of DHEA than that of the homozygous AW/AW mice . 
Experiment # 1  
Table 1 .  ANOVA of  Mouse Weight Changes {g. )  
Degrees Sum · 
of of Mean 
Source Freedom Squares Squares F Values 
Treatment 3 66 1 . 52 220 . 5 1 54 . 85** 
Genotype 3 253 . 46 84 . 49 2 1 . 02** 
Gen. -Trt . 9 160 . 90 1 7 . 88 4 . 45** 
Residual (Error) 61 245 . 22  4 . 02 
Table 2 .  ANOVA of Average Food Consumption (g . )  
Degrees Sum 
of of Mean 
Source Freedom Squares Squares F Values 
Treatment 3 5247 . 67 1 749 . 22 30 . 1 5** 
Genotype 3 35 1 4 . 60 1 1 7 1 . 53 20 . 20** 
Gen. -Trt . {Error ) 9 522 . 1 1  58 . 0 1 
F Tabulated . OS 
2 . 7 6 
2 . 04 
F Tabulated . 05 
3 . 86 
F Tabulated . 0 1 
4 . 1 3  
2 . 7 2 
F Tabulated . 0 1 
6 . 99 
N "' 
Experiment Il l  
Table 3 .  Least  Square s Means of Mouse Weight Changes ( g . )  
No . o f  
Source Code Observations 
Treatment : 1 --o . o  
( %  DHEA) 2--0 . 1  
3--0 . 2  
4--0 . 4  
Genotype- 1--AY/�� 
Sex : 2--A!/AW� 
3--.AX./A!9-
4--.A!/� 
Treatment- 1-1  
Genotype/ 2-1 


















Least  Squares Means 
- 0. 46 
- 1 . 74 
- 3 . 03 
- 7 . 42 
- 5 . 70  
- 0 . 85 
- 3 . 22  
- 1 . 95 
- 2 . 80 
- 2 . 88 
- 7 . 28 
- 9 . 82 
4 . 08 
2 . 40 
- 2 . 1 8  
- 7 .  7 2  
0 . 1 0  
- 4 . 4 2  
- 1 . 68 
- 6 . 90 
0 . 46  
- 2 . 06 
- 0. 98 
- 5 . 24 
(g . )  
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Conf idence 
Level 0 . 05 
+ 0 . 63 
+ 0 . 63 
+ 0. 90 
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Experiment Il l 
Figure 4 .  Mouse Wei ght Changes Leas t Squares Means ( g )  Vs . Treatments 
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Experiment IF 1  
Table 4 .  Least  Squares Means of Average Food Consumption ( g . ) 
II o f  
Source Code Observations 
Treatment : 1 --0 . 0  8 
( %  DHEA) 2--0 . 1  
3--0 . 2  
4--0 . 4  
Genotype- 1--� � � 
Sex : 2--AW/AW� 
3--AY/AW9 
4--AW/AW� 
Treatment- · 1 - 1  
Genotype/ 2- 1 
















Average Food Consumpt ion Confidence 
Least  Squares Means (g . ) Level 0 . 05 
126 . 8 2  + 6 . 09 
1 1 9 . 86 
90 . 70 
84 . 7 2 
124 . 39 
1 15 . 4 4  
88 . 92 
93 . 34 
140 . 67 
149 . 26 
1 10 . 4 2  
97 . 2 2  
14 1 . 45 
130 . 1 7 
103 . 39 
86 . 7 7  
1 13 . 9 1 
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74 . 99 
70 . 80 
1 1 1 . 24 
104 . 05 
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84 . 07 
+ 6 . 09 
+ 8 . 6 1  
30 
Experiment Il l  













































Treatments ( %  DHEA) . ( Treatment-Genotype Interaction 
P <O . Ol ) . 
50 �------------------------------------. 0 . 0 0 . 1 0 . 2 0 . 4  
Treatments ( %  DHEA) 
EXPERIMENT 11 2 
EFFECTS OF DIETARY DEHYDROEPIANDROSTERONE 
ON GLUCOSE-6-PHOSPHATE DEHYDROGENASE ACTIVITY , 
BODY WEIGHT , AND FOOD CONSUMPTION IN LETHAL YELLOW 
( AY / AW) AND WHITE-BELLIED AGOUTI ( AW /_A
w) MI CE 
( STRAIN 129/ Sv)  
SUMMARY 
Dehydroepiandrosterone ( DHEA) , an adrenal androgen , reduces 
weight gain and tumor de velopment in genetically obese labo ratory mice 
without suppressing appetite . The objective of the following experiment 
was to tes t  the hypothesis that DHEA prevents weight gain in obese  
·-
yellow mice by decreasing the activity of the enzyme glucose-6-
phosphate dehydrogenase ( G6PDH) , the rate-limiting enzyme of the 
pentose-phosphate pathway . 
Four genotype-sex combinations of agouti  and yellow mice ( AW/Aw� , 
AY/AW� , AW/AWo, and AY/AW�) at two separate ages ( adults  and young 
adults ) were subjected to four dietary treatments ( 0 . 0 ,  0 . 1 , 0 . 2 ,  and 
0 . 4% DHEA) f or a ten-week period . Body weight changes and food con-
sumption were measured weekly , while G6PDH activity in red blood cell 
lysates  was determined before , during , and following DHEA t reatment . 
The first study revealed significant differences ( ANOVA; P� 
0 . 0 1 ) in G6PDH activity be tween treatments ( activity increased as 
levels of DHEA increased ) and between males and females ( males showed 
higher act ivit ies ) .  Results from a second study showed significant 
differences ( P < 0 . 05 )  between treatments ( 0 . 2  and - 0 . 4 %  were highes t ) , 
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sex (males were highe r ) , and genotype (�/Aw mice had higher G6PDH 
activit ies  than �w;Aw mice ) . In addit ion , the fact that DHEA reduces 
weight gain was confirmed ; yellow males and females  los t  signif icant ly 
more weight than agouti males  and females ( P  � 0 . 0 1 ) a s  DHEA treatment 
levels increased.  With regard to amount of food consumed , analysis of 
variance did reveal  signif icant dif ferences ( P  , 0 . 0 1 ) ;  AY/AW mice ate 
more food than AWfAW mice , except at the 0 . 4 %  leve l ,  where there were 
no significant dif ferences in food consumption . 
These data sugges t  that dietary DHEA has an effect  on G6PDH acti­
vity . Surprisingly , however ,  increased DHEA levels promoted rather 
than inhibited G6PDH activity .  In addit ion , DHEA had a differential 
effect on le thal  yellow (AY /AW) as  compared to white-bellied agouti 
(AW/AW) genotypes . The AY-induced altered metabolism of AY/AW mice is 
apparent ly more sus ceptible to the ef fects  of DHEA than the normal 
metabolism of AW/AW mice . 
INTRODUCTION 
To explain the anti-obesity effects of DHEA it has been suggested 
that DHEA acts through inhibition of G 6PDH and affects  obesity via the 
subsequent loss  of NADPH f or fat ty acid biosynthesis  ( Schwartz  and 
Tannen ,  1 98 1 ) .  Coleman et al . ( 1 983 ) , on the other hand , found that 
DHEA fed at 0 . 4%  t o  genetically diabe t ic ( db/db )  o r  _obese ( ob /ob ) 
C57BL/KsJ ( BL/Ks ) o r  C5 7 BL/6J ( BL/6 )  mice , while effective as an ant i­
hyperglycemic and an ant i-obesi ty agent , fai led to inhibit G 6PDH . In 
fact , Coleman has concluded that "ef fect ive doses of ( dietary ) DHEA 
with respect to ei ther  diabe tes or obes ity cause no significant change 
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in G6PDH , whereas injected doses sufficient to inhibit G 6PDH have no 
effect on eithe r  diabetes or obesity " (Coleman , 1 984 ) • 
The two studies presented here were performed to tes t  these  
co·nclusions about the action of  DHEA and it s inf luence on G6PDH acti-
vity in red blood cell  lysates using a standard spectrophotometric 
determination .  AY/AW and AW/AW male and female mice of the 1 29 / Sv - - - -
s t rain were fed 0 . 0 ,  0 . 1 , 0 . 2 ,  and 0 . 4%  DHEA diets ; body wei ght change 
and food consumption were measured  weekly ; G6PDH activi ty in erythrocy-
tes was determined be f ore , during , and following the experimental study 
period . 
.-- · . 
MATERIALS AND METHODS 
Study 1 
Four mouse genotype-sex combinations ( AW/AW� , AY/AW� , AW/AW�, and 
AY I AW�) at  two separate  ages ( > 60- and < 60-day-olds -- desi gnated as 
adults and young adults , respectively ) were subjected to four dietary 
treatments . ( O . O ,  0 . 1 , 0 . 2 ,  and 0 . 4%  DHEA) f or a ten-week period . For 
each age group at each treatment level there were four individual cages 
with five mice all of the same genotype and sex in each cage . 
Therefore , there were a total of 1 60 mice used in this study . ( See  
Photographs M and N ,  p .  1 36 ,  for  the cage arrangement ) .  
All mice were wei ghed on a manually-operated basket ba lance at 
the be ginning and end of each week during the study , and the differen-
ces in wei ght from week to week and the total weight changes ·were com-
puted ( see Appendix Tables  6- 13 , pp . 1 52- 159 ) .  The food was also 
weighed on the same ba lance at the beginning and end of each week in 
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paper basket s ( see Phot ograph 0 ,  P• 1 3 7 ) . Food consumption was then 
taken to be the differences in food weight measured each week . These 
food consumpt ion weights and the average food consumption for  each cage 
of five mice is found in Appendix Table 1 4 ,  PP • 1 60 and 1 6 1 . Mouse 
diets were commercially prepared by Bioserve , Inc . o f  Frenchtown , New 
Jersey . Diets  consisted  of pellets  made of Purina Mouse Breede r ' s  Chow 
( 1 1 %  fat ) , DHEA at  the specific  concentrat ions , and aca cia , a gum used 
to adhere the ingredients togethe r .  
Bef ore , during , and following the treatment period , blood was 
drawn from each mouse and as say�d spectrophotometrically to determine 
G6PDH activity in red blood cell lysates at 340 nm, sli t width 0 . 6 , on 
0 
a Beckman DU at app roximately 2 6  C ( Si�a Bulletin ,  No . 345  UV ) . Blood 
was obtained from the ret ro-orbital sinus of each mouse without 
anes thesia , us ing sterile , heparinized micropipets as collection tube s  
(Riley , 1 96 0 ) . The change in absorbance over a five-minute period 
caused by the rate  of NADPH f ormation ( see p .  1 8  for an explanation of 
the chemical reactions involved in this  as say , and Photographs R-U , 
PP • 1 38- 1 39 , for the procedure ) ,  plus the red blood cell  count of the 
blood samples taken with an electronic Coulter counter ,  were used  to 
determine the unit  act ivity of G6PD� using the following calculat ions 
( S igma Bulletin ,  No . 345  UV) : 
G6PDH ( U/ 1 0 1 2  RBC ) = A/min . X 3 . 0 1 x · 1 o 1 2  X TCF 
0 . 0 1  X 6 . 2 2  X N X 1 06 X 1 000 
• A/min . x 48390 x TCF 
N 
Where : 3 . 0 1  = Total volume ( mL )  in cuvet 
1 0 1 2 • Factor for express ing activity in 1 0 1 2 cells 
0 . 0 1  • Volume ( mL) of  sample in cuvet 
6 . 2 2  • Millimolar absorptivity of NADPH 
. N x 1 06 • Number of erythrocytes/mm3 
1 000 • Conversion of red cell  count from count per 
mm3 to count per mL 
factor ( 1 . 28 at 26 o C )  TCF • Temperature correction 
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The initial and final absorbance readings , the changes in absor-
bance during a five-minute  period , red blood cell count s , and ca lcu-
lated G6PDH activitie s/ 10 1 2  RBC for S tudy 1 are presented in Appendix 
Tables 1 5-22 , pp . 1 62-1 7 7 . 
S tudy 2 
Thi s  study was ca rried out in the same manner as S tudy 1 except 
for the following changes : 
The mice classified  as adults were 90-days-old and the young 
adults were 90-days-old . 1 92 mice were used in S tudy 2 ,  six mice in 
each genotype-sex group , at each age , on each DHEA t reatment level . 
There were two mice in each cage , so that three replications could be 
compared in the stat istical  analysis . ( See Appendix Tables 23-30 , 
PP • 1 78- 184 , for S tudy 2 mouse weight data , and Appendix Table 3 1 , 
PP • 1 85- 188 , for S tudy 2 food consumption data ) . 
In addition to mouse and food weights , bedding wei ghts were also  
obtained in  S tudy 2 ( Appendix Table 32 , pp . 1 89- 1 9 2 )  at equal intervals 
three times during the ten-week experimental period (see  Photographs p 
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and Q , P •  1 37 ) .  Bedding was weighed in order to detect differences in 
was te amount as DHEA t reatment levels varied , but , because water intake 
was not measured and varying amounts of the food pellets  were was ted 
rather than consumed ,  these  weight measurements  were not accurate 
enough to yield quant itatively reliable data . Therefore , this part of 
Study 2 was primari ly observat ional . 
During the G6PDH determination proces s  hemoglobin concent rations 
were measured electronically using a Coulter hemoglobinometer at the 
same time that the red blood cell counts were taken ( see Photographs 
V-Z , pp . 1 3 9- 1 40 )  s o  that G6PDH activity could be calculated as a func­
tion of both 1 0 1 2  RBC and grams hemoglobin ( Hb ) . The hemoglobin calcu-
lat ions used are as follows ( Sigma Bulletin , No . 345 UV) : 
G6PDH ( U/ g .  Hb ) • A/min . x 1 00 x 3 . 0 1  x TCF 
. 0 . 0 1 x 6 . 22 X Hb( g/dL ) 
Where : 
• A/min . x 4839 x TCF 
Hb( g/dL )  
1 0 0  • Factor to convert activity to 100 mL 
.3 . 0 1  • Total volume ( mL) in cuvet 
0 . 0 1  • Volume ( mL )  of sample in cuvet 
6 . 2 2  • Millimolar absorptivity of NADPH 
Hb( g/ dL )  • Hemoglobin concent ration 
TCF • Temperature correction factor ( 1 . 2 8  at 26 ° C ) 
The init ial  and final absorbance readings ,  the . changes in absor­
bance during a five-minute period , red blood cell count s ,  hemoglobin 
concentrat ions ,  and G6PDH activit ies / 1 0 12 RBC and g. Hb are present in 
Appendix Tables 3 3-40 , pp . 1 93-2 1 6 . 
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RESULTS 
The total weight change , average food consumption , average 
bedding weights , and all G6PDH activities for both studies were sta­
tistically analyzed by computer .  Least  squares means ( "minimum sum of 
squares " ) , which are the deviations from the means squared and summed , 
were calculated for each parameter at each genotype , sex ,  treatment , 
and age level , _ and for analysis of these factors in combination to 
detect signif icant interactions . Analysis of variance was then per­
formed on these least  squares means , and significant differences at 
0 . 0 1  and 0 . 05 levels were designated .  These analyses of variance and 
all least  squares means - are lis ted in tables found within the Results  
section . In  addition , confidence level values , which specify limits 
within which each leas t  squares mean may deviate , were also  calculated 
and included in these tables . For ins tance , if the least  squares means 
of average food consumption for females is 45 g . �nd for males is 60 g .  
and the confidence level 0 . 05  i s  + 20 , the least squares means mus t  
differ from each other by 2 0  g .  t o  be significant ly dif ferent . In this 
case they are not ,  so food consumption for these males and females is 
not significant ly different ( the confidence levels of 4 5  and 60  g . 
overlap ) . 
Study 1 
Tables 1 1 , 1 2 ,  1 3 ,  and 14  on pages 60-63 provide a summary of all 
data at each of the DHEA t reatment levels . For examp le Table 1 1  lists  
the leas t  squares means of  weight changes ,  food consumption , and G6PDH 
activity for all groups at the 0 . 0% or  cont rol DHEA level . By comparing 
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paring the figures lis ted for each parameter , one can readily ident ify 
numerical  dif ferences . The confidence level figure can then be used to 
determine if thes e  numerical  dif ferences are statist ically significant 
at the P 0 . 05 level of confidence . 
MOUSE WEIGHT CHANGE (g . ) 
ANOVA Table 5 ,  P • 40 , reveals highly significant differences in 
weight change ( P  0 . 0 1 )  be twen treatment levels , age , genotypes , 
and sexes . The total weight change decreased as levels of DHEA 
increased ( Table 6 ,  p .  4 1 , Treatment Section) , young mice gained signifi­
cant ly more weight than adult mice ( Appendix Table 6 ,  P •  4 1 , Age 
Section ) , AY/AW' s  gained mo re weight than AW/AW ' s  ( Table 6 ,  p. 4 1 , 
Genotype Section ) , and males gained more weight than females ( Table 6 ,  
P • 42 , Sex S ection ) . 
Significant interactions are present between treatment and age 
(P 0 .05 ) ; treatment and genotype (P 0 .0 1 ) ;  treatment and sex (P 
0 . 0 1 ) ; genotype and sex (P 0 . 05 ) ;  treatment , genotype , and sex (P 
0 .05 ) ; and treatment , age , genotype , and sex (P 0 . 05 )  (ANOVA Table 
5 ,  P • 40 ) . Young mice gained more weight than adult mice at all treat­
ment levels , but all weight changes decreased as treatment levels 
increased ( Table 6 ,  p .  4 1 , Treatment-Age Section ) . AY/AW mice on 0 . 0% 
and 0 . 1 % DHEA gained the most weight , AW/AW and AY/AW mice on 0 . 2 %  DHEA 
gained about the same weight , and AY/AW mice on 0 . 4%  DHEA lost the most  
weight ( Table 6 ,  p .  4 1 , Treatment-Genotype Section ) . Males gained more 
than females ,  with a gradual decrease  in all weights as treatment 
levels increased ( Table 6 ,  p .  4 2 , Treatment-Sex Section ) . AY/AW males 
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gained the mos t  wei ght , AY/AW females gained the next highes t amount , 
AW/AW males were next , and AW/AW females gained the leas t { Table 6 ,  p. 4 3 , 
Genotype-Sex Section ) . Both genotypes and sexes suf fered weight losses 
as the amount of DHEA in  the diet increased , but the AY/Aw males and 
females demonstrated a dramatic  change in wei ght from level to level 
while the AW/AW males and females stayed relatively stable , except at 
the 0 . 4% DHEA t reatment level { Table 6 ,  p .  4 3 , Treatment -Genotype-Sex 
Section , and Figure 6 , P • 4 5 ) . Note that there is a greater numerical 
dif ference between AY/AW and AW/AW wei ghts at the 0 . 0% level than at 
the other DHEA levels , especially at 0 . 4% .  In both the adult and young 
mice there is a signif i cant dif ference in wei ght change between AW/AW 
and AY/AW mice of both sexes in response  to increased levels  of DHEA 
{Table 6 , PP • 4 3  and 4 4 , Treatment-Age-Genotype-Sex Sec tion and Figures 
8 and 9 , PP • 64  and 6 5 ) . Comparing young adults  and adults , a similar 
pattern of weight los s  exists for both , but young AY/AW f emales did not 
show as dra�tic a drop in weight as the adult s .  Females  of both geno­
types in both age groups demons trated the greates t response to DHEA. 
Experiment #2 : 
Table 5 .  ANOVA of Mouse Weight Changes (g. ) 
Degrees Sum 
of of Mean 
Source Freedom Squares Squares 
Treatment 3 4 1 54 . 56 1384 . 85 
Age 1 1293 . 9 1  1293 . 9 1  
Treatment-Age 3 136 . 42 45 . 47 
Genotype 1 647 . 22  647 . 22 
Treatment -Genotype 3 1505 . 22 501 . 74 
Age-Genotype 1 32 . 58 32 . 58 
Treatment -Age- 3 66 . 30 22 . 10 
Genotype 
Sex 1 308 . 02 308 . 02 
Treatment-Sex 3 209 . 94 69 . 98 
Age-Sex 1 3 . 02 3 . 02 
Treatment-Age-Sex 3 1 10 . 2 1  36 . 74 
Genotype-Sex 1 79 . 52 79 . 52 
Treatment-Genotype-Sex 3 144 . 1 7 48 . 06 
Age-Genotype-Sex 1 1 5 . 38 15 . 38 
Treatment-Age- 3 134 . 74 44 . 9 1  
Genotype-Sex 
Error 128 1790 . 72 13 . 99 
Study 1 .  
F Values 
98 . 99** 
92 . 49** 
3 . 2 5* 
46 . 26** 
35 . 86** 
2 . 33 
. 1 . 58 
22 . 02** 
5 . 00** 
0 . 22 
2�. 63 
5 . 68* 
3 . 44* 
1 . 1 0 
3 . 2 1* 
F Tabulated . 05 
2 . 68 
3 . 92 
F Tabulated . 0 1 
3 . 95 
6 . 85 
.p. 0 
4 1  
Experiment 112 :  Study 1 .  
Table 6 .  Mouse Weight Change Least Squares Means ( g . ) .  
No . o f  Weight Change Confidence 
Source Code Obse rvations Leas t  Sguares Means (g. ) Level 0 . 05 
Treatment : 1-0 . 0  40 1 1 . 56 + 1 . 1 6 
( %  DHEA) 2--0 . 1  8 . 28 
3--0 . 2  4 . 1 3  
4--0 . 4  -2 . 08 
Age : 1--Adults 80 2 . 63 + 0 . 82 
2--Young 8 . 32 
Adults 
Treatment- 1-1  20  10 . 0 1 + 1 . 64 
Age : 1 -2 13 . 1 2 
-
2- 1 4 . 78 
2-2 1 1 . 79 
3- 1 0 . 22 
3-2 8 . 03 
4- 1 -4 . 49 
4-2 0 . 33 
Genotype : 1-AWLAW 80 3 . 46 + 0 . 8 2  
2--AY/AW 7 . 48 
Treatment- 1-1  20  5 . 0 1 + 1 . 64 
Genotype : 1-2 18 . 1 2 
2- 1 5 . 36 
2-2 1 1 . 20 
3- 1 4 . 04 
3-2 4 . 2 1  
4- 1 -0 . 56 
4-2 -3 . 60 
Age- 1-1  40  1 . 07 + 1 . 1 6 
Genotype : 1-2 4 . 1 9  
2- 1 5 . 86 
2-2 10 . 78 
Treatment- 1- 1- 1  10  2 . 98 + 2 . 3 2 
Age- 1-1-2 1 7 . 04 
Genotype : 1 -2- 1 7 . 04 
1-2-2 1 9 . 20 
2- 1 - 1  2 . 1 6  
2- 1-2 7 . 39  
2--2-1  8 . 56 
2-2-2 15 . 02 
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Table 6 .  (cont inued ) 
No . of  Weight Change Confi dence 
Source Code Observa tions Least  Squares Means (g . )  Level 0 . 05 
3- 1-1  1 . 45 
3- 1-2 -1 . 00 
3-2- 1 6 . 64 
3-2-2 9 . 4 2  
4- 1-1  -2 . 3 1  
4- 1-2 -6 . 67 
4-2- 1 1 . 1 8 
4-2-2 -0 . 52 
Sex : 1� 80 4 . 09 + 0 . 82 
2d' 6 . 86 
Treatment- 1- 1  2 0  1 1 . 60 + 1 . 64 
Sex : 1-2 1 1 . 54 
-
2- 1 7 . 7 2 
2-2 8 . 84 
3- 1 1 . 47 
3-2 6 . 7 8 
4- 1 -4 . 4 4  
4-2 0 . 28 
Age-Sex : 1- 1  40 1 . 38 + 1 . 1 6 
1-2  3 . 88 
-
2- 1 6 . 7 9 
2-2 9 . 84 
Treatment- . 1- 1- 1  10  1 1 . 2 5 + 2 . 3 2  
Age-Sex : 1- 1-2 8 . 7 7 
1-2-1 1 1 . 94 
1-2-2 14 . 30 
2- 1- 1  4 . 5 0 
2-1 -2 5 . 05 
2-2-1 10 . 94 
2-2-2 12 . 64 
3- 1-1  -2 . 2 6  
3- 1-2 2 . 7 1  
3-2-1 5 . 20 
3-2-2 10 . 8 6 
4- 1-1  -7 . 9 7 
4- 1 -2 -1 . 0 1  
4-2-1 -0 . 9 1  
4-2-2 1 . 57  
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Table 6 .  ( continued ) 
No . o f  Weight Change Confidence 
Source Code Obse rvations Least  Squares Means (g . ) Level 0 . 05 
Genotype- 1-1  40  2 . 78 + 1 . 1 6 -
Sex : 1-2 4 . 1 4  
2-1 5 . 39 
2-2 9 . 58 
Treatment- 1- 1- 1  1 0  4 . 74 + 2 . 3 2 
Genotype- 1-1-2 5 . 28 
Sex : 1 -2- 1 18 . 4 5  
1 -2-2 1 7 . 79 
2-1 - 1  4 . 7 1  
2-1-2 6 . 0 1  
2-2- 1 10 . 7 3 
2-2-2 1 1 . 68 
3- 1 - 1  3 . 4 1  
3-1 -2 4 . 68 
3-2-1 -0 . 47 
3-2-2 8 . 89 
4- 1 - 1  - 1 . 74 
4- 1-2 0 . 6 1  
4-2- 1 -7 . 1 4 
4-2-2 -0 . 05 
Age- 1- 1- 1  20  0 . 22 + 1 . 64 
Genotype- 1-1-2 1 . 92  
-
Sex : 1-2- 1 2 . 54 
1-2-2 5 . 84 
2- 1- 1  5 . 34 
2-1 '-2 6 . 36 
2-2-1  8 . 24 
2-2-2 1 3 . 32 
Treatment- 1- 1- 1- 1  5 2 . 1 6 + 3 . 28 
Age- 1- 1- 1-2 3 . 80 
Genotype- 1-1-2- 1 20 . 34 
Sex : 1- 1-2-2 13 . 74 
1 -2- 1- 1  7 . 3 2  
1-2- 1-2 6 . 7 6  
1-2-2- 1 16 . 56 
1 -2-2-2 2 1 . 84 
2- 1- 1- 1  1 . 6 2  
2- 1 � 1-2 2 . 70 
2- 1-2- 1 7 . 38 
2- 1 -2-2 7 . 40 
2.:..2- 1- 1  7 . 80 
2-2- 1-2 9 . 3 2  
2-2-2- 1 14 . 08 
44 
Table 6 .  ( continued ) 
Source 
No . o f  Wei ght Change Confidence 
Code Observations Least Squares Means {g . )  Level 0 . 05 
2-2-2-2 
3- 1- 1-1 
3- 1 - 1 -2 
3- 1 -2-1 
3-1 -2-2 
3-2-1- 1  
3-2- 1 -2 
3-2-2-1 
3-2-2-2 
4- 1 - 1 - 1  
4- 1 .:;.1-2 
4- 1 -2-1  
4- 1 -2-2 




1 5 . 96 
0 . 90 
2 . 00 
-5 . 4 2  
3 . 4 2  
5 . 9 2 
7 . 36  
4 . 48 
14 . 36 
-3 . 8 2  
-0 . 80  
- 12 . 1 2  
- 1 . 22 
0 . 34 
2 . 02  
-2 . 1 6  
1 . 1 2  
+ 3 . 2 8 
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Experiment #2 : Study 1 
Figure 6 .  Mouse Wei ght Change Leas t Squares Means ( g . ) V s .  Treatment s 
( %  DHEA) . ( Treatment-Genotype-Sex Interaction -- P <O . O l ) .  
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FOOD CONSUMPTION (g . ) 
Highly significant differences ( P �  0 . 0 1 ) exist  between the food 
consumption of mice at the different treatment levels , ages , genotypes , 
and sexes ( ANOVA Table 7 ,  p .  4 8 ) . Mice on the 0 . 1 %  diets  ate the most , 
then 0 . 0% ,  then 0 . 2% ,  and 0 . 4% DHEA mice ate the leas t ( Table 8 , P •  4 9 , 
Treatment Section ) . Adults consumed more food than young adults ( Table 
8 , p .  4 9 , Age Section) and males consumed more than females ( Table 8 ,  
P •  50 , Sex Section ) . 
Only one significant interaction ( ANOVA Table 7 ,  p .  4 8 ) is  pre­
sent for food consumption in S tudy 1 ,  between treatment and genotype 
( P � 0 . 01 ) .  AY/AW mice on 0 . 1 %  DHEA diets consumed the mos t food ; at 
all treatment levels AY/AW mice ate more than AW/AW mice , but the dif­
ference is  signif icant only at the 0 . 0  and 0 . 1 %  t reatment levels ( Table 
8 , P • 49 , Treatment-Genotype Section , and Figure 7 ,  p .  5 3 ) . 
G6PDH ACTIVITY 1 0 1 2  RBC 
There are highly significant differences ( P  � 0 . 0 1 ) in the G6PDH 
activity leas t squares  means between treatment levels and sexes ( ANOVA 
Table 9 ,  P •  5 4 ) . The 0 . 4% DHEA t reatment gave the highest  activities , 
0 . 2% gave the next highest , then 0 . 1 % ,  and finally 0 . 0% gave the lowes t 
activities ( Table 10 , p .  5 5 , Treatment Section ) . Males had higher acti­
vities than females ( Table 1 0 , p .  5 6 , Sex Section ) . 
ANOVA Table 9 ,  p .  5 4 , also shows a significant interaction ( P � 
0 . 05 )  between age and sex (Table 10 , p .  56 ) with adult males having the 
highest activit ies , young males with the next highes t , young females 
next , and adult females with the lowes t activities . When such a signi-
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ficant interaction exis ts , the factors involved are not independent of 
one another ;  the simp le effects of a factor differ and the magnitude of 
any simple effect depends on the level of the other factor of the 
interaction term. Where factors interact , a single-factor experiment 
will lead to dis connected and possibly mis leading information . If the 
interaction is non-si gnificant , it is concluded that the factors under 
considerat ion act independent ly of each other ; the simple effects of a 
factor are the same for all levels of the other factors , within chance 
variat ion as measure d  by experimental error . 
DISCUSS ION 
The significant interactions found in this study indicate 
that each factor ( sex,  treatment , genotype and age ) cannot be isolated 
and examined separately in regard to each parameter measured . Sex , 
age , and genotype all affect weight gain or loss , and these  same fac­
tors determine how wei ght will change in response to dif fering levels 
of DHEA treatment . Therefore , it is impossible to analyz e the effects 
of DHEA on wei ght in female mice without also defining their  age and 
genotype , because an adult yellow female will react dif ferent ly than a 
young agouti female . 
These interact ions are more prevalent in the weight change data 
than in the G6PDH or  food consumpt ion data , indicat ing that sex ,  geno­
type ,  age , and treatment level act more independent ly of one another in 
regard to G6PDH activity and food consumpt ion than in regard to wei ght 
change . 
Experiment 112 : 
Table 7 .  ANOVA o f  Average Food Consumption (g. }  
Degrees Sum 
of of Mean 
Source Freedom Squares Squares 
Treatment 3 8253 . 50 27 5 1 . 1 6 
Age 1 5 1 30 . 34 5 1 30 . 39 
Treatment -Age 3 326 . 25 108 . 7 5  
Genotype 1 4990 . 50 4990 . 50 
Treatment-Genotype 3 2343 . 08 78 1 . 03 
Age-Genotype 1 1 1 6 . 36 1 1 6 . 36 
Treatment -Age- 3 496 . 1 9 16 5 . 40 
Genotype 
Sex 1 10906 . 1 7  10906 . 1 7 
Treatment -Sex 3 634 . 04 2 1 1 . 35 
Age-Sex 1 3 1 . 44 3 1 . 44 
Treatment-Age-Sex 3 278 . 7 7 92 . 92 
Genotype-Sex 1 8 1 . 02 8 1 . 02 
Treatment-Genotype-Sex 3 292 . 1 9  97 . 40 
Age-Genotype-Sex 1 40 . 1 4 40 . 1 4 
Treatment-Age- 3 254 . 1 0  84 . 70 
Genotype-Sex 
Error 12 977 . 68 8 1 . 47 
Study 1 .  
F Values 
33 . 7 7** 
62 . 97** 
1 . 33 
6 1 . 26** 
9 . 59** 
1 . 43  
2 . 03 
133 . 87** 
2 . 59 
0 . 38 
1 . 1 4 
0 . 99 
1 . 20 
0 . 49 
1 . 04 
F Tabulated . 05 
3 . 49 
4 . 7 5 
F Tabulated . 0 1 
5 . 95 




Experiment 112 :  Study 1 .  
Table 8 .  Average Food Consumption Leas t Squares Means ( g . ) .  
No . o f  Food Consumpt ion Confidence 
Source Code Obse rvations Least  Squares Means (g. )  Level 0 . 05 
Treatment : 1 -0 . 0  8 123 . 06 + 6 . 9 5  
( %  DHEA) 2-0 . 1 1 33 . 94 
3--0 . 2  1 1 9 . 48 
4--0 . 4  90 . 50 
Age : 1--Adults 16  129 . 4 1  + 4 . 9 2  
2--Young 104 . 08 
Adults 
Treatment- 1- 1  4 136 . 7 2  + 9 . 83 
Age : 1-2 109 . 40 
2- 1 149 . 74 
2-2 1 1 8 . 1 3 
3- 1 133 . 3 3 
3-2 105 . 62 
4- 1 97 . 83 
4-2 83 . 1 8 
Genotype : 1--AW/AW 1 6  104 . 26 + 4 . 92  
2--AY/Aw 1 2 9 . 23 
Treatment- 1- 1  4 104 . 66 + 9 . 83  
Genotype : 1-2 14 1 . 46 
-
2- 1 1 10 . 66 
2-2 1 5 7 . 22 
3- 1 1 14 . 38 
3-2 124 . 58 
4- 1 87 . 33 
4-2 93 . 67 
Age- 1-1  8 1 1 5 . 0 1  + 6 . 95  
Genotype : 1-2 143 . 80 
2-1 93 . 50 
2-2 1 14 . 66 
Treatment - 1-1-1  2 1 14 . 84 +13 . 9 1  
Age- 1- 1-2 158 . 60 
Genotype : 1 -2-1 94 . 49 
1-2-2 124 . 32 
2- 1- 1  1 1 9 . 54 
2- 1-2 1 7 9 . 9 5 
2-2-1 10 1 . 7 7  
2-2-2 134 . 49 
5 0  
Table 8 .  (cont inued ) 
No . o f  Food Consumption Conf idence 
Source Code Observations Least  Squares Means (g. ) Level 0 . 05 
3- 1 - 1  1 3 2 . 1 4 
3- 1 -2 134 . 53 
3-2-1 96 . 62 
3-2- 2  1 14 . 62 
4- 1 - 1  93 . 54 
4- 1 -2 1 0 2 . 1 2 
4-2- 1 8 1 . 1 3 
4-2- 2  85 . 2 2 
Sex : 1� 1 6  98 . 2 8 + 4. 9 2  
2� 1 3 5 . 20 
Treatment- 1 - 1  4 106 . 28 + 9 . 8 3  
Sex : 1 - 2  1 3 9 . 84 
2- 1 1 1 9 . 9 3  
2-2 147 . 94 
3- 1 93 . 60 
3-2 145 . 35 
4- 1 73 . 3 2 
4- 2 107 . 69 
Age-Sex : 1 - 1  8 109 . 9 5 + 6 . 9 5  
1 - 2  148 . 86 
2- 1 86 . 6 1  
2-2 1 2 1 . 5 5 
Treatment- 1 - 1 - 1  2 1 1 9 . 9 2 + 1 3 . 9 1  
Age-Sex : 1 - 1 -2 1 5 3 . 5 2 
1 -2-1 92 . 64 
1 - 2-2 1 2 6 . 1 6  
2- 1 - 1  1 3 9 . 0 1  
2- 1 -2 160 . 48 
2-2- 1  100 . 86 
2-2-2 1 3 5 . 40 
3- 1 - 1  104 . 86 
3- 1 - 2  1 6 1 . 80 
3-2- 1 82 . 34 
3-2-2 1 2 8 . 90 
4- 1 - 1  7 6 . 02 
4- 1 -2 1 1 9 . 64 
4- 2- 1 70 . 6 1  
4-2-2 95 . 74 
5 1  
Table 8 . (continued ) 
No . of  Food Consumption Conf idence 
Source Code Observations Least  Squares Means (g . ) Level 0 . 05 
Genotype- 1-1  8 87 . 3 9  + 6 . 9 5  
Sex : 1-2 12 1 . 1 3 
2- 1 109 . 1 8 
2-2 149 . 28 
Treatment- 1-1-1  2 87 . 00 +13 . 9 1  
Genotype- 1-1-2 122 . 3 2 
Sex : 1 -2- 1 125 . 56 
1 -2-2 15 7 . 36 
2- 1 - 1  95 . 46 
2- 1 -2 125 . 85 
2-2-1 144 . 40 
2-2-2 1 70 . 04 
3- 1 - 1  94 . 82 
3- 1-2 133 . 92 
3-2- 1 92 . 38 
3-2-2 1 56 . 78 
4- 1-1  72 . 26 
4- 1-2 102 . 40 
4-2- 1 74 . 37 
4-2-2 1 1 2 . 97 
Age- 1- 1- 1  4 96 . 03 + 9 . 8 3 
Genotype- 1-1-2 133 . 99 
Sex : 1 -2- 1 123 . 88 
1-2-2 163 . 7 2 
2- 1 - 1  78 . 74 
2- 1-2. 108 . 26 
2-2-1 94 . 48 
2-2-2 134 . 84 
Treatment- 1-1- 1- 1  1 92 . 60 +1 9 . 6 7  
Age- 1-1- 1-2 137 . 07 
Genotype- 1-1-2- 1 147 . 24 
Sex :  1- 1-2-2 169 . 9 7 
1-2- 1- 1  8 1 . 40 
1-2- 1-2 107 . 58 
1-2-2- 1 103 . 89 
1-2-2-2 144 . 7 5 
2- 1- 1- 1  106 . 98 
2- 1-1-2 132 . 1 0 
2- 1-2- 1 1 7 1 . 04 
2- 1 -2-2 188 . 86 
2-2- 1- 1  83 . 94 
2-2-1-2 1 1 9 . 60 
2-2-2- 1 1 1 7 . 7 7 
52  
Table 8 .  (cont inued ) 
Source 
No . of Food Consumpt ion Conf idence 
Code Observat ions Least  Squares Means (g . )  Level 0 . 05 
2-2-2-2 
3- 1- 1- 1  
3- 1- 1-2 
3- 1-2- 1 
3- 1-2-2 




4- 1- 1- 1  
4- 1- 1-2 
4- 1 -2-1 
4- 1 -2-2 




1 5 1 . 2 1  
107 . 57 
156 . 70 
102 . 1 6 
166 . 90 
82 . 08 
1 1 1 . 1 5  
82 . 60 
146 . 65 
76 . 97 
1 10 . 1 0 
75 . 07 
129 . 1 7  
67 . 55 
94 . 7 1  
73 . 67 
96 . 7 7 
53 
Experiment #2 : Study 1 
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Experiment 112 : 
Table 9 .  ANOVA o f  G6PDH activi ty_iU/ 1 0 1 2RBC ) . 
Degrees Sum 
of of Mean 
Source Freedom Squares Square s 
Treatment 3 1 1 82 1 4 . 62 39404 . 8 7 
Age 1 2 2 7 7 8 . 3 7 227 78 . 3 7 
Treatment-Age 3 35045 . 09 1 1 6 8 1 . 70 
Genotype 1 1 1 683 . 8 3 1 1 6 8 3 . 83 
Treatment-Genotype 3 1 9507 . 1 8 6 502 . 39 
Age-Genotype 1 39 2 . 6 1  39 2 . 6 1  
Treatment-Age- 3 1 7 5 56 . 3 1  5852 . 1 0 
Genotype 
Sex 1 145903 . 6 1  145903 . 6 1  
Treatment-Sex 3 1 9 1 3 1 . 1 8 63 7 7 . 06 
Age-Sex 1 33700 . 2 7 33700 . 2 7 
Treatment-Age-Sex 3 27 5 7 . 53 9 1 9 . 1 8 
Genotype-Sex 1 1 9 57 9 . 20 1 9 5 7 9 . 20 
Treatment-Genotype-Sex 3 378 1 . 0 3  1 260 . 34 
Age-Genotype-Sex 1 1 2 87 . 38 1 2 8 7 . 38 
Treatment -Age- 3 6 1 98 . 42  2066 . 1 4 
Genotype-Sex 
Error 459 402 6880 . 00 8 7 7 3 . 1 6 
Study 1 .  
F Values 
4 . 49** 
2 . 60 
1 . 3 3  
1 . 3 3  
0 . 74 
0 . 04 
0 . 67 
1 6 . 6 3** 
0 . 7 3  
3 . 84* 
0 . 1 0  
2 . 2 3 
0 . 1 4  
0 . 1 5  
0 . 24 
F Tabula t ed . OS 
2 . 6 0 
3 . 84 
F Tabula ted . 0 1 
3 . 7 8 
6 . 6 3 
l/1 
� 
Table 10 . 
Source 
Treatment : 











Geno type : 
55  
Experiment #2 :  Study 1 
G6PDH act ivity ( U/ 1 0 12  RBC ) Leas t Squares Means . 
No . of  G6PDH Ac tivity Conf idence 
Code Observat ions Leas t Squares Means Leve l 0 . 05 
(U/ 1 0 1 2  RBC ) 
1 --o . o  1 20 468 . 39 + 16 . 7 6 
2--0 . 1  483 . 7 2 
3--0 . 2  492 . 1 3 
4--0 . 4  5 1 1 . 86 
!--Adults 240 495 . 9 1 + 1 1 . 85 
2--Young 482 . 1 3 
Adults 
1- 1  60  48 1 . 92 +23 . 70 
1-2 454 . 86 
2- 1 486 . 79 
2-2 480 . 64 
3- 1 486 . 89 
3-2 49 7 . 36  
4- 1 528 . 04 
4-2 495 . 68 
1--AW/AW 240 484 . 09 +1 1 . 85 
2--AY/AW 493 . 96 - --
1- 1  60 466 . 74 +23 . 70 
1-2 470 . 04 
2-1  470 . 40 
2-2 49 7 . 03 
3- 1 483 . 88 
3-2 500 . 37 
4- 1 5 1 5 . 33 
4-2 508 . 3 9  
1- 1  1 20 490 . 07 + 16 . 7 6 
1-2 501 . 7,5 
2- 1 478 . 1 0 
2-2 486 . 1 6 
1 - 1- 1  30 485 . 7 5 +33 . 52 
1- 1-2 478 . 09 
1-2- 1- 447 . 7 3 
1 -2-2 46 1 . 98 
2- 1 - 1  469 . 80 
2- 1-2 503 . 7 9 
2-2- 1 47 1 . 00 
2-2-2 490 . 2 7 








( cont inued)  
No . of 
Code Observations 


































4- 1- 1  




G6PDH Act ivity Confidence 
Leas t Squares Means Level 0 . 0 5  
(U/ 1 0 1 2  RBC ) 
482 . 70 
49 1 . 08 
485 . 07 
509 . 66 
522 . 04 
534 . 04 
508 . 6 1  
482 . 74 
47 1 . 59  +1 1 . 8 5  
506 . 46 
442 . 05 +23 . 70 
494 . 7 3 
474 . 49  
49 2 . 94 
47 2 . 54 
5 1 1 . 7 2 
49 7 . 28  
526 . 44 
470 . 1 0 +16 . 7 6 
52 1 . 72 
47 3 . 08 
49 1 . 1 9 
449 . 62 +33 . 52 
5 1 4 . 22 
434 . 48 
47 5 . 24 
47 1 . 06 
502 . 52 
47 7 . 9 1  
483 . 3 7 
458 . 2 5  
5 1 5 . 5 3 
486 . 82 
507 . 90 
501 . 46 
554 . 6 3 
493 . 1 0 
498 . 25 
Table 10 . ( cont inued ) 
No . o f  
Source Code Observat ions 
Genotype- 1- 1  1 2 0  
Sex : 1 -2 
2- 1 
2-2 
Treatment- 1- 1- 1  30 
GenotyP.e- 1-1-2 
Sex : 1-2- 1 
1-2-2 
2- 1 -1 
2- 1 -2 
2-2-1  
2-2-2 
3- 1 - 1  
3- 1 -2 
3-2- 1 
3-2-2 




Age- 1- 1- 1  60  
Genotype- 1-1-2 
Sex : 1-2- 1  
1-2-2 
2- 1 - 1  
2- 1 -2 
2-2- 1 
2-2-2 
Treatment - 1 - 1 - 1 -1 1 5  
Age- 1- 1- 1-2 
Genotype- 1- 1-2- 1 
Sex : 1 - 1-2-2 
1-2- 1 - 1  
1-2- 1 -2 
1-2-2- 1 
1-2-2-2 
2- 1 - 1 - 1 
2- 1- 1-2 
2- 1 -2- 1 
2- 1-2-2 




G6PDH Act ivity Conf idence 
Leas t Squares Means Level 0 . 0 5  
(U/ 1 0 1 2  RBC ) 
47 3 . 04 +1 6 . 7 6  
49 5 . 1 4 
470 . 1 4 
5 1 7 . 78 
450 . 30 +33 . 52 
483 . 1 9 
433 . 80 
506 . 27 
467 . 87 
47 2 . 93 
48 1 . 10 
5 1 2 . 96 
47 1 . 20 
496 . 57 
473 . 87 
526 . 8 7 
502 . 80 
52 7 . 86 
49 1 . 77  
525 . 02 
469 . 0 1  +23 . 70 
5 1 1 . 1 4 
47 1 . 1 9 
532 . 3 1  
477 . 07 
479 . 1 4 
469 . 08 
503 . 24 
463 . 4 1 +47 . 40 
508 . 09 
435 . 83 
520 . 35 
437 . 1 9 
458 . 28 
431 . 7 7 
492 . 1 9  
463 . 09 
47 6 . 5 1  
47 9 . 04 
528 . 54 
47 2 . 65  
469 . 36 
483 . 1 6  
Table 10 . ( cont inued ) 
Source 
No . o f  
Code Observations 
G6PDH Act ivity 
Leas t Squares Means 
58 
Conf idence 
Level 0 . 0 5  
( U/ 1 0 1 2  RBC ) ----------------------------------��- ---�----------------
2-2-2-2 
3- 1- 1- 1  
3- 1- 1-2 
3- 1-2-1  
3- 1-2-2 




4- 1- 1- 1  
4- 1- 1-2 
4- 1-2- 1 
4- 1-2-2 




49 7 . 38 
453 . 57 
5 1 1 . 82 
462 . 92 
5 1 9 . 24 
488 . 82 
48 1 . 3 1  
484 . 82 
534 . 49 
495 . 9 6 
548 . 1 3 
506 . 96 
56 1 . 1 2 
509 . 63 
507 . 59 
47 6 . 58 
488 . 9 1 
59 
On the whole , however ,  an important finding of this study is the 
fact that DHEA does affect the weight of yellow mice more dramatically 
than the weight of agout i mice . In both the adult and the young mice 
there is a significant dif ference between AWJAW and AY/AW mice of both 
sexes  in weight loss  as  DHEA levels increased (P � 0 . 0 1 ) .  AY/AW males 
and females both demons t rated dramat ic decreases in weight change as 
the amount of DHEA increased in their  diets  ( P �0 . 0 1 ) .  AWJAW males and 
females also los t  weight with increased DHEA amounts ,  but not as 
dramatically as AY/AW mice ( Figures 8 and 9 ,  pp . 64 and 6 5 ) . 
There is a significant difference ( P � O . O l ) in food consumption 
between genotypes with the lower intakes of DHEA , but at 0 . 2  and 0 . 4 %  
DHEA levels there i s  no significant dif ference be tween AY/AW and 
AW/AW consumption . A significant dif ference ( P � 0 . 0 1 ) in food consump­
tion is noted between sexes ( females usually consumed less  than males ) ,  
treatments ( 0 . 4 %  DHEA mice ate the least , 0 . 1 % DHEA mice ate the mos t ) , 
and age groups ( young mice demons t ra ted a less  dramatic difference in 
consumption between treatment levels )  ( Figures 1 0  and 1 1 , pp . 6 6  and 6 7 ) .  
No signif icant differences in G6PDH act ivity are present between 
AY/AW and AW/AW mice . However , the data do indicate a signif i cant dif­
ference be tween treatment s ( a s  the amount of DHEA increased , G 6PDH 
act ivity also increased , although in a fluctuating manner )  and between 
males and females ( P � 0 . 0 1 ) . There is also a significant difference ( P L  
0 . 05 ) be tween G6PDH a ctivity in the two age groups ( Figures 1 2  and 1 3 , 
PP • 68 and 6 9 ) .  
Experiment 12 , Study 1 
Table 1 1 . Experimental Parameter Lea s t  Squares Means of Lethal Yellow ( AY/AW) and Agout i ( AW/AW) 
Mice Following a 0 . 0% DHEA Die t . 
Female Male 
Parameter Young Adult Adult Young Adult  Adult Confidence 
Measures AY/AW AW/ AW AY/ AW AW/AW AY/AW AW/ AW AY/ AW AW/ AW Level 0 . 05 
Total Mouse 16 . 56 7 . 3 2  20 . 34 2 . 1 6  2 1 . 84 6 . 7 6 1 3 . 7 4 3 . 80 + 3 . 2 8 -
Weight Change ( g . ) 
Average Food 103 . 89 81 . 40 147 . 24 92 . 60 144 . 7  5 107 . 58 169 . 9 7 1 37 . 07 + 19 . 67 
Consumption ( g . ) 
G6PDH Activity 431 . 7 7 437 . 1 9 435 . 83 463 . 4 1  49 2 . 1 9  458 . 2 8 520 . 3 5 508 . 09 + 47 . 40 
/ 10 12 RBC 
Q'\ 0 
Experiment #2 , Study 1 
Table 12 . Experimental Parameter Least Squares Means of Lethal Yellow ( AY/AW) and Agouti ( AW/AW) 
Mice Following a 0 . 1 %  DHEA Diet . 
Female Male 
Parameter Young Adult Adult Young Adult Adult Conf idence 
Measures AY/AW AW/AW AY/AW AW/AW AY/AW AW/AW AY/AW AW/AW Level 0 . 05 
Total Mouse 14 . 08 7 . 80 7 . 38 1 . 62 1 5 . 96 9 . 3 2 7 . 40 2 . 70 + 3 . 2 8 
Weight Change ( g . )  
Average Food 1 1 7 . 77 83 . 94 17 1 . 04 106 . 98 1 5 1 . 2 1  1 1 9 . 60 188 . 86  1 3 2 . 1 0  + 1 9 . 67 
Consumption ( g . ) 
G6PDH Activity 483 . 1 6 47 2 . 65  47 9 . 04 463 . 09 49 7 . 38 469 . 36 528 . 54 47 6 . 5 1  + 47 . 40 
/ 10 12 RBC 
()\ 
........ 
Experiment #2 , Study 1 
Table 13 . Experimental Parameter Least  Squares Means of Lethal Yellow ( AY/AW) and Agout i  (AW/AW) 
Mice Following a 0 . 2% DHEA Diet . 
Female Male 
Parameter Young Adult Adult Young Adult Adult Conf idence 
Measures AY/AW AW/AW AY/AW AW/AW AY/AW AW/AW AY/AW AW/AW Level 0 . 05 
Total Mouse 4 . 48 5 . 9 2 - 5 . 4 2 0 . 90 14 . 36 7 . 36 3 . 4 2  2 . 00 + 3 . 28 -
Weight Change ( g . ) 
Average Food 82 . 60 82 . 08 102 . 1 6 107 . 57 146 . 6 5 1 1 1 . 1 5 166 . 90 1 5 6 . 70 + 19 . 6 7  
Consumption ( g . ) 
G6PDH Activity 484 . 82 488 . 82 462 . 92 453 . 57 534 . 49 48 1 . 3 1  5 1 9 . 24 5 1 1 . 8 2 + 47 . 40 
/ 10 12 RBC 
0\ N 
Experiment #2 , Study 1 
Table 14 . Experimental Parameter Leas t Squares Means of Lethal  Yellow ( AY/AW) and Agout i (AW/AW) 
Mice Following a 0 . 4% DHEA Diet . 
Female Male 
Parameter Young Adult Adult Young Adult Adult Conf idence 
Measures AY/AW AW/AW AY/AW AW/AW AY/AW AW/AW AY/AW AW/AW Level 0 . 05 
Total Mouse - 2 . 1 6  0 . 34 - 1 2 . 1 2 - 3 . 82 1 . 1 2 2 . 02 - 1 . 2 2  - 0 . 80 + 3 . 28  -
Weight Change ( g . ) 
Average Food 73 . 67 67 . 55 75 . 07 76 . 97  96 . 7 7 94 . 7 1  1 2 9 . 1 7  1 10 . 1 0  + 1 9 . 6 7 -
Consumption ( g . ) 
G6PDH Activity 476 . 58 509 . 63 506 . 96 495 . 96 488 . 9 1  507 . 59 56 1 . 1 2 548 . 1 3 + 47 . 40 




Experiment #2 , Study 1 
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Experiment #2 , Study 1 
Figure 9 .  Young Adult Mice Weight Change Leas t Squares Means ( g . ) Vs . 
Treatments ( %  DHEA) . ( Treatment -Age-Genotype-Sex 
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Experiment # 2 , Study 1 













































Treatment s ( %  DHEA) . ( Treatment-Age-Genotype-Sex 
Interact ion ) . 
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Experiment #2 , Study 1 
Figure 1 1 . Young Adult Mice Food Consumption Leas t Squares Means ( g . ) 
Vs . Treatment s ( %  DHEA) . ( Treatment -Age-Genotype-Sex 
Interaction ) . 
220 
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Experiment #2 , Study 1 
Figure 1 2 . Adult Mice G6PDH Act ivity Leas t Squares Means ( U/ 1 0 1 2  RBC ) 
Vs . Treatments ( %  DHEA) . ( Treatment -Age-Genotype-Sex 
Interaction ) . 
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Experiment #2 , Study 1 
Figure 1 3 . Young Adult Mice G6PDH Act ivity Leas t Squares Means ( U/ 1 0 1 2  
RBC ) Vs . Treatment s ( %  DHEA) . ( Treatment -Age-Genotype-Sex 
Interaction ) . 
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S tudy 2 
Tables 25 , 2 6 , 2 7 , 2 8  on pages 1 1 1 , 1 1 2 ,  1 1 3 , and 1 1 4 provide a 
summary of all data at each of the DHEA treatment levels . For example 
Table 25 lis t s  the least  squares means of weight changes ,  food consump­
tion , bedding weight , and G6PDH activity for all groups at the 0 . 0%  or  
cont rol DHEA level . By  comparing the figures lis ted for each para­
meter , . one can readily ident ify numerical  differences . The conf idence 
level figure can then be used to determine if these  numerical  dif feren­
ces are stat ist ica lly signif icant at the P 0 . 05 confidence level . 
MOUSE WEIGHT CHANGE (g. ) 
Highly significant differences ( P  0 . 0 1 ) are present between mice 
in each treatment level , age group , genotype and sex (ANOVA Table 1 5 , 
P •  7 1 ) . Wei ght change decreased in amount as DHEA t reatment levels 
increased , with 0 . 4 %  DHEA producing a negative weight change -- a los s  
in weight ( Table 1 6 , P •  7 2 , Treatment Section) . Young adults gained 
more weight than adults  ( Table 1 6 ,  P• 72 , Age Sect ion ) . Yellow mice 
gained more than agouti mice ( Table 1 6 , P • 7 2 , Genotype Sect ion ) . 
Males gained more than· females ( Table 16 , p .  7 3 , Sex S ec t ion ) . 
Interactions are highly significant ( P  0 . 0 1 ) be tween trea tment 
and genotype , age and genotype , treatment and sex ,  genotype and sex , 
treatment- age- and sex ,  and treatment- genotype- and sex (ANOVA Table 
1 5 ,  p. 7 1 ) . There is a significant difference between AY/AW ' s  and 
AW/AW ' s ,  with the yellows gaining more weight than the agoutis  at each 
treatment level , except at the 0 . 4% level . As the amount of DHEA in 
the diet increased up to 0 . 2% ,  the dif ference in weight changes between 
Experiment 112 : 
Table 1 5 .  ANOVA of Mouse Weight Changes (g ) . 
Degrees Sum 
of of Mean 
Source Freedom Squares Squares 
Treatment _ 3 8564 . 63 2854 . 88 
Age 1 1 1 53 . 95 1 1 53 . 95 
Treatment-Age 3 1 1 . 5 1 3 . 84 
Genotype 1 1283 . 92 1 283 . 92 
Treatment-Genotype 3 3668 . 1 4 122 2 . 7 1  
Age-Genotype 1 267 . 67 26 7 . 67 
Treatment -Age- 3 59 . 03 19 . 68 
Genotype 
Sex 1 1304 . 69 1 304 . 69 
Treatment-Sex 3 185 . 44 6 1 . 8 1 
Age-Sex 1 22 . 07 22 . 07 
Treatment-Age-Sex 3 1 7 6 . 97 58 . 9 9 
Genotype-Sex 1 238 . 74 238 . 74 
Treatment-Genotype-Sex 3 197 . 56 6 5 . 85 
Age-Genotype-Sex 1 9 . 1 4 9 . 1 4 
Treatment-Age- 3 59 . 00 12 . 3 1  
Genotype-Sex 
Error 96 1 1 8 1 . 7 2 12 . 3 1  
Study 2 .  
F Values 
23 1 . 92** 
93 . 74** 
0 . 3 1  
104 . 30** 
99 . 33** 
2 1 . 7 5** 
1 . 60 
105 . 99** 
5 . 02** 
1 . 79 
4 . 7 9** 
1 9 . 40** 
5 . 3 5** 
0 . 74 
1 . 60 
F Tabulated . OS 
2 . 68 
3 . 92 
F Tabulated . 0 1 
3 . 9 5 
6 . 8 5 
....... -
72  
Experiment 112 : Study 2 .  
Table 16 . Mouse Weight Change Leas t Squares Means ( g . ) .  
No . o f  Weight Change Confidence 
Source Code Observations Leas t Squares Means (g. )  Level 0 . 0 5 
Treatment : 1--o . o  48 13 . 24 + 1 . 00 -
( %  DHEA) 2--0 . 1  10 . 2 7 
3--0 . 2  4 . 04 
4--0 . 4  -4 . 1 9 
Age : 1--Adults 96 3 . 3 9 + o.  7 1  
2--Young 8 . 29 
Adults  
Treatment - 1-1 24 10 . 65 + 1 . 4 2  -
Age : 1-2 1 5 . 84 
2- 1 7 . 7 5 
2-2 1 2 . 80 
3- 1 2 . 00 
3-2 6 . 07 
4- 1 -6 . 85 
4-2 -1 . 54 
Genotype : 1--f!:!../AW 96 3 . 2 5 + o.  7 1  
2--AY I!!:!_ 8 . 43  
Treatment- 1-1 24 5 . 1 4 + 1 . 4 2 -
2 1 . 34 Genotype : 1-2 
2- 1 5 . 37 
2-2 15 . 1 8 
3- 1 3 . 1 3  
3-2 4 . 94 
4- 1 -0 . 63 
4-2 -7 . 7 6 
Age- 1-1  48 1 . 98 + 1 . 00 -
Genotype : 1-2 4 . 7 9 
2- 1 4 . 52 
2-2 1 2 . 06 
Treatment - 1-1-1  1 2  3 . 8 1  + 2 . 00 -
Age- 1-1-2 1 7 . 50 
Genotype : 1-2-1 6 . 48 
1-2-2 . 25 . 1 9 
2- 1 - 1  3 . 78 
2- 1-2 1 1 . 7 2 
2-2-1 6 . 9 7 
2-2-2 1 8 . 6 2 
Table 1 6 . ( cont inued ) 
No . o f  
Source Code Observations 




4- 1-1  
4- 1-2 
4-2- 1  
4-2-2 
Sex : IS 96 
2d' 
Treatment- 1-1  24  











Treatment - 1- 1- 1  1 2  
Age-Sex : 1- 1-2 
1 -2- 1 
1 -2-2 












7 3  
Weight Change Confidence 
Least  Squares Means (g . ) Level 0 . 05 
1 . 6 1  
2 . 39 
4 . 6 5 
7 . 49 
-1 . 26 
-12 . 44 
-0 . 00 
-3 . 08 
3 . 23 + o .  7 1  
8 . 45  
1 1 . 29 + 1 . 4 2  -
1 5 . 20 
6 . 4 1  
14 . 1 3 
0 . 8 1  
7 . 26 
-5 . 58 
-2 . 8 1  
1 . 1 2 + 1 . 00 -
5 . 66 
5 . 34 
1 1 . 24 
10 . 22 + 2 . 00 
1 1 . 09 
12 . 36 
1 9 . 32 
4 . 5 5 
10 . 95 
8 . 28 
1 7 . 32 
-0 . 9 1  
4 . 9 1  
2 . 53 
9 . 6 1  
-9 . 38 
-4 . 32 
- 1 . 78 
- 1 . 29 
74  
Table 1 6 . ( cont inued ) 
No . o f  Weight Change Confidence 
Source Code Observations Least  Squares Means (g. ) Level 0 . 05 
Genotype- 1-1  48 1 .  7 6  + 1 . 00 -
Sex : 1-2 4 . 74 
2- 1 4 . 70 
2-2 12 . 1 5 
Treatment- 1-1- 1  1 2  3 . 0 1  + 2 . 00 
Genotype- 1- 1-2 7 . 28 
Sex : 1-2-1 1 9 . 57 
1-2-2 23 . 1 2 
2- 1-1  3 . 4 2 
2- 1-2 7 . 3 2 
2-2-1 9 . 4 1  
2-2-2 20 . 94 
3- 1- 1  2 . 1 9  
3- 1-2 4 . 07 
3-2-1 -0 . 57 
3-2-2 10 . 45 
4- 1- 1  -1 . 57 
4- 1-2 0 . 3 1  
4-2-1 -9 . 59 
4-2-2 -5 . 92 
Age- 1- 1- 1  24 0 . 6 1  + 1 . 42 -
Genotype- 1-1-2 3 . 3 5 
Sex : 1-2- 1 1 . 63 
1 -2-2 7 . 96 
2- 1 - 1  2 . 9 1  
2- 1-2 6 . 1 4 
2-2-1 7 . 78 
2-2-2 16 . 34 
Treatment- 1- 1- 1- 1  6 2 . 20 + 2 . 84 
Age- 1- 1-1-2 5 . 42 
Genotype- 1- 1-2-1 18 . 23 
Sex : 1- 1-2-2 16 . 7 7 
1-2- 1- 1  3 . 82 
1-2- 1-2 9 . 1 5  
1-2-2- 1 20 . 90 
1-2-2-2 29 . 48 
2- 1- 1- 1  2 . 45 
2- 1-1-2 5 . 1 0 
2- 1-2-1 6 . 6 5 
2- 1-2-2 1 6 . 80 
2-2- 1- 1  4 . 38 
2-2- 1-2 9 . 55 
2-2-2-1 1 2 . 1 7 
7 5  
Table 1 6 . ( cont inued ) 
Source 
No . o f  Weight Change Conf idence 
Code Observat ions Least Sguares Means (g. ) Level 0 . 05 
2-2-2-2 
3- 1- 1- 1  







4- 1- 1- 1  
4- 1 - 1-2 
4- 1 -2-1 
4- 1 -2-2 




25 . 08 
0 . 60 
2 . 6 2 
-2 . 4 2 
7 . 20 
3 . 78 
5 . 5 2 
1 . 28  
13 . 70 
-2 . 80 
0 . 28  
-15 . 95 
-8 . 9 3 
-0 . 33 
0 . 33 
-3 . 23 
-2 . 92 
7 6  
Experiment #2 : S tudy 2 
Figure 1 4 . Mouse Weight Change Leas t Squares Means ( g . ) Vs . Treatments 
( %  DHEA) . ( Treatment -Age-Sex Interact ion -- P<O. O l ) .  
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Experiment #2 : Study 2 
Figure 1 5 . Mouse Wei ght Change Leas t Squares Means Vs . Treatment s 
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the two genotypes gradually decreased . At 0 . 4% , however ,  · the wei ght 
changes reversed , with both genotypes losing weight . AY/AW ' s los t  
significant ly more than AW/AW ' s  ( Table 1 6 , p .  7 2 ,  Treatment -Genotype 
Section) .  There is a greater numerical difference in weight changes 
between the genotypes in the young adult s versus adults ( Table 1 6 , P•  
72 , Age-Genotype Section) . At the 0 . 0 , 0 . 1 , and 0 . 2 % DHEA levels , 
males .gained more weight than females , with a decrease in the wei ght 
changes of both sexes as DHEA levels increased . At the 0 . 4% level , 
both males and females lost  weight , but the males lost  less than the 
females ( Table 1 6 , p .  7 3 , Treatment-Sex Section ) . There is a greater 
difference in weight gain be tween males and females in the .AY/AW mice 
than in the AW/AW mice ( Table 16 , P• 74 , Genotype-Sex Section ) . Males 
of both ages followed a similar pat tern of weight change from treatment 
level to treatment level , as did the females of both ages . However the 
young adults of both  sexes always gai�ed more weight than their  adult 
counterparts ( Table 1 6 , P•  73 , Treatment-Age-Sex Section , and Figure 
1 4 , p .  7 6 ) .  AY /AW males and females followed a similar pat tern of 
weight change , decreasing in change as the amount of DHEA level 
increased . �/AW males and females also followed similar pat terns but 
stayed more stable than the AY/AW ' s ,  with a le ss  dramat ic decrease in 
weight change as DHEA levels increased . Therefore , the re is a definite 
difference be tween the way each genotype reacted to DHEA in regard to 
weight change ( Table 1 6 ,  P• 74 , Treatment -Genotype-Sex Section , and 
Figure 1 5 ,  p .  7 7 ) .  
Experiment · /12 : 
Table 1 7 .  ANOVA of Average Food Consumption (g. ) 
Degrees Sum 
of of Mean 
Source Freedom Squares Squares 
Treatment · 3 1 2 79 . 32 426 . 44 
Age 1 2 14 . 20 2 14 . 20 
Treatment-Age 3 37 5 . 69 125 . 2 3 
Genotype 1 5596 . 7 6 5596 . 7 6 
Treatment-Genotype 3 407 9 . 28 1 359 . 7 6  
Age-Genotype 1 4 . 25 4 . 2 5 
Treatment-Age- 3 96 . 00 32 . 00 
Genotype 
Sex 1 7 1 1 3 . 93 7 1 1 3 . 93 
Treatment-Sex 3 386 . 3 1  128 . 7 7  
Age-Sex 1 3 . 84 3 . 84 
Treatment-Age-Sex 3 26 . 8 1  8 . 94 
Genotype-Sex 1 299 . 63 299 . 63 
Treatment-Genotype-Sex 3 1546 . 08 51 5 . 36 
Age-Genotype-Sex 1 37 . 50 37 . 50 
Treatment -Age- 3 47 6 . 89 158 . 96 
Genotype-Sex 
Error 64 6023 . 8 1 94 . 1 2 
Study 2 .  
F Values 
4 . 53** 
2 . 28 
1 . 33 
59 . 46** 
14 . 45** 
0 . 05 
0 . 34 
75 . 58** 
1 . 37 
0 . 04 
0 . 09 
3. 1 8 
5 . 48** 
0 . 40 
1 . 69 
F Tabulated . O S 
2 . 7 6  
4 . 00 
F Tabulated . 0 1 
4 . 1 3  
7 . 08 
......., \0 
80 
Experiment 112 :  Study 2 
Table 1 8 .  Food Consump tion Leas t Squares Means ( g . ) . 
No . o f  Food Consumpt ion Confidence 
Source Code Observat ions Least  Squares Means (g. ) Level 0 . 05 
Treatment : 1 -0 . 0  24 6 1 . 98 + 3 . 96 
( %  DHEA) 2--0 . 1  6 1 . 67 
3--0 . 2  59 . 6 1  
4--0 . 4  52 . 9 2 
Age : !--Adults 48 60 . 54 + 2 . 80 
2--Young 57 . 5 5 
Adults 
Treatment- 1-1  12  65 . 84 + 5 . 60 
Age : 1-2 58 . 1 2 
2- 1 60 . 07 
2-2 63 . 2 7 
3- 1 6 1 . 1 4 
3-2 58 . 08 
4- 1 55 . 1 0 
4-2 50 . 74 
Genotype : 1--AW/AW 48 5 1 . 4 1  + 2 . 80  
2--AY/AW 66 . 68 
Treatment - 1-1  1 2  50 . 2 9 + 5 . 60 
Genotype : 1-2 73 . 67 
2- 1 48 . 8 1  
2-2 74 . 52 
3-1  50 . 1 6 
3-2 69 . 06 
4-1 56 . 38 
4-2 49 . 47 
Age- 1-1  24 52 . 69 + 3 . 9 6  
Genotype : 1-2 68 . 38 
2- 1 50 . 1 2 
2-2 64 . 98 
Treatment- 1- 1- 1  6 53 . 90 + 7 . 9 2 
Age- 1-1-2 77 . 78 
Genotype : 1-2- 1 46 . 68 
1-2-2 69 . 5 5 
2- 1- 1 46 . 0 3 
2- 1-2 74 . 1 0 
2-2- 1 5 1 . 58 
2-2-2 74 . 9 5 
8 1  
Table 1 8 . ( cont inued)  
No . of  Food Consumpt ion Confidence 
Source Code Observations Least Squares Means (g . ) Level 0 . 05 
3- 1- 1  53 . 1 2 
3- 1-2 69 . 1 7 
3-2-1 47 . 20 
3-2-2 68 . 9 5 
4- 1-1  57 . 7 2 
4- 1-2 52 . 48 
4-2- 1 55 . 03 
4-2-2 46 . 45 
Sex : IS. 48 50 . 44 + 2 . 80  
2c¥  67 . 6 5 
Treatment- 1 - 1  1 2  53 . 54 + 5 . 6 0  
Sex : 1-2 70 . 42 
2- 1 5 1 . 60 
2-2 7 1 . 73 
3- 1 49 . 08 
3-2 70 . 1 3 
4- 1 47 . 52 
4-2 58 . 32 
Age-Sex : 1- 1  24 52 . 1 3 + 3. 9 6  
1-2  68 . 94 
2- 1 48 . 74 
2-2 66 . 36 
Treatment- 1- 1- 1  6 57 . 7 7 + 7 . 9 2  
Age-Sex : 1- 1-2 73 . 92 
1-2- 1  49 . 32 
1-2-2 66 . 92 
2- 1- 1  50 . 1 3 
2- 1-2 70 . 00 
2-2-1 53 . 07 
2-2-2 73 . 47 
3- 1-1  50 . 03 
3- 1-2 72 . 25 
3-2- 1 48 . 1 3 
3-2-2 68 . 02 
4- 1- 1  50 . 58 
4- 1-2 59 . 62 
4-2-l 44 . 45 
4-2-2 57 . 03 
Table 1 8 .  ( cont inued )  
No . o f  
Source Code Observations 
Genotype- 1-1  24  
Sex : 1-2 
2- 1 
2-2 
Treatment- 1-1- 1  6 
Genotype- 1-1-2 
Sex : 1-2-1  
1-2-2 












Age- 1-1-1  12  
Genotype- 1-1-2 
Sex : 1-2- 1 
1-2-2 




Treatment- 1- 1- 1- 1  3 
Age- 1-1- 1-2 
Genotype- 1-1-2-1 
Sex : 1- 1-2-2 
1-2- 1- 1  
1 -2-1 -2 
1-2-2-1 
1-2-2-2 
2- 1 - 1- 1 







Food Consumption Confidence 
Least Squares Means (g . )  Level 0 . 05 
44 . 57 + 3 . 96 
58 . 25 
56 . 30 
77 . 05 
43 . 50 + 7 . 9 2 
57 . 08 
63 . 58 
83 . 7 5 
44 . 1 0 
53 . 52 
59 . 10 
89 . 95 
44 . 43 
55 . 88 
53 . 7 3 
84 . 38 
46 . 23 
66 . 52 
48 . 80 
50 . 1 3 
43 . 4 2 + 5 . 6 0  
59 . 96 
58 . 83 
77 . 9 3 
43 . 7 1  
56 . 54 
53 . 78 
76 . 1 8 
44 . 2 3 +1 1 . 20 
63 . 5 7 
7 1 . 30 
84 . 2 7 
42 . 7 7 
50 . 60 
55 . 8 7 
83 . 23 
40 . 67 
5 1 . 40 
59 . 60 
88 . 60 
47 . 53 
55 . 6 3 
58 . 60 
83 
Table 18 . ( continued ) 
Source 
No . of Food Consumpt ion Confidence 
Code Observations Least  Squares Means (g . ) Level 0 . 05 
2-2-2-2 
3- 1- 1-1  
3- 1- 1-2 
3- 1-2- 1 
3- 1-2-2 




4- 1-1-1  
4- 1- 1-2 
4- 1-2-1 





9 1 . 30 
45 . 43 
60 . 80 
54 . 6 3 
83 . 70 
43 . 4 3 
50 . 9 7 
52 . 83 
85 . 07 
5 1 . 3 7 
64 . 07 
49 . 80 
55 . 1 7 
4 1 . 1 0 
68 . 97 
47 . 80 
45 . 1 0 
84 
Experiment # 2 : Study 2 















































Treatments ( %  DHEA) (Treatment-Genotype Interaction -­
p ( Q . O l ) .  
Ay/Aw 
Aw/Aw 
-20 '-----------------��------��------�-0 . 1  0 . 2  0 . 4  0 . 0  
Treatments ( %  DHEA) 
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Experiment #2 : Study 2 
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Treatment s ( %  DHEA) (Treatment-Genotype-Sex Interaction 
P < O . O l ) .  
-20 L.--------�--------------------------------
0 . 0  0 . 1  0 . 2  0 . 4  
Trea tment s ( %  DHEA) 
86 
FOOD CONSUMPTION (g . )  
ANOVA Table 1 7 , P •  7 9 , reveals  highly significant dif ferences 
(P < 0 . 0 1 ) in average food consumption of the mice in each treatment 
level , genotype , and sex .  Food consumpt ion decreased as levels  of DHEA 
increased ( Table 18 , p .  80 , Treatment Section ) , AY/AW ' s  consumed more 
food on the average than �w;�w • s  ( Table 18 , p .  80 , Genotype S ection ) , 
and males consumed more food than females ( Table 1 8 , P •  8 1 ,  Sex 
Section ) . 
There are highly signif icant interactions ( P  .L 0 . 0 1 ) be tween 
treatment and genotype and treatment , genotype , and sex (ANOVA Table 
1 7 , p. 7 9 ) .  AY/AW ' s  ate more food than the AWJ.AW ' s  at all treatment 
levels except 0 . 4% , where AW/AW ' s  ate more than AY/AW ' s ( Table 1 8 , 
P • 80 , Treatment-Genotype Section , and Figure 1 6 , P •  84 ) .  AY/AW males 
and females fo�lowed a similar food consumpt ion pattern , gene ra lly con-
suming less  as DHEA levels increased , but AW/AW males and females con-
sumed a generally more stable diet which leveled off and increased  as 
DHEA levels  increased ( Table 1 8 , P• 82 , Treatment -Genotype-Sex Section , 
and Figure 1 7 , p .  8 5 ) . 
BEDDING WEIGHT (g. )  
Significant differences are present in the average bedding 
weights of mice in each treatment level (P £:. 0 . 0 1 ) , age group ( Pz 0 . 05 ) , 
and genotype ( P L0 . 0 1 ) (ANOVA Table 1 9 , P •  87 ) .  Bedding weight 
increased as treatment levels increased (Table 20 , P• 88 , Treatment 
Sect ion) , adult bedding weighed more than the young adult bedding 
( Table 20 , p .  88 , Age Section ) , and the AY/Aw bedding weighed more than 
the AW/AW bedding ( Table 20 , p .  88 , Genotype Section ) . 
Expe riment 112 : 
Table 1 9 .  ANOVA of Average Bedding Weights (g . ) .  
Degrees Sum 
of of Mean 
Source Freedom Sguares Sguares 
Treatment 3 2447 . 1 3 8 1 5 . 7 1 
Age 1 587 . 07 58 7 . 07 
Treatment -Age 3 570 . 00 190 . 00 
Genotype 1 87 1 . 22 8 7 1 . 2 2 
Treatment-Genotype 3 1279 . 2 2 426 . 4 1  
Age-Genotype 1 1 6 . 1 7  16 . 1 7  
Treatment-Age- 3 6 1 8 . 05 206 . 02 
Genotype 
Sex 1 348 .08 348 . 08 
Treatment-Sex 3 794 . 24 264 . 7 5  
Age-Sex 1 329 . 30 329 . 30 
Treatment -Age-Sex 3 504 . 49 168 . 1 6 
Genotype-Sex 1 144 . 06 144 . 06 
Treatment-Genotype-Sex 3 1089 . 7 6 36 3 . 25 
Age-Genotype-Sex 1 0 . 1 8  0 . 1 8  
Treatment-Age- 3 1 5 4 . 52  5 1 . 5 1 
Genotype-Sex 
Error 64 6146 . 3 2 96 . 04 
Study 2 .  
F Values 
8 . 49** 
6 . 1 1 * 
1 . 98 
9 . 07** 
4 . 44** 
0 . 1 7  
2 . 1 5  
3 . 6 2 
2 . 7 6 
3 . 4 3 
1 . 7 5  
1 . 50 
3 . 78* 
0 . 00 
0 . 54 
F Tabulated . 05 
2 . 7 6 
4 . 00 
F Tabulated . 0 1 
4 . 1 3  
7 . 08 
00 
'-J 
Table 20 . 
Source 
Treatment : 
( %  DHEA) 












Experiment 112 : Study 2 
Average Bedding Weight Leas t Squares Means ( g . ) • 
No . of  Bedding Weights  Confidence 
Code Observations Least Squares Means (g . )  Level 0 . 0 5 
1 --o . o  24 24 . 8 1  + 4 . 00 
2--0 . 1  25 . 1 2 
3--0 . 2  32 . 1 9 
4--0 . 4  36 . 84 
1 --Adult s 48 32 . 2 1  + 2 . 83 
2--Young 27 . 2 7  
Adult s 
1 - 1  1 2  27 . 02 + 5 . 66 
1-2  22 . 6 1  
2- 1 23 . 8 1  
2-2 26 . 44 
3- 1 35 . 96 
3-2 28 . 4 2  
4- 1 42 . 08 
4-2 3 1 . 60 
1--AW/AW 48 26 . 7 3 + 2 . 8 3  
2--AY/AW 32 . 7 5 
1 - 1  1 2  1 9 . 46 + 5 . 66  
1 -2 30 . 1 7 
2- 1 18 . 53 
2-2 3 1 . 7 2 
3- 1 29 . 1 8 
3-2 35 . 20 
4- 1 39 . 74 
4-2 33 . 9 3 
1- 1  24 28 . 7 9 + 4 . 00 
1 -2 35 . 64 
2- 1 24 . 67 
2-2 29 . 8 7 
1 - 1- 1  6 2 1 . 9 5 + 8 . 00 
1 - 1-2 32 . 08 
1-2- 1 16 . 9 7 
1 -2-.2 28 . 25 
2- 1 -1 16 . 40 
2- 1-2 3 1 . 2 2 
2-2- 1 20 . 67 
2-2-2 32 . 2 2 
Table 20 . ( cont inued ) 
No . o f  
Source Code Observations 
3- 1- 1  
3- 1 -2 
3-2- 1 
3-2-2 




Sex : 1S 48 
2c/ 
Treatment- 1 - 1  1 2  







Age-Sex : 1 - 1  2 4  
1 - 2  
2- 1 
2-2 
Treatment- 1 - 1 - 1  6 
Age-Sex : 1 - 1-2 
1 -2- 1 
1 -2-2 
2- 1 - 1  
2- 1-2  
2-2- 1 
2-2-2 
3- 1 - 1  
3- 1 -2 
3-2- 1 
3-2-2 





Least  Squares Means 
35 . 93 
35 . 98 
22 . 4 3 
34 . 4 2 
40 . 88 
43 . 2 7 
38 . 60 
24 . 60 
27 . 84 
3 1 . 64 
1 9 . 59 
30 . 03 
2 1 . 00 
29 . 25 
32 . 1 0 
32 . 28 
38 . 66 
35 . 02 
32 . 1 6 
32 . 2 7 
23 . 5 1  
3 1 . 02 
2 1 . 63 
32 . 40 
1 7 . 55 
27 . 67 
1 9 . 77 
27 . 85 
22 . 23 
30 . 6 5 
37 . 78 
34 . 1 3 
26 . 4 2 
30 . 43 
49 . 47 
34 . 68 
27 . 8 5 
35 . 3 5 
(g . )  
89 
Confidence 
Level 0 . 05 
+ 2 . 83  
+ 5 . 66  
+ 4 . 00 
+ 8. 00 














( cont inued ) 
No . o f  
Code Observations 








2-1 - 1  
2- 1 -2 
2-2-1 
2-2-2 
3- 1 - 1  
3- 1 -2 
3-2- 1 
3-2-2 












1- 1- 1- 1  3 
1- 1- 1-2 
1- 1-2- 1 
1- 1-2-2 




2- 1- 1- 1  
2- 1- 1-2 
2- 1-2-1 
2- 1-2-2 
2-2- 1- 1  
2-2- 1 -2 
2-2-2-1 
90 
Bedding Weights Conf idence 
Least Squares Means (g . )  Level 0 . 05 
26 . 05  + 4 . 00 
27 . 4 1  
29 . 6 2  
35 . 88 
1 5 . 38 + 8 . 00 
25 . 53 
23 . 80 
36 . 5 3 
1 7 . 08 
19 . 98 
24 . 9 2 
38 . 5 2 
34 . 2 3 
24 . 1 3 
29 . 9 7 
40 . 4 3  
37 . 50 
4 1 . 98 
39 . 82 
28 . 05 
30 . 0 1  + 5 . 66 
27 . 58 
34 . 3 2 
36 . 96 
22 . 09 
27 . 24 
24 . 9 3 
34 . 8 1  
1 6 . 03 + 1 1 .  3 2  
27 . 8 7 
27 . 23 
36 . 9 3 
14 . 7 3 
1 9 . 20 
20 . 37 
36 . 1 3 
14 . 40 
1 8 . 40 
25 . 1 3 
37 . 30 
1 9 . 7 7 
2 1 . 5 7 
24 . 70 
9 1  
Table 20 . ( cont inued ) 
Source 
No . of Bedding Wei ghts Confidence 
Code Observations Least Sguares Means (g . )  Level 0 . 05 
2-2-2-2 
3- 1- 1- 1  
3- 1- 1-2 
3- 1-2- 1 
3- 1-2-2 




4- 1 - 1- 1  
4- 1- 1-2 
4- 1-2- 1 
4- 1-2-2 




39 . 7 3 
44 . 40 
27 . 47 
3 1 . 1 7 
40 . 80 
24 . 07 
20 . 80 
28 . 77 
40 . 07 
45 . 20 
36 . 57 
53 . 7 3 
32 . 80 
29 . 80 
47 . 40 
25 . 90 
23 . 30 
92  
Experiment #2 : Study 2 








































Treatment s ( %  DHEA) (Trea tment -Genotype-Sex 
Interaction -- P < 0 . 05 ) . 
0 �------------------------�------�� 0 . 1  0 . 2  0 . 4  0 . 0  
Treatment s ( %  DHEA) 
94 
Male mice at all trea tment levels had higher ac tivities , · especially at 
the 0 . 1 % level , but the margin of numerical difference decreased as the 
amount of DHEA in the diet increased (Table 22 , p .  98 , Treatment-Sex 
Section ) . Young adult AY/AW males possessed the highes t ac tivities . 
AY/AW' s  at both ages and sexes , except young adult AY/AW females , had 
higher ac tivit ies than the ir �/AW counterparts . Young adults ,  other  
than the �/ AW females , had higher  activities than thei r  adult counter­
parts of the same sex and genotype ( Table 22 , p .  9 9 , Age-Genotype-Sex 
Section , and Figure 20 , P • 1 02 ) . 
G6PDH ACTIVITY/g. Hb . 
ANOVA Table 23 , p .  1 03 , reveals  highly significant differences 
( P � O . O l ) in  this measurement of G6PDH act ivity in mice in each treat-
ment leve l ,  age group , and sex .  The 0 . 2% DHEA treatment produced the 
highest  act ivities , 0 . 1  and 0 . 4%  about the same , and 0 . 0% DHEA produced 
the lowest  act ivities ( Table 24 , P • 1 03 , Treatment Sec t ion ) . Young 
adults  had higher  ac tivit ies than adults  ( Table 24 , p .  1 04 ,  Age Section) 
and males had higher act ivities  than females ( Table 24 , P • 1 05 , Sex 
Section ) . 
The signif icant interactions ( ANOVA Table 24 , P • 1 03 )  occur bet-
ween treatment and age (P  � 0 . 0 1 ) ,  be tween treatment and sex ( P � O . O l ) ,  
between genotype and sex (P � O . OS ) , and between age , genotype , and sex 
( P < O . O S ) . The largest  dif ference between the act ivit ies  of adults and 
young adults is at the 0 . 1 %  level . Young adult s had higher activit ies  
at all treatment levels except at  0 . 4% , but the dif ference in activi-
ties at this level is not significant ( Table 24 , P • 1 0 4 , Treatment-Age 
95 
Sect ion , and Figure 2 1 , p .  1 08 ) . Males had higher activit ies at  all 
levels , but the dif ference be tween males and females decreased as DHEA 
levels increased (Table 24 , P •  1 05 , Treatment-Sex Sect ion , and F igure 
22 , P •  1 09 ) . There is a significant difference in the act ivit ies  of 
AW/AW and AY/ AW males , with the AY/AW' s having the higher activi t ies . 
There is no dif ference between AW/AW and AY/AW females ( Table 24 , P • 
1 06 , Genotype-Sex S ection ) . Young adult AY/AW males produced the 
highest  act ivities . AY/AW ' s at both ages and sexes , except young 
adults , other than the AY/AW females ,  had higher activities than their  
adult counterparts  of  the same sex and genotype ( Table 24 , P •  1 06 ,  
Age-Genotype-Sex Section , and Figure 23 , p .  1 1 0 ) .  
Experiment 112 : 
Table 2 1 . ANOVA of G6PDH activity (U/ 1 0 1 2RBC ) . 
Degrees Sum 
of of Mean 
Source Freedom Squares Squares 
Treatment 3 67007 . 7 5 22335 . 92 
Age 1 126587 . 95 1 2 6 587 . 95 
Treatment-Age 3 60386 . 2 3 20 128 . 74 
Genotype 1 2 7743 . 1 8 27 74 3 . 1 8  
Treatment-Genotype 3 326 1 6 . 7 5 1087 2 . 2 5 
Age-Genotype 1 1078 . 54 1078 . 54 
Treatment-Age- 3 5574 . 5 1  1858 . 1 7 
Genotype 
Sex 1 170883 . 1 6 1 70883 . 1 6 
Treatment-Sex 3 4497 5 . 0 1 1499 1 . 67 
Age-Sex 1 26 . 9 3 26 . 93 
Treatment-Age-Sex 3 10449 .48 3483 . 1 6 
Genotype-Sex 1 1 1 942 . 68 1 1 942 . 68 
Treatment-Genotype-Sex 3 142 10 . 85 47 36 . 9 5 
Age-Genotype-Sex 1 29898 . 2 7 29898 . 27 
Treatment-Age- 3 4224 . 59 1408 . 20 
Genotype-Sex 
Error 544 2469095 . 30 4538 . 78 
Study 2 .  
F Values 
4 . 9 2** 
27 . 89** 
4 . 4 3** 
6 . 1 1 * 
2 . 40 
0 . 24 
0 . 4 1  
37 . 65** 
3 . 30* 
0 . 0 1  
0 . 7 7  
2 . 63 
1 . 04 
6 . 59* 
0 . 3 1  
F Tabulated . 05 
2 . 60 
3 . 84 
F Tabulated . 0 1 
3 . 7 8 
6 . 6 3 
\0 0\ 
Table 22 . 
Source 
Treatment : 
( %  DHEA) 










· Genotype : 
• ' 
Experiment 
G6PDH act ivity ( U/ 10 12  
No . of  
Code Observations 
1--o . o  144 
2--0 . 1  
3--0 . 2  


























1- 1- 1  36 
1- 1-2 
1 -2- 1 
1-2-2 
2- 1 - 1  
2- 1 -2 
2-2- 1 
2-2-2 
9 7  
11 2 : Study 2 
RBC ) Leas t Squares Means . 
G6PDH Activity Confidence 
Least Squares Means Level  0 . 05 
( U/ 101 2  RBC )  
397 . 8 7 +1 1 . 00 
4 1 7 . 78 
427 . 6 3 
4 1 1 . 69 
398 . 92 + 7 .  78  
428 . 57 
366 . 94 +15 . 56 
428 . 80 
4 1 0 . 04 
425 . 52 
4 1 1 . 44 
443 . 82 
407 . 25 
4 1 6 . 1 2 
406 . 80 + 7 .  7 8  
420 . 68 
38 7 . 67 +15 . 56 
408 . 07 
400 . 1 3 
435 . 44 
426 . 38 
428 . 89 
4 1 3 . 04 
4 10 . 34 
390 . 6 1  +1 1 . 00 
407 . 23 
423 . 00 
434 . 1 4 
352 . 56 +22 . 0 1  
38 1 . 33 
422 . 79 
434 . 82 
39 2 . 04 
428 . 05 
408 . 22 
442 . 83 
98 
. Table 22 . ( continued ) 
No . o f  G6PDH Activity Confidence 
Source Code Observations Least Squares Means Level 0 . 05 
(U/ 1 01 2  RBC ) 
3- 1 - 1  4 1 3 . 47 
3- 1 -2 409 . 4 2  
3-2- 1 439 . 28 
3-2-2 448 . 36 
4- 1 -1 404 . 38 
4- 1 -2 4 1 0 . 1 2 
4-2- 1 42 1 . 69 
4-2-2 4 10 . 56 
Sex : 1� 288 396 . 52 + 7 .  78  
2CJ 430 . 97 
Treatment- 1 - 1  7 2  37 7 . 93  +1 5 . 56  
Sex : 1-2  4 1 7 . 8 2  
2- 1 390 . 46 
2-2 445 . 1 1  
3- 1 409 . 06 
3-2 446 . 2 1  
4- 1 · 408 . 64 
4-2 4 1 4 . 7 3 
Age-Sex : 1 - 1  144 38 1 . 48 +1 1 . 00 
1-2  4 1 6 . 36 
2- 1 4 1 1 . 56  
2-2 445 . 58 
Treatment- 1 - 1 - 1  36 353 . 1 8 +22 . 0 1  
Age-Sex : 1 - 1 -2 380 . 70 
1 -2-1  402 . 67 
1 -2-2 454 . 94 
2- 1 - 1  378 . 1 3 
2-1 -2 44 1 . 95  
2-2- 1 402 . 78 
2-2-2 448 . 2 7  
3- 1 - 1  393 . 9 2 
3- 1-2 428 . 97 
3-2- 1 424 . 20 
3-2-2 463 . 4 5  
4- 1- 1  400 . 68 
4- 1:-2 4 1 3 . 8 1  
4-2- 1 4 1 6 . 60 
4-2-2 4 1 5 . 6 5  
99 
Table 22 . ( cont inued ) 
No . o f  G6PDH Act ivity Confidence 
Source Code Observations Least Squares Means Level 0 . 05 
( U/ 101 2  RBC) 
Genotype- 1- 1  144 394 . 1 3 +1 1 . 00 
Sex : 1-2  4 1 9 . 47 
2- 1 398 . 9 1  
2-2 442 . 46 
Treatment- 1- 1- 1  3 6  370 . 82 +22 . 0 1  
Genotype- 1- 1-2 404 . 5 2 
Sex : 1 -2- 1 385 . 04 
1-2-2 43 1 . 1 1  
2- 1 - 1  385 . 5 5 
2- 1-2 4 1 4 . 7 1  
2-2-1 39 5 . 36 
2-2-2 47 5 . 5 1  
3- 1 - 1  407 . 1 5 
3- 1-2 445 . 60 
3-2- 1 4 10 . 96 
3-2-2 446 . 8 1  
4- 1 - 1  4 1 3 . 02 
4- 1 -2 4 13 . 06 
4-2-1 404 . 26 
4-2-2 4 1 6 . 4 1  
Age- 1- 1- 1  7 2  370 . 52 +15 . 56 
Genotype- 1- 1-2 4 10 . 70 
Sex : 1-2- 1 39 2 . 44 
1-2-2 422 . 02 
2- 1 -1 4 1 7 . 7 5 
2- 1 -2 428 . 25 
2-2-1 405 . 37 
2-2-2 462 . 9 1  
Treatment- 1 - 1 - 1 - 1  1 8  334 . 30 +3 1 . 1 2 
Age- 1- 1- 1-2 370 . 8 1 
Genotype- 1- 1-2- 1 37 2 . 06 
Sex : 1 - 1-2-2 390 . 59 
1 -2- 1 - 1  407 . 33 
1 -2- 1-2  438 . 24 
1-2-2- 1 398 . 0 1  
1-2-2-2 47 1 . 63 
2- 1 - 1 - 1  370 . 20 
2- 1 - 1 -2 4 1 3 . 88 
2- 1-2- 1 386 .07  
2- 1-2-2 470 . 03 
2-2- 1 - 1  400 . 89 
2-2- 1-2 4 1 5 . 54 
2-2-2- 1 404 . 66 
Table 22 . ( cont inued ) 
Source 
No . o f  
Code Observations 
G6PDH Activity 
Least Squares Means 
1 00 
Confidence 
Level 0 . 05  
( U/ 1 011. RBC )  ------------------------------------�-- ���--------------
2-2-2-2 
3- 1- 1- 1  
3- 1- 1-2 
3- 1 -2- 1 
3- 1 -2-2 
3-2- 1 - 1  
3-2- 1 -2 
3-2-2- 1 
3-2-2-2 
4- 1 - 1 - 1  
4- 1 - 1 -2 
4- 1 -2- 1 
4- 1 -2-2 




480 . 99 
385 . 85 
44 1 . 09 
40 1 . 98 
4 1 6 . 85 
428 . 44 
450 . 1 2 
41 9 . 95 
47 6 . 77 
39 1 . 7 3  
4 1 7 . 0 4  
409 . 64 
4 1 0 . 59 
434 . 3 1  
409 .08  
398 . 88 
422 . 23 
Expe riment #2 : Study 2 
Figure 1 9 .  G6PDH Ac tivity Leas t Squares Means ( U/ 10 12 RBC ) Vs . 
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Experiment #2 : Study 2 
Figure 20 . G6PDH Ac t ivity Least Squares Means ( U/ 1 0 12  RBC ) Vs . 
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Experiment 112 : 
Table 23 . ANOVA of G6PDH Activity (U/g Hb ) . 
Degrees Sum 
of of Mean 
Source Freedom Squares Squares 
Treatment 3 1 94 . 7 1  64 . 90 
Age 1 1 2 1 . 07 1 2 1 . 07 
Treatment-Age 3 1 7 5 . 00 58 . 33 
Genotype 1 23 . 1 3 23 . 1 3 
Treatment -Genotype 3 58 . 58 1 9 . 53 
Age-Genotype 1 1 7 . 94 1 7 . 94 
Treatment-Age- 3 32 . 07 10 . 69 
Genotype 
Sex 1 495 . 66  49 5 . 66 
Treatment-Sex 3 135 . 70 45 . 23 
Age-Sex 1 5 . 04 5 . 04 
Treatment -Age-Sex 3 45 . 47 1 5 . 1 6 
Genotype-Sex 1 44 . 38 44 . 38 
Treatment-Genotype-Sex 3 33 . 2 1  1 1 .07  
Age-Genotype-Sex 1 57 . 57 57 . 5 7 
Treatment-Age- 3 20 . 24 6 . 7 5 
Genotype-Sex 
Error 544 5 1 7 3 . 42 9 . 5 1  
Study 2 .  
F Values 
6 . 82** 
1 2 . 7 3** 
6 . 1 3** 
2 . 43  
2 . 05 
1 . 89 
1 . 1 2 
52 . 1 2** 
4 . 7 6** 
0 . 53 
1 . 59 
4 . 6 7* 
1 . 1 6 
6 . 05* 
0 . 7 1  
F Tabulated . 05 
2 . 60 
3 . 84 
F Tabulated . 0 1 
3 . 7 8 
6 . 63 
....... 
0 w 
Experiment 112 : Study 2 
Table 24 . G6PDH Ac tivity ( U/g .  Hb) Least Squares Means . 
No . o f  G6PDH Act ivity 
Source Code Observations Least Squares  Means 
(U/ 101 2  RBC )  
Treatment : 1 --o . o  144  20 . 49 
( %  DHEA) 2--0 . 1  2 1 . 5 1 
3--0 . 2  22 . 10 
4--0 . 4  2 1 . 49 
Age : !--Adult s 288 20 . 94 
2--Young 2 1 . 86 
Adult s 
Treatment- 1 - 1  7 2  1 9 . 20 
Age : 1-2  2 1 . 7 7 
2- 1 2 1 . 48 
2-2 2 1 . 54 
3- 1 2 1 . 4 7  
3-2 22 . 7 4 
4- 1 2 1 . 60 
4-2 2 1 . 3 8 
Genotype : lAY/AW 288 2 1 . 20 
2Aw/Aw 2 1 . 60 
Treatment- 1 - 1  72  20 . 22 
Genotype : 1 -2 20 . 7 5 
2- 1 20 . 82 
2-2 22 . 2 1  
3- 1 22 . 1 6 
3-2 22 . 05 
4- 1 2 1 . 60 
4-2 2 1 . 38 
Age- 1 - 1  1 44 20 . 56 
Genotype : 1-2  2 1 . 3 2  
2- 1 2 1 . 8 3 
2-2 2 1 . 88 
Treatment- 1- 1- 1  3 6  18 . 44 
Age- 1- 1-2 1 9 . 97 
Genotype : 1-2-1  22 . 0 1  
1-2-2 2 1 . 53 
2- 1 -1 20 . 8 2  
2- 1 -2 22 . 1 4 
2-2-1 20 . 8 1  
2-2-2 22 . 2 8 
104 
Confidence 
Level  0 . 05  
+ o. s o  
+ 0. 36  
+ o.  7 1  
+ 0 . 36  
+ o. 7 1  
+ 0 . 50  
+ 1 . 0 1  -
Table 24 . ( cont inued ) 
No . o f  
Source Code Observations 








Sex : 10  288 
2o 
Treatment- 1 - 1  7 2  











Treatment- 1 - 1 - 1  36 
Age-Sex : 1- 1-2 
1 -2- 1 
1 -2-2 




3- 1 - 1  
3- 1 -2 
3-2- 1 
3-2-2 





Least Squares Means 
(U/ 1 0l1. RBC)  
2 1 . 58 
2 1 . 36 
22 . 7 3 
22 . 74 
2 1 . 4 1  
2 1 . 79 
2 1 . 78 
20 . 98 
20 . 47 
22 . 33 
1 9 . 06 
2 1 . 9 1 
20 . 23 
22 . 79 
2 1 . 28 
22 . 93 
2 1 . 3 1  
2 1 . 67 
20 . 1 1  
2 1 . 7 7 
20 . 84 
22 . 88 
18 . 34 
20 . 07 
19 . 78 
23 . 7 5 
20 . 05 
22 . 9 1  
20 . 4 1 
22 . 68 
20 . 7 1 
22 . 23 
2 1 . 84 
23 . 64 
2 1 . 3 2 
2 1 . 88 
2 1 . 3 1  
2 1 . 4 5  
1 05 
Confidence 
Level 0 . 05 
+ 0 . 36 
+ o. 7 1  
+ o. so 
+ 1 . 0 1  -
1 06 
Table 24 . ( cont inued ) 
No . o f  G6PDH Act ivity Confidence 
Source Code Observations Least Squares Means Level  0 . 05 
(U/ 1 0 1 2  RBC ) 
Genotype- 1-1  144  20 . 55 + 0 . 5 0  
Sex : 1-2  2 1 . 85 
2- 1 20 . 39 
2-2 22 . 80 
Treatment- 1 - 1 - 1  36 18 . 7 9 + 1 . 0 1  
Genotype- 1- 1-2 2 1 . 66 
Sex : 1-2- 1 19 . 34 
1 -2-2 22 . 1 6  
2- 1 - 1  20 . 1 6 
2- 1 -2 2 1 . 47 
2-2- 1 20 . 30 
2-2-2 24 . 1 2 
3- 1 - 1  2 1 . 4 7  
3- 1 -2 22 . 85 
3-2- 1 2 1 . 08 
3-2-2 23 . 02 
4- 1 - 1  2 1 . 78 
4- 1 -2 2 1 . 4 2  
4-2- 1 20 . 85 
4-2-2 2 1 . 9 2 
Age- 1- 1- 1  7 2  1 9 . 69 + o .  7 1  
Genotype- 1- 1 -2 2 1 . 44 
Sex : 1 -2- 1 20 . 5 2 
1-2-2  22 . 1 1 
2- 1 - 1  2 1 . 40 
2- 1 -2 22 . 26 
2-2- 1 20 . 2 7 
2-2-2 23 . 50 
Treatment- 1- 1- 1- 1  18  1 7 . 4 9  + 1 . 42  -
Age- 1- 1- 1-2 1 9 . 38 
Genotype- 1-1-2- 1 1 9 . 1 9 
Sex : 1 - 1-2-2 20 . 7 5  
1-2- 1 - 1  20 . 09 
1-2- 1 -2 23 . 93 
1-2-2-1  1 9 . 48 
1-2-2-2 23 . 57 
2- 1 - 1 - 1  19 . 82 
2- 1 - 1 -2 2 1 . 83 
2- 1 -2-1  20 . 29 
2- 1 -2-2 24 . 00 
2-2- 1 - 1 20 . 5 1  
Table 24 . ( continued ) 
Source 
No . o f  
Code Observations 
G6PDH Act ivity 
Least Squares Means 
107  
Confidence 
Level  0 . 05 




3- 1- 1- 1  
3- 1- 1-2 
3- 1 -2-1 
3- 1 -2-2 




4-1 - 1 - 1  
4- 1 -1-2 
4- 1-2- 1 
4- 1 -2-2 




2 1 . 1 1 
20 . 3 2 
24 . 24 
20 . 52 
22 . 6 5  
20 . 9 1  
2 1 . 8 1  
22 . 4 2 
23 . 04 
2 1 . 26 
24 . 23 
20 . 94 
2 1 . 88 
2 1 . 70 
2 1 . 89 
22 . 6 1  
20 . 96 
20 . 00 
2 1 . 95 
1 08 
Experiment #2 : Study 2 
Figure 2 1 . G6PDH Activity Leas t Squares Means ( U/g . Hb ) Vs . Treatment s 
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Experiment #2 : Study 2 
Figure 22 . G6PDH Ac tivity Leas t Squares Means ( U/g . Hb )  V s . Treatment s 
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Figure 23 . G6PDH Activity Least Squares Means ( U/g . Hb ) Vs . Age 
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Experiment #2 ,  Study 2 
Table 25 . Experimental Parameter Least  Squares Means of Lethal  Yellow ( AY/AW) and Agout i ( AW/AW) 
Mice Following a 0 . 0% DHEA Diet . 
Female Male 
Parameter- Young Adult Adult  Young Adult Adult Confidence 
Measures AY/AW AWJAW AY/AW AWJAW AY/Aw AWJAW AY/Aw AWJAW Level 0 . 05 
Tota l Mouse 20 . 90 3 . 82 18 . 23 2 . 20 29 . 48 9 . 1 5  1 6 . 7 7  5 . 4 2  + 2 . 84 
Weight Change ( g . ) 
Average Food 55 . 87 42 . 7 7 7 1 . 30 44 . 2 3 83 . 23 50 . 60 84 . 2 7 63 . 5 7 + 1 1 . 20 
Consumption ( g . ) 
Average Bedding 20 . 37 14 . 7 3 27 . 23 1 6 . 03 36 . 1 3 1 9 . 20 36 . 93 27 . 8 7 + 1 1 . 3 2 
Weight ( g . ) 
G6PDH Activity 
/ 10 12 RBC 398 . 0 1  407 . 3 3 37 2 . 06 334 . 30 47 1 . 63  438 . 24 390 . 59 370 . 8 1  + 3 1 . 1 2 




Experiment #2 , Study 2 
Table 26 . Experimental Parameter Least Squares Means of Lethal  Yellow ( AY/AW} and Agout i { AW/AW} 
Mice Following a 0 . 1 %  DHEA Diet . 
Female Male 
Parameter Young Adult Adult Young Adult Adult  Conf idence 
Measures AY/AW AW/AW AY/AW AW/AW AY/AW AW/AW AY/AW AW/AW Level 0 . 05 
Total Mouse 1 2 . 1 7 4 . 38 6 . 6 5 2 . 4 5 25 . 08 9 . 5 5 16 . 80 5 . 1 0 + 2 . 84 -
Weight Change ( g . ) 
Average Food 58 . 60 47 . 53 59 . 60 40 . 67 9 1 . 30 55 . 63 88 . 60 5 1 . 40 + 1 1 . 20 -
Consumption ( g . )  
Average Bedding 24 . 70 19 . 7 7  25 . 1 3 14 . 40 39 . 7 3 2 1 . 57 37 . 30 18 . 40 + 1 1 . 3 2 
Weight ( g . ) 
G6PDH Activity 
/ 10 12 RBC 404 . 66 400 . 89 386 . 07 370 . 20 480 . 99 41 5 . 54 470 . 03 4 1 3 . 88 + 31 . 1 2 




Experiment #2 , Study 2 
Table 27 . Experimental Parameter Least  Squares Means of Lethal Yellow ( AY/AW) and Agout i  ( AWfAW) 
Mice Following a 0 . 2% DHEA Diet . 
Female Male 
Parameter Young Adult Adult Young Adult Adult Confidence 
Measures AY/AW AW/AW AY/AW AW/AW AY/AW AW/AW AY/AW AW/AW Level 0 . 05 
Total Mouse 1 . 28 3 . 78 - 2 . 42 0 . 60 13 . 70 5 . 52 7 . 20 2 . 6 2  + 2 . 84 -
Weight Change ( g . ) 
Average Food 52 . 83 43 . 4 3 54 . 63 45 . 4 3  85 . 07 50 . 97 83 . 70 60 . 80 + 1 1 . 20 
Consumption ( g . )  
Average Bedding 28 . 7 7  24 . 07 31 . 1 7 44 . 40 40 . 07 20 . 80 40 . 80 27 . 47 + 1 1 . 3 2  -
Weight ( g . ) 
G6PDH Activity 
/ 10 12 RBC 4 1 9 . 95 428 . 44 40 1 . 98 385 . 85 47 6 . 7 7 450 . 1 2  4 1 6 . 85 441 . 09 + 31 . 1 2 




Experiment #2 , Study 2 
Table 28 . Experimental Parameter Leas t Squares Means of Lethal  Yellow ( AY/AW) and Agouti ( AWJAW) 
Mice Following a 0 . 4% DHEA Diet . 
Female Male 
Parameter Young Adult Adult Young Adult Adult  Conf idence 
Measures AY/AW AW/AW AY/AW AW/AW AY/AW AW/AW AY/AW AW/AW Level 0 . 05 
Total Mouse - 3 . 2 3 - 0. 33  -15 . 95 - 2 . 80 - 2 . 9 2 0 . 3 3 - 8. 93  0 . 28 + 2 . 84 -
Weight Change ( g . ) 
Average Food 47 . 80 41 . 10 49 . 80 5 1 . 37 45 . 1 0 68 . 97 55 . 1 7  64 . 07 + 1 1 . 20 
Consumpt ion ( g . ) 
Average Bedding 25 . 90 29 . 80 53 . 7 3 45 . 20 23 . 30 47 . 40 32 . 80 36 . 5 7 + 1 1 . 3 2  
Weight ( g . )  
G6PDH Activity 
/ 1 0 12  RBC 398 . 88 434 . 3 1  409 . 64 39 1 . 7 3  42 2 . 2 3 409 . 08 4 10 . 59 41 7 . 04 + 31 . 1 2 
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DISCUSSION 
More factors and interactions were found to be signif icant in 
this study than in S tudy 1 ,  most  likely because of the di f ferent 
experimental design ( three replicat ions ins tead of one ) and the change 
in the statist ical analysis that this would produce (a  decreas e  in the 
error terms ) .  In addit ion , some factors and interactions that were 
significant in S tudy 1 are not significant in S tudy 2 ,  and vice versa , 
presumably due to biological  variat ion and perhaps the improved sta-
tistical  analysis . 
Again , as in S tudy 1 , mouse weight changes were mo re affected by 
interactions as compared to the othe r parameters measured  in S tudy 2 .  
And , like S tudy 1 ,  Study 2 confirms the fact that dietary DHEA t reat-
ments do af fect  the weight changes of yellow mice di f ferent ly than the 
weight change of agouti mice . In both the adult and young adult mice 
there is a signif icant dif ference between AY/AW and AW/AW mice of both - - - -
sexes in weight change as DHEA treatment levels  increased (P <.. 0 . 0 1 ) .  
AY/AW males and females both demonstrated dramatic decreases in weight 
as the amount of DHEA increased in their diets , while AWJAW males and 
females , also  los ing weight , did not do so as dramatically as the �Y/AW 
mice ( Figures  24  and 25 , PP • 1 1 8 and 1 1 9 ) .  Males and young adults 
generally gained more weight than females and adult s ( P < 0 .  0 1 ) .  
At the same time , food consumption stayed generally stable at the 
lower DHEA levels  ( 0 . 1  and 0 . 2 % )  f or both genotypes , changing most 
dramatically at  the 0 . 4% level (AW/AW ' s ate more and AY/ AW ' s  ate 
less ) .  There is a signif icant difference between the consumpt ion of 
1 1 6  
the two genotypes ) with the AY/AW ' s  generally consuming more  ( P � 0 � 0 1 ) . 
There is also  a significant diffe rence ( P  <. 0 . 0 1 ) be tween the consump­
tion at the different treatment levels ( 0 . 4% DHEA mice ate the leas t ,  
0 . 0% ate the mos t )  of  each sex (males ate more than females ) (Figures  
26 and 2 7 , pp . 1 20 and 1 2 1 ) . 
S tudy 2 ' s  analysis of variance showed that bedding weight 
increased significant ly ( P �  0 . 0 1 )  with increased treatment levels . 
Also , AY I AW mice had significant ly higher bedding weights  ( �  � 0 . 0 1 ) 
than �/AW mice , and adults had heavier bedding than young adults  
( P  L0 . 05 )  (Figures  28 and 29 , pp . 1 22 and 1 23 ) .  
The purpose for collect ing these bedding weight data  was to com­
pare the urinary and fecal output of yellow and agouti  mice at the dif­
ferent treatment levels . This analysis was not quantitatively 
accurate , howeve r ,  because of the fact that the total input was not 
measured ( the amount of water consumed should have been measured as 
well as food consumption ) . Also ce rtain mice , especially AY/� males , 
fought among themselves and habitually ground up their food mo reso 
than other mice . This was te food would accumulate in large amounts in 
the bedding . If the feces and urine of these animals could have been 
collected and weighed separately , this analysis would have been more 
accurate . 
On a qualitative basis , however , it did seem like more of the 
AY/AW adult females on 0 . 4% DHEA had excess mois ture in thei r  bedding 
opposite the end where drinking water was supplied to the cage and 
1 1 7 
tha t , overall , the 0 . 4% DHEA cages of all the mice were more mois t than 
other cages , indicat ing a probable increase in urinary output due to 
DHEA , while input of  wate r did not seem to increase . 
A significant dif ference ( P  .c.. 0 . 05 )  exists  be tween G 6PDH 
activities / 1 0 1 2  RBC in yellow mice as compared to agouti  mice ( AY/ AW ' s  
had higher ac tivities ) ,  but no such difference was found for G 6PDH 
activities /g .  Hb . The difference in the results given by the two types 
of activit ies  mos t  likely is caused by the inherent dif ference be t ween 
RBC measurements and hemoglobin measurement s -- they  rarely corre late  
perfectly .  For  examp le , the hemoglobin concent ra t i on may be 1 7 . 0 g /dL 
for one sample of blood and 1 6 . 5  g /dL for anothe r ,  whi le each samp le 
has the same RBC count . The two types of G6PDH measurement s both 
reveal significant di f ferences ( P  � 0 . 0 1 )  between treatments ( generally 
as the amount of DHEA increased , activity also increa s ed ) , ages  ( young 
adult s had higher ac tivities ) ,  and sexes (males had higher act i vi t ies ) 
{ Figures 30-33 , PP • /21( -/�T) . 
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Experiment #2 : Study 2 
Adult Mice Weight Change Least Squares Means ( g . ) 
Vs . Treatments ( %  DHEA) (Treatment-Age-Genotype-Sex 
Interact ion ) 
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Treatment s ( %  DHEA) 
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0 . 4  









































Experiment # 2 :  S tudy 2 
Young Adult Mice Wei ght Change Least Squares Means ( g . ) 
Vs . Treatments ( %  DHEA) (Treatment-Age-Genotype-Sex 
Interaction ) 
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Experiment #2 : Study 2 
Figure 26 . Adult Mice Average Food Consumption Leas t Squares Means ( g . ) 
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Experiment #2 : Study 2 
Figure 27 . Young Adult Mice Average Food Consumpt ion Leas t Squares 
Means ( g . ) Vs . Treatments ( %  DHEA) 
( Treatment-Age-Genotype-Sex Interaction ) 
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Experiment #2 : Study 2 
Figure 28 . Adult Mice Average Bedding Leas t Squares Means ( g . ) 
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Experiment #2 : Study 2 
Figure 29 . Young Adult Mice Average Bedding Least  Squares Means 
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Figure 30 . 
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Experiment #2 : Study 2 
Adult Mice G6PDH Activity Leas t Squares Means 
(U/ 1 0 1 2 RBC ) Vs . Treatments ( %  DHEA) (Treatment -Age­
Genotype-Sex Interaction)  
0 . 0  0 . 1  0 . 2  
Treatment s ( %  DHEA) 
124 
0 . 4  
1 2 5  
Expe riment #2 : Study 2 
Figure 3 1 . Young Adult Mice G6PDH Activity Least  Squares ��ans 
( U/ 1 0 1 2  RBC ) Vs . Treatments ( %  DHEA) (Treatment-Age­
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Experiment #2 : Study 2 
Figure 32 . Adult Mice G6PDH Activity Least Squares Means ( U/ g .  Hb . ) 
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Experiment #2 : Study 2 
Figure 33 . Young Adult Mice G6PDH Activity Least  S quares Means 
(U/g . Hb . )  V s .  Treatment s ( %  DHEA) (Treatment -Age­
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OVERALL DISCUSS ION 
Data from these  studies show that dietary DHEA has an ef fect 
on G6PDH activity in the blood of mice but not in the manner expected . 
Since DHEA has been proven to be a non-competitive inhibitor of G6PDH 
in vitro , it seems cont radict ory that G6PDH activity in blood extracts  
would increase as  DHEA dietary treatment levels . It may be that the 
red blood cells are compensating for the increase in DHEA by producing 
higher amounts of G6PDH in re turn . This compensatory ef fect could 
explain the increase  in G6PDH act ivity but no t the fact that DHEA has 
an ant i-obesity effect by de creas ing weight gain . 
The possibi lity that the G6PDH assay used is inaccurate  was con­
sidered , but consis tent results over a year-long period of experimen­
tat ion seemed to counter that argument . The presence of DHEA in the 
blood , however , may have interfered with the react ions used in the 
assay , causing inaccuracies . It  would be wise to tes t  this theory by 
repea ting the as say with dis s olved DHEA mixed art ificially with the 
blood samples  and reactants .  This would detect whethe r small  amounts 
of DHEA interfere with the S i gma G6PDH assay and conf i rm the accuracy 
of earlie r reports that G6PDH is actually inhibited by DHEA . 
Earlier reports  state that DHEA decreases weight gain in mice and 
rats  with no ef fect on food intake , usually . Present studies · seem to 
cont radict those findings as well .  Weight gain decreased in yellow 
obese mice more dramat ically than in their agouti  li t termates but food 
intake also decreased with increased leve ls of DHEA , especially at the 
0 . 4% level . Other researchers , like those at the Hormel Ins t i tute , 
1 29  
University of Minnesota , Austin , MN ,  and Drexel Univers ity , 
Philadelphia , PA , have found this to be true with obese Zucker rat s  as 
well  ( Clearly et al . ,  1 984 ) . These same res earchers als o  be lieve that 
DHEA ' s  inhibition of G6PDH occurs only in vivo when the level of G6PDH 
enzyme activity is art ificially elevated (in their  experiment , by 
feeding BHE rats  a 65% sucrose diet during DHEA adminis t rat ion and com­
pa!ing their  G6PDH activit ies to cont rol BHE rat activi t ies ) .  They 
also found an increase  in hepatic  long-chain fat ty acyl-CoA hydrolase 
in thei r  DHEA-fed rat s  suggesting that DHEA induces a fut ile cycle of 
fatty acid metabolism as free fatty acids produced by the hydrolase 
would need  the CoA reat tached in an ATP-requiring step ( Billheimer  et 
al . , 1 984 ) .  
Another theory of DHEA action proposed by Coleman et al .  ( 1 983 ) 
is  that DHEA may be converted to an es trogen-like steroid in the 
mouse ' s  body because of DHEA ' s es trogen-like ef fects  on dia be t ic mutant 
mice . It seems that female diabetic mutant s are somewhat res is tant to 
diabetes whi le the males are not . Injections of es trogen , l ike DHEA 
treatment s ,  make the male mice react to the mutant gene exact ly as 
their  mutant sis ters do ( Coleman et al . ,  1 983 ) . However ,  thi s  theory 
does not explain the ant i-obesity ef fect of DHEA. 
The true reason ( s ) f or DHEA ' s anti-obesity , ant i-diabetes ,  anti­
aging , and anti-carcinogenic effects are yet to � elucidated .  P resent 
s tudies have revealed that DHEA may promote a compensatory increase  in 
G6PDH act ivity in red blood cells of mice . Furthermore , present data 
show that DHEA has a different ial ef fect on the weight and food con-
1 30 
sumption of AY/AW mice as compared to their  AW/AW littermates . The 
jl- induced altered  metabolism of AY/AW mice is apparent ly more sus cep­
tible to the ef fects of DHEA than the normal metabolism of AW/� 
mice . How or why this  is true has yet to be discovered . 
OVERALL CONCLUSIONS 
Preceding experiment s show that those mice with the . AY a lle le are 
affected different ly by DHEA than their non-yellow li ttermates who do 
not possess this mutation .  It was thought that the increased  wei ght 
loss  of the yellow obese  mice as compared to the agout is is caused by 
inhibit ion of the G6PDH enzyme . However , data from these  studies show 
an increase in G6PDH act ivity ins tead of the reverse . Interes t ingly 
s tatistically significant ly higher G6PDH activity was observed in the 
yellows as compared to their  agouti siblings . 
This increase in activity may be a compensatory act ion by the 
red blood cells in res ponse to the DHEA ' s inhibition of this important 
metabolic enzyme . It may be caused by interference of the blood 
sample ' s  DHEA with the as say ' s  reactants .  It may be that a de rivative 
of DHEA , another  ste roid produced when DHEA enters the mammalian body , 
causes the increased G6PDH levels . It may be that DHEA does not inhi­
bit G6PDH in in vitro blood extracts . Whatever  the exact reason ,  it is 
s till unknown. 
DHEA ' s ef fect may be more hormonal than metabolic in act ion . It 
is the dif ferent ial effects that DHEA has on males and females , young 
and older mice , and yellow and nonyellow mice that supports this 
notion .  Female , adult ,  and genetically yellow mice seemed to be more 
severely af fected by DHEA ' s anti-obesity ef fects than male , young , and 
nonyellow mice . Coleman ' s  proposal ( 1 983 ) that DHEA may act like 
estrogen in the mammalian body seems to be an at t ractive one . It would 
seem wise for future studies of DHEA and it s effects  on the yellow 
obese mouse to cons ider  that avenue of research . 
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PHOTOGRAPHI C INDEX 
AY/ AW Cont rol vs . AY/AW 0 . 4%  (Adult�� ) . 
AW/AW Cont rol vs . AW/AW 0 . 4% (Adult�9 ) . 
AY/AW 0 . 4%  vs . AW/AW 0 . 4% (Adult��) . 
AY/ AW Cont rol vs . AY/AW 0 . 4% (Adult�d} . 
AW/ Aw Cont rol vs . AWJAW 0 . 4%  (Adulto�) . 
AY/AW 0 . 4%  vs . Aw/AW 0 . 4% (Adult��) . 
AY/AW Cont rol vs . AY/AW 0 . 4%  (Neonate�9) . 
AW/AW Cont rol vs . AWJAW 0 . 4% (Neonate��) . 
AY/Aw 0 . 4%  vs . AWjAW 0 . 4% (Neonate��) . 
AY/Aw Cont rol vs . AY/AW 0 . 4% (Neonate6�) .  
AW/Aw Cont rol vs . AW/Aw 0 . 4%  (Neonatet3) .  
AY/AW 0 . 4%  vs . AWJAW 0 . 4% (Neonate�6) .  
Overall  cage arrangement . 
Close-up of cage arrangement . 
Food wei ghing . 
1 3 2  
Soiled  bedding being poured from cage to wei ghing basket . 
Weighing of soiled bedding . 
Ret ro-orbital bleeding . 
Mixing 1 0 . 0  uL tes t blood with 1 . 0 mL recons titu ted G6PDH 
reagent . 
T .  Adding 2 . 0 mL G6PDH substrate solution to blood-reagent 
mixture s ten minutes Later . 
u.  
v .  
w. 
x .  
Y .  
z .  
Reading absorbance on Beckman DU spect rophotometer . 
Adding 20 . 0  uL test  blood to isotonic saline . 
Diluting blood-saline solution ( 1 : 50 , 000 ) with Dual 
Di luter I I I . 
Measuring red blood cell count on Coulter  Counter . 
Adding high-speed stromatolysing and hemoglobin reagent 
to ori ginal blood-saline . 
Determining hemoglobin concent ration with 









D 1 3 3 
E 
F 
G 1 34 
H 







u 1 39 
v 
w 
X 1 4 0  
y 
z 
1. 4 1 
LITERATURE CITED 
Billheimer , J T , s .  Hood , c .  Chanda , and M .  p ,  Cleary . Effect  of 
dehydroepiandros terone ( DHEA) t reatment in sucrose-fed BHE­
female rat s  Federat ion of American Societ ies for Experimental  
Biology P roceedings 43 ( 4 ) : 1 058 . Abstract .  
Bohinski , R .  c. 1 979 . Modern Concepts in Biochem� . 3rd Ed . 
Allyn and Bacon , Inc . , Bos ton . P .  406 . 
Bray , G . , and York . 1 979 . Obesity in experimental animals : an 
aut omat ic and endocrine hypotheses . Phys iol . Rev. 5 9 : 7 1 9 . 
Butler , R . N .  1 98 1 . u .  s .  News and World Report . 9 1 ( 8 ) : 3 5 . 
Interview . 
Calarco , P .  G . , and R .  A. Pedersen.  1 976 . Ultras tructura l  observa­
t ions of lethal  yellow ( AY/AY )  mouse embryos . J .  Embryol . Exp . 
Morphol . 3 5 : 7 3 .  
Carpenter , K .  J . , and J .  Mayer . 1 958 . Physiologic observat ions on 
yellow obesity in the mouse . Amer . J .  Physiol . 1 93 : 4 9 9 . 
Cas t le ,  w. E .  1 94 1 . Influence of certain color mutations on body 
size in mice , ra t s ,  and rabbits . Genet ics . 2 6 : 1 77 .  
Cas t le , w. E . , and c .  c .  Lit t le . 1 9 10 .  On a modified Mendelian 
rat i o  among yellow mice . Science . 3 2 : 868 . 
Cizadlo , G .  R . , N .  H .  Granholm , and G .  w. Bown. 1 97 6 . A pre liminary 
report on the ef fect of the AY allele on respira tory rate  in 
mice . Proc . s .  D .  Acad .  Sci . 55 : 1 79 . Abs tract .  
Cizadlo , G .  R . , N . H .' Granholm , and R .  c .  Wagers . 1 97 7 . Aberrant 
body temperature regulat ion in obese yellow ( AY/a ) mice . Proc . 
s .  D . Acad . Sci . 56 : 1 59 . 
Cleary , M. P . , N .  Fox , B . Laz in ,  and J .  T .  Billheimer . Comparison of 
the ef fec t  of dehydroepiandros terone ( DHEA) and food res trict ion 
on growth in the Zucker obe se rat .  Federat ion of American 
Societ ies for Experimental Biology P roceedings 43 ( 4 ) : 1 060 . 
Abstract . 
Coleman , D .  L .  1 984 . Personal Communication .  
Coleman , D .  L . , E .  H .  Lei ter , and R .  w .  Schwiz er . 1 982 . Therapeutic  
e ffects  of  dehydroepiandrosterone ( DHEA) in diabe t ic mice . 
Diabetes . 3 1 : 830 . 
1 42  
Coleman , D .  L . � R .  w .  Schwizer , and E .  H .  Leiter . 1 983 . Effect of 
genetic  background on the therapeutic ef fects of dehydro­
epiandrosterone ( DHEA) in diabetes-obesity mutant s and in aged 
normal mice . Diabetes . 33 : 26+ .  Preprint . 
Cuenot , L .  1 905 . Les races pures et leurs combinais ons che z  le s 
souris ( 4menote ) .  Arch . Zoo! . Exp . Gen . 4e Ser . 3 : 1 2 3 . 
Dagley , s . , and D .  E .  Nicholson . 1 970 . 
Pathways . John Wiley & Sons , Inc . 
An Introduction to Metabolic 
New York . P .  1 26 .  
Dickie , M .  M. , and G .  Wooley . 1 946 . The age factor in wei ght of 
yellow mice . J .  Heredity . 3 7 : 365 . 
Danforth , c. H .  1 927 � Hereditary adiposity in mice . J .  Hered . 1 8 :  
1 53 . 
Deringer , M.  K .  1 970 . Influence of the lethal yellow ( AY )  gene on the 
development of ret icular neoplasms . J .  Nat . Cancer Ins t . 4 5 : 
1 205 . 
Dickerson , G .  E . , and J .  w. Gowen . 1 946 . Food ut ilizat ion in 
gene t ic obesity  of mice . Genetics . 3 1 : 2 1 4 .  Abs t ract . 
Dickerson , G .  E . , and J .  w. Gowen . 1 947 . 
efficient food utilizat ion in mice . 
Hereditary obesity and 
Science . 1 05 : 49 6 . 
Eaton , G .  J .  1 968 . St imulation of trophoblas tic giant cell  differen­
tiat ion in the homozygous yellow mouse embryo . Gene t ica . 3 9 : 3 7 1 . 
Eaton , G .  J . , and M .  M. Green . 1 962 . Implantat ion and lethality of 
the yellow mouse . Genet ica . 3 3 : 1 06 . 
Eaton , G .  J . , and M .  M .  Green . 1 963 . Giant cell different iat ion and 
lethality of homozygous yellow mouse embryos . Genetica .  3 4 : 1 55 . 
Ganong , w. F .  1 979 . Review of Medical Physiology . 9 th Ed . Lange 
Medical Publications , Los Altos , CA . P .  2 82 . 
Gluecksohn-Waelsch , s .  1 9 79 . Genetic  control of morphogenetic  and 
biochemical different iat ion : Lethal albino deletions in the 
mouse .  Cell . 1 6 : 2 25 . 
Granholm , N .  H . , and P .  M. Johnson . 1 9 78 . Enhanced ident if icat ion 
of lethal  yellow ( AY/AY )  mouse embryos by means of delayed 
development of four-cell  stages . J .  Exp . Zoo! . 2 05 : 3 2 7 . 
Granholm , N .  H . , and K .  T . Brock . 1 980 1 Ef fect of the le tha l  
yellow gene ( AY )  o n  mat ing preference in C57BL/6J-AY mice . 
Proc . S . D .  Acad . Sci . 59 : 1 56 . 
1 43  
Green , M. c .  1 96 6a .  Mutant genes and linkages : Biology of the 
Laboratory Mouse , 2nd ed . ,  edited by E .  1 .  Green . McGraw-Hill , 
New York , P .  8 7 . 
Gruneberg , H .  1 952 . The Genetics of the Mouse 2nd ed . Ni jhoff ,  
The Hague . 
Hausberger , F .  X . , and B .  Hausberger . 1 960 . The et iologic mechanism 
of some forms of hormonally induced obesity . Am. J .  Clin . 
Nutrition . 8 : 67 1 . 
Hellerstrom , C . , and B .  Hellman . 1 963 . The is let s  of Langerhans in 
yellow obese  mice . Metabolism. 1 2 ( 6 ) : 527 . 
Henderson , E . , A. Schwartz , L .  Pashko , M. Abou-Gharbia , and D .  Swern . 
1 98 1 . Dehydroepiandros terone and 1 6  -bromo-epiandrosterone : 
inhibitors of Epstein-Barr virus-induced transformat ion of 
human lymphocytes . Carcinogenesis . 2 ( 7 ) : 683 . 
Heston ,  w. E .  1 942 . Relationship be tween the lethal  yellow ( AY )  gene 
of the mouse and sus ceptibility to induced pulmonary tumors . 
J .  Nat .  Cancer Inst . 3 : 303 . 
Hes ton ,  w. E .  and M .  K .  Deringer . 1 947 . Relationship be tween the 
letha l yellow ( AY )  gene of the mouse and sus ceptibility to 
spontaneous pulmonary tumors . J .  Nat .  Cancer Inst . 7 : 463 . 
Heston ,  w. E . , and G .  Vlahakis . 1 96 1 a .  Inf luence of the AY gene on 
mammary-gland tumors , hepatomas , and normal growth in mice , 
J .  Nat .  Cancer Ins t . 2 6 : 9 69 . 
Holstein , T . , c .  Stowell , w .  Zuevedo , R .  Zarcaro , and T .  Bieniek! . 
1 9 73 . Peroidase ,  '" p rotyrosinase , "  and the multip le forms of 
tyros inase in mice . Yale J .  Bio i .  Med . 4 6 : 56 0 . 
Holten , D . , D .  P rocsal , and H .  Chang . 1 976 . Regulat ion of pentose 
phosphate pathway dehydrogenases by NADP+/NADPH rat ios . 
Biochemical and B iophysical Research Communicat ions . 6 8 ( 2 ) : 436 . 
Hummel ,  K .  P . , D .  1 .  Coleman , and P .  w. Lane . 1 972 . The inf luence 
of genet ic background on expression of mutat ions at the diabe tes 
locus in the mouse , r .  C57BL/KsJ and C57B1 /6J s trains . Biochem. 
Genet . 7 : 1 .  
Ibsen , H .  1 . , and E . Steiglede r .  1 9 1 7 . Evidence for the death in 
utero of the homozygous yellow mouse, Amer .  Nat . 5 1 : 740 . 
144  
Jackson , E . , D .  Stolz , and R . Mart in . 1 9 79 . Effect of  adrenalectomy 
on weight gain and body compos ition of yellow obese mice C AY/a ) . 
Horm. Metab . Res . 8 : 452 . 
Johnson , L .  L . , and N .  H .  Granholm. 1 978 . In vit ro analysi s  of pre­
and early pos timplantation development�£ le thal  yellow ( AY/AY) 
mouse embryos . J .  Exp . Zoo! . 204 : 38 1 . 
Kas ten , F .  H .  1 952 . Comparative his tological studies of endocrine 
glands of yellow ( AY/a ) and non-agouti ( a /a )  mice in relat ion 
to the problem of he reditary obes ity . Science . 1 1 5 : 647 . 
K�lly , s .  J . , J .  G .  Mulnard , and c .  F .  Graham. 1 978 . 
and cell alloca tion in early mouse development . 
Morpho! . 4 8 : 37 . 
Cell division 
J .  Embryo! .  Exp . 
Kirkham , w. B .  1 9 1 9 . The fate of homozygous yellow mice . J .  Exp . 
Zool . 2 8 : 1 25 . 
Lehninger ,  A. L .  1 982 . Principles of Biochemistry.  Worth Publishers , 
Inc . , New York . P .  4 57 . 
Lopez-S ,  A. , and w .  Krehl . 1 967 . A pos sible interrelat ion be tween 
glucose-6-phosphate dehydrogenase and dehydroepiandros te rone 
in obesity . Lancet .  2 : 485 . 
Marks , P .  H . , and J .  Banks . 1 960 . Inhibition of mammalian glucose-
6-phosphate dehydrogenase by steroids . Proc . Nat l .  Acad . Sci . 
u . s . A .  4 6 : 447 . 
Marshall , N . , Andrus , and J .  Mayer . 1 957 . 
of experimental  obesity in the mouse . 
1 89 : 343 . 
Organ wei ghts in three forms 
Am .  Jour .  Physiol . 
Mayer , J .  1 960 . The obese-hype rglycemic syndrome of mice as an 
example of "metaboli c "  obesity . Am .  J .  o f  Clin . Nut ri t ion .  8 : 7 1 2 .  
Papaioannou , v .  E . , and R .  L .  Gardner . 1 976 . Discussion ( Table 1 ) :  
Embryogenesis  in Mammals . Ciba Foundation Sympos ium 40  ( new 
series ) .  Elsevier/Excerpta Medica/North-Holland , Amsterdam 
p .  232 . 
Papaioannou , v .  and R .  L .  Gardne r .  1 979 . Investigat ions of the lethal  
yellow AY /AY embryo using mouse chimeras . J .  Embryo! . Exp . 
Morpho! . 5 2 : 1 53 . 
Pedersen , R.  A. 1 974 . 
embryos in vit ro . 
Development of le thal yellow ( AY/AY )  mouse 
J .  Exp . Zool . 1 88 : 307 . 
1 4 5  
Pede rsen,  R .  A. , and A .  I .  Spindle . 1 976 . Genetic - ef fects  on 
mammalian development during and af ter implantat ion : Embryo­
genesis in Mammals . Ciba Foundation Symposium 40 ( new series ) 
Elsevier/Exce rpta Medica/North-Holland , Amsterdam P .  1 33 .  
Pedersen , R .  A. , and A .  I .  Spindle . 1 98 1 . Cellular and genet ic 
analysis of mouse blastocys t development : Cellular and Molecular 
Aspects  of  Implantation edi ted by s .  R. Glasser  and D .  w. 
Bullock . Plenum Publishing Corp . 
Raineri , R. , and H .  R .  Levy . 1 9 70 . On the specificity of steroid 
interaction with mammary glucose 6-phosphate dehydrogenase . 
Biochemis t ry .  9 ( 1 1 ) : 2 233 . 
Riley , v .  1 960 . Adaptat ion of orbital bleeding technic to rapid 
serial blood studies . Proc Soc.  Exp . Bio . and Med .  1 04 : 7 5 1 . 
Robe rt s on ,  G .  G .  1 94 2a .  An analysis of the development of homozygous 
yellow mouse embryos . J .  Exp . Zool . 89 : 1 97 . 
Robert s on ,  G .  G .  1 942b .  Increased viability of homozygous yellow 
mouse embryos in new uterine environment s .  Genet ics . 2 7 : 1 6 6 . 
Abs t ract . 
Schwart z , A. G .  1 979 . Inhibition of spontaneous breast  cancer  
format ion in female C3H( Avy/a ) mice by long-term treatment with 
dehydroepiandros terone . Cancer Research . 39 : 1 1 2 9 . 
Schwart z , A. G . , G .  C.  Hard , L .  L .  Pashko , M. Abou-Gharbia , and D .  
Swern . 1 98 1 . Dehydroepiandros terone : an ant i-obes i ty and 
ant i-carcinogenic agent . Nutrit ion and Cance r . 3 ( 1 ) : 4 6 . 
Schwart z , A. G . , and R .  H .  Tannen . 1 98 1 . Inhibition of 7 , 1 2-
dimethylbenz [ a ] anthracene- and urethan-induced lung tumor 
formation in A/J mice by long-term treatment with dehydroepian­
drosterone . Carcinogenesis . 2 ( 1 2 ) : 1 335 . 
Searle , A. G . , c .  v .  Beechey , E .  M. Eicher , M. N .  Nesbit t , and L .  L .  
Washburn . 1 9 79 . Colinearity in the mouse genome : A study of 
chromosome 2 .  Cytogenet . Cell Genet . 2 3 : 255 . 
S ilberberg , R . , and M .  Si lberberg . 1 957 . Lesions in "yellow" mice 
fed stock , high fat , or high-carbohydrate diets . Yale J . 
Biol . Med .  2 9 : 525 . 
Silvers , w .  K .  1 979 . The Coat Colors o f  Mice : A Model for Mammalian 
Gene Ac tion and Interaction .  Springer-Verlag , New York . Pp . 6-7 .  
Sonka , J . , and J . Gregorova . 1 965 . J .  Physio . ,  Paris 56 : 6 50 . 
The Quant itat ive Ultraviolet Kinetic Determinat ion oi' G lucos e-6-
Phosphate Dehydrogenase ( G6PDH ) in Blood at 340 nm. Sigma 
Technical Bullet in No . 3 4 5-UV . Revised Aug . 1 982 . Sigma 
Chemical Co . , St . Louis . 
Vlahakis , G . , and W .  E .  Heston .  1 963 . Increase in induced skin 
tumors in the mouse by the lethal yellow gene ( AY ) . J .  Nat . 
Cancer Inst . 3 1 : 1 89 . 
146  
Wallace , M. E .  1 954 . A mutat ion or a crossover in the house mouse . 
Heredity . 8 : 8 9 . 
Wang , D .  Y . , R .  D .  Bulbrook , M. Herian , J .  1 .  Hayward . 1 97 4 . 
S tudies on the sulphate es ters of dehydroepiandros terone and 
androsterone in the blood of women with breas t  cancer . Eur . 
J .  Cancer . 1 0 : 47 7 . 
Weitze , M. 1 940 . Hereditary adiposity in mice and the cause of the 
anomaly . University of Copenhagen , Copenhagen . Ph . D .  Thesis . 
Wolff , G .  1 .  1 963 . Growth of inbred yellow (AY/a)  and non-yellow 
(�/a ) mice in parabiosis . Genet ics . 48 : 1 0 4 1 . 
Wolff , G .  L .  1 97 1 . 
in the mouse . 
Genetic modification of homeos tat ic regulation 
Am. Nat .  1 05 : 24 1 . 
Wolff , G .  1 . , and A .  Bartke . 1 966 . 
in yellow ( AY/a ) female mice . 
Decreased survival of embryos 
J .  Hered .  5 7 : 1 4 .  
Yen , T .  T . , J .  A. Allan , D .  v .  Pearson , J .  M. Acton and M .  M. Greenbe rg . 
1 9 7 7 . Prevent ion of obesity and Avy/a mice by dehydroepiandro­
s terone . Lipids 1 2 ( 5 ) : 409 . 
Zomzely ,  D .  and J .  Mayer . 1 959 . Fat metabolism in experimental  
obesities . Am .  Jour . Physiol . 1 96 : 6 1 1 .  
Expe r i ment I 1 
Append i x  Table 1 .  Body Wei ght  Data  and D i f f e re nces in We i gh t  f rom Week to Week { in grams ) . 
Mouse Week 
I 0 Week 1 Week 2 
60-day-old { Ad u l t s ) on 0 . 0% DHEA 
Week 3 Week 4 Week 5 Week 6 Week 7 Week 8 Week 9 
Tot a l  
We i gh t  
Week 1 0  Cha nge 
AY / Aw 1 24 . 7  22 . 3 { - 2 . 4 )  2 5 . 4 {  3 . 1 )  28 . 1 {  2 . 7 )  2 5 . 5 { -2 . 6 )  26 . 2 {  o . 7 )  30 . 1 {  3 . 9 )  26 . 6 { -3 . 5 )  25 . 2 { - 1 . 4 )  25 . 2 {  o . o )  24 . 2 { - 1 . 0 )  -o . 5  
2 24 . 1  2 1 . 7 ( - 2 . 4 )  2 5 . 8 (  4 . 1 )  2 7 . 6 {  1 . 8 )  26 . 5 { - 1 . 1 )  2 6 . 3 { -0 . 2 )  29 . 6 {  3 . 3 )  2 5 . 8 { -3 . 8 )  23 . 7 ( -2 . 1 )  24 . 1 (  0 . 4 )  2 2 . 3 ( - 1 . 8 )  - 1 . 8  
3 29 . 5  25 . 7 ( -3 . 8 )  30 . 4 (  4 . 7 )  32 . 6 (  2 . 2 )  30 . 5 ( -2 . 1 )  3 1 . 3 ( 0 . 8 )  3 5 . 3 ( 4 . 0 )  2 9 . 7 { -5 . 6 )  2 7 . 3 ( -2 . 4 )  2 5 . 0 ( -2 . 3 )  2 1 . 8 { -3 . 2 )  -7 . 7  
4 25 . 7  23 . 8{ - 1 . 9 )  2 7 . 5 (  3 . 7 )  30 . 0 (  2 . 5 ) 2 5 . 2 { -4 . 8 )  28 . 7 (  3 . 5 )  3 1 . 7 ( 3 . 0 )  26 . 2 { -5 . 5 )  26 . 1 ( -D . 1 )  26 . 0 ( -Q . 1 )  24 . 6 ( - 1 . 4 )  - 1 . 1  
5 30 . 2  27 . 4 ( - 2 . 8 )  3 1 . 3 { 3 . 9 )  34 . 2 (  2 . 9 )  30 . 0{ -4 . 2 )  3 1 . 3 { 1 . 3 )  35 . 7 ( 4 . 4 )  28 . 7 { -7 . 0 )  28 . 1 ( -Q . 6 )  29 . 1 { 1 . 0 )  27 . 3 { -1 . 8 ) -2 . 9  
AWjAW 6 20 . 3  2 1 . 6 { 1 . 3 )  24 . 6 (  3 . 0 )  26 . 4 {  1 . 8 )  26 . 5 { 0 . 1 )  2 9 . 5 {  3 . 0 )  2 9 . 6 {  0 . 1 )  2 5 . 2 { -4 . 4 )  24 . 5 { -Q . 7 ) 2 4 . 8 (  0 . 3 )  24 . 9 {  0 . 1 )  4 . 6  
7 23 . 4  22 . 6 { -0 . 8 )  2 7 . 1 (  4 . 5 )  28 . 6 (  1 . 5 )  2 7 . 3 { - 1 . 3 )  28 . 7 {  1 . 4 )  2 9 . 4 {  0 . 7 )  26 . 3 { -3 . 1 )  26 . 2 { -D . 1 )  2 7 . 4 (  1 . 2 )  26 . 5 { -Q . 9 )  3 . 1 
8 20 . 4  2 1 . 9 ( 1 . 5 )  2 5 . 4 (  3 . 5 )  2 7 . 1 {  1 . 7 )  2 5 . 6 { - 1 . 5 )  2 7 . 8 {  2 . 2 )  2 9 . 6 {  1 . 8 )  26 . 3 ( -3 . 3 )  24 . 8 { - 1 . 5 )  2 5 . 3 (  0 . 5 )  2 5 . 1 ( -Q . 2 )  4 . 7  
9 28 . 1  28 . 0 ( -0 . 1 )  3 2 . 8 ( 4 . 8 )  34 . 4 (  1 . 6 )  32 . 5 { - 1 . 9 )  36 . 0 (  3 . 5 )  36 . 8 (  0 . 8 )  32 . 2 { -4 . 6 )  3 3 . 0 (  0 . 8 )  32 . 6 ( -Q . 4 )  3 3 . 1 (  0 . 5 )  5 . 0  
1 0  1 7 . 2  18 . 2 (  1 . 0 )  20 . 4 (  2 . 2 )  2 2 . 4 ( 2 . 0 )  20 . 4 ( -2 . 0 )  2 3 . 4 (  3 . 0 )  25 . 2 (  1 . 8 )  2 1 . 1 ( -4 . 1 )  20 . 2 ( -0 . 9 )  20 . 6 (  0 . 4 )  2 0 . 2 ( -D . 4 )  3 . 0  
AY / AW 1 1  22 . 8  20 . 7 ( -2 . 1 )  2 4 . 5 ( 3 . 8 )  2 5 . 1 ( 0 . 6 )  2 5 . 5 ( 0 . 4 )  2 5 . 6 (  0 . 1 )  27 . 8 (  2 . 2 )  2 5 . 2 ( -2 . 6 )  2 2 . 5 ( -2 . 7 )  2 2 . 2 ( -Q . 3 )  2 1 . 7 ( -Q . 5 )  - 1 . 1  
1 2  1 8 . 1  16 . 7 ( - 1 . 4 )  1 9 . 8 (  3 . 1 )  2 2 . 0 ( 2 . 2 )  2 2 . 5 ( 0 . 5 )  2 3 . 3 ( 0 . 8 )  24 . 2 (  0 . 9 )  2 2 . 4 ( - 1 . 8 )  20 . 8 ( - 1 . 6 )  2 1 . 0 (  0 . 2 )  1 9 . 9 ( - 1 . 1 )  1 . 8 
1 3  22 . 2  20 . 0 ( - 2 . 2 )  2 2 . 8 (  2 . 8 )  2 4 . 9 (  2 . 1 )  24 . 1 ( -0 . 8 )  2 5 . 5 ( 1 . 4 )  26 . 8 (  1 . 3 )  2 4 . 5 ( -2 . 3 )  2 2 . 2 ( -2 . 3 )  2 2 . 0 ( -Q . 2 )  2 1 . 2 ( -Q . 8 )  - 1 . 0  
1 4  1 8 . 2  1 7 . 7 ( -0 . 5 ) 20 . 1 (  2 . 4 )  2 1 . 3 ( 1 . 2 )  2 1 . 7 ( 0 . 4 )  2 2 . 5 ( 0 . 8 )  24 . 3 (  1 . 8 )  2 2 . 4 ( - 1 . 9 )  20 . 5 ( - 1 . 9 )  20 . 4 ( -Q . 1 )  1 9 . 7 ( -Q . 7 )  1 . 5 
1 5  23 . 4  2 1 . 8( - 1 . 6 )  2 4 . 1 (  2 . 3 )  26 . 5 (  2 . 4 )  2 5, . 4 ( - 1 . 1 )  2 7 . 0 (  1 . 6 )  2 9 . 2 (  2 . 2 )  26 . 9 ( -2 . 3 )  2 3 . 8 ( -3 . 1 )  2 3 . 6 ( -Q . 2 )  2 2 . 7 ( -D . 9 )  -o . 7  
AW/AW 16 18 . 1  1 7 . 2 ( -0 . 9 )  20 . 4 (  3 . 2 )  2 2 . 3 ( 1 . 9 )  2 2 . 3 ( 0 . 0 )  24 . 6 (  2 . 3 )  2 5 . 1 ( 0 . 5 )  2 2 . 6 ( -2 . 5 )  20 . 8 ( - 1 . 8 )  20 . 7 ( -Q . 1 )  2 1 . 5 (  0 . 8 )  3 . 4  
1 7  2 2 . 2  1 9 . 8 ( - 2 . 4 )  2 2 . 1 ( 2 . 3 )  2 3 . 4 (  1 . 3 )  2 3 . 1 ( -0 . 3 )  2 5 . 5 ( 2 . 4 )  25 . 7 (  0 . 2 )  2 3 . 8 ( - 1 . 9 )  2 1 . 0 ( -2 . 8 )  2 1 . 2 (  0 . 2 )  20 . 4 ( -Q . 8 )  - 1 . 8  
1 8  2 2 . 9  22 . 6 ( -0 . 3 )  2 6 � 0 (  3 . 4 )  24 . 8 ( - 1 . 2 )  24 . 2 ( -0 . 6 )  26 . 5 ( 2 . 3 ) 2 5 . 6 ( -0 . 9 )  2 3 . 4 ( -2 . 2 )  2 1 . 7 ( - 1 . 7 )  2 2 . 1 (  0 . 4 )  2 2 . 6 (  0 . 5 )  -o . 3  
1 9  2 2 . 0  21 . 9 ( -0 . 1 )  2 3 . 0( 1 . 1 )  24 . 1 (  1 . 1 )  24 . 1 ( 0 . 0 )  2 5 . 1 ( 1 . 0 )  2 5 . 5 (  0 . 4 )  24 . 5 ( - 1 . 0 )  2 2 . 9 ( - 1 . 6 )  2 3 . 8 (  0 . 9 )  24 . 0 (  0 . 2 )  2 . 0 
20 1 7 . 5  16 . 8 ( -0 . 7 )  1 9 . 2 (  2 . 4 )  20 . 3 (  1 . 1 )  20 . 8 ( 0 . 5 )  2 2 . 3 ( 1 . 5 )  2 2 . 7 (  0 . 4 )  2 1 . 2 ( - 1 . 5 )  1 8 . 6 ( -2 . 6 )  1 8 . 3 ( -Q . 3 )  1 6 . 5 ( - 1 . 8 ) - 1 . 0  
-� " 
Expe r i ment I 1 
Append i x  Ta ble 2 .  Body Wei ght  Data & Di f f e re nces in We i ght  from Week to Week ( i n  gra ms ) . 
Mouse Week 
# 0 Week 1 Week 2 
60-day-old (Adu l t s ) on 0 . 1 %  DHEA 
Week 3 Week 4 Week 5 Week 6 Week 7 Week 8 Week 9 
Tot a l  
We i g h t  
Week 1 0  Change 
AY / Aw 2 1  26 . 4  25 . 1 ( - 1 . 3 )  30 . 1 (  5 . 0 )  3 1 . 4 (  1 . 3 )  32 . 4 (  1 . 0 )  2 7 . 9 ( -4 . 5 )  30 . 9 (  3 . 0 )  30 . 7 ( -Q . 2 )  29 . 6 ( - 1 . 1 )  29 . 3 ( -Q . 3 )  2 5 . 6 ( -3 . 7 ) -Q . 8  
2 2  30 . 8  27 . 4 ( -3 . 4 )  3 1 . 4 (  4 . 0 )  3 2 . 7 (  1 . 3 )  34 . 5 ( 1 . 8 )  20 . 7 ( - 1 3 . 8 ) 34 . 1 ( 1 3 . 4 )  3 2 . 6 ( - 1 . 5 )  3 1 . 4 ( - 1 . 2 ) 30 . 0 ( - 1 . 4 ) 26 . 4 ( -3 . 6 )  -4 . 4  
2 3  25 . 1  23 . 0 ( - 2 . 1 )  2 7 . 7 (  4 . 7 )  2 8 . 3 (  0 . 6 )  2 9 . 3 (  1 . 0 )  2 5 . 3 ( -4 . 0 )  28 . 0 (  2 . 7 )  2 7 . 5 ( -Q . 5 )  24 . 8 ( -2 . 7 ) 2 4 . 3 ( -Q . 5 )  2 1 . 9 ( -2 . 4 ) -3 . 2  
24 24 . 4  2 1 . 9 ( -2 . 5 )  2 4 . 8 (  2 . 9 )  2 5 . 9 (  1 . 1 )  26 . 6 (  0 . 7 )  2 2 . 6 ( -4 . 0 )  2 5 . 3 (  2 . 7 )  2 4 . 5 ( -Q . 8 )  2 1 . 7 ( -2 . 8 )  2 1 . 6 ( -Q . 1 )  1 9 . 0 ( -2 . 6 )  -5 . 4  
25  24 . 9  22 . 7 ( -2 . 2 )  2 7 . 4 (  4 . 7 )  30 . 5 ( 3 . 1 )  3 2 . 7 ( 2 . 2 )  28 . 8 ( -3 . 9 )  30 . 9 (  2 . 1 )  3 1 . 4 (  0 . 5 )  28 . 7 ( -2 . 7 ) 27 . 0 ( - 1 . 7 )  2 4 . 3 ( -2 . 7 ) -o . 6 
AW/ AW 26 24 . 8  25 . 9 ( 1 . 1 )  2 9 . 5 ( 3 . 6 )  30 . 7 (  1 . 2 )  3 2 . 1 ( 1 . 4 )  2 9 . 7 ( -2 . 4 )  3 1 . 2 (  1 . 5 )  3 2 . 3 (  1 . 1 )  3 1 . 5 ( -Q . 8 )  3 1 . 4 ( -Q . 1 )  29 . 1 ( -2 . 3 )  4 . 3  
27  1 5 . 8 1 7 . 7 (  1 . 9 )  20 . 7 (  3 . 0 )  20 . 9 (  0 . 2 )  2 1 . 9 ( 1 . 0 )  1 9 . 5 ( -2 . 4 )  20 . 1 (  0 . 6 )  20 . 8 (  0 . 7 )  1 9 . 3 ( - 1 . 5 )  20 . 0 (  0 . 7 )  1 9 . 1 ( -Q . 9 )  3 . 3  
2 8  19 . 8  2 1 . 1 (  1 . 3 )  24 . 5 ( 3 . 4 )  2 4 . 9 (  0 . 4 )  2 5 . 3 (  0 . 4 )  2 3 . 0 ( -2 . 3 )  2 3 . 0 ( 0 . 0 )  2 3 . 6 (  0 . 6 )  2 1 . 6 ( -2 . 0 )  2 2 . 9 (  1 . 3 )  2 0 . 8 ( -2 . 1 )  1 . 0 
29 22 . 3  22 . 6 ( 0 . 3 )  26 . 3 (  3 . 7 )  26 . 6 (  0 . 3 )  2 8 . 7 ( 2 . 1 )  2 7 . 0 ( - 1 . 7 )  2 7 . 5 (  0 . 5 )  2 7 . 2 ( -Q . 3 )  2 5 . 6 ( - 1 . 6 )  27 . 0 (  1 . 4 )  2 5 . 6 ( - 1 . 4 )  3 . 3  
30 1 8 . 3  18 . 6 (  0 . 3 )  2 2 . 1 (  3 . 5 )  2 4 . 3 (  2 . 2 )  2 3 . 8 ( -0 . 5 )  20 . 3 ( -3 . 5 )  2 1 . 4 (  1 . 1 )  20 . 5 ( -Q . 9 )  1 8 . 6 ( - 1 . 9 )  1 9 . 7 (  1 . 1 )  1 8 . 4 ( - 1 . 3 )  0 . 1 
AY / AW 3 1 1 8 . 2  17 . 2 ( - 1 . 0 )  1 9 . 0 (  1 . 8 )  1 9 . 1 (  0 . 1 )  1 9 . 3 (  0 . 2 )  1 8 . 7 ( -0 . 6 )  1 9 . 3 (  0 . 6 )  1 9 . 9 (  0 . 6 )  1 9 . 3 ( -Q . 6 )  20 . 0 (  0 . 7 )  1 5 . 5 ( -4 . 5 )  -2 . 7  
3 2  22 . 5  18 . 5 ( -4 . 0 )  2 2 . 9 (  4 . 4 )  2 3 . 9 (  1 . 0 )  2 3 . 8 ( -0 . 1 )  1 9 . 2 ( -4 . 6 )  1 8 . 1 ( - 1 . 1 )  1 8 . 4 (  0 . 3 )  1 6 . 5 ( - 1 . 9 )  1 7 . 3 (  0 . 8 ) 1 3 . 9 ( -3 . 4 )  -8 . 6  
3 3  2 1 . 1  18 . 6( - 2 . 5 ) 2 1 . 3 ( 2 . 7 )  2 3 . 0 (  1 . 7 )  2 3 . 7 ( 0 . 7 )  2 1 . 3 ( -2 . 4 )  2 1 . 4 (  0 . 1 )  2 2 . 0 (  0 . 6 )  2 1 . 4 ( -Q . 6 )  2 2 . 2 (  0 . 8 ) 1 7 . 1 ( -5 . 1 )  -4 . 0  
34 2 3 . 4  20 . 6 ( -2 . 8 )  2 3 . 9 ( 3 . 3 )  2 4 . 0 ( 0 . 1 )  24 . 3 ( 0 . 3 )  2 2 . 5 ( - 1 . 8 )  24 . 3 ( 1 . 8 )  2 3 . 9 ( -Q . 4 )  2 2 . 8 ( - 1 . 1 )  2 3 . 7 (  0 . 9 )  1 8 . 7 ( -5 . 0 )  -4 . 7  
35  20 . 7  20 . 0 ( -0 . 7 )  2 1 . 5 ( 1 . 5 )  20 . 8 ( -0 . 7 )  2 2 , 2 ( 1 . 4 )  2 2 . 2 ( 0 . 0 )  2 2 . 2 (  0 . 0 )  2 2 . 3 ( 0 . 1 )  2 1 . 8 ( -Q . 5 )  2 2 . 0 (  0 . 2 )  1 8 . 6 ( -3 . 4 )  -2 . 1  
AW/ AW 36 19 . 4  1 7 . 1 ( -2 . 3 )  1 9 . 8 (  2 . 7 )  20 . 0 (  0 . 2 )  2 1 . 3 ( 1 . 3 )  1 8 . 9 ( -2 . 4 )  1 9 . 6 (  0 . 7 )  1 9 . 6 (  0 . 0 )  1 8 . 1 ( - 1 . 5 )  1 9 . 0 (  0 . 9 )  1 4 . 7 ( -4 . 3 )  -4 . 7  
37  2 1 . 1  20 . 0( - 1 . 1 )  2 1 . 3 ( 1 . 3 )  2 2 . 1 (  0 . 8 )  2 2 . 3 ( 0 . 2 )  2 1 . 4 ( -0 . 9 )  2 2 . 2 ( 0 . 8 )  2 3 . 6 (  1 . 4 )  2 2 . 5 ( -1 . 1 )  2 4 . 0 (  1 . 5 )  2 1 . 0 ( -3 . 0 )  -Q . 1 
38 22 . 9  2 1 . 2 ( - 1 . 7 )  2 3 . 8 (  2 . 6 )  24 . 3 (  0 . 5 )  2 3 . 1 ( - 1 . 2 )  2 2 . 5 ( -0 . 6 )  24 . 6 (  2 . 1 )  24 . 8 (  0 . 2 )  2 3 . 7 ( - 1 . 1 )  2 5 . 1 (  1 . 4 )  2 1 . 8 ( -3 . 3 )  - 1 . 1  
39 1 9 . 2  18 . 2 ( - 1 . 0 )  20 . 0( 1 . 8 )  2 0 . 1 (  0 . 1 )  1 9 . 2 ( -0 . 9 )  1 8 . 0 ( - 1 . 2 )  1 9 . 0 (  1 . 0 )  20 . 8 (  1 . 8 )  1 9 . 5 ( - 1 . 3 )  20 . 4 (  0 . 9 )  1 6 . 7 ( -3 . 7 ) -2 . 5  
40 24 . 2  23 . 6 ( -0 . 6 )  2 4 . 5 ( 0 . 9 )  24 . 8 (  0 . 3 )  2 5 . 2 (  0 . 4 )  2 4 . 0 ( - 1 . 2 )  2 5 . 4 (  1 . 4 )  2 5 . 7 (  0 . 3 )  2 5 . 6 ( -Q . 1 )  26 . 4 (  0 . 8 )  2 2 . 3 ( -4 . 1 )  - 1 . 9  
-� 00 
Expe r i ment # 1 
Append i x  Table 3 .  Body Wei gh t  Data and D i f fe rences i n  We i gh t  f rom Week to Week ( i n  grams ) .  
Mouse Week 
# 0 Week 1 Week 2 
60-day-old ( Adu l t s )  on 0 . 2 %  DHEA 
Week 3 Week 4 Week 5 Week 6 Week 7 Week 8 Week 9 
AY / Aw 4 1  30 . 4  26 .0(-4 . 4 )  2 5 . 8 ( -0 . 2 )  2 5 . 2 ( -0 . 6 )  2 4 . 6 ( -0 . 6 )  2 2 . 9 ( - 1 . 7 )  2 4 . 2 (  1 . 3 )  2 3 . 5 ( -D . 7 )  2 2 . 2 ( - 1 . 3 )  1 9 . 7 ( -2 . 5 )  
42 2 2 . 0  20 . 0 ( - 2 . 0 )  20 . 8 (  0 . 8 )  2 1 . 6 ( 0 . 8 )  2 2 . 5 ( 0 . 9 )  2 1 . 0 ( - 1 . 5 )  20 . 7 ( -0 . 3 )  20 . 2 ( -D . 5 )  1 9 . 9 ( -D . 3 )  1 8 . 5 ( - 1 . 4 ) 
43  26 . 4  26 . 0 { -0 . 4 )  2 5 . 9 ( -0 . 1 )  26 . 2 (  0 . 3 )  2 7 . 4 ( 1 . 2 )  2 5 . 6 ( - 1 . 8 )  26 . 2 (  0 . 6 )  24 . 3 ( - 1 . 9 )  2 2 . 9 ( - 1 . 4 ) 2 1 . 7 ( - 1 . 2 )  
44 28 . 9  25 . 4 ( - 3 . 5 )  24 . 8 ( -0 . 6 )  2 3 . 6 ( - 1 . 2 )  2 3 . 6 ( 0 . 0 )  2 2 . 0 ( - 1 . 6 )  2 3 . 5 ( 1 . 5 )  2 2 . 7 ( -D . 8 )  2 2 . 3 ( -G . 4 ) 20 . 4 ( -1 •. 9 )  
4 5  30 . 5  27 . 9 ( -2 . 6 )  2 9 . 6 ( 1 . 7 )  28 . 7 ( -0 . 9 )  2 3 . 2 ( -5 . 5 )  2 3 . 2 ( 0 . 0 )  2 3 . 7 (  0 . 5 )  2 3 . 5 ( -D . 2 )  2 3 . 4 ( -G . 1 )  2 1 . 5 ( -1 . 9 )  
AW/ AW 46 27 . 7  28 . 9 (  1 . 2 )  32 . 3 ( 3 . 4 )  3 1 . 8 ( -0 . 5 )  30 . 2 ( - 1 . 6 )  2 9 . 5 ( -0 . 7 )  3 1 . 2 (  1 . 7 )  2 9 . 0 ( -2 . 2 )  3 1 . 1 (  2 . 1 )  28 . 9 ( -2 . 2 )  
4 7  22 . 4  1 9 . 4 ( -3 . 0 )  2 2 . 1 (  2 . 7 )  2 2 . 7 (  0 . 6 )  2 2 . 5 ( -0 . 2 )  2 1 . 0 ( - 1 . 5 )  20 . 7 ( -0 . 3 )  1 8 . 5 ( -2 . 2 )  1 8 . 3 ( -G . 2 )  1 7 . 9 ( -Q . 4 )  
48 2 1 . 6  18 . 8 ( - 2 . 8 )  20 . 8( 2· . 0 )  2 1 . 8 ( 1 . 0 )  2 1 . 8 (  0 . 0 )  20 . 8 ( - 1 . 0 )  2 1 . 6 (  0 . 8 )  1 9 . 2 ( -2 . 4 )  20 . 5 ( 1 . 3 )  1 9 . 7 ( -G . 8 )  
49 22 . 9  20 . 8 ( -2 . 1 )  2 2 . 4 (  1 . 6 )  20 . 8 ( - 1 . 6 )  2 0 . 5 ( -0 . 3 )  1 9 . 5 ( - 1 . 0 )  1 9 . 8 (  0 . 3 )  1 7 . 8 ( -2 . 0 )  1 9 . 2 (  1 . 4 )  1 9 . 4 (  0 . 2 )  
so 
AY / Aw 5 1  27 . 2  2 1 . 6 ( -5 . n )  2 1 . 4 ( -0 . 2 )  2 2 . 8 ( 1 . 4 )  2 1 . 7 ( - 1 . 1 )  2 2 . 9 ( 1 . 2 )  2 3 . 6 (  0 . 7 )  2 2 . 6 ( - 1 . 0 )  2 3 . 4 (  0 . 8 )  2 3 . 6 (  0 . 2 )  
52  1 4 . 7  14 . 1 ( -0 . 6 )  1 3 . 2 ( -0 . 9 )  1 4 . 6 (  1 . 4 )  1 3 . 7 ( -0 . 9 )  1 4 . 5 ( 0 . 8 )  1 4 . 2 ( -0 . 3 )  1 2 . 7 ( - 1 . 5 )  1 2 . 1 ( -G . 6 )  1 3 . 4 (  1 . 3 )  
5 3  20 . 3  17 . 5 ( -2 . 8 )  1 6 . 4 ( - 1 . 1 )  1 9 . 1 (  2 . 7 )  1 8 . 1 ( - 1 . 0 )  1 8 . 9 (  0 . 8 )  1 9 . 3 ( 0 . 4 )  1 7 . 8 ( - 1 . 5 )  1 8 . 5 (  0 . 7 )  1 9 . 2 (  0 . 7 )  
54 1 9 . 5  17 . 9 ( - 1 . 6 )  1 6 . 5 ( - 1 . 4 )  1 8 . 8 (  2 . 3 ) 1 7 . 2 ( - 1 . 6 )  1 7 . 9 (  0 . 7 )  1 8 . 4 (  0 . 5 )  1 7 . 0 ( - 1 . 4 )  1 7 . 8 (  0 . 8 )  1 8 . 8 (  1 . 0 )  
5 5  
AW/AW 56 20 . 6  18 . 9 ( - 1 . 7 )  2 2 . 1 (  3 . 2 )  2 3 . 0 ( 0 . 9 )  2 2 . 2 ( -0 . 8 )  2 2 . 0 ( -0 . 2 )  2 2 . 5 (  0 . 5 )  1 9 . 2 ( -3 . 3 )  20 . 6 (  1 . 4 )  1 9 . 6 ( -1 . 0 )  
5 7  2 1 . 8  18 . 3 ( -3 . 5 )  2 1 . 8 ( 3 . 5 )  2 1 . 1 ( -0 . 7 )  1 9 . 3 ( - 1 . 8 )  1 9 . 9 (  0 . 6 )  1 9 . 7 ( -0 . 2 )  1 8 . 5 ( - 1 . 2 )  20 . 0 (  1 . 5 )  1 9 . 6 ( -G . 4 )  
58 1 3 . 8 1 2 . 7 ( - 1 . 1 )  1 4 . 7 (  2 . 0 )  1 4 . 6( -0 . 1 )  1 3 . 8 { -0 . 8 )  1 4 . 3 ( 0 . 5 )  1 3 . 6 ( -0 . 7 )  1 3 . 6 (  0 . 0 )  1 3 . 3 ( -G . J )  1 4 . 3 (  1 . 0 )  
59 20 . 8  16 . 5 ( -4 . 3 )  1 8 . 7 (  2 . 2 )  1 8 . 5 ( -0 . 2 )  1 7 . 9 ( -0 . 6 )  1 8 . 8 (  0 . 9 )  1 9 . 0 (  0 . 2 )  2 1 . 2 ( 2 . 2 )  20 . 9 ( -G . 3 )  1 9 . 6 (  1 . 3 )  
60 
Tot a l  
We i g h t  
Week 1 0  Cha nge 
- 1 0 . 7  
- 3 . 5 
- 4 . 7  
- 8. 5 
- 9 . 0  
1 . 2 
- 4 . 5  
- 1 . 9 
- 3 . 5  
- 3 . 6  
- 1 . 3  
- 1 . 1  
- 0 . 7 
- 1 . 0 
- 2 •. 2 
0 . 5  
- 1 . 2  
...... � \0 
Expe r i ment I 1 
Append i x  Ta ble 4 .  Body We i gh t  Data and D i f f e renc e s  in We i gh t  f rom Week to Week ( in gra ms ) .  
AY / AW 
AW/AW 
AY I AW 
AW/ AW 
Mouse Week 60-day-old ( Ad u l t s ) on 0 . 4 % DHEA 
II 
6 1  










7 2  
7 3  
7 4  
7 5  
76 
7 7  
7 8  
7 9  
80 
0 
34 . 3  
30 . 8  
24 . 8  
27 . 1  
28 . 7  
26 . 8  
28 . 5  
24 . 9  
2 2 . 7  
2 1 . 3  
Week 1 Week 2 Week 3 Week 4 Week 5 Week 6 Week 7 
28 . 7 ( -5 . 6 )  2 8 . 0 ( -0 . 7 )  2 8 . 4 (  0 . 4 )  2 3 . 7 ( -4 . 7 )  2 3 . 6 ( -0 . 1 )  2 1 . 2 ( -2 . 4 )  
22 . 0 ( -8 . 8 )  1 9 . 3 ( - 1 . 7 )  2 1 . 0 ( 1 . 7 )  20 . 3 ( -0 . 7 )  20 . 2 ( -0 . 1 )  1 9 . 1 ( - 1 . 1 )  
18 .0( -6 . 8 )  1 9 . 1 (  1 . 1 )  1 9 . 2 (  0 . 1 )  1 8 . 3 ( -0 . 9 )  1 8 . 8 (  0 . 5 )  1 8 . 2 ( -0 . 6 )  
20 . 1 ( -7 . 0 )  2 1 . 9 (  1 . 8 )  2 3 . 0 (  1 . 1 )  20 . 3 ( -2 . 7 )  20 . 1 ( 0 . 2 )  1 8 . 3 ( - 1 . 8 )  
20 . 6 ( -8 . 1 )  20 . 2 ( -0 . 4 )  2 1 . 8 ( 1 . 6 )  20 . 7 ( - 1 . 1 )  2 1 . 7 (  1 . 0 )  1 9 . 8 ( - 1 . 9 )  
Week 8 
23 . 3 ( -3 . 5 )  26 . 7 (  3 . 4 )  2 7 . 3 (  0 . 6 )  2 5 . 3 ( - 2 . 0 )  26 . 9 (  1 . 6 )  28 . 3 (  1 . 4 )  2 3 . 4 ( -4 . 9 )  20 . 8 ( -2 . 6 )  
22 . 7 ( -5 . 8 )  2 5 . 9 (  3 . 2 )  26 . 0 (  0 . 1 )  2 2 . 8 ( -3 . 2 )  2 5 . 2 ( 2 . 4 )  2 3 . 5 ( - 1 . 7 )  20 . 5 ( -3 . 0 )  1 9 . 2 ( - 1 . 3 )  
20 . 4 ( -4 . 5 )  20 . 2 ( -0 . 2 )  20 . 0 ( -0 . 2 )  1 5 . 6 ( -4 . 4 )  1 7 . 3 (  1 . 7 )  1 5 . 9 ( - 1 . 4 ) 1 7 . 0 (  1 . 1 )  
19 . 5 ( - 3 . 2 )  1 8 . 7 ( -0 . 8 )  2 0 . 0 (  1 . 3 )  1 8 . 0 ( -2 . 0 )  1 9 . 7 (  1 . 7 )  1 8 . 0 ( - 1 . 7 )  1 6 . 5 ( - 1 . 5 )  1 4 . 8 ( - 1 . 7 )  
18 . 2 ( - 3 . 1 )  1 6 . 4 ( - 1 . 8 )  1 6 . 8 (  0 . 4 )  1 4 . 8 ( - 2 . 0 )  1 4 . 8 (  0 . 0 )  1 3 . 8 ( - 1 . 0 )  
. 
Week 9 
24 . 4  16 . 9 ( -7 . 5 )  1 8 . 5 ( 1 . 6 )  1 8 . 2 ( -0 . 3 )  1 6 . 1 ( -2 . 1 )  1 9 . 0 (  2 . 9 )  1 7 . 8 ( - 1 . 2 )  1 7 . 1 ( -0 . 7 )  1 6 . 9 ( -D . 2 )  1 6 . 3 ( -D . 6 )  
24 . 3  17 . 3 ( -7 . 0 )  1 7 . 9 (  0 . 6 )  1 8 . 8 (  0 . 9 )  1 7 . 0 ( - 1 . 8 )  1 9 . 2 (  2 . 2 )  1 7 . 1 ( -2 . 1 )  1 6 . 0 ( - 1 . 1 )  1 5 . 2 ( -Q . 8 )  
1 7 . 6  1 2 . 8 ( -4 . 8 )  1 4 . 4 (  1 . 6 )  1 3 . 8 ( -0 . 6 )  1 2 . 5 ( - 1 . 3 )  1 4 . 3 ( 1 . 8 )  1 2 . 6 ( - 1 . 7 )  1 2 . 5 ( -Q . 1 )  1 2 . 4 ( -D . 1 )  
18 . 6  14 . 6 ( -4 . 0 )  1 5 . 3 (  0 . 7 )  1 5 . 3 ( 0 . 0 )  1 3 . 5 ( - 1 . 8 )  1 4 . 9 (  1 . 4 )  1 3 . 7 ( - 1 . 2 )  1 3 . 6 ( -0 . 1 )  1 3 . 1 ( -Q . 5 )  1 2 . 1 ( - 1 . 0 )  
1 9 . 7  1 5 . 2 ( -4 . 5 )  1 5 . 9 (  0 . 7 )  1 7 . 5 (  1 . 6 )  1 5 . 7 ( - 1 . 8 )  1 7 . 5 (  1 . 8 )  1 5 . 9 ( - 1 . 6 )  1 4 . 9 ( - 1 . 0 )  1 4 . 9 (  0 . 0 )  1 4 . 1 ( -Q . 8 )  
24 . 3  20 . 9 ( -3 . 4 )  2 2 . 1 (  1 . 2 )  2 2 . 0( -0 . 1 )  1 9 . 0 ( - 3 . 0 )  20 . 9 (  1 . 9 )  1 9 . 4 ( - 1 . 5 )  1 8 . 1 ( - 1 . 3 )  1 8 . 7 (  0 . 6 )  1 8 . 5 ( -Q . 2 )  
22 . 4  19 . 0( - 3 . 4 )  20 . 7 ( 1 . 7 )  2 1 . 5 ( 0 . 8 )  1 9 . 0 ( -2 . 5 )  2 1 . 9 (  2 . 9 )  20 . 8 ( - 1 . 1 )  1 7 . 7 ( -3 . 1 )  1 7 . 3 ( -Q . 4 )  1 6 . 4 ( -D . 9 )  
1 8 . 6  1 5 .0 ( - 3 . 6 )  1 6 . 8 (  1 . 8 )  1 8 . 7 (  1 . 9 )  1 6 . 5 ( -2 . 2 )  1 8 . 0 (  1 . 5 )  1 6 . 8 ( - 1 . 2 )  1 4 . 5 ( -2 . 3 )  1 4 . 9 (  0 . 4 ) 1 4 . 1 ( -D . B )  
18 . 7  1 5 . 3 ( -3 . 4 )  1 7 . 1 (  1 . 8 )  1 9 . 7 (  2 . 6 )  1 5 . 2 ( -4 . 5 )  1 6 . 3 ( 1 . 1 ) 1 4 . 8 ( - 1 . 5 )  1 2 . 9 ( - 1 . 9 )  1 3 . 4 (  0 . 5 )  1 2 . 5 ( -D . 9 )  
1 7 . 0 1 3 . 5 ( -3 : 5 )  1 5 . 4 (  1 . 9 )  1 7 . 3 (  1 . 9 )  1 5 . 3 ( -2 . 0 )  1 6 . 0 (  0 . 7 )  1 5 . 7 ( -0 . 3 )  1 3 . 6 ( -2 . 1 )  1 3 . 9 (  0 . 3 )  1 3 . 3 ( -Q . 6 )  
Tot a l  
We ight  
Week 10  Cha nge 
- 1 3 . 1 
- 1 1 . 7  
- 6 . 6  
- 8 . 8  
- 8 . 9  
- 6 . 0  
- 9. 3 
- 7 . 9  
- 7 . 9  
- 7 . 5  
- 8 . 1 
- 9. 1 
- 5 . 2  
- 6 . 5  
- 5 . 6  
- 5 . 8  
- 6 . 0  
- 4 . 5  
- 6 . 2 
- 3 . 7  
,_. Vl 0 
Experiment Il l  
Appendix Table 5 .  Food Consumption ( in grams ) .  
Average 
Food 
Weeks : 1 2 3 4 5 6 7 8 9 1 0  Consumption 
0 . 0% DHEA 
AY/AW ( ll ' s  1-5 ) 69 . 1  234 . 6  222 . 5  133 . 7  164 . 5  2 1 6 . 7  1 3 1 . 4  104 . 4  15 . 3  1 14 . 5  140 . 67 
AWJAW ( II '  s . 6- 10 )  77 . 7  226 . 7  189 . 7  1 1 9 . 3 174 . 4  1 7 1 . 8 102 . 9  107 . 1  149 . 9  95 . 0  141 . 45 
AY/AW ( ll ' s  1 1 -1 5 )  57 . 4  167 . 3  15 1 . 0 1 1 2 . 5  136 . 2  149 . 3  1 1 2 . 0  65 . 0  9 1 . 0  97 . 4  1 13 . 9 1  
AW/AW ( II '  s 1 6-20 )  70 . 3  169 . 9  134 . 8  109 . 3  130 . 9  125 . 6  106 . 7  69 . 3  66 . 7  1 28 . 9 1 1 1 . 24 
0 . 1 % DHEA 
AY/AW ( II '  s 2 1-25 ) 80 . 1  222 . 9  221 . 6  18 1 . 3 1 18 . 1  1 54 . 8  156 . 9  135 . 2  157 . 6  64 . 1  149 . 26 
AW/AW ( II ' s 2 6-30 ) 84 . 0  186 . 4  196 . 6  144 . 1  103 . 3  1 1 5 . 3  1 2 1 . 2  1 2 1 . 1  149 . 5  80 . 2  130 . 1 7  
AY/AW ( ll ' s  3 1-35 ) 42 . 9  145 . 1  1 44 . 9  1 12 . 4 87 . 1  81 . 4  98 . 0  100 . 1 1 1 7 . 7  30 . 2  95 . 98 
AWJAW ( II '  s 36-40 ) 62 . o  149 . 4  137 . 6  1 1 3 . 4 89 . 4  94 . 8  1 1 9 . 8 103 . 6  1 24 . 6  45 . 9  104 . 05  
0 . 2% DHEA 
AY/AW ( 1/ ' s 41-45 ) 1 10 . 1  137 . 7  158 . 5  1 1 1 . 1  8 1 . 5  1 14 . 0 107 . 0  95 . 9  78 . 0  1 10 . 42 
AW/AW ( II '  s 46-50) 106 . 5  133 . 5  153 . 9  104 . 8  77 . 0  130 . 6  79 . 8  94 . 4  77 . 0  103 . 39 
AY/AW ( ll ' s 5 1-55 ) 66 . 8  66 . 9  100 . 7  61 . 9  70 . 6  83 . 1  7 1 . 5  75 . 2  78 . 2  74 . 99 
AW/AW ( ll ' s 56-60) 49 . 2  90 . 2  100 . 6  65 . 1  55 . 4  77 . 3  79 . 0  73 . 5  7 5 . 6  73 . 99 
0 . 4% DHEA 
AY/AW ( II '  s 6 1-65 )  67 . 1  10 1 . 2  1 5 5 . 1  87 . 4  79 . 8  92 . 7  97 . 22 
AW/AW ( ll ' s  66-70 )  70 . 0  129 . 0  169 . 1  80 . 4  89 . 5  1 1 6 . 4  50 . 7  38 . 6  37 . 2  86 . 7 7 
AY/AW ( ll ' s  7 1-75 ) 38 . 2  82 . 0  1 16 . 1  59 .3  69 . 2  85 . 5  78 . 9  63 . 4  44 . 6  70 . 80 ...,..:. 
AW/AW ( II '  s 76-80 ) 62 . 2  1 1 7 . 4  1 22 . 9  7 1 . 1  74 . 9  95 . 3  72 . 5  7 1 . 3  69 . 0  84 . 07 V1 ...... 
Expe r i ment # 2 ,  Study 1 
Append i x  Table 6 .  Mouse We i ght Data and D i f f e rences in We i ght f rom Week to Week ( i n gra ms ) . 
House Week 
I 0 Week 1 Week 2 
60-day-old ( Adu l t s )  on 0 . 0% DHEA 
Week 3 Week 4 Week 5 Week 6 Week 7 Week 8 Week 9 
Tot a l  
We i gh t  
Week 1 0  Change 
AW/ AW 1 33 . 0  32 . 3 ( -0 . 3 )  3 3 . 1 (  0 . 8 )  3 3 . 2 (  0 . 1 )  34 . 1 (  0 . 9 )  3 5 . 0 (  0 . 9 )  3 1 . 9 ( -3 . 1 )  3 3 . 4 (  1 . 5 )  3 3 . 1 ( -Q . 3 )  3 3 . 5 (  0 . 4 ) 3 3 . 9 (  0 . 4 ) 1 . 3  
2 26 . 6  25 . 8 (  0 . 3 )  2 5 . 5 ( -0 . 3 )  2 5 . 7 (  0 . 2 )  2 5 . 9 (  0 . 2 )  26 . 2 (  0 . 3 )  2 5 . 7 ( -0 . 5 )  28 . 3 (  2 . 6 )  27 . 2 ( - 1 . 1 )  27 . 9 (  0 . 7 ) 28 . 2 (  0 . 3 )  2 . 7  
3 27 . 2  27 . 6 (  0 . 7 )  2 7 . 9 (  0 . 3 )  2 7 . 4 ( -0 . 5 )  28 . 3 (  0 . 9 )  28 . 2 ( -0 . 1 )  2 9 . 5 (  1 . 3 )  29 . 3 ( -D . 2 )  29 . 7 (  0 . 4 ) 30 . 2 (  0 . 5 )  30 . 3 (  0 . 1 )  3 . 4  
4 22 . 4  22 . 0( 0 . 1 )  2 1 . 8 ( -0 . 2 )  2 2 . 1 (  0 . 3 )  2 3 . 1 ( 1 . 0 )  2 3 . 1 (  0 . 0 )  2 3 . 0 ( -0 . 1 )  2 2 . 0 ( - 1 . 0 )  2 3 . 6 (  1 . 6 )  2 3 . 7 (  0 . 1 )  2 2 . 9 ( -D . 8 )  1 . 0 
5 22 . 1  22 . 8 (  0 . 5 )  2 2 . 7 ( -0 . 1 )  2 2 . 9 (  0 . 2 )  2 3 . 8 ( 0 . 9 )  2 3 . 1 ( -0 . 7 )  2 3 . 1 (  0 . 0 )  2 5 . 2 (  2 . 1 )  24 . 0 ( - 1 . 2 )  2 5 . 1 (  1 . 1 )  2 4 . 7 ( -D . 4 ) 2 . 4  
AY / AW 6 43 . 2  47 . 5 ( 3 . 5 )  5 1 . 7 (  4 . 2 )  5 1 . 0 ( -0 . 7 )  52 . 5 ( 1 . 5 )  54 . 9 ( 2 . 4 )  54 . 7 (-0 . 2 )  58 . 6 (  3 . 9 )  60 . 7 (  2 . 1 )  62 . 5 (  1 . 8 )  6 5 . 2 (  2 . 7 ) 2 1 . 2  
7 35 . 2  37 . 2 (  3 . 0 )  3 7 . 9 (  0 . 7 )  38 . 9 (  1 . 0 )  40 . 5 ( 1 . 6 )  4 1 . 2 (  0 . 7 )  4 2 . 8 (  1 . 6 )  4 2 . 6 ( -D . 2 )  4 1 . 0 ( - 1 . 6 )  4 4 . 8 (  3 . 8 )  4 6 . 8 (  2 . 0 )  1 2 . 6  
8 39 . 7  45 . 7 (  6 . 5 )  4 2 . 4 ( - 3 . 3 )  49 . 4 (  7 . 0 )  56 . 2 (  6 . 8 )  58 . 9 (  2 . 7 )  62 . 3 (  3 . 4 )  67 . 0 ( 4 . 7 )  69 . 8 (  2 . 8 )  73 . 1 (  3 . 3 )  7 5 . 4 (  2 . 3 )  36 . 2  
9 26 . 6  31 . 2 ( 4 . 2 )  3 2 . 7 (  1 . 5 )  2 9 . 6 ( -3 . 1 )  3 1 . 8 ( 2 . 2 )  3 1 . 9 (  0 . 1 )  3 3 . 7 (  1 . 8 )  36 . 6 (  2 . 9 )  38 . 4 (  1 . 8 )  40 . 4 (  2 . 0 )  4 2 . 6 (  2 . 2 )  1 5 . 6  
1 0  23 . 1  25 . 7 ( 1 . 5 )  2 5 . 9 (  0 . 2 )  2 7 . 5 ( 1 . 6 )  2 8 . 1 (  0 . 6 )  30 . 0 (  1 . 9 )  3 1 . 1 (  1 . 1 )  34 . 4 (  3 . 3 )  35 . 9 (  1 . 5 )  39 . 5 (  3 . 6 )  40. 3 (  0 . 8 )  1 6 . 1  
AW/AW 1 1  37 . 7  37 . 5 ( -0 . 9 )  38 . 6 (  1 . 1 ) 36 . 6 ( -2 . 0 )  38 . 2 (  1 . 6 )  38 . 8 (  0 . 6 )  39 . 3 (  0 . 5 )  38 . 9 ( -0 . 4 )  39 . 5 (  0 . 6 )  40 . 0 (  0 . 5 ) 4 1 . 0 (  1 . 0 )  2 . 6  
1 2  28 . 4  28 . 8 ( -0 . 8 )  30 . 7 (  1 . 9 )  3 1 . 7 (  1 . 0 )  28 . 3 ( -3 . 4 ) 30 . 4 (  2 . 1 )  30 . 5 ( 0 . 1 )  3 2 . 6 (  2 . 1 )  3 1 . 6 ( - 1 . 0 )  3 2 . 5 (  0 . 9 )  3 2 . 3 ( -D . 2 )  2 . 7  
1 3  29 . 6  30 . 2 (  0 . 7 )  3 1 . 2 (  1 . 0 )  3 1 . 1 ( -0 . 1 )  3 2 . 4 (  1 . 3 )  3 2 . 1 ( -0 . 3 )  3 1 . 9 ( -0 . 2 )  3 2 . 5 (  0 . 6 )  3 2 . 1 ( -D . 4 ) 34 . 1 (  2 . 0 )  3 3 . 6 ( -D . 5 )  4 . 1  
1 4  23 . 2  24 . 5 ( 0 . 4 )  26 . 8 (  2 . 3 )  2 7 . 5 ( 0 . 7 )  24 . 9 ( -2 . 6 )  28 . 6 (  3 . 7 )  28 . 2 ( -0 . 4 ) 2 9 . 3 (  1 . 1 )  29 . 8 (  0 . 5 )  29 . 2 ( -D . 6 )  29 . 1 ( -D . 1 )  5 . 0  
1 5  2 1 . 4  22 . 3 ( 0 . 2 )  2 4 . 1 ( 1 . 8 )  2 3 . 8 ( -0 . 3 )  3 1 . 1 ( 7 . 3 )  2 5 . 4 ( -5 . 7 )  26 . 6 (  1 . 2 )  2 7 . 4 (  0 . 8 )  26 . 7 ( -D . 7 ) 26 . 9 (  0 . 2 )  26 . 7 ( -D . 2 )  4 . 6  
AY / AW 16 36 . 7  35 . 6 (  0 . 7 )  3 7 . 6 (  2 . 0 )  3 9 . 3 (  1 . 7 )  40 . 4 (  1 . 1 )  4 3 . 0 ( 2 . 6 )  4 5 . 6 (  2 . 6 )  4 6 . 2 (  0 . 6 )  4 7 . 5 (  1 . 3 )  49 . 5 (  2 . 0 )  50 . 4 (  0 . 9 )  1 5 . 5  
1 7  34 . 9  37 . 6 (  3 . 2 )  38 . 7 (  1 . 1 )  3 9 . 5 (  0 . 8 )  3 9 . 4 ( -0 . 1 )  4 1 . 3 ( 1 . 9 )  4 2 . 5 ( 1 . 2 )  4 4 . 0 ( 1 . 5 )  4 2 . 5 ( -1 . 5 )  4 2 . 7 (  0 . 2 )  4 4 . 5 (  1 . 8 )  1 0 . 1 
1 8  30 . 7  30 . 2 (  1 . 7 )  3 2 . 1 ( 1 . 9 )  3 1 . 2 ( -0 . 9 )  30 . 5 ( -0 . 7 )  3 1 . 4 (  0 . 9 )  3 1 . 7 (  0 . 3 )  3 2 . 4 (  0 . 7 )  32 . 5 (  0 . 1 )  3 2 . 5 (  0 . 0 )  34 . 8 (  2 . 3 )  6 . 3  
1 9  28 . 1  31 . 1 (  3 . 1 )  3 3 . 8 (  2 . 7 )  34 . 3 ( 0 . 5 )  36 . 1 (  1 . 8 )  38 . 9 (  2 . 8 )  40 . 5 ( 1 . 6 )  4 2 . 5 (  2 . 0 )  4 4 . 4 (  1 . 9 )  4 5 . 9 (  1 . 5 )  4 6 . 4 (  0 . 5 )  18 . 4  
20 24 . 7  27 . 6 (  2 . 8 )  30 . 5 (  2 . 9 )  3 1 . 4 (  0 . 9 )  30 . 3 ( - 1 . 1 )  32 . 8 ( 2 . 5 ) 3 5 . 1 ( 2 . 3 )  38 . 8 (  3 . 7 )  40 . 4 (  1 . 6 )  4 2 . 5 (  2 . 1 )  4 3 . 2 (  0 . 7 ) 18 . 4  
.... 
l/1 N 
Expe r i ment  # 2 , Study 1 
Ap pend i x  Ta ble 7 .  Mouse We i ght  Data and D i f f e rences in We i gh t  f rom Week to Week ( i n  gra ms ) . 
Mouse Week 
H 0 Week 1 Week 2 
60-day-old ( Adu lt s )  on 0 . 1 % DHEA 
Week 3 Week 4 Week 5 Week 6 Week 7 Week 8 Wee k 9 
Tot a l  
We igh t 
Week 1 0  Change 
AW/ AW 2 1  3 1 . 1  3 1 . 7 (  0 . 6 )  3 1 . 7 (  0 . 0 )  30 . 1 ( - 1 . 6 )  3 2 . 4 (  2 . 3 )  3 1 . 3 ( - 1 . 1 )  30 . 5 ( -0 . 8 )  3 2 . 2 (  1 . 7 )  30 . 2 ( -2 . 0 )  30 . 0 ( -Q . 2 )  29 . 0 ( -1 . 0 )  -2 . 1  
2 2  24 . 8  25 . 6 (  0 . 8 )  2 5 . 5 ( -0 . 1 )  2 7 . 6 (  2 . 1 )  28 . 0 (  0 . 4 )  28 . 6 (  0 . 6 )  28 . 2 ( -0 . 4 )  29 . 3 (  1 . 1 )  29 . 0 ( -Q . 3 )  28 . 9 ( -D . 1 )  28 . 9 (  0 . 0 )  4 . 1  
23 24 . 2  25 . 9 (  1 . 7 )  24 . 7 ( - 1 . 2 )  26 . 1 {  1 . 4 )  26 . 4 (  0 . 3 )  26 . 4 (  0 . 0 )  26 . 1 ( -D . 3 )  2 7 . 5 (  1 . 4 )  26 . 9 ( -D . 6 )  26 . 5 ( -D . 4 ) 2 7 . 1 (  0 . 6 ) 2 . 9 
24 23 . 3  25 .0(  1 . 7 )  2 5 . 7 (  0 . 7 )  26 . 1 (  0 . 4 )  2 5 . 9 ( -0 . 2 )  2 5 . 9 ( 0 . 0 )  2 5 . 7 ( -0 . 2 )  26 . 3 (  0 . 6 )  2 5 . 7 ( -D . 6 )  26 . 2 (  0 . 5 )  2 5 . 2 ( - 1 . 0 )  1 . 9 
25 2 1 . 5  2 1 . 3 ( -0 . 2 )  2 1 . 2 ( -0 . 1 )  2 2 . 8 ( 1 . 6 )  2 3 . 2 ( 0 . 4 )  2 3 . 4 (  0 . 2 )  2 2 . 5 ( -0 . 9 )  24 . 1 (  1 . 6 )  2 3 . 1 ( - 1 . 0 )  2 4 . 6 (  1 . 5 )  2 2 . 8 ( - 1 . 8 ) 1 . 3 
AY / AW 26 43 . 4  41 . 5 ( - 1 . 9 )  3 7 . 8 ( - 3 . 7 )  3 7 . 9 (  0 . 1 )  40 . 4 (  2 . 5 ) 4 1 . 1 (  0 . 7 )  42 . 0 ( 0 . 9 )  4 4 . 6 ( 2 . 6 )  4 5 . 4 (  0 . 8 )  4 5 . 9 (  0 . 5 )  49 . 4 (  3 . 5 )  6 . 0  
27  32 . 5  32 . 0 ( -0 . 5 )  3 1 . 6 ( -0 . 4 )  3 2 . 2 (  0 . 6 )  3 3 . 3 (  1 . 1 )  3 3 . 5 (  0 . 2 )  3 3 . 8 (  0 . 3 )  3 5 . 6 (  1 . 8 )  36 . 2 (  0 . 6 )  39 . 0 (  2 . 8 )  4 2 . 0 (  3 . 0 )  9 . 5  
28  33 . 1  33 . 1 (  0 . 0 )  32 . 7 ( -0 . 4 )  3 3 . 4 (  0 . 7 )  34 . 3 (  0 . 9 )  3 3 . 7 ( -0 . 6 )  3 3 . 1 ( -0 . 6 )  3 3 . 7 (  0 . 6 )  34 . 5 (  0 . 8 )  3 5 . 4 (  0 . 9 )  37 . 4 (  2 . 0 )  4 . 3  
29 3 1 . 6  29 . 1 ( -2 . 5 ) 2 7 . 8 ( - 1 . 3 )
,
2 9 . 7 (  1 . 9 )  30 . 9 (  1 . 2 )  3 2 . 7 ( 1 . 8 )  3 2 . 8 (  0 . 1 )  3 5 . 3 (  2 . 5 )  38 . 1 (  2 . 8 )  40 . 0 (  1 . 9 )  4 2 . 4 (  2 . 4 )  1 0 . 8  
3 0  27 . 2  26 . 6 ( -0 . 6 )  26 . 3 ( -0 . 3 )  28 .0(  1 . 7 )  2 9 . 1 (  1 . 1 )  28 . 9 ( -0 . 2 )  28 . 8 ( -0 . 1 )  29 . 6 (  0 . 8 )  30 . 8 (  1 . 2 )  3 1 . 2 (  0 . 4 ) 3 3 . 5 (  2 . 3 )  6 . 3  
AW/ AW 3 1 35 . 0  35 . 5 (  0 . 5 ) 3 5 . 8 (  0 . 3 )  3 5 . 2 ( -0 . 6 )  36 . 0 (  0 . 8 )  36 . 1 (  0 . 1 )  3 5 . 1 ( - 1 . 0 )  36 . 8 (  1 . 7 )  3 7 . 3 ( 0 . 5 )  36 . 4 ( -Q . 9 )  37 . 4 (  1 . 0 )  2 . 4  
3 2  32 . 1  33 . 6 ( 1 . 5 )  3 3 . 4 ( -0 . 2 )  3 3 . 7 (  0 . 3 )  3 3 . 5 ( -0 . 2 )  34 . 3 ( 0 . 8 )  3 3 . 5 ( -0 . 8 )  3 4 . 8 (  1 . 3 )  34 . 7 ( -D . 1 )  34 . 4 ( -D . 3 )  34 . 9 (  0 . 5 )  2 . 8  
3 3  30 . 1  30 . 9 (  0 . 8 )  30 . 4 ( -0 . 5 )  3 1 . 3 ( 0 . 9 )  32 . 6 ( 1 . 3 )  3 3 . 3 (  0 . 7 )  3 1 . 3 ( -2 . 0 )  3 2 . 8 (  1 . 5 )  3 3 . 9 (  1 . 1 )  32 . 3 ( - 1 . 6 )  3 2 . 2 ( -D . 1 )  2 . 1  
34 22 . 7  23 . 2 (  0 . 5 )  2 3 . 9 (  0 . 7 )  2 3 . 6 ( -0 . 3 )  24 . 3 (  0 . 7 )  2 4 . 4 (  0 . 1 )  24 . 4 (  0 . 0 )  2 5 . 9 (  1 . 5 )  26 . 9 (  1 . 0 )  26 . 7 ( -D . 2 ) 26 . 2 ( -Q . 5 )  3 . 5  
3 5  26 . 5  28 .0(  1 . 5 )  28 . 3 ( 0 . 3 )  28 . 7 (  0 . 4 )  2 9 . 5 ( 0 . 8 )  2 9 . 2 ( -0 . 3 )  2 9 . 1 ( -0 . 1 )  30 . 5 (  1 . 4 )  30 . 9 (  0 . 4 ) 28 . 8 ( -2 . 1 )  29 . 2 (  0 . 4 ) 2 . 7  
AY / AW 36 44 . 8  45 . 9 (  1 . 1 )  46 . 4 ( 0 . 5 )  4 7 . 7 (  1 . 3 )  48 . 9 (  1 . 2 )  4 4 . 2 ( -4 . 7 )  4 3 . 1 ( - 1 . 1 )  4 7 . 4 (  4 . 3 )  48 . 7 (  1 . 3 )  4 7 . 5 ( - 1 . 2 )  5 1 . 0 (  3 . 5 )  6 . 2  
3 7  35 . 8  35 . 6 ( -0 . 2 )  36 . 6 (  1 . 0 )  3 7 . 5 ( 0 . 9 )  39 . 7 (  2 . 2 )  40 . 3 (  0 . 6 )  4 1 . 3 ( 1 . 0 )  4 2 . 0 (  0 . 7 )  4 1 . 7 ( -Q . J )  4 1 . 2 ( -D . 5 )  4 2 . 9 (  1 . 7 )  7 . 1 
38 31 . 7  32 . 5 ( 0 . 8 )  34 . 7 (  2 . 2 )  3 5 . 0 (  0 . 3 )  3 7 . 1 (  2 . 1 )  3 5 . 4 ( - 1 . 7 )  3 5 . 6 (  0 . 2 )  38 . 4 (  2 . 8 )  38 . 5 (  0 . 1 )  37 . 4 ( - 1 . 1 )  40 . 1 (  2 . 7 )  8 . 4  
3 9  32 . 2  32 . 9 ( 0 . 7 )  34 . 4 (  1 . 5 )  34 . 3 ( -0 . 1 )  3 5 . 1 (  0 . 8 )  36 . 5 ( 1 . 4 )  36 . 7 (  0 . 2 )  39 . 2 (  2 . 5 )  40 . 6 (  1 . 4 )  38 . 9 ( - 1 . 7 ) 4 1 . 2 (  2 . 3 )  9 . 0  
4 0  30 . 0  29 . 7 ( -0 . 3 )  3 2 . 2 ( 2 . 5 ) 3 2 . 1 ( -0 . 1 )  3 3 . 5 (  1 . 4 )  3 2 . 7 ( -0 . 8 )  3 2 . 4 ( -0 . 3 )  3 4 . 4 (  2 . 0 )  3 5 . 1 (  0 . 7 )  3 2 . 5 ( -2 . 6 )  36 . 3 (  3 . 8 ) 6 . 3  
.... Ul � 
Expe r i ment # 2 ,  Study 1 
Append i x  Table 8 .  Mouse We i ght  Data and D i f f e rence s in Wei gh t  f rom Week to Week ( in grams ) . 
Geno-
ty pe- Mouse Week 
Sex I 0 Week 1 Week 2 Week 3 
60-day-old ( Adult s )  on 0 . 2 % DHEA 
Week 4 Week 5 Week 6 Week 7 Week 8 Week 9 
Tot a l  
We i g h t  
Week 1 0  Cha nge 
AW/ AW 41 29 . 9  29 . 2 ( -0 . 7 )  2 8 . 9 ( -0 . 3 )  2 7 . 3 ( - 1 . 6 )  2 7 . 9 (  0 . 6 )  28 . 2 (  0 . 3 )  2 7 . 0 (  1 . 2 )  29 . 0 (  2 . 0 )  27 . 7 ( - 1 . 3 )  27 . 8 (  0 . 1 )  27 . 8 (  0 . 0 )  -2 . 1  
4 2  2 5 . 4  25 . 0 ( -0 . 4 )  2 3 . 9 ( - 1 . 1 )  2 3 . 9 ( 0 . 0 )  2 3 . 5 ( -0 . 4 )  2 3 . 8 ( 0 . 3 )  2 3 . 7 ( -0 . 1 )  2 5 . 4 (  1 . 7 )  26 . 5 ( 1 . 1 )  2 5 . 7 ( -Q . 8 )  2 5 . 8 (  0 . 1 )  0 . 4  
4 3  23 . 9  23 . 8 ( -0 . 1 )  2 3 . 2 ( -0 . 6 )  2 3 . 1 ( -0 . 1 )  24 . 4 (  1 . 3 )  24 . 3 ( -0 . 1 )  24 . 8 (  0 . 5 )  26 . 3 (  1 . 5 )  2 5 . 7 ( -Q . 6 )  26 . 0 (  0 . 3 )  26 . 1 (  0 . 1 )  2 . 2  
4 4  23 . 3  22 . 4 ( -0 . 9 )  2 3 . 2 ( 0 . 8 )  2 2 . 9 ( -0 . 3 )  2 4 . 3 (  1 . 4 )  2 4 . 3 ( 0 . 0 )  2 2 . 8 ( - 1 . 5 )  2 4 . 4 (  1 . 6 )  24 . 3 ( -Q . 1 )  2 4 . 7 (  0 . 4 ) 2 5 . 1 (  0 . 4 ) 1 . 8 
4 5  18 . 9  19 . 0 ( -0 . 1 )  1 9 . 3 ( 0 . 3 )  1 9 . 6 (  0 . 3 )  1 8 . 8 ( -0 . 8 )  1 9 . 6 (  0 . 8 )  1 9 . 1 ( -0 . 5 )  20 . 2 (  1 . 1 )  20 . 1 ( -Q . l )  2 0 . 7 (  0 . 6 )  2 1 . 1 (  0 . 4 ) 2 . 2  
AY / AW 46 42 . 5  35 . 3 ( -7 . 2 )  3 1 . 7 ( -3 . 6 )  30 . 8 ( -0 . 9 )  29 . 4 ( - 1 . 4 )  3 1 . 1 (  1 . 7 )  30 . 6 ( -0 . 5 )  3 3 . 3 (  2 . 7 )  34 . 8 (  1 . 5 )  34 . 1 ( -Q . 7 )  3 3 . 7 ( -Q . 4 ) -8 . 8  
4 7  38 . 8  32 . 5 ( -6 . 3 )  30 . 4 ( - 2 . 1 )  2 8 . 5 ( - 1 . 9 )  26 . 7 ( - 1 . 8 )  26 . 8 (  0 . 1 )  26 . 2 ( -0 . 6 )  28 . 1 (  1 . 9 )  30 . 2 {  2 . 1 )  30 . 1 ( -Q . 1 )  30 . 5 (  0 . 4 ) -8 . 3  
48 28 . 7  23 . 9 ( -4 . 8 )  2 3 . 3 ( -0 . 6 )  2 3 . 9 ( 0 . 6 )  2 1 . 0 ( -2 . 9 )  2 1 . 9 (  0 . 9 )  20 . 4 ( - 1 . 5 )  2 1 . 5 (  1 . 1 )  2 3 . 6 (  2 . 1 )  2 3 . 1 ( -Q . 5 )  2 3 . 6 (  0 . 5 )  -5 . 1  
49 25 . 6  21 . 8 ( -3 . 8 )  2 0 . 9 ( -0 . 9 ), 20 . 0 ( -0 . 9 )  1 8 . 6 ( - 1 . 4 )  1 9 . 2 (  0 . 6 )  1 9 . 5 (  0 . 3 )  2 1 . 1 ( 1 . 6 )  2 2 . 2 (  1 . 1 )  2 2 . 1 ( -Q . 1 )  2 2 . 4 (  0 . 3 )  -3 . 2  
50 25 . 6  21 . 5 ( -4 . 1 )  20 . 1 ( - 1 . 4 )  1 9 . 2 ( -0 . 9 )  1 8 . 5 ( -0 . 7 )  1 9 . 7 (  1 . 2 )  1 9 . 7 (  0 . 0 )  2 1 . 5 ( 1 . 8 )  2 2 . 0 (  0 . 5 )  2 2 . 9 (  0 . 9 )  2 3 . 9 (  1 . 0 )  - 1 . 7  
AW/AW 5 1  
5 2  
5 3  
54 
5 5  
35 . 2  34 . 3 ( -0 . 9 )  36 . 6 ( 2 . 3 )  36 . 2 ( -0 . 4 )  3 7 . 1 (  0 . 9 )  36 . 4 ( -0 . 7 )  36 . 0 ( -0 . 4 ) 3 7 . 7 (  1 . 7 )  36 . 9 ( -Q . S )  3 7 . 5 (  0 . 6 )  36 . 9 ( -Q . 6 )  
3 1 . 6  31 . 7 (  0 . 1 )  32 . 0( 0 . 3 )  3 1 . 8 ( -0 . 2 )  3 1 . 5 ( -0 . 3 )  3 2 . 1 (  0 . 6 )  3 1 . 6 ( -Q . 5 )  3 3 . 8 (  2 . 2 )  32 . 4 ( - 1 . 4 )  3 3 . 0 (  0 . 6 ) 3 2 . 3 ( -Q . 7 )  
33 . 7  33 . 8 (  0 . 1 )  34 . 5 ( 0 . 7 )  3 3 . 8 ( -0 . 7 )  3 3 . 3 ( -0 . 5 )  3 3 . 7 (  0 . 4 )  3 3 . 2 ( -0 . 5 )  3 5 . 3 (  2 . 1 )  3 5 . 2 ( -Q . l )  3 5 . 3 (  0 . 1 )  3 5 . 2 ( -Q . 1 )  
32 . 3  3 1 . 7 ( -0 . 6 )  3 3 . 3 ( 1 . 6 )  3 3 . 6 ( 0 . 3 )  3 3 . 4 ( -0 . 2 )  34 . 0 (  0 . 6 )  3 3 . 4 ( -0 . 6 )  3 4 . 9 (  1 . 5 )  3 4 . 4 ( -Q . 5 )  34 . 4 (  0 . 0 )  34 . 2 ( -Q . 2 )  
28 . 1  26 . 8 ( - 1 . 3 )  2 8 . 4 (  1 . 6 )  2 9 . 6 (  1 . 2 )  30 . 4 (  0 . 8 )  30 . 2 ( -0 . 2 )  30 . 2 (  0 . 0 )  3 1 . 7 (  1 . 5 )  3 1 . 2 ( -G . 5 )  3 1 . 7 (  0 . 5 )  3 2 . 3 (  0 . 6 ) 
1 . 7 
0 . 7  
1 . 5 
1 . 9 
4 . 2  
AY/ Aw 56 37 . 3  34 . 9 ( -2 . 4 )  3 5 . 8 (  0 . 9 )  3 5 . 4 ( -0 . 4 )  3 5 . 1 ( -0 . 3 )  3 7 . 1 (  2 . 0 )  37 . 8 (  0 . 7 )  39 . 9 (  2 . 1 )  40 . 2 (  0 . 3 )  4 1 . 8 (  1 . 6 )  4 2 . 1 (  0 . 3 )  4 . 8 
57  37 . 5  35 . 6 ( - 1 . 9 )  3 5 . 2 ( -0 . 4 )  3 5 . 6 (  0 . 4 )  3 3 . 4 ( -2 . 2 )  3 5 . 5 ( 2 . 1 )  3 3 . 7 ( - 1 . 8 )  3 5 . 2 (  1 . 5 )  3 5 . 1 ( -Q . 1 )  36 . 7 (  1 . 6 )  37 . 3 (  0 . 6 ) -o . 2  
58 30 . 1  28 . 1 ( -2 . 0 ) 2 7 . 9 ( -0 . 2 )  2 8 . 9 (  1 . 0 )  28 . 2 ( -0 . 7 )  2 9 . 5 (  1 . 3 )  2 9 . 9 (  0 . 4 ) 3 1 . 7 (  1 . 8 )  3 2 . 6 (  0 . 9 )  3 2 . 2 ( -Q . 4 )  3 3 . 0 (  0 . 8 ) 2 . 9 
59 30 . 3  28 . 0 ( -2 . 3 ) 2 9 . 2 (  1 . 2 )  2 9 . 0 ( -0 . 2 )  28 . 3 ( -0 . 7 )  28 . 7 (  0 . 4 )  2 9 . 6 (  0 . 9 )  30 . 5 ( 0 . 9 )  3 2 . 3 (  1 . 8 )  3 3 . 9 (  1 . 6 )  34 . 5 (  0 . 6 ) 4 . 2  
6 0  26 . 0  24 . 4 ( - 1 . 6 )  2 5 . 7 ( 1 . 3 )  2 7 . 2 ( 1 . 5 )  26 . 6 ( -0 . 6 )  2 8 . 5 ( 1 . 9 )  2 8 . 6 (  0 . 1 )  30 . 6 (  2 . 0 )  30 . 6 (  0 . 0 )  30 . 7 (  0 . 1 )  3 1 . 4 (  0 . 7 )  5 . 4  
...... l.Jl � 
Expe r i ment # 2 ,  Study 1 
Append i x  Tab le 9 .  Mouse We i gh t  Data and D i f f e rences in We i ght f rom Week to Week ( i n grams ) .  
Geno-
ty pe- Mouse Week 60-day-old ( Adult s )  on 0 . 4 % DHEA 
Sex I 0 Week 1 Week 2 Week 3 Week 4 Week 5 Week 6 Week 7 Week 8 Week 9 
Tot a l  
We i ght 
Week 10 Change 
AW/AW 61 2 1 . 8  18 . 0 ( - 5 . 8 )  2 1 . 5 ( 3 . 5 )  2 1 . 5 ( 0 . 0 )  2 1 . 7 (  0 . 2 )  2 2 . 7 (  1 . 0 )  2 1 . 5 ( - 1 . 2 )  2 2 . 7 (  1 . 2 )  2 2 . 2 ( -D . 5 )  2 1 . 1 ( - 1 . 1 )  20 . 8 ( -D . 3 )  -3 . 0  
6 2  25 . 5  19 . 3 ( -6 . 2 )  1 9 . 5 ( 0 . 2 )  1 6 . 9 ( -2 . 6 )  1 8 . 6 (  1 . 7 )  20 . 2 (  1 . 6 )  2 2 . 0 ( 1 . 8 )  2 3 . 7 (  1 . 7 )  2 3 . 6 ( -D . 1 )  2 2 . 0 ( - 1 . 6 ) 20 . 9 ( -1 . 1 )  -4 . 6  
6 3  24 . 6  18 . 9 ( -5 . 7 )  1 7 . 7 ( - 1 . 2 )  1 6 . 4 ( - 1 . 3 )  1 8 . 7 (  2 . 3 )  1 8 . 9 (  0 . 2 )  1 9 . 0 (  0 . 1 )  20 . 4 (  1 . 4 )  1 9 . 6 ( -D . 8 )  1 9 . 4 ( -D . 2 )  20 . 0 (  0 . 6 ) -4 . 6  
6 4  2 2 . 8  18 . 5 ( -4 . 3 ) 20 . 2 (  1 . 7 )  1 6 . 9 ( -3 . 3 )  1 9 . 2 (  2 . 3 )  20 . 7 (  1 . 5 )  1 9 . 7 ( - 1 . 0 )  2 1 . 4 (  1 . 7 )  2 1 . 1 ( -D . 3 )  2 1 . 3 ( 0 . 2 )  2 2 . 2 (  0 . 9 )  -o . 6 
6 5  23 . 5  19 . 0 ( -4 . 5 )  1 7 . 5 (  1 . 5 )  1 6 .0( - 1 . 5 )  1 8 . 0 (  2 . 0 )  1 8 . 4 (  0 . 4 ) 1 8 . 8 (  0 . 4 )  1 8 . 3 ( -Q . 5 )  1 7 . 9 ( -0 . 4 )  1 7 . 5 ( -D . 4 ) 1 7 . 2 ( -D . 3 )  -6 . 3  
AW/AW 66 36 . 1  27 . 1 ( -9 . 0 )  2 2 . 1 ( -5 . 0 )  1 8 . 8 ( -3 . 3 )  1 9 . 8 (  1 . 0 )  2 1 . 2 ( 1 . 4 )  20 . 9 ( -D . 3 )  1 9 . 8 ( - 1 . 1 )  20 . 3 (  0 . 5 )  1 9 . 4 ( -D . 9 )  20 . 0 (  0 . 6 )  - 1 6 . 1  
6 7  39 . 5  31 . 0 ( -8 . 5 ) 2 5 . 8 ( -5 . 2 )  2 1 . 0 ( -5 . 8 )  20 . 1 ( -0 . 9 )  23 . 7 ( 3 . 6 )  2 2 . 2 ( - 1 . 5 )  2 4 . 4 (  2 . 2 )  2 5 . 4 (  1 . 0 )  2 4 . 4 ( - 1 . 0 )  24 . 8 (  0 . 4 ) -1 4 . 7  
68 35 . 0  26 . 6 ( -8 . 4 )  2 3 . 8 ( -2 . 8 )  20 . 9 ( -2 . 9 )  2 0 . 3 ( -0 . 6 )  20 . 3 ( 0 . 0 )  20 . 0 ( -0 . 3 )  2 1 . 2 (  1 . 2 )  2 2 . 4 (  1 . 2 )  2 2 . 5 (  0 . 1 )  2 2 . 9 (  0 . 4 ) -1 2 . 1  
69 31 . 8  24 . 9 ( -6 . 9 )  20 . 9 ( -4 . 0 )  1 8 . 4 ( -2 . 5 )  1 8 . 3 ( -0 . 1 )  20 . 0 (  1 . 7 )  1 9 . 2 ( -0 . 8 )  20 . 3 (  1 . 1 )  1 9 . 5 ( -D . 8 )  1 9 . 5 ( 0 . 0 )  20 . 4 (  0 . 9 )  -1 1 . 4 
7 0  25 . 7  1 7 . 6 ( -8 . 1 )  1 5 . 6 ( -2 . 0 )  1 6 . 9 (  1 . 3 )  1 8 . 6 (  1 . 7 )  1 8 . 7 (  0 . 1 )  1 8 . 9 (  0 . 2 )  20 . 0 (  1 . 1 )  1 9 . 7 ( -D . 3 )  1 9 . 3 ( -D . 4 ) 1 9 . 4 (  0 . 1 )  -6 . 3  
AY/ AW 7 1  33 . 2  30 . 0 ( -3 . 2 )  32 . 6 (  2 . 6 )  3 1 . 7 ( -0 . 9 )  3 3 . 2 (  1 . 5 )  32 . 9 ( -0 . 3 )  3 3 . 7 ( 0 . 8 )  34 . 8 (  1 . 1 )  34 . 9 (  0 . 1 )  3 5 . 0 (  0 . 1 )  36 . 1 (  1 . 1 )  2 . 9  
72  33 . 9  26 . 6 ( -7 . 3 )  2 5 . 5 ( - 1 . 1 )  2 7 . 8 (  2 . 3 )  2 9 . 1 (  1 . 3 )  2 8 . 9 ( -0 . 2 )  29 . 3 (  0 . 4 ) 30 . 6 (  1 . 3 )  3 1 . 4 (  0 . 8 )  30 . 8 ( -D . 6 ) 3 1 . 8 (  1 . 0 )  -2 . 1  
7 3  30 . 5  25 . 4 ( -5 . 1 )  26 . 9 (  1 . 5 )  2 5 . 9 ( - 1 . 0 )  2 7 . 4 (  1 . 5 )  26 . 1 ( - 1 . 3 )  26 . 0 ( -0 . 1 )  2 7 . 4 (  1 . 4 )  29 . 0 (  1 . 6 )  28 . 7 ( -D . 3 )  30. 1 (  1 . 4 )  -o . 4 
7 4  29 . 3  25 . 1 ( -4 . 2 )  24 . 8 ( -0 . 3 )  2 5 . 8 (  1 . 0 )  2 5 . 8 (  0 . 0 )  2 4 . 9 ( -0 . 9 )  24 . 5 ( -0 . 4 )  2 5 . 0 (  0 . 5 )  26 . 4 (  1 . 4 )  26 . 4 (  0 . 0 )  26 . 1 ( -D . 3 )  -3 . 2  
7 5  26 . 2  20 . 5 ( -5 . 7 )  2 1 . 0( 0 . 5 ) 2 1 . 4 (  0 . 4 )  2 1 . 7 (  0 . 3 )  2 2 . 5 (  0 . 8 )  20 . 9 ( - 1 . 6 )  2 3 . 0 (  2 . 1 )  2 3 . 7 (  0 . 7 )  2 4 . 0 (  0 . 3 )  2 5 . 0 (  1 . 0 )  - 1 . 2  
AW/ AW 76 36 . 0  28 . 4 ( -7 . 6 )  30 . 7 (  2 . 3 )  3 1 . 1 (  0 . 4 )  30 . 3 ( -0 . 8 )  2 9 . 9 ( -0 . 4 )  2 8 . 8 ( - 1 . 1 )  3 2 . 8 (  4 . 0 )  34 . 1 (  1 . 3 )  3 5 . 5 (  1 . 4 )  3 5 . 9 (  0 . 4 ) -o . 1  
1 1  38 . 8  34 . 8 ( -4 . 0 )  3 3 . 7 ( - 1 . 1 )  3 3 . 9 (  o . 2 )  3 3 . 8 ( -0 . I )  34 . 2 (  o . 4 )  3 3 . 9 ( -0 . 3 )  3 5 . 3 ( 1 . 4 )  36 . 4 (  1 . 1 )  36 . 7 (  o . 3 )  38 . 3 (  1 . 6 )  -o . 5  
78  3 1 . 0  25 . 4 ( - 5 . 6 )  2 6 . 6 (  1 . 2 )  26 . 8 (  0 . 2 )  2 5 . 7 ( - 1 . 1 )  26 . 1 (  0 . 4 )  2 5 . 3 ( -0 . 8 )  2 7 . 0 (  1 . 7 )  28 . 5 (  1 . 5 )  29 . 0 (  0 . 5 )  30 . 0 (  1 . 0 )  - 1 . 0  
7 9  29 . 7  22 . 8 ( -6 . 9 )  24 . 2 ( 1 . 4 )  24 . 6 (  0 . 4 )  2 3 . 9 ( -0 . 7 )  2 3 . 6 ( -0 . 3 )  2 3 . 9 (  0 . 3 )  2 4 . 9 (  1 . 0 )  24 . 8 ( -D . 1 )  26 . 0 (  1 . 2 )  27 . 0 (  1 . 0 )  -2 . 7  
80 24 . 9  19 . 9 ( -5 . 0 )  1 9 . 2 ( -0 . 7 )  1 9 . 8 (  0 . 6 )  20 . 1 (  0 . 3 )  20 . 1 (  0 . 0 )  1 9 . 1 ( - 1 . 0 )  20 . 7 (  1 . 6 )  2 2 . 8 (  2 . 1 )  2 2 . 7 ( -D . 1 )  2 3 . 1 (  0 . 6 )  -1 . 8  
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Expe r i ment # 2 ,  Study 1 
Append i x  Table 1 0 .  Mouse Wei gh t  Data and D i f f e renc e s in We i gh t  f rom Week to Week ( in gra ms ) .  
Geno-
ty pe- House Week 60-day-old ( Adult s )  on 0 . 0% DHEA 
Sex # 0 Week 1 Week 2 Week 3 Week 4 Week 5 Week 6 Week 7 Week 8 Week 9 
Tot al 
We i g h t  
Week 1 0  Change 
AW/AW 1 1 9 . 3  2 1 . 4 (  2 . 1 )  2 1 . 1 ( -0 . 3 )  2 2 . 2 ( 1 . 1 )  2 1 . 8 ( -0 . 4 )  2 2 . 6 (  0 . 8 )  2 2 . 7 (  0 . 1 )  2 3 . 7 (  1 . 0 )  24 . 7 (  1 . 0 )  2 4 . 7 (  0 . 0 )  2 3 . 8 ( -Q . 9 )  4 . 5  
2 1 3 . 0 1 5 . 7 ( 2 . 7 )  1 8 . 5 ( 2 . 8 )  1 5 . 9 ( 2 . 6 )  1 8 . 3 (  2 . 4 )  1 9 . 4 (  1 . 1 )  20 . 5 (  1 . 1 )  20 . 5 ( 0 . 0 )  20 . 0 ( -Q . 5 )  20 . 9 (  0 . 9 )  20 . 8 ( -Q . 1 )  7 . 8  
3 14 . 1  15 . 7 ( 1 . 3 )  1 5 . 5 ( -0 . 2 )  1 6 . 6 (  1 . 1 )  1 5 . 7 ( -0 . 9 )  1 7 . 3 (  1 . 6 )  1 7 . 8 (  0 . 5 )  1 9 . 1 (  1 . 3 )  1 8 . 8 ( -o . 3 )  1 9 . 2 (  0 . 4 )  1 9 . 1 ( -Q . 1 )  5 . 0  
4 1 2 . 3  15 . 7 (  3 . 4 )  1 7 . 7 (  2 . 0 )  1 9 . 8 ( 2 . 1 )  1 9 . 0 ( -0 . 8 )  1 9 . 8 (  0 . 8 )  20 . 4 (  0 . 6 )  20 . 9 (  0 . 5 )  20 . 8 ( -Q . 1 )  2 2 . 3 (  1 . 5 )  2 1 . 4 ( -Q . 9 )  9 . 1 
5 1 2 . 8  15 . 1 (  2 . 3 )  1 6 . 9 (  1 . 8 )  1 8 . 6 (  1 . 7 )  1 7 . 6 ( - 1 . 0 )  1 9 . 0 (  1 . 4 )  20 . 5 ( 1 . 5 )  20 . 7 (  0 . 2 )  2 1 . 2 ( -Q . 5 )  2 2 . 3 (  1 . 1 )  2 3 . 0 (  0 . 7 )  1 0 . 2  
AY / AW 6 1 7 . 3  20 . 0 (  2 . 7 )  2 2 . 0( 2 . 0 )  2 3 . 2 ( 1 . 2 )  2 3 . 8 (  0 . 6 )  2 5 . 9 ( 2 . 1 )  27 . 6 (  0 . 7 )  28 . 8 (  1 . 2 )  30 . 5 ( 1 . 7 )  3 3 . 0 (  2 . 5 )  3 5 . 8 (  2 . 8 )  18 . 5  
7 1 7 . 8  2 1 . 0( 3 . 2 )  2 2 . 9 ( 1 . 9 )  2 3 . 9 ( 1 . 0 )  24 . 5 ( 0 . 6 )  2 5 . 7 ( 1 . 2 )  2 7 . 0 (  1 . 3 )  30 . 2 (  3 . 2 )  29 . 8 ( -Q . 4 )  32 . 6 (  2 . 8 )  3 2 . 6 (  0 . 0 )  1 4 . 8  
8 20 . 7  26 . 4 (  5 . 7 )  2 7 . 3 (  0 . 9 ) . 26 . 5 ( -0 . 8 )  2 7 . 9 (  1 . 4 )  3 1 . 1 (  3 . 2 )  3 3 . 2 (  2 . 1 )  34 . 4 (  1 . 2 )  37 . 6 (  3 . 2 )  38 . 4 (  0 . 8 )  4 1 . 4 (  3 . 0 )  20 . 7  
9 1 9 . 6  23 . 6 (  4 . 0 )  24 . 6 (  1 . 0 )  2 5 . 7 ( 1 . 1 )  2 5 . 6 ( -0 . 1 )  29 . 9 (  4 . 3 )  3 1 . 5 ( 1 . 6 )  32 . 9 (  1 . 4 )  35 . 4 (  2 . 5 )  37 . 1 (  1 . 7 )  39 . 5 (  2 . 4 )  19 . 9  
1 0  1 6 . 2  19 . 8 ( 3 . 6 )  2 2 . 2 ( 2 . 4 )  2 2 . 5 ( 0 . 3 )  2 1 . 7 ( -0 . 8 )  2 3 . 0 ( 1 . 3 )  2 3 . 3 (  0 . 3 )  24 . 8 (  1 . 5 )  23 . 9 ( -Q . 9 )  2 4 . 4 (  0 . 5 ) 2 5 . 1 (  0 . 7 )  8 . 9  
AW/ AW 1 1  22 . 3  24 . 2 ( 1 . 9 )  2 5 . 2 (  1 . 0 )  26 . 4 (  1 . 2 )  26 . 3 ( -0 . 1 )  2 7 . 8 (  1 . 5 )  28 . 3 (  0 . 5 )  29 . 3 (  1 . 0 )  28 . 6 ( -Q . 7 )  28 . 5 ( -Q . 1 )  28 . 5 (  0 . 0 ) 6 . 2  
1 2  1 3 . 9  20 . 6 (  6 . 7 )  2 3 . 7 ( 3 . 1 )  2 4 . 9 ( 1 . 2 )  2 5 . 1 (  0 . 2 )  26 . 4 (  1 . 3 )  26 . 9 (  0 . 5 )  28 . 3 (  1 . 4 )  28 . 3 (  0 . 0 )  2 7 . 7 ( -Q . 6 )  27 . 1 ( -Q . 6 )  1 3  2 
1 3  22 . 6  23 . 9 (  1 . 3 )  2 3 . 9 ( o . o )  2 5 . 1 (  1 . 2 )  24 . 9 ( -0 . 2 )  26 . 8 (  1 . 9 )  2 1 . o c  o . 2 )  2 7 . 9 (  o . 9 )  2 7 . 5 ( -o . 4 ) 2 7 . 8 (  o . 3 )  21 . o c -o . 8 )  4 . 4  
1 4  24 . 5  26 . 0 (  1 . 5 )  2 5 . 3 ( -0 . 7 )  26 . 1 (  0 . 8 )  26 . 2 (  0 . 1 )  2 7 . 1 (  0 . 9 )  2 7 . 2 (  0 . 1 )  28 . 2 (  1 . 0 )  29 . 3 (  1 . 1 )  28 . 9 ( -Q . 4 ) 28 . 7 ( -Q . 2 )  4 . 2  
1 5  22 . 6  25 . 2 (  2 . 6 )  2 5 . 0 ( -0 . 2 )  26 . 3 (  1 . 3 )  26 . 8 ( 0 . 5 )  2 7 . 7 (  0 . 9 )  2 7 . 2 ( -0 . 5 )  2 7 . 2 (  0 . 0 )  2 7 . 6 (  0 . 4 ) 28 . 1 (  0 . 5 )  28 . 4 (  0 . 3 )  5 . 8  
AY / AW 1 6  23 . 3  27 . 3 (  4 . 0 )  30 . 3 ( 3 . 0 )  32 . 5 ( 2 . 2 )  36 . 3 ( 3 . 8 )  39 . 5 (  3 . 2 )  4 1 . 2 (  1 . 7 )  4 4 . 6 (  3 . 5 )  4 6 . 5 (  1 . 9 )  48 . 5 (  2 . 0 )  49 . 4 (  0 . 9 )  26 . 1  
1 7  23 . 3  25 . 5 ( 2 . 2 )  2 8 . 4 (  2 . 9 )  2 9 . 6 ( 1 . 2 )  30 . 0 (  0 . 4 )  3 1 . 5 ( 1 . 5 )  3 1 . 4 ( -0 . 1 )  3 3 . 3 (  1 . 9 )  36 . 0 (  2 . 7 )  37 . 4 (  1 . 4 )  40 � 0 (  2 . 6 )  1 6 . 7  
1 8  20 . 5  22 . 9 (  2 . 4 )  26 . 9 (  4 . 0 )  2 7 . 3 ( 1 . 4 )  28 . 9 (  1 . 6 )  29 . 8 (  0 . 9 )  32 . 1 ( 2 . 3 )  3 3 . 3 (  1 . 2 )  3 2 . 4 ( -Q . 9 )  3 3 . 5 (  1 . 1 )  34 . 9 (  1 . 4 )  1 4 . 4  
1 9  1 8 . 0 2 1 . 1 ( 3 . 1 )  2 3 . 0( 1 . 9 )  24 . 3 ( 1 . 3 )  26 . 4 (  2 . 1 )  2 9 . 9 (  3 . 5 )  3 2 . 6 (  2 . 7 )  3 5 . 9 (  3 . 3 )  38 . 1 (  2 . 2 )  4 1 . 5 (  3 . 4 ) 4 3 . 0 (  1 . 5 )  25 . 0  
20 1 1 . 7 16 . 6 (  4 . 9 )  2 1 . 5 ( 4 . 9 )  2 3 . 9 ( 2 . 4 )  26 . 9 ( 3 . 0 )  2 9 . 3 (  2 . 4 )  3 2 . 7 (  3 . 4 )  34 . 2 (  1 . 5 )  34 . 7 (  0 . 5 )  36 . 8 (  2 . 1 )  38 . 7 (  1 . 9 )  27 . 0  
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Expe r i ment  1 2 , Study 1 
Append i x  Ta ble 1 1 .  Mouse We i ght Da ta and D i f f e rences in Wei ght f rom Week to Week ( i n gra ms ) . 
Geno-
type- Mouse Week 60-day-o l d  { Adu l t s )  on 0 . 1 %  DHEA 
Sex I 0 We ek 1 Week 2 Week 3 Week 4 Week 5 Week 6 Week 7 Week 8 Week 9 
Tot a l  
We ight  
Week 10  Change 
AW/ AW 2 1  16 . 7  1 7 . 9 { 1 . 2 )  20 . 4 {  2 . 5 ) 2 1 . 2 { 0 . 8 )  20 . 7 { -0 . 5 )  2 2 . 2 {  1 . 5 )  2 2 . 9 { 0 . 7 )  2 2 . 1 ( -0 . 8 )  2 2 . 0 { -D . 1 )  2 2 . 6 (  0 . 6 )  2 2 . 6 {  0 . 0 )  5 . 9  
2 2  1 5 . 0 17 . 9 {  2 . 9 )  1 8 . 1 (  0 . 2 )  1 8 . 6 (  0 . 5 )  1 9 . 3 ( 0 . 7 )  20 . 7 (  1 . 4 )  20 . 9 (  0 . 2 )  2 1 . 7 (  0 . 8 )  2 2 . 0 (  0 . 3 )  2 2 . 4 (  0 . 4 )  2 2 . 7 (  0 . 3 )  7 . 7  
2 3  1 5 . 7  17 . 5 (  1 . 8 )  1 8 . 7 (  1 . 2 )  1 9 . 4 (  0 . 7 )  20 . 0 (  0 . 6 )  20 . 7 (  0 . 7 )  2 1 . 8 (  1 . 1 )  2 1 . 5 ( -Q . 3 )  2 1 . 7 (  0 . 2 ) 2 3 . 5 (  1 . 8 )  2 3 . 2 ( -Q . 3 )  7 . 5  
24 1 3 . 8  1 7 . 7 {  3 . 9 )  1 9 . 7 ( 2 . 0 )  20 . 4 (  0 . 7 )  1 9 . 3 ( - 1 . 1 )  20 . 5 ( 1 . 2 )  2 2 . 7 (  2 . 2 )  2 2 . 8 (  0 . 1 )  2 2 . 2 ( -Q . 6 )  2 2 . 3 (  0 . 1 )  2 3 . 7 (  1 . 4 )  9 . 9  
25  10 . 8  1 3 . 5 ( 2 . 7 )  1 4 . 4 (  0 . 9 )  1 4 . 3 ( -0 . 1 )  1 4 . 5 ( 0 . 2 )  1 7 . 7 (  3 . 2 )  1 8 . 6 (  0 . 9 )  1 7 . 9 { -0 . 7 ) 1 8 . 8 {  0 . 9 )  1 9 . 0 {  0 . 2 )  18 . 8 ( -D . 2 ) 8 . 0  
AY / AW 26 16 . 2  18 . 9 ( 2 . 7 )  1 9 . 9 ( 1 . 0 )  2 0 . 5(  0 . 6 )  2 1 . 4 (  0 . 9 )  2 2 . 7 {  1 . 3 )  2 5 . 1 (  2 . 4 )  2 5 . 7 {  0 . 6 )  2 7 . 7 {  2 . 0 )  30 . 4 (  2 . 7 )  3 2 . 5 (  2 . 1 )  16 . 3  
27  1 5 . 2  1 7 . 8 ( 2 . 6 )  1 8 . 8 {  1 . 0 )  1 9 . 8 (  1 . 0 )  1 9 . 8 ( 0 . 0 )  2 1 . 8 (  2 . 0 )  23 . 1 {  1 . 3 )  2 4 . 5 { 1 . 4 )  2 5 . 1 {  0 . 6 )  26 . 5 {  1 . 4 )  28 . 3 {  1 . 8 )  1 3 . 1 
28 1 9 . 3  20 . 4 (  1 . 1 )  2 1 . 7 (  1 . 3 )  2 2 . 5 { 0 . 8 )  2 2 . 7 { 0 . 2 )  2 4 . 5 {  1 . 8 )  26 . 1 (  1 . 6 )  2 7 . 0 (  0 . 9 )  2 7 . 3 {  0 . 3 )  28 . 7 (  1 . 4 )  29 . 5 {  0 . 8 )  1 0 . 2  
29 20 . 3  2 1 . 3 { 1 . 0 )  2 2 . 5 ( 1 . 2 )  2 3 . 7 ( 1 . 2 )  2 2 . 8 ( -0 . 9 )  2 4 . 4 (  1 . 6 )  2 5 . 7 (  1 . 3 )  26 . 8 (  1 . 1 )  28 . 8 (  2 . 0 )  3 1 . 4 {  2 . 6 )  3 2 . 6 (  1 . 2 )  1 2 . 3  
30 1 4 . 6  19 . 3 (  4 . 7 )  2 1 . 0( 1 . 7 )  2 2 . 9 ( 1 . 9 )  2 3 . 1 ( 0 . 2 )  2 5 . 5 ( 2 . 4 )  2 7 . 1 (  1 . 6 )  28 . 7 {  1 . 6 )  29 . 3 ( 0 . 6 )  30 . 9 (  1 . 6 )  3 3 . 1 (  2 . 2 )  18 . 5  
AW/ AW 3 1  25 . 4  26 . 3 ( 0 . 9 )  28 .0(  1 . 7 )  2 9 . 8 (  1 . 8 )  2 9 . 6 ( -0 . 2 )  3 1 . 6 (  2 . 0 )  32 . 8 (  1 . 2 )  3 3 . 3 (  0 . 5 )  3 5 . 1 (  1 . 8 )  3 5 . 8 (  0 . 7 )  36 . 3 { 0 . 5 )  10 . 9  
32 20 . 0  21 . 9 ( 1 . 9 )  2 4 . 4 (  2 . 5 )  2 5 . 4 (  1 . 0 )  2 5 . 2 { -0 . 2 ) 2 7 . 0 (  1 . 8 )  28 . 4 (  1 . 4 )  28 . 7 (  0 . 3 )  29 . 7 (  1 . 0 )  29 . 7 (  0 . 0 )  30. 5 (  0 . 8 ) 1 0 . 5  
33 2 1 . 6  22 . 6 ( 1 . 0 )  2 5 .0(  2 . 4 )  2 5 . 7 (  0 . 7 )  2 4 . 8 ( -0 . 9 )  26 . 3 (  1 . 5 )  2 7 . 2 (  0 . 9 )  2 7 . 4 (  0 . 2 )  27 . 6 (  0 . 2 ) 28 . 7 (  1 . 1 )  28 . 4 ( -o . l )  6 . 8  
34 26 . 8  27 . 0( 0 . 2 )  2 9 . 8 ( 2 . 8 )  30 . 2 (  0 . 4 )  2 9 . 2 ( - 1 . 0 )  3 1 . 2 (  2 . 0 )  3 2 . 4 (  1 . 2 )  32 . 5 ( 0 . 1 )  3 3 . 4 (  0 . 9 )  34 . 0 (  0 . 6 )  3 3 . 7 ( -Q . 3 )  6 . 9  
35 1 3 . 6  15 . 6 (  2 . 0 )  1 8 . 4 (  2 . 8 )  1 9 . 4 (  1 . 0 )  20 . 1 (  0 . 7 )  2 1 . 6 (  1 . 5 )  2 2 . 4 (  0 . 8 )  2 3 . 9 (  1 . 5 )  24 . 3 (  0 . 4 ) 2 5 . 6 (  1 . 3 )  2 5 . 1 ( -D . 5 )  1 1 . 5 
AY/ Aw 36 24 . 7  26 . 1 ( 1 . 4 )  26 . 3 (  0 . 2 )  2 7 . 7 (  1 . 4 )  2 5 . 5 ( -2 . 2 )  26 . 4 (  0 . 9 )  2 5 . 2 ( - 1 . 2 )  26 . 0 (  0 . 8 )  2 7 . 2 (  1 . 2 )  27 . 2 (  0 . 0 )  28 . 7 (  1 . 5 )  4 . 0 
37 22 . 9  25 . 3 ( 2 . 4 )  2 6 . 9 ( 1 . 6 )  26 . 1 ( -0 . 8 )  26 . 8 ( 0 . 7 )  30 . 9 (  4 . 1 )  3 2 . 6 (  1 . 7 )  34 . 6 (  2 . 0 )  37 . 2 (  2 . 6 )  39 . 6 (  2 . 4 )  4 2 . 6 (  3 . 0 )  19 . 7  
38 22 . 8  25 . 5 ( 2 . 7 )  2 7 . 4 (  1 . 9 )  28 . 1 (  0 . 7 )  2 7 . 9 ( -0 . 2 )  2 9 . 3 (  1 . 4 )  28 . 1 ( - 1 . 2 )  2 9 . 3 ( 1 . 2 )  30 . 3 (  1 . 0 )  28 . 9 ( - 1 . 4 ) 30 . 7 (  1 . 8 )  7 . 9 
39 1 9 . 3  22 . 2 (  2 . 9 )  2 4 . 5 ( 2 . 3 )  26 . 6 (  2 . 1 )  28 . 7 (  2 . 1 )  3 2 . 5 (  3 . 8 )  3 5 . 0 (  2 . 5 )  3 7 . 8 (  2 . 8 )  40 . 3 (  2 . 5 )  4 2 . 1 (  1 . 8 )  4 5 . 3 (  3 . 2 )  26 . 0  
40 1 1 . 5 17 . 1 {  5 . 6 )  20 . 8 (  3 . 7 )  2 3 . 8( 3 . 0 )  2 3 . 6 ( -0 . 2 )  26 . 0 (  2 . 4 )  26 . 4 (  0 . 4 ) 29 . 5 (  3 . 1 )  30 . 7 (  1 . 2 )  3 1 . 8 (  1 . 1 )  3 3 . 7 (  1 . 9 )  2 2 . 2  
.... 
VI "'-J 
Expe r i ment # 2 ,  Study 1 
Appendi x  Tab le 1 2 .  Mouse We i gh t  Data and D i f f e re nces  in Wei gh t  f rom Week to Week ( in grams ) .  
Geno-
ty pe- House Week 60-day-old ( Ad u lt s )  on 0 . 2 %  DHEA 
Tot a l  
We ight  
Week 10  Change Sex I 0 Week 1 Week 2 Week 3 Week 4 Week 5 Week 6 Week 7 Week 8 Week 9 
AW/AW 41 1 5 . 1  1 5 . 4 (  0 . 3 )  1 6 .0(  0 . 6 )  1 6 . 1 (  0 . 1 )  1 6 . 1 (  0 . 0 )  1 7 . 4 (  I . : I )  1 7 . 4 (  0 . 0 )  1 8 . 7 (  1 . 3 )  1 8 . 6 ( -0 . 1 )  1 9 . 2 (  0 . 6 ) 1 9 . 4 (  0 . 2 )  
4 2  1 7 . 1  1 7 . 5( 0 . 4 )  1 6 . 7 ( -0 . 8 )  1 7 . 8 (  1 . 1 )  1 8 . 2 (  0 . 4 )  1 9 . 1 (  0 . 9 )  20 . 3 (  1 . 2 )  2 1 . 1 (  0 . 8 )  2 1 . 0 ( -Q . 1 )  2 1 . 8 (  0 . 8 ) 2 1 . 4 ( -Q . 4 )  4 . 3  
4 3  1 6 . 2  1 7 . 4 (  1 . 2 )  1 6 . 7 ( -0 . 7 )  1 5 . 9 ( -0 . 8 )  1 7 . 8 ( 1 . 9 )  1 8 . 3 ( 0 . 5 )  1 8 . 8 (  0 . 5 )  20 . 6 (  1 . 8 )  1 9 . 7 ( -Q . 9 )  1 9 . 1 ( -Q . 6 )  1 9 . 6 (  0 . 5 )  3 . 4  
44 14 . 1  16 . 4 (  2 . 3 ) 1 7 . 9 (  1 . 5 )  1 8 . 5 ( 0 . 6 )  1 9 . 2 (  0 . 7 )  20 . 1 (  0 . 9 )  20 . 9 (  0 . 8 )  2 2 . 0 (  1 . 1 )  2 1 . 7 ( -0 . 3 )  2 2 . 0 (  0 . 3 )  2 2 . 4 (  0 . 4 ) 8 . 3  
4 5  1 4 . 8  1 7 .0(  2 . 2 ) 1 6 . 0( - 1 . 0 )  1 5 . 6 ( -0 . 4 )  1 8 . 4 (  2 . 8 )  20 . 2 ( 1 . 8 )  2 2 . 0 (  1 . 8 )  2 3 . 6 (  1 . 6 )  2 2 . 7 ( -0 . 9 )  2 4 . 1 (  1 . 4 )  24 . 1 (  0 . 0 )  9 . 3  
   -D -D
-D  
3  
� r � r � r - r • I )  1 9 . 4 (  0 . 4 ) 2 1 . 3 ( 1 . 9 )  2 1 . 7 (  0 . 4 ) 2 2 . 0 (  0 . 3 )  2 2 . 4 (  0 . 4 ) 
1 9 . 9  1 7 . 7 ( - 2 . 2 )  1 7 . 5 ( -0 . 2 )  1 8 . 6 (  1 . 1 )  1 9 . 2 (  0 . 6 )  20 . 5 (  1 . 3 )  20 . 8 ( 0 . 3 )  2 1 . 7 (  0 . 9 )  2 2 . 2 (  0 . 5 )  2 2 . 8 (  0 . 6 )  2 3 . 2 (  0 . 4 ) 
1 8 . 5  18 . 6 (  0 . 1 )  1 9 . 0 (  0 . 4 )  20 . 2 (  1 . 2 )  1 9 . 7 ( -0 . 5 )  20 . 9 ( 1 . 2 )  20 . 7 ( -0 . 2 )  2 1 . 3 ( 0 . 6 )  2 1 . 5 ( 0 . 2 )  2 2 . 2 (  0 . 7 )  2 2 . 6 (  0 . 4 ) 
1 3 . 8  14 . 4 (  0 . 6 )  1 4 . 4 (  0 . 0 )  1 5 . 5 (  1 . 1 )  1 6 . 5 ( 1 . 0 )  1 7 . 8 (  1 . 3 )  1 7 . 9 (  0 . 1 )  1 8 . 9 (  1 . 0 )  1 9 . 2 (  0 . 3 )  1 9 . 9 (  0 . 7 )  2 1 . 0 (  1 . 1 )  
1 9 . 4  1 7 . 8 ( - 1 . 6 )  1 7 . 6 ( -0 . 2 )  1 8 . 7 (  1 . 1 )  1 8 . 2 ( -0 . 5 )  1 8 . 5 (  0 . 3 )  1 9 . 2 (  0 . 7 )  1 9 . 9 (  0 . 7 )  20 . 8 (  0 . 9 )  2 1 . 9 (  1 . 1 )  2 2 . 6 (  0 . 7 )  
AW/AW 5 1  1 6 . 4  1 7 . 8 (  1 . 4 )  1 8 . 5 ( 0 . 7 )  1 9 . 4 (  0 . 9 )  1 9 . 6 (  0 . 2 )  2 1 . 4 (  1 . 8 )  2 1 . 7 (  0 . 3 )  2 3 . 2 (  1 . 5 )  2 3 . 3 (  0 . 1 )  24 . 3 (  1 . 0 )  2 4 . 8 (  0 . 5 )  8 . 4  
5 2  1 7 . 8  18 . 6 (  0 . 8 )  1 9 . 5 ( 0 . 9 )  20 . 1 (  0 . 6 )  20 . 0 ( -0 . 1 )  2 1 . 4 (  1 . 4 )  2 1 . 6 (  0 . 2 )  2 3 . 4 (  1 . 8 )  23 . 6 (  0 . 2 )  2 5 . 0 (  1 . 4 )  26 . 4 (  1 . 4 )  8 . 6  
5 3  23 . 3  24 . 1 (  0 . 8 )  24 . 2 (  0 . 1 )  24 . 9 (  0 . 7 )  2 5 . 0 (  0 . 1 )  2 5 . 4 (  0 . 4 )  2 7 . 2 (  1 . 8 )  26 . 7 ( -0 . 5 )  2 7 . 5 (  0 . 8 )  29 . 0 (  1 . 5 )  28 . 5 ( -D . 5 )  5 . 2  
5 4  25 . 7  25 . 2 ( -0 . 5 )  26 . 2 ( 1 . 0 )  26 . 2 (  0 . 0 )  2 5 . 6 ( -0 . 6 )  2 7 . 1 (  1 . 5 ) 26 . 2 ( -0 . 9 )  2 6 . 8 (  0 . 6 )  2 7 . 4 (  0 . 6 ) 2 7 . 4 (  0 . 0 )  2 7 . 0 ( -D . 4 )  1 . 3 
5 5  1 5 . 6  18 . 4 (  2 . 8 )  20 . 7 (  2 . 3 ) 2 2 . 8( 2 . 1 )  2 2 . 1 ( -0 . 7 )  2 3 . 8 ( 1 . 7 )  2 4 . 5 ( 0 . 7 )  2 5 . 4 (  0 . 9 )  26 . 1 (  0 . 7 )  2 7 . 6 (  1 . 5 )  28 . 9 (  1 . 3 )  1 3 . 3  
AY /AW 56 25 . 7  26 . 1 (  0 . 4 )  2 8 . 4 (  2 . 3 )  30 . 4 (  2 . 0 )  3 1 . 4 (  1 . 0 )  34 . 2 (  2 . 8 )  3 3 . 1 ( - 1 . 1 )  34 . 9 (  1 . 8 )  36 . 2 (  1 . 3 )  39 . 5 (  3 . 3 )  4 2 . 3 ( 2 . 8 )  1 6 . 6  
5 7  23 . 4  23 . 7 ( 0 . 3 )  2 3 . 3 ( -0 . 4 )  2 5 . 2 ( 1 . 9 )  24 . 7 ( -0 . 5 )  2 9 . 1 (  4 . 4 )  2 7 . 0 ( -2 . 1 )  28 . 9 (  1 . 9 )  3 1 . 6 (  2 . 7 )  3 2 . 6 (  1 . 0 )  3 5 . 7 (  3 . 1 )  1 2 . 3  
58 23 . 3  24 . 8 (  1 . 5 )  2 5 . 4 (  0 . 6 )  28 . 6 (  3 . 2 )  28 . 9 ( 0 . 3 )  32 . 2 (  3 . 3 )  3 2 . 0 ( -0 . 2 )  3 3 . 3 (  1 . 3 )  34 . 8 (  1 . 5 )  34 . 8 (  0 . 0 )  36 . 7 (  1 . 9 )  1 3 . 4  
59 22 . 4  22 . 9 (  0 . 5 ) 2 2 . 9 ( 0 . 0 )  2 5 . 4 (  2 . 5 ) 2 5 . 2 ( -0 . 2 )  28 . 3 (  3 . 1 )  2 7 . 4 ( -0 . 9 )  29 . 4 (  2 . 0 )  3 1 . 1 (  1 . 7 )  34 . 2 (  3 . 1 )  3 5 . 7 (  1 . 5 )  1 3 . 3  
60 1 3 . 2  16 . 1 ( 2 . 9 )  1 8 . 2 (  2 . 1 )  2 1 . 2 (  3 . 0 )  2 2 . 6 ( 1 . 4 )  2 5 . 2 (  2 . 6 )  2 4 . 6 ( -0 . 6 )  2 5 . 7 (  1 . 1 )  26 . 6 (  0 . 9 )  2 7 . 5 (  0 . 9 )  29 . 4 (  1 . 9 )  1 6 . 2  
.... 1..11 00 
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Append i x  Tab le 1 3 .  Mouse Wei ght Data and D i f f e rences in Wei gh t  f rom Week to Week ( i n grams ) .  
Geno-
type- House Week 60-day-old ( Adu lt s )  on 0 . 4 %  DHEA 
Sex I 0 Week 1 Week 2 Week 3 Week 4 Week 5 Week 6 Week 7 Week 8 Week 9 
Tot a l  
We ight  
Week 10  Change 
AW/AW 6 1  1 7 . 6  1 3 . 3 ( -4 . 3 )  1 4 . 9 (  1 . 6 )  1 6 . 1 (  1 . 2 )  1 4 . 6 ( - 1 . 5 )  1 5 . 9 (  1 . 3 )  1 5 . 1 ( -0 . 8 )  1 5 . 7 (  0 . 6 )  1 6 . 0 (  0 . 3 )  1 6 . 4 (  0 . 4 ) 1 6 . 8 (  0 . 4 ) -Q . 8  
62 18 . 2  1 5 . 3 ( - 2 . 9 )  1 3 . 9 ( - 1 . 4 )  1 4 . 3 ( 0 . 4 )  1 4 . 1 ( -0 . 2 )  1 4 . 8 ( 0 . 7 )  1 5 . 7 (  0 . 9 )  1 6 . 5 (  0 . 8 )  1 6 . 6 (  0 . 1 )  1 6 . 4 ( -G . 2 )  1 6 . 1 ( -D . J )  -2 . 1  
6 3  1 4 . 6  14 . 0( -0 . 6 )  1 4 . 8 (  0 . 8 )  1 5 . 4 (  0 . 6 )  1 5 . 0 ( -0 . 4 )  1 5 . 1 (  0 . 1 )  1 5 . 1 (  0 . 0 )  1 6 . 1 (  1 . 0 )  1 6 . 5 ( 0 . 4 ) 1 6 . 4 ( -D . 1 )  1 7 . 4 (  1 . 0 )  2 . 8  
64 16 . 1  1 3 . 6 ( -2 . 5 ) 1 4 . 9 ( 1 . 3 )  1 7 . 2 (  2 . 3 )  1 7 . 7 (  0 . 5 )  1 8 . 2 ( 0 . 5 )  1 8 . 5 ( 0 . 3 )  1 8 . 1 ( -0 . 4 ) 1 7 . 7 ( -D . 4 ) 1 8 . 2 (  0 . 5 )  1 8 . 3 (  0 . 1 )  2 . 2  
6 5  14 . 6  12 . 5 ( - 2 . 1 )  1 3 . 6 (  1 . 1 )  1 4 . 0 (  0 . 4 )  1 2 . 8 ( - 1 . 2 )  1 3 . 6 (  0 . 8 )  1 4 . 0 (  0 . 4 )  1 3 . 7 ( -0 . 3 )  1 3 . 4 ( -D . 3 )  1 3 . 6 (  0 . 2 )  1 4 . 2 ( 0 . 6 ) -o . 4  
AY / AW 66 2 1 . 6  16 . 8 ( -4 . 8 )  1 5 . 3 ( - 1 . 5 )  1 6 . 5 (  1 . 2 )  1 3 . 0 ( -3 . 5 )  1 4 . 5 ( 1 . 5 )  1 7 . 1 (  2 . 6 )  1 8 . 2 (  1 . 1 )  1 8 . 4 (  0 . 2 )  1 8 . 9 (  0 . 5 )  1 9 . 1 (  0 . 2 )  -2 . 5  
67 2 1 . 4  16 . 0( -5 . 4 )  1 4 . 7 ( - 1 . 3 )  1 5 . 6 (  0 . 9 )  1 5 . 6 (  0 . 0 )  1 4 . 7 ( -0 . 9 )  1 6 . 1 (  1 . 4 )  1 7 . 4 (  1 . 3 )  1 7 . 4 (  0 . 0 )  1 7 . 4 (  0 . 0 )  1 6 . 4 ( - 1 . 0 )  -5 . 0  
68 2 1 . 5  1 7 . 4 ( -4 . 1 )  1 7 . 2 ( -0 . 2 )  1 7 . 9 (  0 . 7 )  1 7 . 9 ( 0 . 0 )  1 9 . 1 (  1 . 2 )  1 9 . 8 (  0 . 7 )  2 0 . 3 (  0 . 5 )  1 9 . 7 ( -D . 6 )  1 9 . 5 ( -D . 2 ) 1 8 . 8 ( -D . 7 )  -2 . 7  
69 23 . 1  17 . 0 ( -6 . 1 )  1 5 . 3 ( - 1 . 7 )  1 6 . 2 ( 0 . 9 )  1 5 . 6 ( -0 . 6 )  1 6 . 1 (  0 . 5 )  1 7 . 4 (  1 . 3 )  1 8 . 1 (  0 . 7 )  1 8 . 4 (  0 . 3 )  1 9 . 0 (  0 . 6 )  1 8 . 4 ( -Q . 6 )  -4 . 7  
70 1 4 . 8  14 . 3 ( -0 . 5 )  1 3 . 9 ( -0 . 4 )  1 4 . 8 (  0 . 9 )  1 5 . 2 (  0 . 4 )  1 5 . 6 (  0 . 4 ) 1 6 . 7 (  1 . 1 )  1 7 . 7 (  1 . 0 )  1 8 . 0 (  0 . 3 )  1 8 . 4 (  0 . 4 ) 1 8 . 9 (  0 . 5 ) 4 . 1 
AW/AW 7 1  2 3 . 8  18 . 2 ( -5 . 6 )  1 9 . 4 (  1 . 2 )  2 1 . 0( 1 . 6 )  2 1 . 1 ( 0 . 1 )  2 1 . 5 (  0 . 4 )  2 1 . 9 (  0 . 4 )  2 2 . 4 (  0 . 5 )  2 3 . 8 (  1 . 4 )  2 3 . 7 ( -Q . 1 )  24 . 9 (  1 . 2 )  1 . 1  
7 2  25 . 0  19 . 2 ( -5 . 8 )  1 8 . 7 ( -0 . 5 )  1 7 . 7 ( - 1 . 0 )  1 9 . 0 (  1 . 3 )  20 . 6 (  1 . 6 )  2 2 . 4 (  1 . 8 )  2 4 . 8 (  2 . 4 )  2 5 . 3 (  0 . 5 )  2 5 . 5 (  0 . 2 )  2 7 . 1 (  1 . 6 )  2 . 1  
7 3  26 . 1  2 1 . 3 ( -4 . 8 )  2 0 . 7 ( -0 . 6 )  2 1 . 3 ( 0 . 6 )  20 . 5 ( -0 . 8 )  2 1 . 5 (  1 . 0 )  2 1 . 1 ( -0 . 4 )  2 1 . 9 (  0 . 8 )  2 2 . 9 ( 1 . 0 )  2 4 . 0 (  1 . 1 )  2 3 . 8 ( -D . 2 )  -2 . 3  
7 4  25 . 2  2 1 . 2 ( -4 . 0 )  2 2 . 2 ( 1 . 0 )  2 3 . 9 (  1 . 7 )  2 4 . 4 (  o �5 )  24 . 8 ( o . 4 )  2 5 . 9 (  1 . 1 )  26 . 9 (  1 . 0 )  2 7 . 5 (  o . 6 )  28 . 1 ( o . 6 )  28 . 3 (  o . 2 )  3 . 1 
7 5  1 5 . 7  1 3 . 4 ( -2 . 3 )  1 5 . 6 (  2 . 2 )  1 6 . 7 (  1 . 1 )  1 6 . 8 (  0 . 1 )  1 7 . 3 (  0 . 5 )  1 7 . 6 (  0 . 3 )  1 9 . 0 (  1 . 4 )  20 . 0 (  1 . 0 )  20 . 8 (  0 . 8 )  2 1 . 8 (  1 . 0 )  6 . 1 
AY / AW 7 6 25 . 5  1 9 . 4 ( -6 . 1 )  1 9 . 0 ( -0 . 4 )  2 1 . 5 ( 2 . 5 ) 2 2 . 7 (  1 . 2 )  2 3 . 4 (  0 . 7 )  24 . 0 (  0 . 6 )  2 4 . 7 (  0 . 7 )  24 . 2 ( -0 . 5 )  2 5 . 8 (  1 . 6 )  26 . 0 (  0 . 2 )  0 . 5  
7 7  27 . 1  20 . 9 ( -6 . 2 )  1 9 . 9 ( - 1 . 0 )  2 2 . 7 (  2 . 8 )  2 2 . 5 ( -0 . 2 )  2 4 . 2 ( 1 . 7 )  2 3 . 0 ( - 1 . 2 )  2 3 . 9 (  0 . 9 )  2 4 . 9 (  1 . 0 )  26 . 4 (  1 . 5 )  27 . 8 (  1 . 4 )  0 . 7  
78  26 . 9  2 1 . 5 ( -5 . 4 )  1 8 . 3 ( -3 . 2 )  1 9 . 3 (  1 . 0 )  20 . 5 ( 1 . 2 )  2 1 . 2 (  0 . 7 )  2 1 . 7 (  0 . 5 )  2 3 . 6 (  1 . 9 )  2 3 . 4 ( -0 . 2 )  2 4 . 3 (  0 . 9 )  2 3 . 7 ( -D . 6 )  -3 . 2  
7 9  2 1 . 7  16 . 9 ( -4 . 8 )  1 6 . 5 ( -0 . 4 )  1 7 . 3 (  0 . 8 )  1 6 . 7 ( -0 . 6 )  1 6 . 7 (  0 . 0 )  1 6 . 9 (  0 . 2 )  1 8 . 0 (  1 . 1 )  1 8 . 5 (  0 . 5 )  20 . 4 (  1 . 9 )  2 0 . 2 ( -G . 2 )  - 1 . 5  
8 0  1 4 . 3  1 3 . 7 ( -0 . 6 )  1 4 . 2 (  0 . 5 )  1 6 . 9 ( 2 . 7 )  1 6 . 9 (  0 . 0 )  1 8 . 9 (  2 . 0 )  1 9 . 9 ( 1 . 0 )  2 0 . 9 (  1 . 0 )  2 1 . 5 (  0 . 6 )  2 2 . 6 (  1 . 1 )  2 3 . 4 (  0 . 8 )  9 . 1  
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Appendix Table 14 . Food Consumption ( in grams ) .  
Average 
Food 
Weeks : 1 2 3 4 5 6 7 8 9 1 0  Consumption 
60-day-olds ( Adults )  on 0 . 0% DHEA 
AW/AW ( ll ' s 1-5 )  1 10 . 0 87 . 8  78 . 6  126 . 5  72 . 6  75 . 2  96 . 9  9 1 . 5  123 . 5  63 . 4  92 . 60 
AY/AW ( II ' s 6- 10 )  163 . 8  123 . 4  1 1 2 . 5  193 . 8  104 . 4  126 . 0  166 . 1  160 . 0  197  . o  1 25 . 4  147 . 24 
AW/AW ( ll ' s  1 1 - 1 5 )  140 . 7  1 26 . 2  1 1 7 . 4  190 . 7  102 . 0  122 . 2  145 . 7  14 1 . 7  17 8 . 8  105 . 3  137 . 07 
AY/AW ( ll ' s  1 6-20 )  1 7 7 . 6  157 . 0  140 . 7  223 . 1  123 . 4  1 57 . 4  186 . 7  1 79 . 9  2 1 9 . 1  134 . 8 169 . 9 7 
60 day-olds ( Adults )  on 0 . 1 % DHEA 
AW/AW ( ll ' s  2 1-25 ) 1 1 9 . 2 109 . 9  103 . 0  124 . 1  99 . 9  89 . 3  1 1 1 . 1  106 . 2  134 . 4  72 . 7  106 . 98 
AY/AW ( II ' s 26-30 ) 1 38 . 1  134 . 8  144 . 8  234 . 6  148 . 4  150 . 5  189 . 8  205 . 7  222 . 6  14 1 . 1  17 1 . 04 
AW/AW ( II ' s 3 1-35 )  148 . 8  129 . 6  122 . 0  185 . 7  99 . 1  1 1 1 . 8  136 . 1  136 . 0  1 5  7 . 1  94 . 8  132 . 1 0 
AY/AW ( II '  s 36-40 ) 182 . 6  178 . 5  1 73 . 6  228 . 9  14J . 3  1 72 . 6  2 14 . 2  207 . 2  227 . 9  159 . 8  188 . 86 
60 day-olds ( Adults )  on 0 . 2%  DHEA 
AW/AW ( ll ' s  4 1-45 ) 99 . 4  105 . 8  94 . 6  128 . 6  89 . 9  97 . 0  1 1 1 . 3  1 1 3 . 9  1 5 1 . 1  84 . 1  107 . 57 
AY/AW ( II ' s 46-50) 68 . 5  74 . 2  80 . 0  1 1 2 . 2 8 1 . 4  89 . 9  1 2 1 . 6  133 . 3  16 1 . 8 98 . 7  102 . 1 6 
AW/AW ( ll ' s 5 1-SS )  1 57 . 5  162 . 2  143 . 4  220 . 3  135 . 2  137 . 1  160 . 4  1 5 1 . 7  192 . 1  107 . 1  156 . 70 
AY/AW ( II ' s 56-60 ) 134 . 9  142 . 9  14 1 . 5  21 8 . 3 122 . 0  157 . 4  190 . 3  19 1 . 7 23 1 . 1  138 . 9  166 . 90 
60  day-olds ( Adult s )  on 0 . 4% DHEA 
AW/AW ( II ' s 6 1 -65 )  54 . 1  6 1 . 5  53 . 6  10 1 . 0  66 . 7  74 . 8  98 . 0  89 . 4  105 . 2  65 . 4  76 . 97 
AY/AW ( ll ' s  66-70 )  65 . 3  35 . 7  35 . 9  86 . 7  70 . 9  73 . 0  94 . 1  90 . 0  1 1 2 . 5 86 . 6  7 5 . 07 
AW/AW ( If ' s  7 1-7 5 )  79 . 0  88 . 1  93 . 6  162 . 1  77 . 3  94 . 3  124 . 6  1 24 . 7  160 . 4  96 . 9  1 10 . 1 0  ...... 
AY/AW ( II ' s 76-80 ) 88 . 8  103 . 4  1 1 7 . 0  174 . 4  87 . 8  1 1 3 . 5  152 . 1  16 1 . 4 183 .0  1 10 . 3 1 29 . 1 7 Q'\ 0 
Experiment #2 , Study 1 .  
Appendix Table 14 . (continued ) 
Average 
Food 
Weeks : 1 2 3 4 5 6 7 8 9 1 0  Consumption 
6G-day-olds ( Adults )  on 0 . 0% DHEA 
AW/AW ( ll ' s  1 -5 )  91 . 9  83 . 2  86 .0  82 . 5  64 . 0  82 . 7  75 . 1  80 . 4  84 . 5  83 . 7  8 1 . 40 
AY/AW ( II ' s 6- 10 )  106 . 5  10 1 . 8  90 . 8  95 . 2  94 . 7  108 . 9  106 . 4  105 . 2  1 1 2 . 8 1 16 . 6 103 . 89 
AW/AW ( ll ' s  1 1- 1 5 )  1 18 .0 109 . 8  105 . 0  96 . 9  92 . 9  108 . 3  105 . 8  1 10 . 2 1 10 . 7  1 18 . 2 107 . 58 
AY/AW ( II ' s 1 6-20 ) 1 26 .0  1 30 . 4  1 23 . 1  1 5 5 . 9  1 18 . 3  1 53 . 0  156 . 1  1 58 . 4  154 . 7  17 1 . 6 144 . 7 5 
60-day-olds ( Adults )  on 0 . 1 % DHEA 
AW/AW ( ll ' s  2 1-25 ) 92 . 1  93 . 0  88 . 0  90 . 4  69 . 6  85 . 0  72 . 6  80 . 0  84 . 3  84 . 4  83 . 94 
AY/AW ( II ' s 26-30 ) 1 0 1 . 8  1 1 2 . 1  107 . 7  1 10 . 4 95 . 3  120 . 2  122 . 4  127 . 5  132 . 4  147 . 9  1 17 . 7 7 
AW/AW ( II ' s 3 1-35 )  1 1 5 . 8 1 1 5 . 3  1 1 5 . 9 1 3 1 . 3  96 . 3  1 2 1 . 6  1 2 1 . 8  126 . 2  120 . 0  1 3 1 . 8  1 1 9 . 60 
AY/AW ( II ' s 36-40 ) 133 . 5  135 . 4  129 . 4  1 5 1 . 2  1 1 8 . 0 1 5 1 . 9  1 55  . o  169 . 3  17 2 . 5 195 . 9  15 1 . 2 1  
6G-day-olds ( Adult s )  on 0 . 2 % DHEA 
AW/AW ( II '  s 4 1 -45 ) . 72 . 6  67 . 9  60 . 5  108 . 3  72 . 3  9 1 . 5  82 . 4  88 . 1  87 . 5  89 . 7  82 . 08 
AY/AW ( II ' s 46-50) 69 . 2  73 . 2  77 . 2  10 1 . 4  65 . 9  83 . 5  78 . 6  86 . 5  92 . 1  98 . 4  82 . 60 
AW/AW ( ll ' s  5 1 -55 )  97  . o  1 1 2 . 7  106 . 2  1 1 5 . 6  58 . 7  124 . 2  123 . 4  127 . 8  122 . 1  1 23 . 8  1 1 1 . 1 5 
AY/AW ( II ' s 56-60 ) 1 1 3 . 7 133 . 9  135 . 8  17 6 . 7  52 . 0  156 . 8  160 . 0  170 . 2  17 2 . 7 194 . 7  146 . 6 5  
6G-day-olds ( Adults )  on 0 . 4% DHEA 
AW/AW ( II ' s 6 1-6 5 )  39 . 8  61 . 2  63 . 9  75 . 6  56 . 2  72 . 5  67 . 2  74 . 8  74 . 1  90 . 2  67 . 5 5 
AY/AW ( ll ' s  66-70}  46 . 6  55 . 1  65 . 9  74 . 6  63 . 4  90 . 2  86 . 3  84 . 9  84 . 1  85 . 6  73 . 67 
AW/AW ( ll ' s  7 1-75 ) 61 . 0  8 1 . 6  77 . 4  104 . 2  7 1 . 9  100 . 8  104 . 6  1 1 1 . 4 1 14 . 6  1 19 . 6 94 . 7 1  ....... 
AY/AW ( If ' s  76-80 ) 60 . 2  74 .0  86 . 8  128 . 1  86 . 3  104 . 9  104 . 3  106 . 5  106 . 1  1 10 . 5  96 . 7 7  
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Appendix Table 1 5 . Change in Absorbance at 340 nm ,  Red Blood  Cell Count , 
and Calculated G6PDH Activity ( U/ 10 1 2  RBC ) for  Each 
Mouse ( 60-day-old -- (Adults )  on 0 . 0%  DHEA. 
Genotype- RBC G6PDH 
Sex Mouse II A1 Af A (x1 06fmm3 ) ( U/ 1 0 1 2  RBC ) 
Before DHEA Treatment 
AW/AW 1 . 204 . 537  .333  8 . 48 486 . 456 
2 . 1 1 3 .409 . 296 7 . 34 499 . 564 
3 . 1 2 2  .402 . 280 7 . 79  445 . 263 
4 . 302  • 700 . 398 8 . 7 1  566 . 057  
5 . 26 1 . 587 . 326 8 . 97  450 . 2 1 6  
AY/AW 6 . 2 29 . 503 . 274 8 . 35  406 . 499  
7 . 2 7 6  . 604 . 328 8 . 45  480 . 853 
8 . 2 14 . 5 59 . 345 8 . 1 3  525 . 683 
9 . 2 29 .499  . 270 8 . 0 1  4 1 7 . 568 
10  . 1 99 . 556  . 357 7 . 95  5 56 . 2 84 
AW/AW 1 1  .457  . 7 9 7  . 340 9 . 70  434 . 2 1 3 
1 2  . 3 27 . 7 39 . 367  9 . 1 9  494 . 705 
1 3  .40 1 . 783  . 382 9 . 2 9  509 . 382  
1 4  .354  . 683 .329  9 . 54 427 . 2 1 2 
1 5  . 382  . 7 4 1  . 3 59 9 . 83  452 . 4 1 5  
.£_/}:! 1 6  . 2 7 8  . 6 5 6  . 378  8 . 44 554 . 8 1 1  
1 7  . 3 28 . 657  .329  9 . 0 1  452 . 342 
1 8  . 253  . 58 1  . 3 28 8 . 74 464 . 898 
1 9  . 2 89 . 6 5 1  . 362  9 . 32  48 1 . 1 59  
20  . 3 1 5  . 6 63 . 348 9 . 42  457 . 640 
During DHEA Treatment 
!!:!JAW 1 . 263  . 5 74 . 3 1 1 9 . 50  405 . 539 
2 . 347 • 7 23 . 3 7 6  9 . 24 504 . 094 
3 . 3 29 . 669 . 340 9 . 20  457-. 8 1 2 
4 . 3 1 4 . 6 58 . 344 9 . 44 45 1 . 42 1 
5 . 3 27 . 6 59 . 332  9 . 1 8 448 . 0 1 3  
.!:! I AW 6 . 2 6 6  . 5 2 7  . 26 1 8 . 83 366 . 1 64 
7 . 2 96 . 5 74 . 2 78  9 . 9 3  346 . 8 1 0 
8 . 1 1 1  . 37 1 . 260 8 . 07  39 9 . 1 1 3 
9 . 3 54 . 686 . 332  10 . 20 403 . 2 1 2  
1 0  . 3 6 1 . 684 . 3 23 9 . 1 3  438 . 2 55 
Appendix Table 1 5 . 
Genotype-
Sex Mouse II 
�JAW 1 1  1 2  
1 3  
1 4  
1 5  
!!l./AW 1 6  1 7  
1 8  











1 0  
�IE:_ 1 1  
1 2  
1 3  
1 4  
1 5  
AY/AW 1 6  
1 7  
1 8  
1 9  
20 
Experiment 112 , Study 1 
( continued ) 
RBC 
Ai At A ( x1 06Jmm3 ) 
During DHEA Treatment 
. 3 24 . 688 . 3 64 9 . 1 3 
. 3 1 7  . 6 7 5  . 3 58  8 . 39 
. 2 7 3  . 6 1 2  . 339 7 . 3 5  
. 344  . 686 . 342  8 . 60  
. 2 9 2  . 6 2 2  . 330 8 . 6 5  
. 3 38 . 7 24 . 386 8 . 3 7  
. 287  . 6 53 .366  8 . 4 4  
. 3 1 1 . 697 . 386 8 . 7 7  
. 3 36 • 7 1 3 . 3 7 7  8 . 96 
. 302 . 668 .366  8 . 6 1  
After  DHEA Treatment 
. 288 . 5 59 . 2 7 1 8 . 84 
. 356  . 6 70 . 3 1 4  8 . 1 8 
. 3 59 . 642  . 283 7 . 83 
. 3 52 . 648 . 296 8 . 09 
. 3 7 2  . 697  . 3 25 8 . 38 
. 2 7 6  . 545 . 269 8 . 1 2 
. 352 . 6 50 2 . 98 8 . 79 
. 346  . 692  . 346 8 . 45  
. 3 1 3 . 609 . 296 8 . 90 
. 3 5 9  . 675  . 3 1 6  8 . 7 5  
. 307  . 68 1  . 3 74  8 . 3 3  
. 384 . 7 29  .345  8 . 5 6  
. 393  . 7 7 1  . 378  8 . 04  
. 3 38 . 684 . 346 8 . 6 2  
. 342  . 703 . 36 1  7 . 34  
. 3 26 . 688 . 362  7 . 9 6  
. 403  . . 7 54 . 3 5 1  7 . 98  
. 2 7 9  . 664 . 385  8 . 47  
. 3 39 . 7 1 8  . 3 7 9  8 . 8 2  
. 3 6 1  • 7 1 6 . 3 5 5  8 . 9 9  
1 6 3  
G6PDH 
( U/ 1 0 1 2  RBC )  
493 . 885  
528 . 58 7  
57 1 . 3 5 7  
49 2 . 6 3 3  
47 2 . 600  
57 1 . 2 9 1 
537 . 1 9 8  
545 . 23 5  
52 1 . 22 9  
526 . 59 1  
37 9 . 7 63 
475 . 5 23 
447 . 7 34 
453 . 25 1  
480 . 4 35  
4 1 0 . 385  
4 1 9 . 9 7 5  
507 . 242  
4 1 2 . 000 
447 . 3 78  
556 . 1 89 
499 . 27 6  
582 . 4 1 3  
497 . 238 
609 . 266  
563 . 36 7  
544 . 8 79  
563 . 084 
532 . 3 1 2  
489 . 1 7 5 










2 1  
2 2  








3 1  
3 2  
3 3  
34  
3 5  
3 6  
37  
38  
3 9  
40  
2 1  
2 2  
2 3  
2 4  
25  
26  
2 7  




Experiment #2 , Study 1 
Change in Absorbance at 340 nm , Red Blood Cell Count , 
and Calculated G6PDH Activity ( U/ 10 1 2  RBC ) f or Each 
House ( 60-day-old -- ( Adults )  on 0 . 1 % DHEA. 
RBC G6PDH 
A1 Af A (x 106/mm3 ) ( U/ 1 0 1 2  RBC ) 
Before DHEA Treatment 
. 286  . 564 . 278  8 . 1 9 420 . 49 1  
. 3 9 2  • 7 1 9 . 3 27  9 . 1 9 440 . 786  
. 343  . 625  .282  8 . 70  40 1 . 537  
. 423  . 7 52  . 329 9 . 32  437 . 29 6  
. 29 9  . 586 . 287  10 . 3 1  344 . 84 1  
. 3 38 . 667  . 329  9 . 1 9 443 . 482  
. 3 67  . 7 2 7  . 360 9 . 37  475 . 947 
. 3 6 1  . 666  . 305  9 . 7 7  386 . 7 24 
. 346 . 643 . 297  8 . 7 7  4 1 9 . 5 20 
. 2 1 7  . 5 1 2  . 29 5  8 . 35  437 . 6 54 
. 3 1 8  . 6 1 2  . 294 � . 68 37 6 . 242  
. 3 73  . 694 . 3 2 1  9 . 85  403 . 705 
. 383  . 7 50 . 367  9 . 48 479 . 5 7 1  
. 347 . 675  . 3 28 9 . 94 408 . 7 74 
. 38 1 . 738 . 3 57 9 . 2 2  479 . 6 59 
. 2 9 5  . 6 2 2  . 3 27 8 . 37  483 . 969  
. 305  . 5 5 1  . 246 8 . 78 347 . 085  
. 1 94 . 5 7 1  . 3 77  8 . 78  53 1 . 9 1 5 
. 203 . 492  . 289 8 . 08 443 . 080 
. 233  . 538 .305  8 . 56 441 . 389 
During DHEA Treatment 
. 3 1 4  . 6 1 6  .302 8 . 40 445 . 3 7 2  
. 2 37  . 5 83 .346 8 . 66 494 . 94 1  
. 3 3 1  . 6 58 .327  8 . 48 47 7 . 69 1  
. 407  . 7 39 . 332  9 . 1 0  45 1 . 9 52  
. 296  . 6 3 2  . 336 8 . 69 478 . 9 7 7  
. 249 . 549 . 300 7 . 95 46 7 . 466  
. 27 6  . 6 1 7  . 34 1  8 . 1 3 5 1 9 . 5 88 
. 2 94 . 6 6 1  . 367  8 . 07 563 . 363 
. 2 7 3  . 5 74  .301  8 . 42 442 . 843  
. 2 9 3  . 637  . 344 8 . 70 489 . 8 1 8 
1 6 5  
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Appendix Table 1 6 . ( continued ) 
Genotype- RBC G6PDH 
Sex Mouse II Ai Af A (x1 06Jmm3 ) ( U/ 1 0 1 2 RBC )  
During DHEA Treatment 
AW/AW 3 1  . 3 52  . 7 1 4 . 3 62  8 . 1 9  547 . 546  
32  . 383  . 7 42 . 359  8 . 99 494 . 68 7  
3 3  . 2 93 . 609 . 3 1 6  8 . 99  435 . 43 5  
3 4  . 3 4 2  . 7 1 3  . 37 1 9 .09  505 . 59 8  
3 5  . 3 23 . 689 . 366  9 . 24  490 . 68 7  
AY/AW 36 . 392  . 8 16 . 424 8 . 1 1  647 . 650  
37  . 344 . 7 4 1  . 397  8 .40  585 . 47 3  
3 8  .342  . 7 37 . 395  8 . 0 5  607 . 85 1  
3 9  . 3 64 • 768  . 404 8 . 90 562 . 324  
40  . 376  . 790 . 4 1 4  9 .0 1  569 . 208 
After DHEA Treatment 
AW/AW 2 1  . 296 . 64 1  . 345  8 . 5 1  502 . 2 1 0  
- - 22  . 3 60  . 774  . 4 1 4  8 . 67 59 1 . 530  
2 3  . 3 29  . 646  . 3 1 7  9 .4 3  4 1 6 . 4 3 1  
2 4  . 308 . 642  . 334 8 . 49  487 . 34 3  
25  .399  • 7 78 . 379  8 . 4 6  544 . 964 
AY/AW 26 .360  • 722  . 3 62 8 . 64 5 1 9 . 0 28 ·- -
27  .309 . 6 58 . 349 8 . 1 3  53 1 . 7 78 
28  . 3 23 . 6 4 1  . 3 1 8  8 " 7 3 45 1 . 2 4 1  
29  . 3 23 . 6 5 1  . 328 8 . 07  503 . 496  
30  . 2 88 . 649  . 3 6 1  8 . 38 533 . 6 53 
AWJAW 3 1  . 3 29  . 682  . 3 53 8 . 62 507 . 2 98  
32  . 3 54 . 7 3 3  . 37 9  9 . 04 5 1 9 . 3 57  
33  . 3 26 . 6 7 7  . 3 5 1  8 . 6 2  504 . 4 24 
34 . 3 5 1 • 7 18 . 367  9 . 66  470 . 635  
35  . 3 27 . 698 . 3 7 1 8 . 7 7 524 . 047  
AYJAW 36 . 2 5 2  . 6 2 2  . 370 8 . 1 4 563 . 084 
37 . 3 1 6  . 678  . 362  8 . 62  520 . 2 32  
38  . 246 . 547  .30 1 8 . 07  462 . 050  
39  . 289 . 664 . 37 5  8 . 37  5 55 . 0 1 1 
40  . 3 7 9  . 7 96 . 4 1 7  8 . 50 607 . 7 3 3  
1 66 
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Appendix Table 1 7 . Change in Absorbance at 340 nm , Red Blood Cell  Count , 
and Calculated G6PDH Activity ( U/ 1 0 1 2  RBC ) f or Each 
Mouse ( 60-day-old -- (Adults )  on 0 . 2 % DHEA. 
Genotype- RBC G6PDH 
Sex Mouse II Ai At A (x 106fmm3 ) ( U/ 1 0 1 2  RBC )  
Before DHEA Treatment 
AW/AW 4 1  . 2 1 9  . 499  . 2 80 7 . 56  458 . 809  - -
4 2  . 24 5  . 5 2 1 . 2 7 6  8 . 34  409 . 957  
43  . 3 1 7  . 592  . 2 7 5  9 . 1 0 374 . 358 
44  . 2 3 8  . 5 1 3  . 2 7 5  8 . 85 384 . 93 3  
4 5  . 2 68 . 554 . 286 8 . 60 4 1 1 . 968 
AY/Aw 46 . 36 6  . 6 1 9  . 25 3  8 . 86  353 . 7 39 - --
47  . 408 . 694 . 286  8 . 70 407 . 23 2  
4 8  . 3 6 2  . 639  . 2 7 7  8 . 6 1  398 . 5 40 
49 . 406  . 6 7 3  . 26 7  8 . 87  372 . 892  
50  . 337  . 639  . 302 8 . 46  442 . 2 14 
AW/AW 5 1  . 3 42  . 664  . 322  8 . 93 446 . 684 - -
52  . 3 1 8  . 6 1 1  . 293  8 . 4 1  4 3 1 . 586  
53  . 3 8 1  • 707 . 3 26 9 . 78 4 1 2 . 9 28 
5 4  . 3 7 8  . 6 52 . 2 74 8 . 94 379 . 67 2  
5 5  . 3 3 1  . 684 . 3 53  8 . 5 1  5 13 . 85 5  
AY/Aw 56  . 3 5 7  . 7 53 . 3 96 8 . 9 3  549 . 338 · - -
5 7  . 340  . 7 1 3  . 3 7 3  8 . 4 9  544 . 248 
58  . 303  . 6 14 . 3 1 1  8 . 6 5  445 . 389 
59 . 344  . 693  . 349  8 . 5 1  508 . 03 3  
6 0  . 4 1 3  • 7 58 . 345  8 . 80 485 . 660 
During DHEA Treatment 
AW/AW 4 1  . 2 1 6  . 489 . 2 7 3  8 . 2 1  4 1 1 . 922  
4 2  . 2 7 7  . 597  . 3 20 8 . 44  469 . 68 1  
4 3  . 2 1 6  . 496  . 2 80 8 . 1 1  427 . 694  
44  . 2 7 1 . 5 6 5  . 2 94 8 . 42  432 . 545 
45 . 3 0 1  . 6 1 4  . 3 1 3  8 . 7 3 444 . 1 46 
AYfAW 46 . 2 6 1 . 544  .283  8 . 53 4 1 0 . 992  - -
47  . 1 84 .435  . 2 5 1 8 . 1 9 379 . 6 52 
48 . 248 . 58 1 . 3 33  8 . 5 1  484 . 742 
49 . 2 1 3  . 492  . 279  8 . 84 390 . 974 
5 0 . 2 1 8  . 530 . 3 1 2  8 . 4 3  458 . 482 
' 1 67 
Experiment 112 , Study 1 
Appendix Table 1 7 . ( continued ) 
Genotype- RBC G6PDH 
Sex Mouse It Ai At A ( x1 06 Jmm3 ) (U/ 1 0 1 2  RBC ) 
During DHEA Treatment 
AW/AW 5 1  . 346 . 6 96 . 3 50  9 . 04 479 . 6 18 
5 2  . 368 • 7 69 .40 1  8 . 23 603 . 587  
53  . 346 . 700 . 3 54 9 . 12 480 . 844 
5 4  . 2 8 1  . 6 2 2  . 3 4 1  8 . 68 486 . 6 6 5  . 
5 5  • 3 24 • 7 28 .404 8 . 1 2 6 1 6 . 34 1  
AY/AW 5 6  . 268 . 6 14 . 346  8 . 08 530 . 46 9  - -
5 7  . 252  . 604 . 3 52  8 . 1 9 53 2 . 420 
5 8  . 253 . 587  . 334 8 . 24 502 . 1 29 
5 9  . 223 . 588 . 3 6 5  7 . 7 7 58 1 . 926  
60 . 2 5 3 . 597  . 344 9 . 04 47 1 . 396  
After DHEA Treatment 
AW/AW 4 1  . 1 7 1  .493 . 3 2 2  8 . 2 1  485 . 857  - -
42  . 3 1 8  . 7 25 . 407  8 . 3 2  605 . 99 2  
4 3  . 264 . 620 . 35 6  8 . 94 493 . 2 97  
44 . 258  . 609 . 3 5 1  8 . 78 495 . 23 1  
4 5  . 346 . 698 . 352  8 . 7 7 49 7 . 209 
E_/AW 46 . 282 
. 6 57 . 3 7 5  8 . 0 1  579 . 95 5  
47 . 247  . 598 . 3 5 1  7 . 62  570 . 62 1 
48 . 286  . 608 . 3 22  7 . 84 508 . 786 
49 . 303 . 708 .405  8 . 33 602 . 290 
so . 2 7 7  . 682 . 405 8 . 6 1  582 . 703 
E:_f.AW 5 1  . 294 . 68 1  . 387  7 . 45  643 . 503 
52  . 274 . 632  . 358 8 . 3 5  53 1 . 1 1 9 
53 . 2 5 9  . 646 . 387  9 . 1 7  52 2 . 802 
54  . 245 . 589 . 344 8 . 30  5 1 3 . 4 24 
5 5  . 2 39  . 632  . 393  7 . 92  6 1 4 . 700  
AY/AW 56 . 3 1 3  . 67 2  . 3 59 8 . 49  523 . 820 
57 . 3 1 6  . 623  . 307 6 . 7 7 56 1 . 7 53 
58  . 3 1 1  . 6 53 . 342 8 . 1 5 5 1 9 . 833  
59  . 304 . 6 7 7  . 3 7 3  8 . 36 552 . 7 1 1  
6 0  . 3 2 2  . 663  . 34 1  8 . 8 1  479 . 484 
1 68 
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Appendix Table 1 8 . Change in Absorbance at 340 nm , Red Blood Cell Count , 
and Calculated G6PDH Activity ( U/ 1 0 1 2  RBC ) f or Each 
Mouse ( 60-day-old -- (Adults )  on 0 . 4 %  DHEA. 
Genotype- RBC G6PDH 
Sex Mouse II Ai Af A (x1 06 fmm3 ) ( U/ 1 0 1 2  RBC )  
Before DHEA Treatment 
AW/AW 6 1  . 2 7 3  . 568 . 295 9 . 34 39 1 . 2 6 5 
6 2  . 343  . 643 . 300 9 . 0 5  4 10 . 64 7  
6 3  . 342  . 6 5 5  . 3 1 3  9 . 3 7  4 1 3 . 809  
64  . 3 3 1  . 644 . 3 1 3  9 . 07  427 . 4 9 7  
6 5  . 3 3 2  . 607 . 2 7 5  9 . 1 5  37 2 . 3 1 2 
AY/AW 66  . 2 54 . 582  . 3 28 8 . 56 474 . 674 
67  . 3 1 4  . 6 1 4  . 300 8 . 7 1  426 . 67 7  
6 8  . 2 78  . 604 . 3 26 8 . 80 458 . 9 1 3  
6 9  . 2 5 2  . 544 . 292  8 . 3 2  434 . 766  
70  . 2 82 . 62 2  . 340 9 . 07  464 . 37 3  
AW(AW 7 1  . 2 88 . 67 5  . 387  8 . 48 56 5 . 34 1  
7 2  . 293 . 6 1 6  . 3 23 9 . 1 6 436 . 820 
7 3  . 2 7 1  . 574 .303 9 . 1 2 4 1 1 . 5 70 
74  . 3 1 6  . 648 . 332  9 . 1 2 450 . 96 1  
7 5  . 3 38 . 687 .349 8 . 86  48 7 . 964 
AY/AW 7 6  . 2 37 . 543  . 306 8 . 44 449 . 1 3 3  
7 7  . 303 . 607 . 304 8 . 7 8 428 . 9 1 8 
78  . 2 7 5  . 6 2 1  . 346  8 . 1 6 525 . 26 9  
79  . 2 86 . 64 1  . 3 5 5  8 . 66 507 . 8 1 6  
8 0  . 254  . 602 . 348 8 . 70 495 . 5 1 4  
During DHEA Treatment 
AW/AW 6 1  . 283 . 6 54 . 3 7 1 9 . 60 478 . 7 38 - -
62  . 3 58 . 7 7 3  . 4 1 5  8 . 7 2 589 . 559  
63  . 360 . 708 . 348 9 . 70 444 . 4 30 
64  . 3 58 • 7 27 . 369  9 . 5 9  47 6 . 6 54 
6 5  . 2 78  . 6 1 7  . 3 39 9 . 25  453 . 998 
AY/AW 66 . 2 2 9  . 584 . 3 5 5  9 . 2 1  47 7 . 490 
6 7  . 3 7 7  . 7 39 . 362  9 . 20  48 7 . 4 35 
68 . 348 . 6 9 1  . 343 9 . 2 5  459 . 35 5  
69  . 35 1  • 7 1 3 . 362  8 . 5 5 524 . 49 1  
7 0  . 2 73  . 6 5 5 .382  9 . 0 1  525 . 2 1 1  
Appendix Table 18 . 
Genotype-
Sex Mouse II 
�/AW 7 1  7 2  
73  
7 4  
7 5  
�/AW 7 6  7 7  
7 8  
7 9  
80 
AW/AW 6 1  - - 6 2  







7 0  
AW/AW 7 1  - --
7 2  
7 3  
7 4  
7 5  
AY/AW 76  




Experiment 1!2 , Study 1 
( continued ) 
RBC 
Ai At A (x 106Jmm3 ) 
During DHEA Treatment 
. 3 1 8  . 7 39 . 4 2 1  8 . 5 1  
. 2 32  . 5 93  . 3 6 1  8 . 09 
. 3 1 9  . 672  . 3 53 8 . 22 
. 409 . 808 . 3 99 8 . 6 5  
. 3 1 4  . 7 36 . 4 2 2  8 . 46 
. 2 56 . 70 1  . 445 7 . 59 
. 2 98 . 638 • 340 8 . 64 
. 3 1 0  . 68 1  . 3 7 1 8 . 4 2  
.304 . 6 90 . 386  9 . 3 2  
.339  . 7 65 . 426 8 . 89 
After DHEA Treatment 
. 342  . 7 29 . 387  7 . 85 
. 359  • 786  .427  8 . 83 
. 367  .803 . 4 36 8 . 54 
. 343  . 747  . 404 8 . 69  
. 289  . 664 . 3 7 5  8 . 26  
. 1 84 . 549 . 3 65  7 . 59  
. 2 7 6  . 687 . 4 1 1 8 .40  
. 289 . 646 . 3 57 8 . 5 5  
. 286 . 6 57 . 3 7 1 8 . 34 
. 3 1 8  . 7 23 . 405  8 . 3 5  
. 353 . 7 7 3  . 420 8 . 22  
. 394  . 7 98 . 404 8 . 49 
. 342  • 7 50 .408 8 . 1 2 
. 3 1 8  • 705 . 387  8 . 69 
. 348 • 740 . 3 92  8 . 29 
. 2 7 9  . 6 7 2  . 3 9 3  7 . 38  
. 3 5 1  • 7 63 . 4 1 2  7 . 5 1  
. 334 . 7 1 3  . 3 79  8 . 47 
. 282 . 688 . 406 7 . 8 1  
. 2 70  . 683 .4 1 3  8 . 4 4  
1 69 
G6PDH 
( U/ 1 0 1 2  RBC ) 
6 1 2 . 84 1  
552 . 782  
53 1 . 984 
57 1 . 4 1 6  
6 1 7 . 928 
726 . 296  . 
48 7 . 484 
545 . 830 
5 1 3 . 059  
593 . 6 1 3  
6 10 . 7 13 
599 . 050  
632 . 447 
575 . 9 1 3  
562 . 402 
595 . 7 26 
606 . 1 1 9 
5 1 7 .247  
55 1 . 066  
600 . 847  
632 . 95 5  
589 . 480 
62 2 . 443 
5 5 1 . 679  
585 . 770 
659 . 678  
679 . 599 
5 54 . 308 
643 . 97 7  
606 . 1 82 
' 1 70 
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Appendix Table 1 9 . Change in Absorbance at 340 nm, Red B lood Cell Count , 
and Calculated G6PDH Activity ( U/ 1 0 1 2  RBC ) f or Each 
Mouse ( 60-day-old -- (Adult s )  on 0 . 0 %  DHEA . 
Genotype- RBC G6PDH 
Sex Mouse II A1 Af A (x1 06fmm3 ) ( U/ 1 0 1 2 RBC ) 
Before DHEA Treatment 
A,W/AW 1 . 303 . 602 . 299  8 . 2 7  447 . 880 - - 2 . 244  . 6 1 4  . 3 70  7 . 7 2 593 . 7 1 8 
3 . 386 . 74 3  . 3 5 7  9 . 92 445 . 8 1 2  
4 . 2 33  . 5 7 5  . 3 42  6 . 88 6 1 5 . 79 1  
5 . 2 24  . 553  . 3 29  6 . 5 8  6 1 9 . 392  
AY/AW 6 . 2 92  . 600  . 308 7 . 5 7  504 . 023 - - 7 . 306 . 6 7 9  . 3 7 3  7 . 1 4  647 . 1 52 
8 . 3 74  . 69 5  . 3 2 1  8 . 20 484 . 9 39 
9 . 3 7 3  . 6 59 . 286  8 . 5 7  4 1 3 . 4 10 
0 . 408 • 7 1 7  . 309 8 . 43  454 . 074 
AW/AW 1 1  . 2 98 . 6 2 1 .343  7 . 0 5  567 . 5 56 
1 2  . 303 . 707  . 404 7 . 26  689 . 35 1  
1 3  . 3 1 3  . 6 27 . 3 1 4  7 . 93  490 . 5 1 5 
1 4  . 3 96 • 7 23 . 3 27 8 . 46  478 . 8 2 1  
1 5  . 408 . 7 9 1  . 383  8 . 6 5  548 . 502 
£_/AW 1 6  . 2 78  . 632  . 3 54 7 . 23  606 . 542  
1 7  . 2 68 . 5 93 . 3 25 6 . 96  578 . 45 5  
1 8  . 333  . 7 28 . 39 5  7 . 48 6 54 . 1 7 1  
1 9  . 2 52  . 6 1 9  . 367  6 . 92 6 56 . 985 
20 . 1 93 . 502 . 309 6 . 4 3  595 . 3 1 0 
During DHEA Treatment 
�/AW 1 . 3 1 8  . 6 3 2  . 3 1 4  8 . 20 474 . 3 64 
2 . 3 2 1  . 674  . 353 8 . 5 5  5 1 1 . 4 5 1  
3 . 2 47 . 56 1  . 3 1 4  8 . 46 459 . 7 85 
4 . 3 34 . 688 . 3 54 8 . 69 504 . 6 37 
5 . 2 69  . 599  . 330  8 . 02  509 . 7 24 
AY/AW 6 . 3 6 9  • 7 1 4 . 345  8 . 28 5 1 6 . 1 60 
7 . 407  . 7 8 1  . 3 74  8 . 64 536 . 233  
8 . 3 37 . 662  . 3 25 8 . 6 1  467 . 60 1  
9 . 2 8 7  . 602 . 3 1 5  8 . 47  460 . 705 
0 . 2 8 7  . 602 . 3 1 5  7 . 50  520 . 289 
Appendix Table 1 9 . 
Genotype-
Sex Mouse II 
AW/AW 1 1  
1 2  
1 3  
1 4  
1 5  
AY /AW 1 6  - -
1 7  
1 8  












AW/AW 1 1  
1 2  
1 3  
1 4  
1 5  
AY/AW 1 6  - · - 1 7  
1 8  
1 9  
20  
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( continued) 
RBC 
Ai Af A (x l06 fmm3 ) 
During DHEA Treatment 
. 354  . 744  . • 390  9 . 06  
. 3 2 2  . 7 32  . 4 1 0  8 . 85  
. 2 7 8  . 654 . 3 7 6  8 . 7 7  
. 2 98  . 633 . 3 35 9 . 7 0  
. 2 8 1  . 636 . 3 55  8 . 7 8 
. 2 8 1  . 6 53 . 3 7 2  8 . 94 
. 2 7 1 . 6 27 . 356  8 . 7 1  
. 268  . 6 1 7  .349  8 . 1 5  
. 2 3 5  . 593 . 3 58 8 . 08 
. 23 6  . 6 1 3 . 3 7 7  7 . 94 
After DHEA Treatment 
. 3 1 9  . 5 1 5  . 1 96 9 . 38 . 
. 2 89 . 485 . 1 96 9 . 3 2  
. 3 1 2  . 5 2 1 . 209 8 . 8 4  
. 2 6 5  .462  . 1 97  8 . 7 2  
. 242  . 442 . 200 8 . 7 5  
. 2 99 . 5 1 7  . 2 1 8  8 . 52 
. 2 88 .489 . 20 1  8 . 9 1  
. 2 35  . 444 . 209 8 . 7 7  
. 2 1 2  .403 . 1 9 1  8 . 3 5  
.249  . 442  . 1 93 8 . 05  
. 264 . 5 1 1  . 247  8 . 50 
. 2 6 2  .480 . 2 1 8  8 . 4 7  
. 2 28 . 435  . 207 9 . 07  
. 2 5 6  .44 1 . 1 85 8 . 2 8  
. 2 7 9  .488 . 209 8 . 80 
. 246  .470  . 224 8 . 50 
. 2 7 4  . 5 06 . 2 32  8 . 50 
. 23 1 . 4 6 1  . 230 7 . 9 2 
. 247  . 446 . 1 99 8 . 4 9  
. 1 32  . 3 1 4  . 1 84 7 . 9 3  
' 1 7 1  
G6PDH 
( U/ 10 1 2 RBC) 
533 . 2 5 1  
573 . 900 
53 1 . 1 09 
427 . 827  
500 . 875  
5 1 5 . 467  
506 . 323 
530 . 47 3  
548 . 867  
588 . 1 88  
258 . 8 50  
260 . 5 1 7 
29 2 . 880 
279 . 8 63 
283 . 1 5 1  
3 1 6 . 96 6  
279 . 4 56  
295 . 2 18 
283 . 363 
297 . 000 
359 . 97 6  
3 1 8 . 837  
282 . 7 2 1  
276 . 78 1  
294 . 2 1 1  
326 . 456 
338 . 1 1 5 
359 . 748 
290 . 363 
287 . 435 
Appendix Table 20 . 
Genotype-
Sex Mouse II 
AW/AW 2 1  - · -
2 2  
2 3  
2 4  






AW/AW 3 1  
3 2  




3 7  
3 8  
3 9  
40 
AWfAW 2 1  
2 2  
2 3  
24 







Experiment #2 , Study 1 
Change in Absorbance at 340 nm, Red Blood Cell  Count , 
and Calculated G6PDH Act ivity ( U/ 1 0 1 2  RBC ) f or Each 
Mouse ( 60-day-old -- (Adults ) on 0 . 1 %  DHEA. 
RBC 
Ai Af A (x 106Jmm3 ) 
Before DHEA Treatment 
. 285 .688 .403 7 . 5 0  
. 358  • 753  .395  8 . 04 
.4 1 2  . 7 97  . 385 8 . 34  
. 2 84 . 668 . 384 6 . 85  
. 3 78 .674 . 2 96 7 . 9 1  
. 384 . 7 23 . 3 39 7 . 88 
. 3 1 6  . 7 23 .407 7 . 07  
. 3 5 3  • 7 34 . 38 1 7 . 88 
. 266  . 6 1 2  . 346 7 . 6 2  
. 242 . 5 66 . 3 24 6 . 67 
. 263  . 6 73  . 4 10  7 . 1 1  
. 3 1 2  . 688 . 3 76  7 . 3 6  
. 25 3  . 5 70 . 3 1 7  8 . 96  
. 4 1 1 • 7 62 . 3 5 1  8 . 85  
. 2 1 3  . 5 5 7  . 344 8 . 00 
. 3 27 . 65 1  . 3 24 8 . 05  
. 30 1  . 697  .396  7 . 42  
. 302  . 664 . 362  7 . 3 7  
. 302  . 687 . 385  7 . 7 6  
. 304  • 705  .40 1  7 . 49 
During DHEA Treatments  
. 349  • 733  . 384 8 . 88 
. 347  . 7 36 . 389 9 . 64 
. 3 2 1  . 6 39 . 3 1 8  9 . 2 2  
. 268 . 59 1 . 3 23 9 . 24 
. 284 . 588 . 304 8 . 85  
. 27 3  . 597  . 3 24 8 . 89 
. 304 .68 1 . 3 7 7  7 . 6 5  
. 303  . 6 5 1  .348 8 . 04 
. 257  . 596  . 339  8 . 48 
. 3 2 7  .670  . 343  9 . 2 1  
G6PDH 
( U/ 10 1 2  RBC ) 
665 . 640 
608 . 607  
57 1 . 86 1  
694 . 443 
463 . 56 5  
532 . 9 29 
7 1 3 . 1 33 
598 . 9 55  
562 . 492  
60 1 . 748 
7 1 4 . 348 
632 . 857 
438 . 2 75  
49 1 . 3 14 
5 32 . 677  
498 . 59 1  
6 6 1 . 1 30 
608 . 4 67 
6 1 4 . 603 
663 . 2 2 1  
535 . 690 
499 . 883 
427 . 2 60 
433 . 038 
425 . 5 26 
45 1 . 480 
6 1 0 . 486 
536 . 1 90 
495 . 2 2 1  
46 1 . 350  










3 1  
3 2  








2 1  









3 1  
3 2  
3 3  
3 4  
3 5  
3 6  
3 7  
3 8  
39  
40 
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( cont inued ) 
RBC 
Ai Af A (x1 06fmm3 ) 
During DHEA Treatment 
. 336  . 7 94 . 458 9 . 5 4  
.306 . 687  . 38 1 8 . 9 6  
. 283  . 638 . 3 55  8 . 8 1  
. 397  . 66 1  . 264  9 . 0 5  
. 296 . 705 . 409 8 . 64 
. 289 . 628 .339  8 . 53 
. 328  . 7 1 9 . 39 1 8 . 56 
. 2 5 1 . 6 14 . 363  8 . 99 
. 25 7 . 645  . 388 8 . 8 2 
. 25 1 . 6 1 2  . 36 1 8 . 1 9  
After DHEA Treatment 
. 339  . 5 78 . 2 39 8 . 74 
. 3 1 1  . 569 . 2 58 8 . 88 
. 299  . 547  . 248 8 . 8 2 
. 258 . 492  . 2 34 7 . 7 9  
. 297  . 538 . 2 4 1  8 . 6 5 
. 2 3 7  . 4 59  . 2 2 2  8 . 4 4  
. 302  . 547  . 245  8 . 0 1  
. 2 58  . 459  . 201  8 . 8 1  
. 248 .499  . 2 5 1  8 . 3 1  
. 292  . 529  . 237  9 . 1 2 
. 269  . 563  . 2 94 8 . 8 1  
. 2 2 1 . 453  . 2 3 2  8 . 89  
. 30 1  . 562  . 26 1  9 . 58  
. 1 94 . 4 1 8  . 2 2 4  9 . 23  
. 283  . 5 1 8  . 2 3 5  10 . 1 2 
. 224  .46 1 . 237  8 . 38  
. 238 . 508 . 2 7 0  8 . 4 5  
. 222  .480 . 258  9 . 1 0  
. 252  . 530 . 2 7 8  9 . 3 7  
. 268 .501  . 233  9 . 6 1  
' 1 7 3  
G6PDH 
( U/ 1 0 1 2  RBC ) 
594 . 7 20 
526 . 7 60 
499 . 1 70 
36 1 . 369  
586 . 4 1 5  
4 9 2 . 3 1 9  
565 . 846 
500 . 1 99 
544 . 953 
546 . 033  
3 38 . 7 52 
359 . 9 1 7  
348 . 3 20 
3 72 . 1 1 2 
345 . 1 4 1  
325 . 84 1  
378 . 904 
282 . 6 28 
374 . 1 69 
3 2 1 . 9 2 1  
4 1 3 . 3 9 7  
323 . 282  
337 . 4 98 
300 . 637  
28 7 . 662  
350 . 348 
395 . 8 25 
3 5 1 . 2 1 6 
367 . 53 7  
300 . 3 50 
' 1 7 4  
Experiment #2 , Study 1 
Appendix Table 2 1 . Change in Absorbance at 340 nm, Red Blood Cell  Count , 
and Calculated G6PDH Act ivity ( U/ 1 0 1 2  RBC ) f or Each 
Mouse ( 60-day-old -- (Adult s )  on 0 . 2 %  DHEA. 
Genotype- RBC G6PDH 
Sex Mouse II A1 Af A (x 106Jmm3 ) ( U/ 1 01 2  RBC ) 
Before DHEA Treatment 
AWJAW 4 1  . 368 . 746 . 378  8 . 7 5  535 . 1 5 5  
42  . 4 1 3  .829  . 4 1 6  8 . 95 57 5 . 7 92  
4 3  . 4 2 2  . 878 .456  9 . 96 56 7 . 1 54 
44 . 2 2 3  . 6 1 7  . 394  6 . 82  7 1 5 . 6 6 1  
4 5  . 2 3 1  . 609 . 378  6 . 74  694 . 748 
AY/AW 46 . 226  . 563 . 337 6 . 95 600 . 6 77  
47  . 2 8 1  . 6 3 1  . 350 7 . 27  596 . 3 89 
48 . 342  . 705 . 363  8 .44 532 . 7 94 
49 . 2 2 2  . 5 78 . 3 56  6 . 62 666 . 1 74 
50  . 429  • 778 . 349 8 . 82 490 . 1 7 6 
AW/AW 5 1  . 36 7  . 7 64 . 3 9 7  8 . 6 6  567 . 895  
52  . 22 2  . 544  . 3 2 2  8 . 6 5  46 1 . 1 43  
5 3  . 267  . 6 1 5  . 348 8 . 58 502 . 444 
54  . 1 98 . 488 . 290 8 .42  426 . 6 60 
5 5  . 248 . 623  . 3 7 5  7 . 07  657 . 064 
AY/AW 56 . 2 6 1  . 6 1 7  . 356  7 . 96 554 . 029  - ·-
57  . 249 . 6 1 8  . 369  7 . 98 57 2 . 82 1 
58  . 293  . 639 . 346 7 . 08 605 . 394 
59 . 2 7 6  . 6 1 3  . 337  6 . 54 638 . 334 
60  . 2 2 3  . 579  . 356  6 . 48 680 . 5 56 
During DHEA Treatment 
AW/AW 4 1  . 2 2 9  . 549 . 3 20 8 . 5 7  462 . 556  
42  . 2 3 2  . 548 . 3 1 6  9 . 02 443 . 987 
43 . 1 94 . 5 1 2  . 3 1 8 8 . 59  458 . 59 5  
44 . 1 5 7  .49 1 . 334 8 . 68 476 . 67 5  
4 5  . 209 . 5 7 9  . 370 8 . 85 5 1 7 . 9 1 0  
AY/AW 46 .406 . 579  . 3 1 3  8 . 03 482 . 863 
47 . 289 . 630 . 34 1  8 . 60 49 1 . 1 92 
48 . 2 24 . 5 7 7  . 3 53 8 . 8 1  496 . 357  
49  . 1 78  .493  . 3 1 5  8 . 77  444 . 945 
s o  . 245 . 5 7 2  . 3 27 7 . 96 508 . 897  
Appendix Table 2 1 . 
Genotype-
Sex Mouse II 
.AW/ A
W 5 1  
5 2  
5 3  
5 4  
5 5  
AY/AW 56  - -
5 7  
5 8  
5 9  
6 0  
AW/AW 4 1  
4 2  
4 3  
44  
45  
AY/AW 46  
4 7  
48  
4 9  
50  
AWJAW 5 1  - -
52  
5 3  
5 4  
5 5  




Experiment 112 ,  Study 1 
( cont inued ) 
RBC 
Ai Af A (x1 06/mm3) 
During DHEA Treatment 
. 2 8 1  . 663 . 38 2  9 . 00 
. 24 1  . 6 10 . 369  8 . 3 2  
. 367  . 787  . 420 8 . 64 
. 259  . 655  .396  8 . 1 6 
. 2 1 7  . 5 7 5  . 358 8 . 7 4  
. 240 .633 . 39 3  8 . 1 9  
. 253  . 6 1 0  . 35 7  8 . 1 9  
. 2 7 9  . 708 . 429  8 . 0 1  
. 2 6 7  . 665  . 39 8  7 . 79 
. 2 1 9  . 620 . 40 1  7 . 48 
After DHEA Treatment 
. 29 9  . 5 5 3  . 254  9 .4 5  
. 298  . 550 . 252  9 .4 5  
. 1 84 .463 . 2 7 9  8 . 20 
. 2 6 2  . 54 1  . 2 7 9  8 . 45  
. 3 1 4  . 589 . 2 7 5  8 . 5 1  
. 2 1 8  .468 . 250 8 . 2 6  
. 25 1  . 502 . 2 5 1  8 . 5 1  
. 246  . 503 . 2 5 7  7 . 9 1  
. 1 97 . 464 . 26 7  7 . 73 
. 2 4 1  . 505 . 264 8 . 3 6  
. 26 9  . 529  . 260 8 . 48  
. 2 1 6  . 467  . 2 5 1  8 . 7 2  
. 3 1 9  . 574 . 2 5 5  9 . 0 7  
. 2 5 3  . 502 . 249 8 . 8 1  
. 26 1 . 5 28 . 267  8 . 6 2  
. 246 . 503 . 2 5 7  8 . 7 5  
. 209 . 4 78  . 269  8 . 5 1  
. 263  . 553 . 2 90 8 . 83 
. 229  . 490 . 26 1 9 . 06  
. 237  . 498 . 2 6 1  9 . 1 8 
' 1 7 5  
G6PDH 
( U/ 1 0 1 2  RBC ) 
525 . 795  
549 . 4 1 3  
602 . 1 8 7  
601 . 1 7 5  
507 . 420  
594 . 435 
539 . 983 
663 . 469  
632 . 909 
664 . 1 07 
332 . 964 
330 . 342  
42 1 . 489 
409 . 0 1 9  
400 . 3 1 2  
374 . 9 35 
36 5 . 3 7 6  
402 . 487  
427 . 885 
39 1 . 1 95 
3 79 . 8 1 6  
356 . 57 7  
348 . 280 
350 . 1 2 2  
383 . 707  
363 . 849 
39 1 . 5 78  
406 . 849 
356 . 868 
352 . 203 
· 1 7 7  
Experiment 1!2 , Study 1 
Appendix Table 22 . ( cont inued ) 
Genotype- RBC G6PDH 
Sex Mouse II Ai At A (x1 06 /mm3 ) ( U/ 10 1 2 RBC) 
During DHEA Treatment 
AW/AW 7 1  . 280 . 684 . 404 7 . 9 7  627 . 94 1  
7 2  . 3 1 1  • 7 20 . 409 8 . 2 7  6 1 2 . 6 5 1  
7 3  . 2 6 7  . 663 . 396  8 . 70 563 . 860 
74 . 204  . 589 . 385  7 . 84  608 . 3 3 1  
7 5  . 2 1 9  . 624 . 405 8 . 30  604 . 467  
AY/AW 7 6  . 27 2  . 633 . 3 6 1  8 . 5 0  526 . 1 1 9 - -
7 7  . 238  . 593  . 3 5 5  8 . 2 9  530 . 48 1  
7 8  . 2 1 3  . 547 . 334 8 . 1 8  505 . 8 1 2  
7 9  . 1 98 . 538 . 340 8 . 0 1  525 . 826 
80 . 2 3 2  . 594 . 362  8 . 1 4 550 . 909 
After DHEA Treatment 
AW/AW 6 1  . 1 99 . 482  . 283  9 . 06 386 . 949 
62 . 2 4 1  . 5 58 . 3 1 7  8 . 94 439 . 2 56 
6 3  . 2 4 5  . 567 . 3 2 2  8 . 97 444 . 692  
64  . 253  . 5 54 . 30 1 9 . 26 402 . 67 2  
6 5  . 2 36 .479  . 243  9 . 89  304 . 373  
AY/AW 66  . 3 33 . 637 . 304 9 . 88  38 1 . 1 64 - -
6 7  . 1 92 . 4 58 . 26 6  8 . 98 366 . 945  
6 8  . 2 38 . 5 54 . 3 1 6  8 . 66 452 . 028 
69 . 2 6 7  . 542  . 2 75  10 . 0 1  340 . 3 25 
7 0  . 2 24  . 4 8 1  . 2 5 7  9 . 60 33 1 . 63 3  
AW/AW 7 1  . 2 94 . 5 7 4  . 280 10 . 0 1 346 . 5 1 3 
7 2  . 26 5  . 5 5 7  . 2 9 2  10 . 4 3  346 . 8 1 2  
7 3  . 254  . 5 2 8  . 274  9 . 99 339 . 7 67 
7 4  . 246  . 5 1 2  . 2 66  9 . 5 5  345 . 043 
7 5  . 1 93 . 478  . 285 9 . 9 1  356 . 260 
AY/AW 76  . 258  . 528 . 2 70  9 . 4 1  355 . 443  - - 7 7  . 248 . 5 1 0 . 262  9 . 07  357 . 84 1  
78  . 208 . 462  . 2 54 8 . 9 2 352 . 748 
79  . 204 .458  . 254 8 . 94 35 1 . 959  
80 . 25 1  . 5 1 3  . 262  9 . 3 2  348 . 242  
Expe r i ment # 2 , Study 1 
Append i x  Table 23 . Mouse We i ght Data and D i f fe rences in Wei gh t  from Week to Week ( in gra ms ) .  
Mouse Week 
# 0 Week 1 Week 2 Week 3 
60-day-o ld ( Adult s )  on 0 . 0% DHEA 
Week 4 Week 5 Week 6 Week 7 Week 8 Week 9 
Tot a l  
We igh t 
Week 1 0  Change 
AW/AW 1 22 . 5  23 . 8 (  1 . 3 )  2 3 . 1 ( -0 . 7 )  2 2 . 7 ( -0 . 4 ) 24 . 5 ( 1 . 8 )  24 . 6 (  0 . 1 )  2 3 . 5 ( - 1 . 1 )  24 . 3 (  0 . 8 )  2 5 . 9 (  1 . 6 )  2 4 . 2 ( - 1 . 7 ) 2 4 . 5 (  0 . 3 )  2 . 0 
2 23 . 1  23 . 5 ( 0 . 4 )  2 2 . 9 ( -0 . 6 )  24 . 5 (  1 . 6 )  2 4 . 6 (  0 . 1 )  2 3 . 4 ( - 1 . 2 )  24 . 4 (  1 . 0 )  2 5 . 2 (  0 . 8 )  2 3 . 7 ( - 1 . 5 ) 24 . 4 (  0 . 7 )  2 4 . 6 (  0 . 2 )  1 . 5 
3 26 . 5  28 . 2 (  1 . 7 )  26 . 3 ( - 1 . 9 )  2 7 . 8 (  1 . 5 )  2 6 . 9 ( -0 . 9 )  28 . 9 (  2 . 0 )  28 . 9 (  0 . 0 )  28 . 0 (  0 . 9 )  3 1 . 0 (  3 . 0 )  28 . 7 ( -2 . 3 )  30 . 4 (  1 . 7 )  5 . 7  
4 23 . 5  2 1 . 5( - 2 . 0 )  2 4 . 1 (  2 . 6 )  2 2 . 2 ( - 1 . 9 )  2 3 . 5 (  1 . 3 )  2 2 . 9 ( -0 . 6 )  2 5 . 3 (  2 . 4 )  2 4 . 3 ( - 1 . 0 )  26 . 4 (  2 . 1 )  24 . 3 ( -2 . 1 )  24 . 7 (  0 . 3 )  1 . 1  
5 26 . 2  25 . 1 ( - 1 . 1 )  2 7 . 3 (  2 . 2 )  2 5 . 5 ( - 1 . 8 )  26 . 3 (  0 . 8 )  26 . 4 (  0 . 1 )  26 . 8 (  0 . 4 )  26 . 5 ( -D . 3 )  26 . 5 (  0 . 0 )  27 . 0 (  0 . 5 )  2 7 . 2 (  0 . 2 ) 1 . 0 
6 22 . 9  25 . 9 (  3 . 0 )  2 3 . 0 ( -2 . 9 )  2 3 . 8 (  0 . 8 )  24 . 1 ( 0 . 3 )  2 5 . 5 ( 1 . 4 )  2 5 . 2 ( -0 . 3 )  2 5 . 2 (  0 . 0 )  24 . 7 ( -D . 5 )  2 5 . 4 (  0 . 7 ) 24 . 8 ( -D . 6 )  1 . 9 
AY /AW 7 37 . 3  42 . 9 (  5 . 6 )  48 . 1 (  5 . 2 )  50 . 0 {  1 . 9 )  52 . 5 { 2 . 5 )  5 1 . 7 { -0 . 8 )  52 . 8 {  1 . 1 )  56 . 3 (  3 . 5 )  5 5 . 8 ( -0 . 5 )  57 . 6 {  1 . 8 )  58 . 6 {  1 . 0 )  2 1 . 3  
8 30 . 3  34 . 3 ( 4 . 0 )  38 .0{ 3 . 7 )  4 1 . 4 (  3 . 4 )  4 3 . 8 ( 2 . 4 )  4 3 . 5 ( -0 . 3 )  44 . 0( 0 . 5 )  4 7 . 7 (  3 . 7 )  4 6 . 8 ( -D . 9 )  4 7 . 3 (  0 . 5 )  49 . 3 (  2 . 0 )  19 . 0  
9 37 . 7  40 . 2 (  2 . 5 )  4 4 .0(  3 . 8 )  4 7 . 0 {  3 . 0 )  49 . 7 (  2 . 7 ) 4 7 . 7 (�2 . 0 )  50 . 3 (  2 . 6 )  5 1 . 9 (  1 . 6 )  53 . 2 (  1 . 3 )  52 . 2 ( - 1 . 0 )  54 . 4 (  2 . 2 )  16 . 7  
10  33 . 6  37 . 6 (  4 . 0 )  4 1 . 3 (  3 . 7 )  4 5 . 5 ( 4 . 2 )  48 . 0 (  2 . 5 )  4 7 . 1 ( -0 . 9 )  49 . 0 (  1 . 9 )  5 1 . 6 (  2 . 6 )  52 . 7 (  1 . 1 )  54 . 5 (  1 . 8 )  54 . 3 ( -D . 2 )  20 . 7  
1 1  32 . 2  34 . 3 ( 2 . 1 )  39 . 8 (  5 . 5 ) 4 1 . 1 (  1 . 3 )  4 3 . 4 (  2 . 3 )  4 3 . 3 ( -0 . 1 )  36 . 0 ( -7 . 3 )  39 . 3 (  3 . 3 )  4 1 . 4 (  2 . 1 )  4 3 . 5 (  2 . 1 )  46 . 0 (  2 . 5 )  1 3 . 8 
1 2  30 . 6  34 . 2 (  3 . 6 )  40 . 3 ( 6 . 1 )  4 2 . 1 (  1 . 8 )  4 4 . 0( 1 . 9 )  4 3 . 3 ( -0 . 7 )  46 . 0 (  2 . 7 )  46 . 2 (  0 . 2 )  46 . 0 ( -Q . 2 )  47 . 6 (  1 . 6 )  48 . 5 (  0 . 9 )  1 7 . 9  
AW/AW 1 3  28 . 3  28 . 6 (  0 . 3 )  2 9 . 8 (  1 . 2 )  30 .0(  0 . 2 )  30 . 4 {  0 . 4 )  30 . 8 (  0 . 4 ) 3 1 . 8 (  1 . 0 )  3 1 . 5 ( -Q . 3 )  3 2 . 9 (  1 . 4 )  3 3 . 4 (  0 . 5 )  34 . 0 (  0 . 6 ) 
1 4  25 . 1  26 . 3 (  1 . 2 )  2 7 . 9 (  1 . 6 )  28 . 0 (  0 . 1 )  29 . 2 (  1 . 2 )  30 . 0 (  0 . 8 )  30 . 0 (  0 . 0 )  30 . 3 (  0 . 3 )  30 . 4 (  0 . 1 )  3 1 . 2 (  0 . 8 )  3 2 . 1 (  0 . 9 ) 
1 5  31 . 9  32 . 3 ( 0 . 4 )  3 2 . 3 { 0 . 0 )  30 . 7 ( - 1 . 6 )  30 . 8 (  0 . 1 )  3 2 . 2 (  1 . 4 )  3 2 . 0 ( -0 . 2 )  3 3 . 0 (  1 . 0 )  34 . 9 (  1 . 9 )  34 . 5 ( -D . 4 ) 34 . 7 (  0 . 2 )  
1 6  27 . 6  27 . 5 ( -0 . 1 )  2 8 . 2 (  o . 7 )  2 8 . 1 { -0 . 1 )  28 . 7 (  o . 6 )  28 . 2 ( -0 . 5 )  28 . 6 (  o . 4 ) 28 . 8 (  o . 2 )  29 . 7 (  o . 9 )  3o . o (  o . 3 )  29 . 5 ( -o . 5 )  
1 7  34 . 3  35 .0(  0 . 7 )  3 5 . 7 { 0 . 7 )  36 . 1 {  0 . 4 )  36 . 7 (  0 . 6 )  37 . 0 (  0 . 3 )  38 . 7 (  1 . 7 )  4 0 . 0 (  1 . 3 )  40 . 8 (  0 . 8 )  4 1 . 2 (  0 . 4 ) 4 1 . 6 (  0 . 4 ) 
1 8  34 . 9  34 . 7 ( -0 . 2 )  3 5 . 9 (  1 . 2 )  36 . 7 ( 0 . 8 )  38 . 0 (  1 . 3 )  38 . 7 ( 0 . 7 )  40 . 2 (  1 . 5 )  4 1 . 5 (  1 . 3 )  4 1 . 9 (  0 . 4 ) 4 2 . 5 (  0 . 6 )  4 2 . 7 (  0 . 2 )  
AY/ AW 1 9  3 5 . 6  39 . 3 (  3 . 7 )  44 . 2 {  4 . 9 )  4 6 . 2 {  2 . 0 )  4 6 . 9 ( 0 . 7 )  49 . 0 (  2 . 1 )  49 . 1 (  0 . 1 )  50 . 6 (  1 . 5 )  5 1 . 5 (  0 . 9 )  5 1 . 2 { -D . 3 ) 52 . 6 {  1 . 4 )  
20 4 1 . 9  46 . 7 ( 4 . 8 )  50 . 1 (  3 . 4 )  5 3 . 0 {  2 . 9 ) 54 . 2 (  1 . 2 )  5 5 . 9 (  1 . 7 )  5 5 . 3 ( -0 . 6 )  5 6 . 9 (  1 . 6 )  58 . 2 (  1 . 3 )  5 7 . 7 ( -D . 5 )  59 . 9 (  2 . 2 )  
2 1  37 . 8  40 . 8 (  3 . 0 )  4 2 . 7 ( 1 . 9 )  4 5 . 3 ( 2 . 6 )  4 7 . 3 (  2 . 0 )  4 7 . 9 ( 0 . 6 )  49 . 0 (  1 . 1 )  49 . 7 (  0 . 7 )  5 1 . 5 ( 1 . 8 )  51 . 8 (  0 . 3 ) 53 . 3 (  1 . 5 )  
2 2  36 . 6  42 . 3 ( 5 . 7 ) 4 4 . 8 ( 2 . 5 )  4 5 . 9 ( 1 . 1 )  4 7 . 6 (  1 . 7 )  4 7 . 4 ( -0 . 2 )  4 7 . 7 ( 0 . 3 )  48 . 5 ( 0 . 8 )  50 . 8 (  2 . 3 )  50 . 8 (  0 . 0 )  5 1 . 7 (  0 . 9 )  
5 . 7  
7 . 0 
2 . 8 
1 . 9 
7 . 3  
7 . 8  
1 7  . o  
18 . 0  
1 5 . 5  
1 5 . 1  
.... 
"""'� CD 
Expe r iment # 2 , Study 2 
Appendi x  Table 24 . Mouse We i ght Data and D i f f e rences in Wei gh t  f rom Week to Week ( i n grams ) .  
AW/ AW 
AY / AW 
AW/ AW 
AY / AW 
Mouse Week 60-day-old ( Adu lt s )  on 0 . 1 %  DHEA 
I o Week 1 Week 2 Week 3 Week 4 Week 5 Week 6 Week 7 Week 8 Week 9 
Tot a l  
We ight  
Week 10  Change 
25  
26 














4 1  
4 2  
43  
4 4  
4 5  
25 . 1  
22 . 3  
22 . 5  
22 . 2  
23 . 0  
26 . 1  
24 . 4  
27 . 3  
26 . 5  
3 1 . 3  
40 . 7  
34 . 3  
30 . 0  
28 . 2  
30 . 8  
29 . 7  
27 . 2  
28 . 4  
45 . 3  
35 . 3  
38 . 2  
22 . 9 ( -2 . 2 )  24 . 2 (  1 . 3 )  2 3 . 1 ( - 1 . 1 )  2 4 . 2 (  1 . 1 )  2 3 . 9 ( -0 . 3 )  2 5 . 2 (  1 . 3 )  2 5 . 9 (  0 . 7 )  2 4 . 6 ( - 1 . 3 )  26 . 2 (  1 . 6 )  2 5 . 5 ( -Q . 7 ) 0 . 4  
23 . 2 (  0 . 9 )  2 3 . 2 (  0 . 0 )  23 . 5 ( 0 . 3 )  2 4 . 0 (  0 . 5 )  24 . 5 (  0 . 5 )  2 5 . 3 (  0 . 8 )  2 5 . 3 ( 0 . 0 )  2 5 . 3 (  0 . 0 )  2 5 . 3 (  0 . 0 )  26 . 4 (  1 . 1 )  4 . 1 
22 . 7 (  0 . 2 )  2 2 . 8 ( 0 . 1 )  2 2 . 7 ( -0 . 1 )  2 3 . 5 ( 0 . 8 )  2 3 . 5 ( 0 . 0 )  2 3 . 7 (  0 . 2 )  2 5 . 0 (  1 . 3 )  2 5 . 0 (  0 . 0 )  2 3 . 8 ( - 1 . 2 )  2 5 . 1 ( 1 . 3 )  2 . 6  
22 . 3( 0 . 1 )  2 2 . 8 ( 0 . 5 )  2 2 . 7 ( -0 . 1 )  2 2 . 4 ( -0 . 3 )  2 2 . 9 ( 0 . 5 )  23 . 2 (  0 . 3 )  2 4 . 2 (  1 . 0 )  2 4 . 1 ( -D . 1 )  24 . 4 (  0 . 3 )  24 . 8 (  0 . 4 ) 2 . 6  
23 . 5 ( 0 . 5 )  24 . 4 (  0 . 9 )  2 3 . 7 ( -0 . 7 )  2 5 . 0( 1 . 3 )  2 5 . 3 (  0 . 3 )  2 5 . 6 (  0 . 3 )  2 5 . 8 (  0 . 2 )  26 . 6 (  0 . 8 )  26 . 0 ( -Q . 6 )  26 . 9 (  0 . 9 )  3 . 9  
25 . 1 ( - 1 . 0 )  26 . 8 (  1 . 7 )  24 . 8 ( -2 . 0 )  2 7 . 4 (  2 . 6 )  26 . 2 ( - 1 . 2 )  26 . 9 (  0 . 7 )  2 4 . 8 ( -2 . 1 )  26 . 2 (  1 . 4 )  2 5 . 4 ( -D . 8 )  27 . 2 (  1 . 8 )  1 . 1  
24 . 0( -0 . 4 )  2 4 . 2 (  0 . 2 )  2 5 . 3 (  1 . 1 )  2 4 . 7 ( -0 . 6 )  26 . 1 (  1 . 4 )  26 . 7 (  0 . 6 )  2 7 . 8 (  1 . 1 )  27 . 3 ( -0 . 5 )  2 1 . 9 ( -5 . 4 )  27 . 8 (  5 . 9 )  3 . 4 
26 . 5 ( -0 . 8 )  2 8 . 1 (  1 . 6 )  2 8 . 0 ( -0 . 1 )  2 8 . 9 (  0 . 9 )  2 9 . 3 (  0 . 4 )  30 . 1 (  0 . 8 )  3 1 . 7 (  1 . 6 )  3 3 . 0 (  1 . 3 )  27 . 3 ( -5 . 7 )  3 3 . 4 (  6 . 1 )  6 . 1 
25 . 3 ( - 1 . 2 )  26 . 6 ( 1 . ) )  2 7 .0(  0 . 4 )  2 9 . 6 (  2 . 6 )  2 9 . 4 ( -0 . 2 )  3 1 . 5 (  2 . 1 )  34 . 9 (  3 . 4 )  36 . 7 (  1 . 8 )  36 . 9 (  0 . 2 ) 39 . 2 (  2 . 3 )  1 2 . 7  
30 . 8( -0 . 5 )  30 . 8 ( 0 . 0 )  3 1 . 8 ( 1 . 0 )  3 2 . 3 ( 0 . 5 )  32 . 9 (  0 . 6 )  34 . 5 (  1 . 6 )  3 5 . 5 (  1 . 0 )  38 . 0 (  2 . 5 )  3 7 . 4 ( -D . 6 )  39 . 1 (  1 . 7 )  7 . 8  
4 1 . 5 ( 0 . 8 )  i 9 . 0 ( -2 . 5 ) 38 . 0 ( - 1 . 0 )  3 7 . 7 ( -0 . 3 )  39 . 5 (  1 . 8 )  40 . 4 (  0 . 9 )  4 1 . 0 (  0 . 6 )  4 3 . 2 (  2 . 2 )  4 5 . 9 (  2 . 7 ) 47 . 9 (  2 . 0 )  7 . 2  
32 . 2 ( - 2 . 1 )  2 9 . 9 ( -2 . 3 )  2 9 . 8 ( -0 . 1 )  30 . 2 (  0 . 4 )  30 . 0 ( -0 . 2 )  3 2 . 0( 2 . 0 )  3 3 . 4 (  1 . 4 )  3 5 . 4 (  2 . 0 )  34 . 5 ( -D . 9 )  37 . 0 (  2 . 5 )  2 . 7  
31 . 5( 1 . 5 )  32 . 5 (  1 . 0 )  3 3 . 3 ( 0 . 8 )  34 . 5 (  1 . 2 )  34 . 2 { -0 . 3 )  34 . 6 (  0 . 4 )  3 5 . 5 (  0 . 9 )  37 . 0 (  1 . 5 )  38 . 5 (  1 . 5 )  38 . 8 (  0 . 3 )  8 . 8  
21 . 1 c - 1 . 1 )  28 .o(  o . 9 )  2 8 . 3 (  o . 3 )  2 8 . 8 (  o . 5 )  2 7 . 9 { -0 . 9 }  28 . 9 { 1 . 0 )  28 . 6 ( -o . 3 )  29 . 8 (  1 . 2 )  30 . 1 (  o . 3 )  29 . 6 ( -o . s >  1 . 4 
31 . 4 (  0 . 6 )  3 1 . 8( 0 . 4 )  3 2 . 1 (  0 . 3 )  3 2 . 0 ( -0 . 1 )  32 . 7 (  0 . 7 )  3 3 . 0 (  0 . 3 )  35 . 1 (  2 . 1 )  3 5 . 4 (  0 . 3 )  3 5 . 5 (  0 . 1 )  3 5 . 4 ( -D . 1 ) 4 . 6  
29 . 7 (  0 . 0 )  3 1 . 1 (  1 . 4 )  3 1 . 8 ( 0 . 7 )  3 2 . 6 (  0 . 8 )  3 2 . 7 (  0 . 1 )  3 3 . 5 (  0 . 8 )  3 5 . 9 (  2 . 4 )  36 . 3 (  0 . 4 ) 36 . 4 (  0 . 1 )  35 . 6 ( -Q . 8 )  5 . 9  
27 . 6 (  0 . 4 )  28 .0(  0 . 4 )  2 9 . 0 (  1 . 0 )  2 8 . 3 ( -0 . 7 )  29 . 9 (  1 . 6 )  29 . 2 ( -0 . 7 )  2 9 . 8 (  0 . 6 )  29 . 5 ( -D . 3 )  30 . 1 (  0 . 6 )  30 . 3 (  0 . 2 )  3 . 1  
28 . 5 ( 0 . 1 )  2 9 . 4 (  0 . 9 )  30 . 8 (  1 . 4 )  3 1 . 4 (  0 . 6 )  3 1 . 9 (  0 . 5 )  3 3 . 2 (  1 . 3 )  3 3 . 3 (  0 . 1 )  3 3 . 6 (  0 . 3 )  3 5 . 3 (  1 . 7 )  3 5 . 2 ( -D . 1 )  6 . 8  
47 . 8 (  2 . 5 )  50 . 4 (  2 . 6 )  50 . 6 (  0 . 2 )  52 . 1 (  1 . 5 )  52 . 6 (  0 . 5 )  53 . 9 (  1 . 3 )  54 . 1 (  0 . 2 )  5 5 . 3 (  1 . 2 )  56 . 3 ( 1 . 0 )  57 . 5 (  1 . 2 )  1 2 . 2  
38 . 7 ( 3 . 4 )  4 2 . 8 ( 4 . 1 )  46 . 6 (  3 . 8 )  49 . 5 (  2 . 9 )  50 . 1 (  0 . 6 )  5 1 . 9 (  1 . 8 )  52 . 6 (  0 . 7 )  53 . 9 (  1 . 3 )  5 5 . 1 (  1 . 2 )  54 . 0 ( -1 . 1 )  18 . 7  
39 . 3 (  1 . 1 )  40 . 0( 0 . 7 )  4 3 . 2 (  3 . 2 )  4 5 . 7 (  2 . 5 ) 4 7 . 7 (  2 . 0 )  49 . 9 (  2 . 2 )  5 1 . 4 (  1 . 5 )  5 1 . 3 ( -Q . 1 )  52 . 6 (  1 . 3 )  52 . 3 ( -Q . ) ) 1 4 . 1  
...... "'-J 
\0 
Expe r i ment 1 2 ,  Study 2 
Append i x  Ta ble 25 . Mouse We i ght Data and D i f f e rences in We i gh t  from Week to Week ( i n  gra ms ) . 
Mouse Week 
# 0 Week 1 Week 2 
60-day-old ( Ad u l t s )  on 0 . 2 %  DHEA 
Week 3 Week 4 Week 5 Week 6 Week 7 
Tot a l  
We i ght 
Week 8 Week 9 Week 1 0  Cha nse 
AW/ AW 49 22 . 1  20 . 5 ( - 1 . 6 )  2 0 . 6 (  0 . 1 )  2 0 . 6 (  0 . 0 )  20 . 0 ( -0 . 6 )  2 1 . 7 ( 1 . 7 )  2 2 . 3 ( 0 . 6 )  2 3 . 1 ( 0 . 8 )  2 3 . 6 (  0 . 5 )  
50 24 . 0  2 1 . 8 ( - 2 . 2 )  2 1 . 1 ( -0 . 7 )  20 . 7 ( -0 . 4 )  20 . 4 ( -0 . 3 )  20 . 3 ( -0 . 1 )  2 1 . 7 (  1 . 4 )  2 2 . 9 (  1 . 2 )  2 4 . 0 (  1 . 1 )  
5 1  23 . 2  2 1 . 4 ( - 1 . 8 )  2 1 . 2 ( -0 . 2 )  2 1 . 1 ( -0 . 1 )  20 . 8 ( -0 . 3 )  20 . 9 (  0 . 1 )  2 1 . 3 (  0 . 4 ) 2 1 . 2 ( -0 . 1 )  2 2 . 4 (  1 . 2 )  
52 24 . 3  24 . 8 (  0 . 5 )  24 . 7 ( -0 . 1 )  2 4 . 8 (  0 . 1 )  2 5 . 5 ( 0 . 7 )  2 5 . 3 ( -0 . 2 )  2 5 . 4 (  0 . 1 )  26 . 8 (  1 . 4 )  26 . 7 ( -0 . 1 )  
53  23 . 6  22 . 8 ( -0 . 8 )  2 2 . 6 ( -0 . 2 )  20 . 9 ( - 1 . 7 )  2 1 . 2 (  0 . 3 )  1 9 . 8 ( - 1 . 4 ) 20 . 6 (  0 . 8 )  20 . 7 (  0 . 1 )  2 1 . 8 (  1 . 1 )  
54 22 . 2  20 . 9 ( - 1 . 3 )  2 1 . 7 (  0 . 8 )  2 1 . 2 ( -0 . 5 )  2 1 . 3 ( 0 . 1 )  2 1 . 0 ( -0 . 3 )  20 . 9 ( -0 . 1 ) 2 1 . 3 (  0 . 4 )  2 2 . 1 (  0 . 8 ) 
2 4 . 4 (  0 . 8 )  2 3 . 5 ( -Q . 9 )  
2 3 . 8 ( -Q . 2 )  2 3 . 0 ( -Q . 8 )  
2 3 . 1 (  0 . 7 )  2 2 . 8 ( -Q . 3 )  
27 . 9 (  1 . 2 )  2 7 . 1 ( -Q . S )  
2 2 . 4 (  0 . 6 )  2 2 . 5 (  0 . 1 )  
2 3 . 6 (  1 . 5 )  2 4 . 1 (  0 . 5 ) 
1 . 4 
- 1 . 0  
-o . 4 
2 . 8  
- 1 . 1  
1 . 9 
AY / AW 55 30 . 6 25 . 4 ( -5 . 2 )  2 3 . 4 ( -2 . 0 )  2 3 . 4 (  0 . 0 )  24 . 4 (  1 . 0 )  24 . 8 (  0 . 4 )  24 . 0 ( -0 . 8 )  2 4 . 8 (  0 . 8 )  2 5 . 6 (  0 . 8 )  26 . 5 (  0 . 9 )  26 . 4 ( -Q . 1 )  -4 . 2  
56 23 . 2  19 . 8 ( - 3 . 4 )  1 9 . 8 (  0 . 0 }  1 8 . 3 ( - 1 . 5 )  1 8 . 8 (  0 . 5 )  1 9 . 5 ( 0 . 7 )  20 . 3 (  0 . 8 )  20 . 8 (  0 . 5 )  2 1 . 5 (  0 . 7 )  2 2 . 4 (  0 . 9 )  2 2 . 6 (  0 . 2 )  -o . 6 
57 33 . 7  28 . 5 ( - 5 . 2 )  2 5 . 5 ( - 3 . 0 )  23 . 1 ( -2 . 4 )  2 3 . 0 ( -0 . 1 )  2 2 . 3 ( -0 . 7 )  2 2 . 8 ( 0 . 5 )  2 4 . 1 (  1 . 3 )  2 5 . 8 (  1 . 7 )  28 . 1 (  2 . 3 )  28 . 8 (  0 . 7 )  -4 . 9  
58 25 . 9  2 1 . 1 ( -4 . 8 )  20 . 3 ( -0 . 8 )  2 1 . 4 (  1 . 1 )  2 1 . 0 ( -0 . 4 )  2 1 . 0 (  0 . 0 )  2 1 . 5 ( 0 . 5 )  2 1 . 1 ( -0 . 4 )  2 1 . 4 (  0 . 3 )  2 3 . 1 (  1 . 7 )  2 3 . 4 (  0 . 3 )  -2 . 5  
5 9  25 . 4  2 1 . 7 ( - 3 . 7 )  2 1 . 9 ( 0 . 2 )  2 2 . 9 ( 1 . 0 )  24 . 2 (  1 . 3 )  2 5 . 3 (  1 . 1 )  2 5 . 7 ( -0 . 2 )  2 5 . 5 (  0 . 4 )  2 5 . 9 (  0 . 4 ) 26 . 5 (  0 . 6 )  26 . 8 (  0 . 3 )  1 . 4 
60 33 . 6  28 . 7 ( -4 . 9 )  26 . 6 ( - 2 . 1 )  26 . 3 ( -0 . 3 )  26 . 2 ( -0 . 1 )  2 7 . 5 ( 1 . 3 )  2 7 . 8 ( -0 . 3 )  28 . 6 (  0 . 8 )  30 . 0 (  1 . 4 )  29 . 3 ( -Q . 7 )  29 . 9 (  0 . 6 )  -3 . 7  
AWf AW 6 1 3 1 . 3  30 . 3 ( - 1 . 0 )  32 . 2 (  1 . 9 )  3 1 . 0 ( - 1 . 2 )  3 1 . 6 (  0 . 6 )  3 1 . 6 (  0 . 0 )  32 . 2 (  0 . 6 )  32 . 8 (  0 . 6 )  34 . 2 (  1 . 4 )  34 . 2 (  0 . 0 )  34 . 3 (  0 . 1 )  3 . 0  
6 2  30 . 8  30 . 5 ( -0 . 3 ) 30 . 8 (  0 . 3 )  30 . 5 ( -0 . 3 )  30 . 3 ( -0 . 2 )  2 9 . 7 ( -0 . 6 )  30 . 0 (  0 . 3 )  30 . 4 (  0 . 4 )  3 1 . 1 (  0 . 7 )  3 1 . 0 ( -D . 1 )  3 1 . 1 (  0 . 1 )  0 . 3  
6 3  30 . 5  30 . 6 ( 0 . 1 )  3 2 . 2 (  1 . 6 )  3 1 . 1 ( - 1 . 1 )  3 1 . 6 (  0 . 5 )  32 . 0 (  0 . 4 )  3 1 . 9 ( -0 . 1 )  3 1 . 4 ( -0 . 5 )  30 . 8 ( -Q . 6 )  3 1 . 1 (  0 . 3 )  30 . 4 ( -Q . 7 )  -o . l  
64 30 . 3  31 . 3 ( 1 . 0 )  32 . 4 (  1 . 1 )  3 2 . 4 (  0 . 0 )  32 . 8 ( 0 . 4 )  3 3 . 8 (  1 . 0 )  35 . 0 (  1 . 2 )  36 . 0 (  1 . 0 )  36 . 5 (  0 . 5 )  36 . 0 ( -Q . 5 )  36 . 4 (  0 . 4 ) 6 . 1 
65 30 . 5  31 . 5 ( 1 . 0 )  3 2 . 2 (  0 . 7 )  3 1 . 9 ( -0 . 3 )  3 1 . 6 ( -0 . 3 )  3 1 . 8 (  0 . 2 )  3 3 . 1 (  1 . 3 )  32 . 6 ( -0 . 5 )  3 3 . 4 (  0 . 8 )  32 . 3 ( - 1 . 1 )  33 . 5 (  1 . 2 )  3 . 0  
6 6  33 . 8  33 . 9 ( 0 . 1 )  3 5 . 2 (  1 . 3 )  34 . 2 ( - 1 . 0 )  35 . 0( 0 . 8 )  3 5 . 5 (  0 . 5 )  36 . 0 (  0 . 5 )  3 5 . 9 ( -0 . 1 )  37 . 0 (  1 . 1 )  36 . 6 ( -Q . 4 ) 37 . 2 (  0 . 6 ) 3 . 4 
AY I AW 67 40 . 3  36 . 1 ( -4 . 2 )  35 . 6 ( -0 . 5 )  34 . 0( - 1 . 6 )  35 . 2 (  1 . 2 )  36 . 0 (  0 . 8 )  36 . 5 (  0 . 5 )  38 . 4 (  1 . 9 )  40 . 1 (  1 . 7 )  4 2 . 2 (  2 . 1 )  4 5 . 0 (  2 . 8 )  4 . 7  
68 39 . 3  36 . 6 ( - 2 . 7 )  3 7 . 2 (  0 . 6 )  3 7 . 1 ( -0 . 1 )  38 . 0 (  0 . 9 )  39 . 8 (  1 . 8 )  40 . 1 (  0 . 3 )  4 2 . 8 (  2 . 7 ) 4 5 . 1 (  2 . 3 )  4 7 . 5 ( 2 . 4 )  48 . 8 (  1 . 3 )  9 . 5  
6 9  4 1 . 6  35 . 2 ( -6 . 4 )  34 . 6 ( -0 . 6 )  34 . 2 ( -0 . 4 )  35 . 7 {  1 . 5 )  3 7 . 9 (  2 . 2 )  40 . 9 (  3 . 0 )  4 3 . 5 ( 2 . 6 )  4 5 . 1 (  1 . 6 )  4 5 . 4 (  0 . 3 )  4 7 . 6 (  2 . 2 )  6 . 0  
7 0  42 . 5  39 . 3 ( - 3 . 2 )  4 1 . 4 (  2 . 1 )  40 . 4 ( - 1 . 0 )  4 1 . 6 ( 1 . 2 )  4 1 . 0 ( -0 . 6 )  4 2 . 1 (  1 . 1 )  4 3 . 8 (  1 . 7 )  46 . 8 (  3 . 0 )  4 6 . 1 ( -Q . 7 )  4 7 . 9 (  1 . 8 )  5 . 4  
7 1  49 . 1  45 . 5 ( - 3 . 6 )  4 7 . 8 ( 2 . 3 )  49 . 4 (  1 . 6 )  5 1 . 9 (  2 . 5 )  52 . 1 (  0 . 2 )  53 . 2 ( 1 . 1 )  54 . 5 (  1 . 3 )  5 5 . 9 (  1 . 4 )  5 7 . 4 (  1 . 5 )  54 . 7 ( -2 . 7 )  5 . 5  
7 2  37 . 0  33 . 8 ( - 3 . 2 )  34 . 6 (  0 . 8 )  3 5 . 7 (  1 . 1 )  37 . 8 (  2 . 1 )  38 . 7 (  0 . 9 )  4 1 . 0 (  2 . 3 )  4 2 . 6 {  1 . 6 )  46 . 2 ( 3 . 6 )  48 . 0 (  1 . 8 )  49 . 1 (  1 . 1 )  1 2 . 1  
..... CXl 0 
Expe r i ment 1 2 , Study 2 
Append i x  Ta b l e  26 . Mouse We i ght Data and D i f f e re nc e s  in We i ght f rom Week to Week ( i n  gra ms ) .  
Mouse Week 
I 0 Week 1 Week 2 Week 3 
60-day-o l d  ( Ad u l t s )  on 0 . 4 %  DHEA 
Week 4 Week 5 Week 6 Week 7 Wee k  8 Week 9 
Tot a l  
We i g h t  
Week 1 0  Cha nge 
AW/ AW 7 3  
7 4  
7 5  
7 6  
7 7  
7 8  
2 1 . 5  16 . 6 ( - 4 . 9 )  1 5 . 4 ( - 1 . 2 )  1 9 . 0 (  3 . 6 )  1 7 . 4 ( - 1 . 6 )  1 5 . 2 ( - 2 . 2 )  1 8 . 9 (  3 . 7 )  1 9 . 6 (  0 . 7 )  1 9 . 5 ( -0 . 1 )  1 9 . 7 (  0 . 2 )  1 9 . 8 (  0 . 1 )  
24 . 0  17 . 7 ( - 6 . 3 )  1 4 . 8 ( - 2 . 9 )  1 9 . 5 ( 4 . 7 )  20 . 2 ( 0 . 7 )  1 8 . 0 ( -2 . 2 )  20 . 5 ( 2 . 5 ) 20 . 9 (  0 . 4 )  2 1 . 0 (  0 . 1 )  20 . 4 ( -D . 6 )  20 . 7 (  0 . 3 )  
24 . 1  18 . 3 ( - 5 . 8 )  1 9 . 9 (  1 . 6 )  1 8 . 2 ( - 1 . 7 )  1 8 . 9 (  0 . 7 )  20 . 1 ( 1 . 2 )  20 . 0 ( -0 . 1 )  1 9 . 6 ( -0 . 4 )  20 . 0 ( 0 . 4 ) 20 . 6 (  0 . 6 )  20 . 7 (  0 . 1 )  
26 . 2  2 1 . 5 ( - 4 . 7 )  2 3 . 0 ( 1 . 5 )  2 2 . 3 ( -0 . 7 ) 2 1 . 9 ( -0 . 4 )  2 3 . 5 (  1 . 6 )  2 4 . 3 (  0 . 8 )  2 3 . 5 ( -D . 8 )  24 . 0 (  0 . 5 )  2 5 . 8 (  1 . 8 )  2 4 . 4 ( - 1 . 4 ) 
26 . 2  20 . 8 ( - 5 . 4 )  1 9 . 8 ( - 1 . 0 )  1 9 . 8 (  0 . 0 )  1 9 . 4 ( -0 . 4 ) 20 . 2 (  0 . 8 )  2 0 . 1 ( -0 . 1 )  20 . 6 (  0 . 5 )  20 . 5 ( -D . 1 )  20 . 6 (  0 . 1 )  2 2 . 1 (  1 . 5 )  
24 . 2  2 1 . 4 ( - 2 . 8 )  20 . 1 ( - 1 . 3 )  1 9 . 9 ( -0 . 2 )  20 . 3 ( 0 . 4 )  20 . 5 (  0 . 2 )  2 1 . 6 (  1 . 1 )  20 . 8 ( -0 . 8 )  2 1 . 0 (  0 . 2 )  2 1 . 6 (  0 . 6 ) 2 1 . 7 (  0 . 1 )  
- 1 . 7  
-3 . 3  
-3 . 4  
- 1 . 8  
-4 . 1  
-2 . 5  
AY /AW 79 40 . 9  29 . 8 ( - 1 1 . 1 )  2 3 . 8 ( -6 . 0 )  1 9 . 1 ( -4 . 7 )  1 9 . 4 (  0 . 3 )  2 2 . 8 ( 3 . 4 )  2 2 . 4 ( -0 . 4 )  2 2 . 1 ( -0 . 3 )  2 2 . 9 (  0 . 8 ) 2 2 . 1 ( -D . 8 )  2 2 . 9 (  0 . 8 )  - 1 8 . 0  
80 38 . 7  27 . 2 ( - 1 1 . 5 )  2 2 . 0 ( -5 . 2 )  1 7 . 2 ( -4 . 8 )  1 6 . 8 ( -0 . 4 )  1 9 . 4 (  2 . 6 )  1 9 . 1 ( -0 . 3 )  1 9 . 8 (  0 . 7 )  1 9 . 2 ( -D . 6 )  1 9 . 4 (  0 . 2 )  1 8 . 5 ( -D . 9 )  -20 . 2  
8 1  26 .6  20 . 0 ( - 6 . 6 )  1 9 . 2 ( -0 . 8 )  1 9 . 8(  0 . 6 )  20 . 3 ( 0 . 5 )  20 . 7 (  0 . 4 )  20 . 1 ( -0 . 6 )  1 9 . 8 ( -0 . 3 )  2 1 . 5 (  1 . 7 )  2 0 . 0 ( -1 . 5 )  20 . 5 ( 0 . 5 )  - 6 . 1 
82  38 . 9  29 . 8 ( - 9 . 1 )  24 . 3 ( -5 . 5 ) 20 . 4 ( -3 . 9 )  1 8 . 5 ( - 1 . 9 )  2 1 . 4 (  2 . 9 )  2 1 . 6 (  0 . 2 )  20 . 2 ( - 1 . 4 )  2 1 . 8 (  1 . 6 )  2 2 . 4 (  0 . 6 )  2 2 . 3 ( -D . 1 )  -1 6 . 6 
83 3 1 . 5  23 . 6 ( - 7 . 9 )  20 . 0 ( - 3 . 6 )  1 9 . 2 ( -0 . 8 )  20 . 4 (  1 . 2 )  1 9 . 8 ( -0 . 6 )  26 . 8 (  7 . 0 )  1 8 . 4 ( -8 . 4 ) 1 8 . 7 (  0 . 3 )  1 9 . 0 (  0 . 3 )  1 9 . 7 (  0 . 7 )  - 1 1 . 8 
84 4 3 . 2  32 . 7 ( - 1 0 . 5 )  2 6 . 0 ( -6 . 7 )  20 . 5 ( -5 . 5 )  1 8 . 1 ( -2 . 4 )  1 8 . 9 (  0 . 8 )  1 9 . 5 (  0 . 6 )  1 9 . 9 (  0 . 4 ) 20 . 5 (  0 . 6 )  20 . 5 (  0 . 0 )  2 0 . 2 { -D . 3 )  -2 3 . 0 
8 5  
8 6  




3 1 . 8  28 . 3 ( - 3 . 5 )  2 9 . 5 ( 1 . 2 )  2 9 . 9 (  0 . 4 )  30 . 9 ( 1 . 0 )  30 . 0 ( -0 . 9 )  30 . 7 (  0 . 7 )  3 1 . 3 (  0 . 6 )  3 2 . 6 (  1 . 3 )  3 2 . 8 (  0 . 2 ) 3 3 . 2 (  0 . 4 ) 1 . 4 
33 . 9  31 . 6 ( - 2 . 3 )  3 3 . 6 (  2 . 0 )  34 . 1 (  0 . 5 )  34 . 1 ( 0 . 0 )  34 . 8 ( 0 . 7 )  35 . 6 (  0 . 8 )  34 . 7 ( -D . 9 )  3 5 . 1 (  0 . 4 ) 34 . 5 ( -D . 6 )  34 . 8 (  0 . 3 )  0 . 9  
30 . 0  27 . 3 ( - 2. 7 )  2 8 . 9 (  1 . 6 )  2 7 . 4 ( - 1 . 5 ) 26 . 0( - 1 . 4 )  26 . 3 (  0 . 3 )  2 7 . 2 (  0 . 9 )  27 . 4 (  0 . 2 )  27 . 0 ( -D . 4 )  2 7 . 3 (  0 . 3 )  28 . 0 (  0 . 7 ) - 2 . 0  
28 . 3  23 . 8 ( - 4 . 5 )  24 . 1 (  0 . 3 )  24 . 9 ( 0 . 8 )  2 5 . 0 (  0 . 1 )  2 5 . 1 (  0 . 1 )  26 . 5 ( 1 . 4 )  26 . 6 (  0 . 1 )  26 . 4 ( -0 . 2 )  26 . 7 (  0 . 3 )  27 . 1 (  0 . 4 ) - 1 . 2 
32 .4  31 . 4 ( - 1 . 0 )  32 . 9 ( 1 . 5 )  3 2 . 6 ( -0 . 3 )  3 2 . 6 (  0 . 0 )  3 2 . 2 ( -0 . 4 )  3 1 . 9 ( -0 . 3 )  3 3 . 0 (  1 . 1 )  3 3 . 2 (  0 . 2 )  3 3 . 6 (  0 . 4 )  34 . 3 (  0 . 7 )  1 . 9 
33 . 1  30 . 0 ( - 3 . 1 )  30 . 1 ( 0 . 1 )  30 . 4 (  0 . 3 )  3 1 . 6 (  1 . 2 )  3 1 . 5 ( -0 . 1 )  3 1 . 8 (  0 . 3 )  32 . 0 (  0 . 2 )  32 . 4 (  0 . 4 )  3 3 . 3 (  0 . 9 )  3 3 . 8 (  0 . 5 )  0 . 7  
9 1  38 . 2  27 . 1 ( - 1 1 . 1 )  2 5 . 7 ( - 1 . 4 )  26 . 5 ( 0 . 8 )  28 . 4 (  1 . 9 }  28 . 3 ( -0 . 1 )  29 . 0 (  0 . 7 )  30 . 1 (  1 . 1 )  30 . 9 (  0 . 8 )  3 1 . 4 (  0 . 5 )  3 1 . 6 (  0 . 2 )  - 6 . 6  
92 46 . 9  35 . 5 ( - 1 1 . 4 )  32 . 5 ( - 3 . 0 )  30 . 1 ( -2 . 4 )  30 . 9 ( 0 . 8 )  3 1 . 6 (  0 . 7 )  3 2 . 8 (  1 . 2 )  3 5 . 0( 2 . 2 )  36 . 2 (  1 . 2 )  36 . 8 (  0 . 6 )  37 . 7 (  0 . 9 )  - 9 . 2  
9 3  47 . 9  33 . 9 ( - 1 4 . 0 )  2 9 . 0 ( -4 . 9 )  24 . 0 ( -5 . 0 )  26 . 2 (  2 . 2 )  26 . 5 ( 0 . 3 )  2 7 . 6 (  1 . 1 )  2 7 . 6 (  0 . 0 )  28 . 5 ( 0 . 9 )  27 . 1 (  1 . 4 )  29 . 4 (  2 . 3 )  -1 5 . 7  
94 47 .4  � . 3 ( - 1 1 . 1 )  32 . 6 ( -3 . 7 )  3 2 . 1 ( -0 . 5 )  3 3 . 0 ( 0 . 9 )  34 . 0 (  1 . 0 )  35 . 7 (  1 . 7 )  36 . 7 (  1 . 0 )  36 . 9 (  0 . 2 )  37 : 1 ( 0 . 2 ) 37 . 9 (  0 . 8 )  - 9 . 5 
9 5  40 .0 31 . 0( - 9 . 0 )  2 9 . 9 ( - 1 . 1 )  30 . 7 (  0 . 8 )  3 1 . 9 ( 1 . 2 )  3 2 . 6 (  0 . 7 )  3 3 . 5 (  0 . 9 )  34 . 3 ( 0 . 8 )  3 5 . 8 (  1 . 5 )  34 . 8 ( - 1 . 0 )  3 5 . 8 (  1 .0 )  - 4 . 2  
96 46 . 0  36 . 7 ( - 9 . 3 )  3 3 . 5 { - 3 . 2 )  32 . 5 ( - 1 . 0 )  32 . 7 ( 0 . 2 )  3 2 . 8 (  0 . 1 )  3 5 . 0 (  2 . 2 )  36 . 0 (  1 . 0 )  37 . 9 (  1 . 9 )  37 . 9 (  0 . 0 )  37 . 6 ( -D . 3 )  - 8 . 4  
-
00 -
Expe r i ment # 2 ,  Study 2 
Append i x  Ta ble 27 . Mouse We i ght  Data and D i f f e re nces in We i ght  f rom Week to Week ( in gra ms ) .  
Geno-
type- Mouse Week 60-day-old ( Adu l t s )  on 0 . 4 %  DHEA 
Sex # 0 Week 1 Week 2 Week 3 Week 4 Week 5 Week 6 Week 7 Week 8 Week 9 Week 1 0  
AWJ AW 1 1 8 . 9  20 . 6 (  1 . 7 )  20 . 4 ( -0 . 2 )  2 1 . 2 (  0 . 8 )  2 2 . 2 ( 1 . 0 )  2 2 . 8 (  0 . 6 )  24 . 2 (  1 . 4 )  24 . 4 (  0 . 2 )  2 3 . 0 ( - 1 . 4 ) 2 5 . 0 (  2 . 0 )  24 . 6 ( -Q . 4 ) 
2 1 7 . 0 16 . 3 ( -0 . 7 )  1 6 . 5 ( 0 . 2 )  1 7 . 5 ( 1 . 0 )  1 8 . 5 ( 1 . 0 )  1 8 . 1 ( -0 . 4 )  1 9 . 1 (  1 . 0 )  1 9 . 0 ( -0 . 1 )  1 8 . 4 ( -Q . 6 )  1 8 . 7 (  0 . 3 )  1 8 . 8 (  0 . 1 )  
3 2 1 . 5  2 2 . 8 (  1 . 3 )  2 3 . 2 (  0 . 4 )  24 . 8 ( 1 . 6 )  2 3 . 6 ( - 1 . 2 )  24 . 7 ( 1 . 1 )  26 . 1 (  1 . 4 )  2 5 . 2 ( -0 . 9 )  26 . 9 (  1 . 7 )  26 . 4 ( -D . 5 )  26 . 2 ( -Q . 2 )  
4 20 . 5  20 . 8 (  0 . 3 )  2 1 . 3 ( 0 . 5 )  20 . 5 ( -0 . 8 )  2 1 . 9 ( 1 . 4 )  2 2 . 8 (  0 . 9 )  2 2 . 8 (  0 . 0 )  24 . 7 ( 1 . 9 )  24 . 3 ( -D . 4 )  2 3 . 9 ( -D . 4 )  2 3 . 9 (  0 . 0 )  
5 2 1 . 2  22 . 0 (  0 . 8 )  2 2 . 3 ( 0 . 3 )  2 3 . 2 ( 0 . 9 )  2 3 . 7 (  0 . 5 )  2 5 . 1 (  1 . 4 )  24 . 4 ( -0 . 7 )  24 . 8 (  0 . 4 ) 2 5 . 0 ( 0 . 2 )  2 5 . 8 (  0 . 8 )  26 . 0 (  0 . 2 )  
6 2 2 . 1 22 . 0 ( -0 . 1 )  2 2 . 9 (  0 . 9 )  2 2 . 1 ( -0 . 8 )  2 2 . 6 (  0 . 5 )  2 3 . 8 (  1 . 2 )  2 3 . 5 ( -0 . 3 )  2 3 . 7 (  0 . 2 )  2 3 . 8 (  0 . 1 )  24 . 5 (  0 . 7 )  24 . 6 (  0 . 1 )  
AY /AW 7 1 8 . 7  23 . 0( 4 . 3 )  2 5 . 1 (  2 . 1 )  2 7 . 5 ( 2 . 4 )  2 9 . 9 (  2 . 4 )  32 . 3 ( 2 . 4 )  34 . 3 (  2 . 0 )  36 . 6 (  2 . 3 )  38 . 2 (  1 . 6 )  4 1 . 5 (  3 . 3 )  4 2 . 7 (  1 . 2 )  
8 1 9 . 1  19 . 1 (  o . o )  1 9 . 9 (  o .a )  2 1 . 8 (  1 . 9 )  2 2 . 1 ( o . 3 )  2 3 . 4 (  1 . 3 )  26 . 3 (  2 . 9 )  2 7 . 4 (  1 . 1 )  29 . 0 (  1 . 6 )  30 . 8 (  1 . 8 )  3 1 . 0 (  o . 2 )  
9 20 . 4  24 . 2 (  3 . 8 )  2 7 . 9 (  3 . 7 )  2 9 . 4 (  1 . 5 )  3 2 . 1 (  2 . 7 )  3 2 . 0 ( -0 . 1 )  34 . 1 (  2 . 1 )  35 . 1 (  1 . 0 )  3 5 . 7 (  0 . 6 ) 38 . 0 {  2 . 3 )  37 . 9 ( -D . 1 )  
1 0  1 9 . 9  2 1 . 6 (  1 . 7 )  2 3 . 6 (  2 . 0 )  2 5 . 3 ( 1 . 7 )  2 8 . 2 (  2 . 9 )  3 1 . 0 (  2 . 8 )  3 2 . 4 (  1 . 4 )  34 . 7 (  2 . 3 )  36 . 5 (  1 . 8 )  37 . 8 (  1 . 3 )  39 . 5 (  1 . 7 )  
1 1  2 1 . 4  25 . 4 (  4 . 0 )  2 9 .0(  3 . 6 )  3 1 . 3 ( 2 . 3 )  36 . 3 (  5 . 0 )  38 . 7 (  2 . 4 )  4 3 . 7 (  5 . 0 )  4 4 . 0 ( 0 . 3 )  4 5 . 5 (  1 . 5 )  49 . 9 (  4 . 4 )  50 . 2 (  0 . 3 )  
1 2  22 . 9  25 . 7 (  2 . 8 )  28 . 3 ( 2 . 6 )  3 1 . 0 ( 2 . 7 )  3 3 . 8 (  2 . 8 )  36 . 6 (  2 . 8 )  40 . 7 ( 4 . 1 )  4 1 . 4 (  0 . 7 )  4 3 . 3 (  1 . 9 )  46 . 4 (  3 . 1 )  4 6 . 5 (  0 . 1 )  
AWJAW 1 3 1 0 . 0  14 . 5 ( 4 . 5 )  1 7 . 2 (  2 . 7 )  1 9 . 9 (  2 . 7 )  2 2 . 4 (  2 . 5 )  2 3 . 0( 0 . 6 )  24 . 3 (  1 . 3 )  2 5 . 4 (  1 . 1 )  26 . 0 (  0 . 6 )  26 . 1 ( 0 . 1 )  26 . 8 (  0 . 7 ) 
1 4  22 . 6  24 . 1 (  1 . 5 )  2 4 . 6 ( 0 . 5 )  2 5 . 4 (  0 . 8 )  2 5 . 5 { 0 . 1 )  26 . 2 (  0 . 7 )  26 . 6 (  0 . 4 ) 2 7 . 5 (  0 . 9 )  2 7 . 2 ( -Q . 3 )  28 . 4 (  1 . 2 )  28 . 4 (  0 . 0 ) 
1 5  8 . 6  14 . 2 (  5 . 6 )  1 6 . 8 (  2 . 6 )  1 8 . 3 (  1 . 5 )  20 . 8 (  2 . 5 )  2 1 . 9 ( 1 . 1 )  2 3 . 3 ( 1 . 4 )  2 5 . 4 (  2 . 1 )  24 . 9 ( -Q . 5 )  26 . 7 (  1 . 8 )  27 . 4 (  0 . 7 )  
1 6  2 1 . 8  22 . 7 ( 0 . 9 )  2 3 . 2 ( 0 . 5 )  2 2 . 6 ( -0 . 6 )  2 3 . 1 ( 0 . 5 )  2 3 . 4 (  0 . 3 )  2 3 . 8 (  0 . 4 )  2 4 . 8 (  1 . 0 )  26 . 0 (  1 . 2 )  2 5 . 9 ( -D . 1 )  27 . 1 (  1 . 2 )  
1 7  24 . 6  25 . 9 (  1 . 3 )  2 7 . 1 (  1 . 2 )  2 8 . 2 (  1 . 0 )  2 8 . 1 (  0 . 1 )  29 . 6 (  1 . 4 )  28 . 8 { -Q . 8 )  29 . 1 (  0 . 3 )  29 . 5 (  0 . 4 ) 29 . 5 (  0 . 0 )  30 . 2 (  0 . 7 )  
1 8  25 . 6  26 . 1 ( 0 . 5 )  26 . 4 (  0 . 3 )  26 . 3 ( -0 . 1 )  2 6 . 0 ( -0 . 3 )  26 . 3 (  0 . 3 )  2 7 . 8 (  1 . 5 )  2 7 . 5 ( -Q . 3 )  2 7 . 8 (  0 . 3 )  28 . 2 {  0 . 4 ) 28 . 2 (  0 . 0 )  
AY / AW 1 9  1 9 . 6  28 . 4 (  8 . 8 )  3 5 . 3 {  6 . 9 )  4 1 . 2 (  5 . 9 )  4 4 . 7 (  3 . 5 )  48 . 2 (  3 . 5 )  5 1 . 4 (  3 . 2 )  54 . 6 (  3 . 2 )  57 . 7 (  3 . 1 )  60 . 0 (  2 . 3 )  61 . 5 {  1 . 5 )  
20 23 . 0  27 . 5 ( 4 . 5 )  3 1 . 6 {  4 . 1 )  3 5 . 3 (  3 . 7 )  38 . 6 (  3 . 3 )  40 . 1 (  1 . 5 )  4 2 . 3 ( 2 . 2 )  44 . 7 ( 2 . 4 )  4 7 . 0 {  2 . 3 )  49 . 4 {  2 . 4 )  50. 3 (  0 . 9 )  
2 1  20 . 3  i5 . 5 ( 5 . 2 )  2 8 . 2 (  2 . 7 )  2 8 . 5 ( o . 3 )  3 1 . 8 (  3 . 3 )  34 . 9( 3 . 1 )  38 . 1 {  3 . 2 )  38 . 8 (  o . 7 )  40 . 8 {  2 . 0 )  4 3 . 1 {  2 . 3 )  44 . 2 {  1 . 1 )  
2 2  26 � 2  3 1 . 7 ( 5 . 5 )  3 7 . 2 (  5 . 5 ) 4 1 . 3 (  4 . 1 )  4 5 . 7 (  4 . 4 )  48 . 4 (  2 . 7 )  5 1 . 5 {  3 . 1 )  53 . 4 (  1 . 9 )  5 5 . 1 (  1 . 7 )  56 . 4 (  1 . 3 )  57 . 8 (  1 . 4 )  
2 3  28 . 3  33 . 9 (  5 . 6 )  36 . 9 (  3 . 0 )  4 0 . 0( 3 . 1 )  4 3 . 3 ( 3 . 3 )  4 5 . 7 (  2 . 4 )  48 . 9 (  3 . 2 )  52 . 5 ( 3 . 6 )  5 5 . 0 ( 2 . 5 )  56 . 1 ( 1 . 1 )  56 . 8 (  0 . 7 ) 
24 24 . 3  25 . 8 (  1 . 5 )  2 6 . 4 (  0 . 6 )  2 9 . 8 (  3 . 4 )  3 2 . 0 (  2 . 2 )  3 5 . 5 ( 3 . 5 )  3 7 . 9 (  2 . 4 )  4 2 � 3 (  4 . 4 )  4 4 . 1 (  1 . 8 )  46 . 0 (  1 . 9 )  48 . 0 (  2 . 0 )  
Tot a l  
Wei gh t  
Change 
5 . 7  
1 . 8 
4 . 7  
3 . 4 
4 . 8 
2 . 5  
24 . 0  
1 1 . 9 
1 7 . 5  
1 9 . 6  
28 . 8  
2 3 . 6  
16 . 8  
5 . 8  
18 . 8  
5 . 3  
5 . 6  
2 . 6 . 
4 1 . 9  
27 . 3  
23 . 9  
3 1 . 6  
28 . 5  ...... 
23 . 7  00 N 
Expe r i ment  # 2 , Study 2 
Append .ix Table 28 . Mouse We i ght Data and D i f fe re nces in Wei gh t  f rom Week to Week ( i n grams ) .  
Geno-
ty pe- House Week 60-day-old ( Adu l t s )  on 0 . 4 %  DHEA 
Sex I 0 Week 1 Week 2 Week 3 Week 4 Week 5 Week 6 Week 7 Week 8 Week 9 Week 1 0  
AW/ AW 25 19 . 2  20 . 2 (  1 . 0 )  20 . 4 (  0 . 2 )  2 1 . 3 ( 0 . 9 )  2 2 . 0 (  0 . 7 )  2 1 . 1 ( -0 . 9 )  2 2 . 4 (  1 . 3 )  2 2 . 9 (  0 . 5 )  2 2 . 9 (  0 . 0 )  2 2 . 8 ( -Q . 1 )  2 3 . 7 (  0 . 9 )  
26 20 . 4  2 1 . 5 ( 1 . 1 )  2 2 . 0 (  0 . 5 ) 2 2 . 7 (  0 . 7 )  2 3 . 6 (  0 . 9 )  23 . 8 ( 0 . 2 )  2 3 . 7 ( -0 . 1 )  2 3 . 9 (  0 . 2 )  24 . 1 (  0 . 2 )  2 5 . 4 (  1 . 3 )  2 5 . 3 ( -G . 1 )  
27  20 . 3  20 . 0 ( -0 . 3 )  2 1 . 5 ( 1 . 5 )  2 2 . 1 (  0 . 6 )  2 3 . 4 (  1 . 3 )  2 3 . 4 (  0 . 0 )  24 . 9 (  1 . 5 )  2 5 . 0 (  0 . 1 ). 24 . 4 ( -G . 6 )  2 5 . 4 (  1 . 0 )  26 . 3 (  0 . 9 ) 
28 20 . 7  2 1 . 0( 0 . 3 )  2 1 . 4 (  0 . 4 )  2 1 . 5 ( 0 . 1 )  2 1 . 9 ( 0 . 4 )  2 2 . 1 (  0 . 2 )  2 3 . 6 (  1 . 5 )  2 3 . 1 ( -0 . 5 )  2 2 . 7 ( -G . 4 ) 2 3 . 9 (  1 . 2 )  2 3 . 3 ( -G . 6 )  
29 23 . 9  22 . 7 ( - 1 . 2 )  2 2 . 8 (  0 . 1 )  2 3 . 4 ( 0 . 6 )  24 . 9 ( 1 5  ) 24 . 9 (  0 . 0 )  2 2 . 2 ( -2 . 7 )  2 5 . 6 (  3 . 4 )  26 . 7 (  1 . 1 )  26 . 4 ( -Q . 3 )  27 . 7 (  1 . 3 )  
30 2 1 . 9  22 . 3 ( 0 . 4 )  2 3 . 6 ( 1 . 3 )  2 3 . 7 (  0 . 1 )  24 . 4 (  0 . 7 )  24 . 1 ( -0 . 3 )  2 2 . 8 ( - 1 . 3 )  26 . 4 (  3 . 6 )  26 . 2 ( -Q . 2 )  27 . 0 (  0 . 8 ) 26 . 4 ( -G . 6 ) 
AY /AW 3 1  18 . 5  19 . 1 (  0 . 6 )  20 . 4 (  1 . 3 )  2 2 . 0( 1 . 6 )  2 2 . 4 (  0 . 4 )  24 . 2 (  1 . 8 )  24 . 9 (  0 . 7 )  2 5 . 6 (  0 . 7 )  2 5 . 8 (  0 . 2 )  26 . 9 (  1 . 1 )  27 . 6 (  0 . 7 )  
3 2  22 . 9  22 . 8 ( -0 . 1 )  26 .0(  3 . 2 )  26 . 9 (  0 . 9 )  28 . 0 (  1 . 1 )  29 . 0 (  1 . 0 )  29 . 2 (  0 . 2 )  30 . 2 (  1 . 0 )  3 1 . 2 ( 1 . 0 )  3 2 . 1 (  0 . 9 )  3 2 . 4 (  0 . 3 )  
3 3  2 1 . 2  2 1 . 9 ( 0 . 7 )  2 3 . 2 ( 1 . })  24 . 2 (  1 . 0 )  2 5 . 2 (  1 . 0 )  2 7 . 1 (  1 . 9 )  28 . 1 (  1 . 0 )  2 9 . 9 (  1 . 8 )  3 1 . 2 ( 1 . 3 )  3 2 . 9 (  1 . 7 )  3 3 . 6 (  0 . 7 )  
34 22 . 9  23 . 8 (  0 . 9 )  2 3 . 7 ( -0 . 1 )  2 5 . 5 ( 1 . 8 )  26 . 3 (  0 . 8 )  28 . 4 (  2 . 1 )  30 . 6 (  2 . 2 )  3 1 . 1 (  0 . 5 )  3 1 . 8 (  0 . 7 )  34 . 3 (  2 . 5 )  3 3 . 7 ( -G . 6 )  
35  26 . 1  24 . 9 ( - 1 . 2 )  26 . 5 (  1 . 6 )  2 9 . 2 (  2 . 7 ) 30 . 9 ( 1 . 7 )  3 3 . 2 (  2 . 3 )  36 . 9 (  3 . 7 )  37 . 4 (  0 . 5 )  39 . 5 ( 2 . 3 )  4 3 . 7 (  4 . 0 )  4 4 . 4 (  0 . 7 )  
36 24 . 9  26 . 2 (  1 . 3 )  2 7 . 5 ( 1 . 3 )  2 9 . 3 ( 1 . 8 )  3 1 . 8 (  2 . 5 ) 3 3 . 4 (  1 . 6 )  34 . 8 (  1 . 4 )  34 . 3 ( -0 . 5 )  36 . 3 (  2 . 0 )  38 . 2 (  1 . 9 )  37 . 8 ( -G . 4 )  
AW/AW 37 25 . 0  27 . 4 (  2 . 4 )  2 8 . 8 ( 1 . 4 )  30 . 6 (  1 . 8 )  3 1 . 6 ( 1 . 0 )  3 1 . 2 ( -0 . 4 ) 3 1 . 7 (  0 . 5 )  3 3 . 5 (  1 . 8 )  34 . 1 (  0 . 6 )  34 . 1 (  0 . 0 )  34 . 4 (  0 . 3 )  
38 23 . 8  25 . 6 (  1 . 8 )  2 5 . 9 (  0 . 3 )  26 . 1 (  0 . 2 )  2 7 . 1 (  1 . 0 )  2 7 . 0 ( -0 . 1 )  2 7 . 9 (  0 . 9 )  28 . 4 (  0 . 5 )  28 . 9 (  0 . 5 )  28 . 8 ( -G . 1 )  30 . 0 {  1 . 2 )  
39 22 . 1  22 . 9( 0 . 8 )  2 3 . 6 (  0 . 7 )  24 . 2 (  0 . 6 )  24 . 5 ( O . J )  24 . 6 (  0 . 1 )  2 5 . 7 (  1 . 1 )  26 . 4 (  0 . 7 )  26 . 7 (  0 . 3 )  2 7 . 6 (  0 . 9 )  27 . 4 ( -G . 2 )  
40 25 . 5  27 .0(  1 . 5 )  2 7 . 6 (  0 . 6 )  2 8 . 7 (  1 . 1 )  2 8 . 7 (  0 . 0 )  2 9 . 4 (  0 . 7 )  3 1 . 1 (  1 . 7 )  30 . 3 ( -G . 8 )  3 1 . 1 (  0 . 8 )  3 3 . 2 (  2 . 1 )  32 . 6 ( -G . 6 ) 
4 1  2 1 . 2  27 . 3 (  6 . 1 )  2 9 . 7 (  2 . 4 )  3 1 . 2 (  1 . 5 )  3 3 . 0 (  1 . 8 )  34 . 4 (  1 . 4 )  3 5 . 3 (  0 . 9 )  36 . 1 (  0 . 8 )  37 . 0 (  0 . 9 )  37 . 8 (  0 . 8 ) 39 . 5 (  1 . 7 )  
4 2  22 . 4  26 .0(  3 . 6 )  2 8 . 1 (  2 . 1 )  2 9 . 4 (  1 . 3 )  30 . 6 (  1 . 2 )  30 . 9 { 0 . 3 )  3 2 . 9 (  2 . 0 )  32 . 6 ( -G . 3 )  3 3 . 2 (  0 . 6 )  3 3 . 1 ( -G . 1 )  3 3 . 4 (  0 . 3 )  
AY / AW 43 28 . 1  30 . 7 (  2 . 6 )  34 . 9 ( 4 . 2 )  40 . 2 (  5 . 3 ) 4 4 . 7 ( 4 . 5 )  48 . 3 {  3 . 6 )  5 1 . 9 (  3 . 6 )  54 . 5 (  2 . 6 )  5 5 . 2 (  0 . 7 )  56 . 8 (  1 . 6 )  59 . 2 (  2 . 4 )  
44 25 . 6  26 . 1 (  0 . 5 )  2 8 . 9 ( 2 . 8 )  3 1 . 8 ( 2 . 9 )  3 3 . 0 (  1 . 2 )  3 5 . 5 (  2 . 5 )  3 7 . 4 (  1 . 9 )  39 . 4 (  2 . 0 )  4 2 . 8 (  3 . 4 )  4 4 . 5 (  1 . 7 )  46 . 1 (  1 . 8 )  
4 5  1 9 . 1  24 . 1 (  5 . 0 )  2 7 . 4 (  3 . 3 )  3 1 . 4 (  4 . 0 )  34 . 2 (  2 . 8 )  34 . 9 (  0 . 7 )  38 . 1 (  3 . 2 )  39 . 8 (  1 . 7 )  4 1 . 6 (  1 . 8 )  4 4 . 3 (  2 . 7 ) 4 6 . 0 (  1 . 7 )  
46 1 8 . 9  27 . 4 (  8 . 5 )  2 9 . 8 (  2 . 4 )  34 . 2 (  4 . 4 )  3 5 . 8 (  1 . 6 )  38 . 6 (  2 . 8 )  4 1 . 0 ("  2 . 4 )  4 5 . 0 (  4 . 0 )  4 7 . 1 (  2 . 1 )  48 . 6 (  1 . 5 )  49 . 6 (  1 . 0 )  
4 7  25 . 5  29 . 2 (  3 . 7 )  30 . 9 (  1 . 7 )  32 . 0( 1 . 1 )  3 5 . 3 ( 3 . 3 )  3 7 . 0 (  1 . 7 )  40 . 5 ( 3 . 5 )  4 1 . 3 (  0 . 8 )  4 3 . 0 (  1 . 7 )  4 5 . 9 (  2 . 9 )  4 7 . 0 (  1 . 1 )  
48 25 . 5  27 . 6 ( 2 . 1 )  30 . 2 (  2 . 6 )  3 2 . 1 (  1 . 9 )  3 1 . 8 ( -0 . 3 )  32 . 8 ( 1 . 0 )  3 5 . 3 ( 2 . 5 )  3 7 . 6 (  2 . 3 )  39 . 6 (  2 . 0 )  4 3 . 1 (  3 . 5 )  4 5 . 1 (  2 . 0 )  
Tot a l  
We i gh t  
Ch�e 
4 . 5  
4 . 9  
6 . 0 
2 . 6  
3 . 8  
4 . 5  
9 . 1  
9 . 5  
1 2 . 4  
10 . 8  
18 . 3  
1 2 . 9 
9 . 4  
6 . 2  
5 . 3  
7 . 1  
18 . 3  
1 1 . 0 
3 1 . 1  
20 . 7  
26 . 9  
30 . 7  
2 1 . 5  ..... 
1 9 . 6  00 w 
Expe r i ment # 2 ,  Study 2 
Append i x  Table 29 . Mouse We i gh t  Data and D i f f e re nces in We i gh t  f rom Week to Week ( in gra ms ) .  
Geno-
type- Mouse Week 60-day-o ld ( Ad u lt s )  on 0 . 2 %  DHEA 
Tot a l  
We i gh t  
Week 1 0  Cha nge Sex # 0 Week 1 Week 2 Week 3 Week 4 Week 5 Week 6 Week 7 Week 8 Week 9 
AW/ AW 49 1 7 . 4  17 . 0 ( -0 . 4 )  1 7 . 6 (  0 . 6 )  1 8 . 9 (  1 . 3 )  20 . 3 (  1 . 4 )  2 1 . 2 (  0 . 9 )  20 . 9 ( -Q . J )  2 1 . 4 (  0 . 5 )  2 1 . 9 (  0 . 5 ) 2 2 . 8 (  0 . 9 )  2 2 . 8 (  0 . 0 ) 5 . 4  
5 0  2 1 . 1  18 . 5 ( - 2 . 6 )  1 9 . 6 (  1 . 1 )  20 . 2 (  0 . 6 )  20 . 0 ( -0 . 2 )  2 1 . 4 (  1 . 4 )  2 2 . 4 (  1 . 0 )  2 2 . 1 ( -0 . 3 )  24 . 0 (  1 . 9 )  2 5 . 4 (  1 . 4 )  26 . 1 (  0 . 7 )  5 . 0  
5 1  19 . 0  1 7 . 7 ( - 1 . 3 )  1 7 . 9 ( 0 . 2 )  1 8 . 7 (  0 . 8 )  1 9 . 8 (  1 . 1 )  1 9 . 8 (  0 . 0 )  20 . 0 (  0 . 2 )  20 . 6 (  0 . 6 )  2 1 . 0 (  0 . 4 )  2 2 . 5 (  1 . 5 )  2 3 . 1 (  0 . 6 ) 4 . 1  
52 2 1 . 8  2 1 . 1 ( -0 . 7 )  2 1 . 7 ( 0 . 6 )  20 . 8 ( -0 . 9 )  2 1 . 2 (  0 . 4 )  2 2 . 0 ( 0 . 8 )  2 3 . 2 (  1 . 2 )  24 . 7 (  1 . 5 )  2 4 . 5 ( -Q . 2 )  2 4 . 8 (  0 . 3 )  2 5 . 3 (  0 . 5 )  3 . 5  
5 3  20 . 1  19 . 0( - 1 . 1 )  1 9 . 2 (  0 . 2 )  20 . 4 (  1 . 2 )  2 2 . 0( 1 . 6 )  2 1 . 8 ( -0 . 2 )  2 2 . 4 (  0 . 6 )  2 2 . 4 (  0 . 0 )  2 2 . 6 (  0 . 2 )  2 3 . 0 (  0 . 4 ) 2 3 . 9 (  0 . 9 )  3 . 8  
54 18 . 7  17 . 7 ( - 1 . 0 )  1 7 . 5 ( -0 . 2 )  1 7 . 8 (  0 . 3 )  1 8 . 5 ( 0 � 7 )  1 8 . 5 ( 0 . 0 )  1 9 . 3 (  0 . 8 )  1 9 . 0 ( -0 . 3 )  1 9 . 7 (  0 . 7 )  1 9 . 6 ( -Q . 1 )  1 9 . 6 (  0 . 0 ) 0 . 9  
AY/ AW 55 27 . 1  20 . 2 ( -6 . 9 )  1 9 . 6 ( -0 . 6 )  1 9 . 5 ( -0 . 1 )  20 . 0 (  0 . 5 )  20 . 2 (  0 . 2 )  2 1 . 6 (  1 . 4 )  2 3 . 1 (  1 . 5 )  24 . 2 (  1 . 1 )  24 . 9 (  0 . 7 )  2 5 . 3 (  0 . 4 ) - 1 . 8  
56 2 2 . 5  19 . 1 ( - 3 . 4 )  1 9 . 4 (  0 . 3 )  1 9 . 6 (  0 . 2 )  20 . 4 (  0 . 8 )  20 . 9 ( 0 . 5 )  2 1 . 2 (  0 . 3 )  2 1 . 2 (  0 . 0 )  2 2 . 5 ( 1 . 3 )  2 3 . 3 (  0 . 8 )  2 3 . 2 ( -Q . l )  0 . 7  
5 7  22 . 3  20 . 5 ( - 1 . 8 )  2 1 . 3 (  0 . 8 )  2 2 . 1 (  0 . 8 )  2 3 . 2 ( 1 . 1 )  2 3 . 7 (  0 . 5 )  2 3 . 9 ( 0 . 2 )  2 4 . 2 (  0 . 3 )  2 4 . 7 (  0 . 5 )  24 . 7 (  0 . 0 )  2 5 . 3 (  0 . 6 )  3 . 0 
58 2 1 . 0  18 . 6 ( -2 . 4 )  1 8 . 6 (  0 . 0 )  1 8 . 9 (  0 . 3 )  1 9 . 3 (  0 . 4 )  1 9 . 3 (  0 . 0 )  20 . 0 (  0 . 7 ) 1 9 . 6 ( -Q . 4 )  20 . 1 (  0 . 5 )  20 . 4 (  0 . 3 ) 20 . 7 (  0 . 3 )  -o . 3  
59 1 8 . 9  -2 . 7 (  • ) 1 9 . 7 (  0 . 8 )  20 . 8 (  1 . 1 )  20 . 9 (  0 . 1 )  2 1 . 3 (  0 . 4 )  2 2 . 4 (  1 . 1 )  2 2 . 1 ( -Q . 3 )  2 2 . 5 (  0 . 4 ) 2 3 . 2 (  0 . 7 ) 2 3 . 2 (  0 . 0 ) 1 . 6 
60 2 2 . 9  2 1 . 7 ( - 1 . 2 )  2 1 . 5 ( -0 . 2 )  2 2 . 7 ( 1 . 2 )  2 2 . 7 ( 0 . 0 )  2 2 . 8 ( 0 . 1 )  2 3 . 8 (  1 . 0 )  2 4 . 3 (  0 . 5 )  2 5 . 4 (  1 . 1 )  26 . 3 (  0 . 9 )  2 7 . 4 (  1 . 1 )  4 . 5  
AW/ AW 61 24 . 3  24 . 1 ( -0 . 2 )  2 5 .0(  0 . 9 )  2 5 . 8 (  0 . 8 )  2 6 . 3 (  0 . 5 )  2 7 . 5 (  1 . 2 )  2 9 . 0 (  1 . 5 )  29 . 9 (  0 . 9 )  30 . 6 (  0 . 7 )  30 . 5 ( -Q . 1 )  30 . 7 (  0 . 2 )  6 . 4  
62  23 . 8  22 . 2 ( - 1 . 6 )  2 1 . 7 ( -0 . 5 )  2 8 . 9 ( -2 . 8 )  1 8 . 9 (  0 . 0 )  2 1 . 9 (  3 . 0 )  2 2 . 9 (  1 . 0 )  24 . 2 (  1 . 3 )  2 5 . 0 (  0 . 8 )  26 . 6 (  1 . 6 )  2 7 . 4 (  0 . 8 )  3 . 6  
6 3  2 1 . 9  19 . 6 ( - 2 . 3 )  2 1 . 3 ( 1 . 7 )  2 2 . 7 ( 1 . 4 )  2 4 . 0 (  1 . 3 )  2 4 . 4 (  0 . 4 )  2 5 . 4 (  1 . 0 )  2 5 . 6 (  0 . 2 )  26 . 1 (  0 . 5 )  27 . 3 (  1 . 2 )  2 7 . 7 (  0 . 4 ) 5 . 8  
6 4  2 1 . 0  22 . 0( 1 . 0 )  2 2 . 2 ( 0 . 2 )  2 2 . 7 ( 0 . 5 )  2 3 . 9 (  1 . 2 )  2 3 . 8 ( -0 . 1 )  2 3 . 8 (  0 . 0 )  2 4 . 5 ( 0 . 7 )  2 4 . 2 ( -Q . J )  2 4 . 5 (  0 . 3 )  24 . 9 (  0 . 4 ) 3 . 9  
6 5  25 . 3  25 . 6 (  0 . 3 )  28 . 1 (  2 . 5 ) 2 9 . 0 (  0 . 9 )  30 . 6 ( 1 . 6 )  3 1 . 7 (  1 . 1 )  3 1 . 9 (  0 . 2 )  3 2 . 1 (  0 . 2 )  3 2 . 1 (  0 . 0 )  3 3 . 2 (  1 . 1 )  3 3 . 4 (  0 . 2 )  8 . 1 
66 28 . 3  26 . 8 ( - 1 . 5 )  2 9 . 1 (  2 . 3 )  30 . 9 (  1 . 8 )  3 1 . 3 (  0 . 4 )  3 1 . 2 ( -0 . 1 )  32 . 6 (  1 . 4 )  3 2 . 6 (  0 . 0 )  3 3 . 3 ( 0 . 7 )  34 . 2 (  0 . 9 )  3 3 . 6 ( -Q . 6 )  5 . 3 . 
AY / AW 67 29 . 6  29 . 7 (  0 . 1 )  3 1 . 5 ( 1 . 8 )  3 3 . 8 ( 2 • 3 )  3 6 . 8 (  3 . 0 )  39 . 2 (  2 . 4 )  4 1 . 3 (  2 . 1 )  4 3 . 8 (  2 . 5 )  46 . 5 (  2 . 7 )  50 . 3 (  3 . 8 )  52 . 4 (  2 . 1 )  2 2 . 8  
6 8  23 . 9  2 1 . 4 ( -2 . 5 ) 2 1 . 3 ( -0 . 1 )  2 2 . 0 ( 0 . 7 )  2 3 . 2 ( 1 . 2 )  2 3 . 4 (  0 . 2 )  24 . 6 (  1 . 2 )  26 . 6 (  2 . 0 )  28 . 8 (  2 . 2 )  30 . 7 (  1 . 9 )  3 2 . 9 (  2 . 2 )  9 . 0  
69 27 . 5  27 . 9( 0 . 4 )  2 9 . 0 (  1 . 1 )  30 . 0( 1 . 0 )  3 1 . 6( 1 . 6 )  3 2 . 3 ( 0 . 7 )  3 3 . 0 ( 0 . 7 )  3 5 . 6 (  2 . 6 )  38 . 7 (  3 . 1 )  4 0 . 7 (  2 . 0 )  4 4 . 1 (  3 . 4 ) 16 . 6  
7 0  25 . 3  24 . 7 ( -0 . 6 )  2 5 . 1 (  0 . 4 )  2 7 . 0 (  1 . 9 )  2 6 . 6 ( -0 . 4 )  2 9 . 1 (  2 . 5 )  2 9 . 7 (  0 . 6 )  3 1 . 1 (  1 . 4 )  3 1 . 7 (  0 . 6 ) 3 2 . 2 (  0 . 5 )  3 3 . 7 (  1 . 5 )  8 . 4  
7 1  26 . 2  25 . 1 ( - 1 . 1 )  2 6 . 5 ( 1 . 4 )  2 9 . 6 (  3 . 1 )  3 1 . 3 ( 1 . 7 )  3 3 . 3 ( 2 . 0 )  36 . 0 (  2 . 7 )  38 . 4 (  2 . 4 )  39 . 4 (  1 . 0 )  4 2 . 1 (  2 . 7 ) 4 2 . 8 (  0 . 7 ) 1 6 . 6  
7 2  2 8  2 26 . 2 ( - 2 . 0 )  2 7 . 1 (  0 . 9 )  28 . 3 ( 1 . 2 )  2 9 . 8 (  1 . 5 )  30 . 4 (  0 . 6 )  3 1 . 0 (  0 . 6 )  3 1 . 3 ( 0 . 3 )  3 2 . 4 (  1 . 1 )  34 . 8 (  2 . 4 )  37 . 0 (  2 . 2 )  8 . 8  
,_. CXl � 
Expe r i ment  # 2 , Study 2 
Append i x  Ta ble 30 . Mouse We ight Data and D i f f e rences in Wei gh t  f rom Week to Week ( i n gra ms ) . 
Geno-
t y pe- Mouse Week 60-day-old ( Adult s )  on 0 . 4 %  DHEA 
Sex # 0 Week 1 Week 2 Week 3 Week 4 Week 5 Week 6 Week 7 Week 8 Week 9 Week 1 0  
AW/ AW 7 3  
74  
7 5  
7 6  
7 7  
7 8  
AY / Aw 79 
80 




AW/ AW 85 
86  




1 8 . 6  
23 . 4  
1 9 . 3  
2 1 . 7  
1 8 . 6  
2 1 . 2  
23 .0 
26 . 6  
22 . 1  
23 . 3  
22 . 7  
24 . 1  
23 . 3  
27 . 7  
25 .0 
29 . 5  
24 . 0  
29 . 9  
1 5 . 3 ( - 3 . 3 )  1 6 . 9 (  1 . 6 )  1 6 . 9 (  0 . 0 )  1 8 . 0 (  1 . 1 )  1 8 . 5 (  0 . 5 )  1 8 . 7 ( 0 . 2 )  1 9 . 7 (  1 . 0 )  1 9 . 6 ( -Q . 1 )  1 9 . 9 (  0 . 3 )  20 . 7 (  0 . 8 )  
1 7 . 9 (-5 . 5 )  1 9 . 5 (  1 . 6 )  1 7 . 6 ( - 1 . 9 )  1 9 . 3 (  1 . 7 )  1 7 . 6 ( - 1 . 7 )  1 7 . 9 (  0 . 3 )  1 8 . 5 ( 0 . 6 ) 1 7 . 6 ( -Q . 9 )  1 8 . 1 (  0 . 5 )  1 8 . 8 (  0 . 7 )  
1 7 . 5 ( - 1 . 8 )  1 9 . 2 (  1 . 7 )  1 9 . 4 (  0 . 2 )  1 9 . 9 (  0 . 5 )  1 8 . 5 ( - 1 . 4 )  1 8 . 3 ( -0 . 2 )  1 8 . 8 (  0 . 5 )  1 9 . 4 (  0 . 6 )  1 9 . 9 (  0 . 5 )  2 0 . 0 (  0 . 1 )  
18 . 3 ( - 3 . 4 )  1 8 . 2 ( -0 . 1 )  1 7 . 1 ( - 1 . 1 )  1 7 . 1 (  0 . 0 )  1 7 . 0 ( -0 . 1 )  1 7 . 3 (  0 . 3 )  1 8 . 0 (  0 . 7 )  1 9 . 1 (  1 . 1 )  1 8 . 7 ( -Q . 4 ) 1 8 . 5 ( -Q . 2 )  
1 5 . 7 ( -2 . 9 )  1 5 . 3 ( -0 . 4 )  1 5 . 8 (  0 . 5 )  1 6 . 6 (  0 . 8 )  1 6 . 1 ( -0 . 5 )  1 6 . 7 (  0 . 6 )  1 7 . 8 (  1 . 1 )  1 8 . 6 (  0 . 8 ) 1 8 . 3 ( -Q . 3 )  1 9 . 8 (  1 . 5 )  
18 . 7 ( - 2 . 5 )  1 9 . 5 ( 0 . 8 )  1 9 . 4 ( -0 . 1 )  1 9 . 3 ( -0 . 1 )  1 9 . 0 ( -0 . 3 )  1 9 . 5 (  0 . 5 )  20 . 6 (  1 . 1 )  2 2 . 3 (  1 . 7 )  2 2 . 1 ( -Q . 2 )  2 3 . 0 (  0 . 9 )  
1 7 . 5 ( - 5 . 5 )  1 7 . 6 (  0 . 1 )  1 8 . 1 (  0 . 5 )  1 9 . 0 (  0 . 9 )  1 9 . 8 (  0 . 8 )  2 1 . 0 (  1 . 2 )  2 2 . 3 (  1 . 3 )  2 2 . 5 (  0 . 2 )  2 3 . 8 (  1 . 3 )  24 . 3 (  0 . 5 )  
19 . 7 ( -6 . 9 )  2 1 .0(  1 . 3 )  20 . 7 ( -0 . 3 )  2 1 . 2 (  0 . 5 )  20 . 4 ( -0 . 8 )  20 . 0 ( -0 . 4 ) 20 . 8 (  0 . 8 )  20 . 9 (  0 . 1 )  2 2 . 1 (  1 . 2 )  20 . 9 ( - 1 . 2 )  
1 9 . 0( -3 . 1 )  1 8 . 4 ( -0 . 6 )  1 9 . 2 (  0 . 8 )  1 9 . 3 ( 0 . 1 )  1 8 . 7 ( -0 . 6 )  1 9 . 0 (  0 . 3 )  2 0 . 1 (  1 . 1 )  20 . 7 (  0 . 6 )  2 1 . 3 ( -o . 6 )  2 1 . 4 (  0 . 1 )  
1 7 . 1 ( -6 . 2 )  1 6 . 9 ( -0 . 2 )  1 7 . 1 (  o . 2 )  1 7 . 9 (  o . 8 )  1 6 . 6 ( - 1 . 3 )  1 7 . 2 (  o . 6 )  1 8 . 9 (  1 . 7 )  1 9 . 7 (  o . 8 ) 1 9 . 9 (  o . 2 )  1 9 . 1 ( -o . 8 )  
16 . 1 ( -6 . 6 )  1 4 . 9 ( - 1 . 2 )  1 6 . 6 (  1 . 7 )  1 8 . 0 (  1 . 4 )  1 6 . 3 ( - 1 . 7 )  1 7 . 0 ( -0 . 7 )  1 7 . 2 (  0 . 2 )  1 7 . 5 (  0 . 3 )  1 7 . 9 (  0 . 4 ) 1 7 . 2 ( -o . 7 )  
1 9 . 0 ( - 5 . 1 )  20 . 2 (  1 . 2 )  1 9 . 9 ( -0 . 3 )  1 9 . 9 (  0 . 0 )  1 8 . 8 ( - 1 . 1 )  1 7 . 6 ( - 1 . 2 )  1 9 . 4 (  1 . 8 )  1 9 . 7 ( -o . 3 )  1 9 . 6 ( -Q . 1 )  1 9 . 5 ( -Q . 1 )  
20 . 9 ( -2 . 4 )  1 9 . 6 ( - 1 . 3 )  1 9 . 2 ( -0 . 4 )  1 9 . 3 (  0 . 1 )  1 9 . 78 0044 20 . 1 (  0 . 4 ) 20 . 0 ( -0 . 1 )  20 . 5 ( 0 . 5 )  2 2 . 0 (  1 . 5 )  2 3 . 1 (  1 . 1 )  
24 . 3 ( - 3 . 4 )  24 . 8 (  0 . 5 )  2 3 . 7 ( - 1 . 1 )  2 3 . 9 (  0 . 2 )  2 2 . 9 ( - 1 . 0 )  24 . 7 (  1 . 8 )  2 5 . 4 (  0 . 7 )  2 5 . 8 (  0 . 4 ) 26 . 2 (  0 . 4 ) 2 7 . 3 (  1 . 1 )  
2 1 . 2 ( - 3 . 8 )  2 2 . 1 (  o . 9 )  2 3 . 3 ( - 1 . 2 )  2 3 . 3 ( o . o )  2 3 . 6 (  o . 3 )  23 . 7 ( -0 . 1 )  2 4 . 2 (  o . 5 )  2 5 . 7 (  1 . 5 )  26 . 2 ( -o . 5 )  27 . 1 (  o . 9 )  
25 . 4 ( -4 . 1 )  26 . 9 (  1 . 5 )  26 . 4 ( -0 . 5 )  26 . 9 ( 0 . 5 )  2 5 . 7 ( - 1 . 2 )  2 5 . 5 ( -Q . 2 )  26 . 7 (  1 . 2 )  2 8 . 6 (  1 . 9 )  29 . 8 (  1 . 2 )  29 . 6 ( -Q . 2 )  
22 . 1 ( - 1 . 9 )  2 3 .0( 0 . 9 )  23 . 8 (  0 . 8 )  2 3 . 5 ( -0 . 3 )  2 3 . 0 ( -0 . 5 )  2 3 . 3 (  0 . 3 )  2 2 . 9 ( -0 . 4 )  2 3 . 4 (  0 . 5 )  2 3 . 7 (  0 . 3 )  2 4 . 7 (  1 . 0 )  
27 . 5 ( - 2 . 4 )  . 2 8 . 6 (  1 . 1 )  2 8 . 5 ( -0 . 1 )  2 9 .0(  0 . 5 )  2 8 . 0 ( - 1 . 0 )  2 7 . 9 ( -0 . 1 )  28 . 7 (  0 . 8 )  29 . 4 (  0 . 7 )  29 . 5 ( 0 . 1 )  29 . 4 ( -Q . 1 )  
AY / AW 9 1  28 .4  24 . 2 ( �4 . 2 )  24 . 7 (  0 . 5 )  2 5 . 4 (  0 . 7 )  2 5 . 7 (  0 . 3 )  2 5 . 1 ( -0 . 6 )  24 . 9 ( -0 . 2 )  26 . 2 (  1 . 3 )  26 . 5 ( 0 . 3 )  27 . 0 ( -Q . 5 )  28 . 2 (  1 . 2 )  
92  26 . 8  19 . 5 ( -7 . 3 )  1 9 . 4 ( -0 . 1 )  2 2 .0(  2 . 6 )  2 1 . 2 ( -0 . 8 )  20 . 7 ( -0 . 5 )  20 . 7 ( -0 . 0 )  20 . 5 ( -Q . 2 )  20 . 6 (  0 . 1 )  20 . 9 ( -Q . 3 )  20 . 8 ( -Q . 1 )  
93 27 . 9  22 . 3 ( -5 . 6 )  2 1 . 9( -0 . 4 )  2 2 . 4 (  0 . 5 )  2 4 . 3 ( 1 . 9 )  2 3 . 7 ( -0 . 6 )  24 . 8 (  1 . 1 )  2 5 . 6 (  0 . 8 )  2 7 . 4 (  1 . 8 )  29 . 3 ( 1 . 9 )  30 . 0 (  0 . 7 ) 
94 32 . 6  25 . 8 ( -6 . 8 )  2 5 . 1 ( -0 . 7 )  2 6 . 6 (  1 . 5 )  2 7 . 8 (  1 . 2 )  2 7 . 3 ( -0 . 5 )  2 7 . 2 ( -0 . 1 )  2 7 8 5 ( 0068 )  29 . 5 (  1 . 7 )  29 . 4 ( -Q . l )  3 1 . 3 (  0 . 9 ) 
9 5  23 . 7  20 . 1 ( - 3 . 6 )  1 9 . 9 ( -0 . 2 )  1 8 . 9 ( - 1 . 0 )  1 9 . 0 (  0 . 1 )  1 8 . 1 ( -0 . 9 )  20 . 0 (  1 . 9 )  20 . 3 (  0 . 3 )  20 . 1 ( -Q . 2 )  20 . 2 (  0 . 1 )  2 0 . 2 (  0 . 0 ) 
96 32 . 1  2i . 7 ( -8 . 4 )  2 1 . 4 ( -2 . 3 )  1 9 . 8 ( - 1 . 6 )  2 1 . 2 ( 1 . 4 )  2 1 . 9 (  o . 7 )  � 2 . 6 (  o . 7 )  2 3 . 4 (  o . 8 )  24 . o (  o . 6 )  2 4 . 7 (  o . 7 )  24 . 5 ( -o . 2 )  
Tot a l  
We ight  
Ch�e 
2 . 1  
-4 . 6  
o .  7 
-3 . 2  
1 . 2 
1 . 8 
1 . 3 
-5 . 7  
-o . 7  
-4 . 2  
-5 . 5  
-4 . 6  
o . o  
-o . 4  
2 . 1  
0 . 1 
0 . 7  
-o . 5  
-o . 2  
-6 . 0  
2 . 1  
-:2 . 3  
-3 . 5  ,_ 
-7 . 6  00 .&:-Ill 
Experiment #2 , Study 2 
Appendix Table 3 1 . Food Consumpt ion ( in grams ) .  
-
Gena- Average 
type- Mouse Weeks Food 
Sex Numbers 1 2 3 4 5 6 7 8 9 1 0  Consumption 
90-day-old (Adults )  on 0 . 0% DHEA 
AW/AW ( 1-2 ) 46 . 8  42 . 1  43 . 3  42 . 0  43 . 5  35 . 4  43 . 1  39 . 5  34 . 1  39 . 6  40 . 9  
( 3-4 ) 50 . 9  5� . 7  49 . 1  44 . 5  50 . 3  48 . 9  47 . 3  46 . 9  39 . 5  44 . 6  47 . 6  
( 5-6 ) 64 . 4  44 . 4  44 . 4  43 . 3  44 . 8  42 . 9  40 . 7  39 . 1  38 . 9  39 . 3  44 . 2  
AY/AW ( 7-8 ) 83 . 4  93 . 3  85 . 8  79 . 3  10 . 9  74 . 9  75 . 5  66 . 1  63 . 2  68 . 1  80 . 0  
( 9- 10)  77 . 4  80 . 7  85 . 8  72 . 7  62 . 5  69 . 2  62 . 7  68 . 8  55 . 7  63 . 3  69 . 9  
( 1 1- 1 2 )  69 . 8  77 . 7  70 . 9  62 . 3  54 . 7  69 . 8  61 . 1  59 . 6  55 . 2  58 . 4  64 . 0  
AW/AW ( 13-14 )  58 . 4  53 . 7  51 . 9  48 . 6  52 . 1  49 . 8  47 . 5  50 . 3  44 . 3  50 . 8  50 . 7  
( 1 5- 1 6 )  65 . 7  55 . 3  54 . 3  44 . 6  57 . 3  52 . 1  52 . 4  53 . 1  45 . 0  52 . 9  53 . 3  
( 1 7- 18 )  98 . 7  87 . 2  83 . 5  79 . 9  93 . 5  88 . 7  93 . 7  85 . 6  78 . 6  77 . 5  86 . 7  
AY/AW ( 1 9-20) 94 . 5  86 . 7  81 . 4  75 . 7  8 1 . 0  79 . 2  86 . 1  84 . 9  74 . 9  86 . 7  83 . 1  
( 2 1-22)  103 . 1  95 . 0  88 . 8  81 . 7  79 . 1  77 . 6  82 . 1  85 . 9  ' 76 . 1  82 . 3  85 . 2  
( 23-24 ) 92 . 8  92 . 2  85 . 8  81 . 4  85 . 3  82 . 7  81 . 6  87 . 0  74 . 6  81 . 9  84 . 5  
90-day-olds ( Adult s )  on 0 . 1 %  DHEA 
AW/AW ( 25-26 ) 40 . 6  41 . 8  42 . 1  40 . 2  44 . 6  40 . 4  38 . 3  40 . 4  36 . 6  41 . 1  40 . 6  
( 2 7-28 ) 41 . 0  43 . 0  43 . 5  39 . 9  42 . 9  38 . 9  42 . 4  38 . 6  36 . 4  40 . 9  40 . 8  
( 29-30 ) 38 . 2  44 . 3  41 . 6  4 1 . 7  42 . 8  39 . 1  37 . 5  42 . 3  36 . 9  41 . 8  40 . 6  
AWJAW ( 3 1-32 ) 39 . 5  47 . 7  49 . 3  47 . 4  49 . 9  47 . 4  49 . 7  46 . 7  32 . 4  50 . 0  46 . 0  
( 33-34 ) 47 .4  52 . 6  58 . 4  67 . 9  65 . 1  67 . 6  68 . 2  70 . 8  48 . 4  58 . 8  60 . 5  
( 35-36 ) 58 . 0  73 . 2  75 . 8  78 . 0  79 . 9  76 . 2  78 . 4  74 . 1  60 . 9  68 , 2  72 . 3  
AW/AW ( 37-38 ) 54 . 4  5 1 . 4  52 . 0  52 . 2  49 . 5  47 . 1  48 . 2  49 . 8  46 . 7  48 . 8  50 . 0  
( 39-40 ) 56 . 7  59 . 5  56 . 4  55 . 6  57 . 2  57 . 8  58 . 6  56 . 3  48 . 3  51 . 6  55 . 8  
( 4 1 -42 ) 51 . 1  48 . 4  48 . 9  47 . 5  5 1 . 6  48 . 0  48 . 0  48 . 0  43 . 7  48 . 4  48 . 4  ._;.... 
AY/AW ( 43-44)  88 . 9  97 . 6  96 . 8  94 . 1  90 . 9  86 . 3  82 . 3  82 . 4  73 . 7  78 . 4  87 . 1  00 U1 
( 45-46 ) 83 . 6  88 . 5  97 . 4  00 . 4  99 . 0  88 . 7  83 . 5  8 1 . 0  69 . 2  72 . 3  86 . 4  
( 47-48 ) 94 . 3  93 . 3  96 . 1  95 . 6  97 . 0  97 . 9  97 . 5  9 1 . 2  78 . 3  81 . 8  92 . 3  
Experiment #2 , Study 2 
Appendix Table 31 . ( continued ) 
Geno- Average 
type- Mouse Weeks Food 
Sex Numbers 1 2 3 4 5 6 7 8 9 1 0  Consumption 
90-day-olds ( Adults ) on 0 . 2% DHEA 
AW/AW (49-50) 49 . 6  43 . 1  39 . 0  40 . 6  53 . 4  53 . 3  5 1 . 4  52 . 4  45 . 5  47 . 7  47 . 6  
( 5 1-52 ) 48 . 6  40 . 7  43 . 0  43 . 1  47 . 1  50 . 2  54 . 2  48 . 8  43 . 2  33 . 8  45 . 3  
( 53-54 ) 46 . 2  39 . 6  35 . 7  36 . 3  45 . 0  46 . 7  49 . 1  48 . 6  43 . 3  43 . 5  43 . 4  
AY/AW (5 5-56 ) 44 . 5  67 . 5  59 . 8  76 . 7  69 . 7  70 . 4  8 1 . 8  80 . 6  57 . 2  5 1 . 1  65 . 9  
( 57-58 ) 48 . 5  41 . 0  39 . 9  46 . 4  45 . 6  58 . 0  64 . 1  64 . 9  56 . 7  52 . 7  51 . 8  
( 59-60 ) 35 . 5  - 39 . 1  47 . 5  48 . 0  50 . 8  47 . 7  50 . 8  5 1 . 9  44 . 5  46 . 6  46 . 2  
AW/AW (6 1-62 ) 66 . 3  64 . 5  59 . o  55 . 9  59 . 8  56 . 4  52 . 7  54 . 5  46 . 3  49 . 0  56 . 4  
( 63-64 ) 69 . 3  6 1 . 2  60 . 9  60 . 2  62 . 0  6 1 . 2  56 . 1  5 1 . 6  43 . 8  53 . 6  58 . 0  
( 65-66)  73 . 4  72 . 0  90 . 6  7 1 . 2  7 1 . 4  66 . 6  65 . 0  6 1 . 7  53 . 1  55 . 5  68 . 0  
AY/AW (67-68 ) 66 . 0  73 . 7  7 1 . 1  94 . 7  90 . 6  78 . 2  80 . 5  77 . 8  72 . 6  74 . 0  77 . 9  
( 69-70)  57 . 6  76 . 5  84 . 7  92 . 8  100 . 2  92 . 2  94 . 7  87 . 4  75 . 1  72 . 6  83 . 4  
( 7 1-7 2 )  73 . 5  93 . 3  100 . 6  1 10 . 2 97 . 6  9 1 . 8  88 . 6  87 . 1  79 . 0  76 . 2  89 . 8  
90-day-olds ( Adults )  on 0 . 4%  DHEA. 
AW/AW (73-74 ) 26 . 5  36 . 4  40 . 1  34 . 6  35 . 8  42 . 2  81 . 5  94 . 3  96 . 1  104 . 3  59 . 2  
( 7 5-7 6 )  18 . 6  39 . 9  32 . 0  31 . 8  47 . 9  44 . 2  48 . 0  48 . 6  52 . 6  48 . 4  4 1 . 2  
( 7 7-78 )  92 . 0  99 . 8  37 . 3  30 . 1  37 . 3  4 1 . 8  44 . 0  49 . 9  52 . 6  52 . 3  53 . 7  
AY/AW ( 79-80 ) 73 . 4  98 .0  35 . 1  48 . 0  57 . 3  48 . 5  49 . 6  47 . 2  5 1 . 6  53 . 2  56 . 2  
( 8 1-82)  45 . 1  30 . 1  42 . 0  44 . 7  60 . 2  66 . 1  67 . 2  68 . 6  78 . 1  83 . 0  58 . 5  
( 83-84 ) 23 . 5  19 . 2  24 . 6  35 . 8  46 . 8  29 . 0  31 . 6  40 . 9  45 . 5  50 . 2  34 . 7  
AW/AW (85-86)  53 . 5  63 . 6  7 1 . 5  84 . 6  63 . 9  64 . 6  66 . 5  68 . 6  59 . 9  66 . 1  66 . 3  
( 87-88)  38 . 9  49 . 8  45 . 3  54 . 6  57 . 2  56 . 9  55 . 6  50 . 0  52 . 6  60 . 3  52 . 1  
( 89-90) 48 . 1  70 . 4  65 . 5  83 . 2  68 . 2  74 . 3  79 . 7  84 . 2  79 . 7  84 . 5  73 . 8  ....... 
AY/Aw (9 1-92)  28 . 9  42 . 3  50 . 3  68 . 9  63 . 3  66 . 9  7 1 . 0  75 . 8  77 . 5  75 . 7  62 . 1  
00 0\ 
( 93-94)  27 . 3  32 . 7  36 . 4  51 . 0  51 . 1  54 . 5  53 . 6  52 . 3  50 . 6  54 . 2  46 . 4  
( 95-96 ) 77 . 0  49 . 6  46 . 7  50 . 0  64 . 9  60 . 5  59 . 0  62 . 3  50 . 2  49 . 7  57 . 0  
Experiment #2 ,  Study 2 
Appendix Table 31 . (continued ) 
Geno- Average 
type- Mouse Weeks Food 
Sex Numbers 1 2 3 4 5 6 7 8 9 1 0  Consumption 
90-day-olds ( Adults ) on 0 . 0% DHEA 
AW/AW ( 1-2 ) 35 . 9  39 . 9  45 . 6  41 . 1  57 . 1  44 . 5  42 . 7  46 . 8  43 . 5  43 . 4  44 . 0  
( 3-4 ) 44 . 7  42 . 3  44 . 3  34 . 4  53 . 1  42 . 3  40 . 4  49 . 2  39 . 1  4 1 . 6  43 . 1  
( 5-6 ) 43 . 1  42 . 5  42 . 0  34 . 5  5 1 . 9  36 . 2  37 . 9  44 . 9  39 . 9  39 . 5  41 . 2  
AY/AW ( 7-8 ) 46 . 8  44 . 9  50 . 0  42 . 4  62 . 3  54 . 8  54 . 2  54 . 7  54 . 8  5 1 . 5  5 1 . 6  
( 9- 10 )  52 . 3  55 . 7  53 . 5  50 . 4  58 . 7  52 . 3  52 . 2  55 . 1  50 . 5  48 . 3  52 . 9  
( 1 1- 1 2 )  59 . 5  61 . 0  58 . 9  57 . 4  77 . 4  67 . 7  57 . 4  66 . 5  67 . 3  64 . 3  63 . 7  
AW/AW ( 13- 14 )  . 49 . 7  47 . 5  50 . 6  46 . 1  6 1 . 5  5 1 . 0  49 . 7  53 . 7  49 . 1  51 . 4  5 1 . 0  
( 1 5- 1 6 )  48 . 5  43 . 4  43 . 2  39 . 7  52 . 7  48 .0  43 . 9  50 . 0  48 . 3  48 . 8  46 . 6  
( 1 7- 18 )  55 . 6  49 . 8  52 . 6  49 . 3  64 . 9  53 . 4  52 . 0  56 . 6  53 . 1  54 . 3  54 . 2  
AY/AW ( 1 9-20 )  70 . 9  75 . 1  78 . 8  7 1 . 7  92 . 9  81 . 4  82 . 7  90 . 6  9 1 . 0  89 . 6  82 . 5  
( 2 1 -22)  74 . 8  72 . 0  70 . 0  67 . 5  93 . 0  8 1 . 9  81 . 2  87 . 8  85 . 8  83 . 0  79 . 7  
( 23-24 ) 72 . 0  70 . 2  80 . 1  74 . 6  101 . 5  93 . 8  96 . 8  100 . 1  94 . 4  9 1 . 6  87 . 5  
90-day-olds ( Young Adults )  on 0 . 1 % DHEA 
AWjAW (25-26 ) 54 . 9  45 . 0  44 . 5  44 . 4  68 . 5  47 . 1  47 . 8  46 . 3  49 . 1  47 . 2  49 . 5  
( 27-28 ) 36 . 9  38 . 9  39 . 4  3 1 . 6  48 . 5  44 . 4  40 . 3  45 . 7  41 . 9  40 . 4  40 . 8  
( 29-30 } 46 . 1  58 . 8  53 . 9  46 . 1  63 . 2  47 . 0  5 1 . 1  53 . 7  5 1 . 7  51 . 6  52 . 3  
AY/AW ( 3 1-32 ) 47 . 8  53 . 9  51 . 7  46 . 0  65 . 6  58 . 0  54 . 8  60 . 8  60 . 7  61 . 0  56 . 0  
( 33-34 ) 46 . 4  45 . 6  50 . 6  47 . 2  69 . 8  64 . 2  58 . 0  7 1 . 8  66 . 1  6 1 . 7  58 . 1  
( 35-36 ) 47 . o  56 . 3  60 . 0  55 . 6  72 . 2  64 . 3  59 . 7  70 . 4  67 . 9  63 . 4  6 1 . 7  
AW/AW (37-38 ) 62 . 2  54 . 5  52 . 8  46 . 2  58 . 9  48 . 3  53 . 4  60 . 5  52 . 5  52 . 8  54 . 2  
( 39-40 ) 52 . 4  48 . 1  47 . 3  38 . 4  54 . 7  47 . 5  44 . 4  50 . 8  48 . 2  48 . 1  48 . 0  
( 4 1 -42 ) 72 . 8  56 . 2  57 . 6  49 . 9  76 . 0  68 . 7  63 . 4  68 . 5  67 . 6  66 . 0  64 . 7  .,:..... 
AY/AW (43-44) 70 . 4  82 .0  87 . 0  80 . 5  1 10 . 2 92 . 3  90 . 8  99 . 6  98 . 2  97 . 7  90 . 9  
00 
....... 
( 45-46 ) 78 . 6  77 . 6  89 . 7  98 . 1  128 . 6  125 . 0  1 1 9 . 7  1 16 . 9 1 1 2 . 9 102 . 6  105 . o  
( 47-48 ) 63 . 8  64 . 4  68 . 9  62 . 2  90 . 3  86 . 1  86 . 5  87 . 3  87 . 0  83 . 1  78 . 0  
Experiment #2 , Study 2 
Appendix Table 31 . (continued ) 
Geno- Average 
type- Mouse Weeks Food 
Sex Numbers I 2 3 4 5 6 7 8 9 1 0  Consumption 
90-day-olds ( Young Adults )  on 0 . 2 %  DHEA 
AW/AW (49-50) 36 .o  43 . 6  4I . 8  35 . 5  48 . 9  44 . 0  4I . 2  52 . 7  52 . 0  50 . 3  44 . 6  
( 5 1-52)  36 . 7  39 . 5  38 . 4  35 . 9  54 . 4  54 . I  49 . 6  53 . 4  47 . 3  44 . 6  45 . 4  
( 53-54) 34 . 5  37 .4 39 . 5  34 . 2  44 . 3  4I . 4  36 . 6  46 . 3  45 . 8  43 . 1  40 . 3  
AY/AW ( 55-56 ) 38 . 3  46 . 8  48 . 9  42 . 6  57 . 4  60 . 8  50 . 3  58 . 9  59 . 8  53 . 8  5I . 8  
( 57-58 ) 38 . 5  43 . I  46 . 6  36 . I  50 . 8  53 . 4  50 . 2  59 . 6  56 . 4  60 . 2  49 . 5  
( 59-60 ) 48 .4 58 . 2  57 . 9  46 . 4  62 . 6  64 . 3  50 . 5  68 . 9  62 . 3  53 . 0  57 . 2  
AW/AW (6 1-62 ) 45 . 1  49 .0  49 . 1  39 . 9  60 . 2  59 . 5  53 . 7  64 . 6  54 . 4  52 . 3  52 . 8  
( 63-64 ) 32 . 1  38 .4  40 . 4  33 . 8  47 . 1  41 . 9  34 . 8  40 . 7  38 . 9  39 . 5  38 . 8  
( 65-66) 55 . 7  60 . 9  64 . 0  5 1 . 4  7 1 . 4  67 . 8  60 . 1  6 1 . 2  60 . 8  59 . 5  6 1 . 3  
AY/AW ( 67-68 ) 55 . 8  68 . 5  81 . 8  75 . 7  96 . 7  96 . 1  99 . 8  108 . 9  1 1 8 . 8 96 . 8  89 . 9  
( 69-70)  49 . 2  58 . 4  70 . 5  63 . 0  90 . 3  86 . 2  92 . 8  106 . 4  102 . 3  88 . 8  80 . 8  
( 7 1-7 2 )  63 . 4  73 . 6  85 . 7  69 . 1  96 . 5  92 . 0  93 . 8  93 . 1  93 . 8  84 . 4  84 . 5  
90-day-olds ( Young Adult s )  on 0 . 4%  DHEA 
AWJAW ( 73-74 ) 49 . 8  41 . 3  34 ;. 1  34 . 7  39 . 9  36 . 3  34 . 1  37 . 5  36 . 1  38 . 4  38 . 2  
( 75-76 ) 34 . 5  40 . 0  48 . 1  54 . 3  54 . 1  47 . 3  38 . 4  43 . 8  36 . 9  34 . 4  43 . 2  
( 7 7-78 )  30 . 6  36 . 5  40 . 5  37 . 9  43 . 5  4I . 5  4I . 3  48 . 0  47 . 5  5 I . 8  41 . 9  
AY/AW ( 79-80 ) 28 . 0  45 . 9  46 . 9  42 . 2  59 . 8  49 . 5  45 . I  49 . 5  53 . 0  47 . 6  46 . 8  
( 8 1-82 ) 35 . 5  40 . 9  44 . 0  36 . 2  49 . I  46 . 3  6 1 . 2  7 1 . 2  65 . 6  60 . 2  5 I . O  
( 83-84 ) 23 . 2  45 . 9  49 . 0  42 . 6  49 . I  54 . 2  48 . 6  47 . 0  50 . 5  45 . 6  45 . 6  
AW/AW (85-86 ) 35 . 2  40 . 5  43 . 4  36 . 8  46 . 6  46 . 9  45 . 9  5 1 . 8  5 1 . 9  5 1 . 5  45 . 0  
( 87-88)  41 . 5  50 . 9  52 . 5  43 . 1  54 . 4  54 . 3  52 . 0  65 . I  64 . 7  66 . 7  54 . 5  
( 89-90 ) 126 . 9  134 . 8  130 . 7  1 I I . 5 I09 . 6  120 . 2  99 . 3  80 . 3  82 . 2  79 . 0  107 . 4  .,_ 
AY/AW ( 9 1-92)  36 .0  38 . 7  46 . 0  34 . 8  46 . 7  44 . 4  40 . 1  50 . 0  44 . 7  50 . 1  43 . 2  00 00 
( 93-94 ) 36 . 2  42 . 8  49 . 3  44 . 8  54 . 4  50 . 8  5 1 . 4  58 . 5  54 . 9  57 . 2  50 . 0  
( 95-96)  26 . 2  35 . 1  40 . 1  39 . 3  48 . 3  49 . 9  46 . 6  46 . 6  42 . 7  45 . 9  42 . 1  
Experiment #2 , Study #2 . 
Appendix Table 32 . Bedding Weight Differences ( in grams ) . 
Geno- Average 
type- Mouse Weeks Bedding 
Sex Numbers 1 2 3 4 5 6 7 8 9 1 0  Weight 
90-day-old (Adults )  on 0 . 0% DHEA 
AW/AW ( 1-2) 16 . 4  1 3 . 0  9 . 0  1 2 . 8  
( 3-4 ) 1 8 . 8  1 6 . 3  12 . 6  15 . 9  
( 5-6)  32 . 1  1 5 . 0  1 1 . 1  1 9 . 4  
AY/Aw ( 7-8 ) 36 . 1  34 . 0  2 1 . 4  30 . 5  
( 9- 10 )  32 . 7  30 . 8  18 . 4  27 . 3  
( 1 1 - 1 2 )  28 . 9  23 . 4  1 9 . 5  23 . 9  
AWJAW ( 1 3-14 )  · 22 . 6  1 7 . 6  1 7 . 7  1 9 . 3  
( 1 5- 1 6 )  30 . 9  1 7 . 3  1 5 . 3  2 1 . 2  
( 1 7- 18 )  55 . 0  39 .0  35 . 2  43 . 1  
AYJAW ( 1 9-20 ) 44 . 0  30 . 2  28 . 5  34 . 2  
( 2 1-22)  50 . 1  36 . 1  32 . 6  39 . 6  
( 23-24 ) 40 . 7  35 . 9  34 . 3  37 . 0  
90-day-olds ( adults ) on . 1 %  DHEA. 
AW/AW (25-26 ) 1 7 . 5  1 5 . 2  1 1 . 4 1 4 . 7  
( 27-28 ) 17 .4 1 4 . 2  10 . 8  14 . 1  
( 29-30 ) 15 . 9  1 5 . 9  1 1 . 3 1 4 . 4  
AY/AW ( 3 1-32 ) 25 . 5  18 . 8  14 . 2  19 . 5  
( 3 3-34 ) 24 . 8  33 . 3  1 5 . 2  24 . 4  
( 35-36 ) 28 . 1  45 . 2  2 1 . 1  3 1 . 5  
AW/AW (37-38 ) 22 . 6  19 . 5  14 . 2  18 . 8  
( 39-40 ) 23 . 9  1 9 . 9  1 5 . 9  1 9 . 9  
( 4 1 -42 ) 19 . 7  16 . 6  1 3 . 1  1 6 . 5  -
AY/AW (43-44 ) 37 . 9  40 . 5  26 . 7  35 . 0  CX> \.0 
( 45-46 ) 39 . 9  45 . 4  27 . 5  37 . 6  
( 47-48 ) 42 . 9  43 . 9  31 . 1  39 . 3  
Experiment #2 , Study #2 . 
Appendix Table 32 . ( cont inued ) 
-
Geno- Average 
type- Mouse Weeks Bedding 
Sex Numbers 1 2 3 4 5 6 7 8 9 1 0  Weight 
90-day-olds ( Adults )  on 0 . 2 % DHEA 
AW/AW (49-50) 72 . 3  62 . 4  32 . 0  55 . 6  
( 5 1-52 ) 36 . 3  27 . 0  24 . 7  29 . 3  
( 53-54 ) 64 . 7  41 . 3  38 . 8  48 . 3  
AY/AW ( 55-56 ) 30 . 5  54 . 6  34 . 0  39 . 7  
( 5 7-58 ) 36 . 5  3 1 . 5  33 . 3  33 . 8  
( 59-60 ) 20 . 3  22 . 4  1 7 . 3  20 . 0  
AWJAW ( 6 1 -62 )  34 . 3  23 . 5  16 . 3  24 . 7  
( 63-64 ) 34 . 7  25 . 2  1 7 . 6  25 . 8  
( 65-66 ) 39 . 3  34 . 7  2 1 . 7  3 1 . 9  
AY/AW (67-68 ) 35 . 5  49 . 4  29 . 5  38 . 1  
( 69-70)  32 . 2  48 . 8  36 . 6  39 . 2  
( 7 1-72 )  41 . 4  6 1 . 2  32 . 7  45 . 1  
90-day-olds ( Adults )  on 0 . 4% DHEA. 
AW/AW ( 73-74 ) 62 . 6  39 . 9  83 . 3  6 1 . 9  
( 7 5-76)  15 . 6  20 . 7  34 . 8  23 . 7  
( 7 7-78 ) 89 . 7  1 9 . 6  40 . 8  50 . 0  
AY/AW ( 79-80 ) 73 . 3  122 . 4  44 . 1  79 . 9  
( 8 1-82)  40 . 2  3 1 . 7  63 . 7  45 . 2  
( 83-84 ) . 24 . 5  43 . 4  40 . 5  36 . 1  
AW/AW (85-86 )  30 . 0  52 . 6  28 . 5  37 . 0  
( 87-88 ) 23 . 3  32 . 9  30 . 4  28 . 9  
( 89-90 ) 25 . 4  53 . 9  52 . 1  43 . 8  � 
AY/AW (9 1-92 ) 21 . 2  47 . 4  48 . 7 39 . 1  "" 0 
( 93-94 ) 20 . 4  24 . 2  22 . 5  22 . 4  
( 95-96 ) 64 . 5  22 . 8  23 . 5  36 . 9  
Experiment #2 , Study #2 . 
Appendix Table 32 . (cont inued ) 
-
Geno- Average 
type- Mouse Weeks Bedding 
Sex Numbers 1 2 3 4 5 6 7 8 9 1 0  Weight 
90-day-old (Young Adults )  on 0 . 0% DHEA 
AWJAW ( 1-2 ) 1 3 . 7  16 . 0  1 4 . 8  14 . 8  
( 3-4 ) 15 . 8  1 3 . 5  1 2 . 4  13 . 9  
( 5-6 ) 16 . 9  1 5 . 7  1 3 . 9  1 5 . 5  
AY /AW ( 7-8 ) 1 7 . 4  1 6 . 6  1 8 . 1  1 7 . 4  
( 9- 1 0 )  1 9 . 7  20 . 3  1 7 . 4  1 9 . 1  
( 1 1-12)  23 . 2  27 . 4  23 . 3  24 . 6  
AW/AW ( 1 3- 1 4 )  1 9 . 0  1 8 . 8  1 9 . 5  1 9 . 1  
( 1 5 - 1 6 )  1 9 . 4 1 5 . 6  1 7 . 3 1 7 . 4  
( 1 7- 1 8 )  2 1 . 1  2 1 . 6 20 . 6  2 1 . 1  
AY/AW ( 1 9-20) 2 7 . 7  3 1 . 4  40 . 8  33 . 1  
( 2 1 -2 2 )  2 9 . 5  2 9 . 2  52 . 7  3 7 . 1  ( 2 3 - 24 ) 2 9 . 2  3 4 . 3  5 1 . 1  38 . 2  
9 0-day-o l d s  ( Young Adul t s )  on 0 . 1 %  DHEA 
AW/ AW ( 2 5- 2 6 ) 2 9 . 1  2 1 . 2  
( 2 7- 2 8 ) 20 . 3  1 3 . 4  
1 7 . 5  22 . 6  
( 2 9-30) 1 8 . 2 2 1 . 7  1 6 . 7  1 6 . 8  AY/AW ( 3 1 -32 ) 28 . 1  25 . 9  1 9 . 8 1 9 . 9  
( 3 3-3 4 )  1 9 . 1  22 . 1  29 . 0  27 . 7  ( 35-36 ) 23 . 2  2 4 . 7  26 . 1  22 . 4  
AW/AW ( 3 7-38 ) 25 . 9  1 8 . 8  24 . 1  24 . 0  ( 3 9-40 ) 2 0 . 1  1 4 . 0  2 1 . 8  22 . 2  ( 4 1 -42 ) 30 . 8  2 0 . 3  1 7 . 3 1 7 . 1  AY / AW ( 4 3-4 4 )  3 1 . 0  36 . 9  25 . 1 2 5 . 4  
( 4 5-46 ) 
-
4 3 . 9  59 . 4  44 . 3 3 7 . 4  '-0 ( 47 - 48 ) -26 . 1  30 . 1  5 1 . 9  5 1 . 7  
34 . 1  30 . 1  
Experiment #2 , Study . #2 . 
Appendix Table 32 . (cont inued ) 
Geno- Average 
type- Mouse Weeks Bedding 
Sex Numbers 1 2 3 4 5 6 7 8 9 1 0  Weight 
90-day-old (Young Adults )  on 0 . 2 %  DHEA 
AW/AW ( 1 -2 ) 38 . 2  28 . 0  27 . 3  3 1 . 2  
( 3-4 ) 26 . 2  24 . 1  19 . 6  23 . 3  
( 5-6 ) 15 . 2  1 7 . 0  20 . 8  1 7 . 7  
AY/AW ( 7-8 )  29 . 8  28 . 6  29 . 3  29 . 2  
( 9- 10 )  26 . 3  23 . 2  34 . 7  28 . 1  
( 1 1 -12 ) 32 . 0  30 . 1  24 . 8  29 . 0  
AWJAW ( 1 3-14 )  21 . 6  25 . 6  22 . 6  23 . 3  
( 1 5-1 6 )  13 . 0  1 3 . 2  14 . 5  1 3 . 6  
( 1 7- 1 8 )  29 . 3  22 . 9  24 . 3  25 . 5  
AY/AW ( 19-20) 28 . 7  43 . 6  48 . 6  40 . 3  
( 2 1 -22)  23 . 7  43 . 7  50 . 0  39 . 1  
( 23-24 ) 38 . 3  39 . 4  44 . 8  40 . 8  
90-day-olds ( Young Adults )  on 0 . 4% DHEA 
AW/AW (25-26 ) 42 . 5  1 9 . 3  19 . 7  27 . 2  
( 27-28 ) 23 . 7  42 . 7  2 1 . 2  29 . 2  
( 29-30 ) 27 . 1  32 . 1  39 . 7  33 . 0  
AY/AW ( 3 1 -32)  19 . 2  26 . 6  26 . 9  24 . 2  
( 33-34 ) 24 . 7  22 . 4  44 . 1  30 . 4  
( 3 5-36 ) 16 . 1  25 . 3  27 . 8  23 . 1  
AW/AW ( 37-38 ) 26 . 8  22 . 3  24 . 9  24 . 7  
( 39-40 ) 20 . 4  33 . 1  40 . 3  3 1 . 3  
( 4 1 -42 ) 108 . 3  95 . 2  55 . 2  86 . 2  ........ 
AY /AW (43-44 ) 28 . 5  27 . 2  29 . 3  28 . 3  \0 N 
( 45-46 ) 19 . 3  22 . 2  27 . 8  23 . 1  
( 47-48 ) . 13 . 1  2 1 . 5  20 . 8  18 . 5  
1 93 
Experiment #2 , Study 2 
Appendix Table 33 . Change in Absorbance at 340 nm, Red B lood Cell 
Count , Hemoglobin Concent ration and Calculated 
G6PDH Act ivities During DHEA Treatment for Each 
Mouse ( 90-day-olds -- ( Adult s )  on 0 . 0% DHEA) . 
Heme-
Genotype- RBC G6PDH globin G6PDH 












1 0  
1 1  
1 2  
1 3  
1 4  
1 5  
1 6  
1 7  
1 8  
1 9  
2 0  
2 1  
2 2  
2 3  










. 3 34 
.337  
.406 
. 355  
. 2 92 
.353  
. 308 
. 368  
. 367  





. 368  
. 3 14  
. 38 9  
.406 
. 332  
. 373  
. 409 
. 246 
. 2 73  
.344 
. 337  
. 339  
. 326  
Before DHEA Treatment 
. 609 
. 553 
. 633  
. 57 2  
. 608 
. 702  
. 643  
. 53 2  
. 63 1  
. 573  
. 67 2  
. 638 
. 734 
. 704  
. 785 
. 59 2  
. 593 . 
. 6 54 
. 608 
. 67 2  
. 7 38 
. 6 1 5  
. 678  
. 693  
. 265  
. 247  
. 27 2  
. 238 





. 26 5  
. 306 
. 27 1  
. 33 2  
. 297  
. 337 
. 254  
. 267  
. 2 86 
. 2 94 
. 283 
. 3 3 2  
. 283 
. 305  
. 2 84 
8 . 02  
8 . 0 9  
8 . 58 
8 . 2 8  
8 . 39 
8 . 53 
8 . 24 
7 . 99 
8 . 42 
8 . 1 4 
8 . 3 5  
8 . 1 3 
9 . 22 
8 . 83 
9 . 45 
8 . 82 
8 . 1 6  
8 . 82 
8 . 3 3 
8 . 99 
9 . 2 1  
8 . 58 
8 . 8 7  
8 . 96 
Duririg DHEA Treatment 
. 452  
. 488 
. 578  
. 573  
. 57 1  
. 56 1  
. 206  
. 2 1 5  
. 2 34 
. 2 36 
. 23 2  
. 2 35 
9 . 5 1  
9 .04  
9 .46  
8 . 75  
8 . 92 
9 . 07 
409 . 3 24 
378 . 220 
392 . 7 1 5 
356 . 0 76  
400 . 1 3 2  
429 . 8 7 1  
432 . 973 
37 2 . 1 00 
409 .005 
403 . 2 90 
45 1 . 006 
4 1 2 . 928 
446 . 070 
4 1 6 . 669 
441 . 7 68 
356 . 747  
405 . 337 
40 1 . 692  
437 . 2 1 8  
389 . 962  
446 . 5 54 
408 . 597  
425 . 963 
39 2 . 6 50 
268 . 3 38 
294 . 6 22  
306 . 42 2  
334 . 1 1 8 
322 . 1 95  
320 . 964 
1 6 . 1  
16 . 2  
17 . 3  
16 . 6  
1 7 . 3  
1 7 . 1  
16 . 6  
1 6 . 0  
16 . 6  
1 5 . 9  
1 6 . 8  
1 6  . o  
1 8 . 2  
1 7 . 4  
1 8 . 6  
1 7 . 4  
1 6 . 1  
1 6 . 9  
1 5 . 9  
1 7 . 5  
1 7 . 5  
16 . 3  
16 . 7  
1 7 . 5  
1 7 . 3  
16 . 9  
1 7 . 6  
16 . 9  
1 7 . 7  
1 7 . 3  
20 . 3899 
18 . 8876  
1 9 . 47 68 
1 7 . 7 609 
19 . 4052  
2 1 . 4433 
2 1 . 4922  
18 . 58 1 8  
20 . 7459 
20 . 6464 
22 . 4 1 6 1  
20 . 98 1 9  
22 . 5976  
2 1 . 1 448 
22 . 4446 
18 .0834 
20 . 5438 
20 . 9640 
22 . 9058 
20 . 0329 
23 . 50 1 5  
2 1 . 507 7 
22 . 6245 
20 . 10 37 
14 . 7 508 
1 5 . 7 59 7  
1 6 . 4702 
1 7 . 2990 
1 6 . 2 372  
16 . 8274 
194  
Experiment 1!2 , Study 2. 
Appendix Table 33 . ( cont inued ) 
Hemo-
Genotype- RBC G6PDH globin G6PDH 




1 0  
1 1  
1 2  
1 3  
1 4  
1 5  
1 6  
1 7  
1 8  
1 9  
20  
2 1  
2 2  











1 0  
1 1  
. 1 2  
During DHEA Treatment 
. 308 
. 297  
. 3 99 
. 2 7 6  
. 3 27 
. 2 5 1  
. 337  
. 2 79 
. 1 2 2  






. 2 25 
. 348 
. 3 1 9  
. 5 52 
. 54 1  
. 698 
. 529  
. 577  
. 47 3  
. 607  
. 526 
. 3 5 1  
. 453 
. 589 
. 6 52 
. 57 2  
. 488 
. 637 
. 475  
. 645  
. 597  
. 24 4  
. 244  
. 2 99 
. 25 3  
. 250  
. 22 2  
. 2 70 
. 247  
. 2 29  
. 232  
. 2 85 
. 303 
. 285 
. 258  
.301  
. 250  
. 29 7  
. 278  
8 . 87 
8 . 7 7  
8 . 27 
8 . 99 
8 . 82 
8 . 86 
9 . 1 0 
9 . 1 1 
7 . 42  
8 . 49  
9 . 1 7  
9 . 39  
9 . 04 
8 . 68 
8 . 7 2 
7 . 98 
8 . 85 
8 . 8 7  
After DHEA Treatment 
.244  . 458 
. 288 . 52 1  
. 2 84 . 502 
. 328  • 540 
. 344  . 563  
.347  . 59 1  
. 306 . 57 2  
.306 • 542 
.258 • 500 
.332 . 584 
.404 . 694  
. 2 99 . 53 2  
. 2 14 
. 233 
. 2 1 8 
. 2 1 2 
. 2 1 9 
. 244 
. 2 66  
. 236 
. 242  
. 25 2  
. 290 
. 233 
8 . 8 1  
9 . 42 
9 . 05 
9 . 43  
9 . 1 9 
9 . 30 
9 . 09 
8 . 7 2 
8 . 80 
9 . 00 
9 . 74 
9 . 07 
340 . 7 70 
344 . 6 56  
447 . 880 
348 . 623  
35 1 . 1 2 9  
3 10 . 39 5  
367 . 5 5 1  
335 . 87 2  
382 . 3 20 
338 . 5 13 
385 . 009 
399 . 7 35 
390 . 546  
368 . 2 1 0  
427 . 608 
388 . 090  
4 1 5 . 7 28  
388 . 2 5 5  
300 . 908 
306 . 408 
298 . 403  
278 . 497  
295 . 205  
325 . 0 14 
362 . 504 
335 . 267  
340 . 666  
346 . 860 
368 . 837 
3 1 8 . 2 3 2  
1 7 . 2  
1 7 . 1  
1 6 . 3  
1 7 . 1  
1 6 . 9  
1 7 . 7  
1 7 . 5  
1 7 . 2  
1 4 . 3  
1 6 . 5  
1 7 . 8  
1 7 . 5  
1 5  . 1 · 
1 6 . 7  
1 7 . 4  
1 5 . 9  
1 7 . 3  
1 7 . 7  
1 5 . 3  
1 6 . 0  
1 6 . 4  
1 7 . 5  
1 7 . 3  
1 7 . 2  
1 7  . o  
1 6 . 8  
. 1 6 . 0  
1 7 . 0  
1 8 . 1  
1 7 . 3  
1 7 . 5734 
1 7 . 6762 
22 . 7 237 
1 8 . 3 282  
18 . 3 252  
1 5 . 5373  
19 . 1 1 27 
17 . 7895 
19 . 8379  
1 7 . 4 1 8 1  
1 9 . 8345 
2 1 . 4487  
23 . 3 8 1 0  
1 9 . 38 1 0  
2 1 . 4295  
1 9 . 4 7 7 7  
2 1 . 2670  
1 9 . 4566  
17 . 3 268 
18 . 0398 
16 . 4668 
15 . 0070 
1 5 . 68 1 7  
1 7 . 5734 
1 9 .3 833 
1 7 . 4020 
18 . 7366  
18 . 363 2 
1 9 . 847 9 
16 . 6842 
1 9 S  
Experiment #2 , Study 2 
Appendix Table 33 . ( continued ) 
Hemo-
Genotype- RBC G6PDH globin G6PDH 
...;..S..;;..ex�--�M=o..::;u..;;..s e.;::__# _ A=i.L--_�A.�.f _  ___;;,;;A;....__(.!.,:;x:..:l�Q 6 lmm3 ) ( U I 1 0 1 2  RBC) ( gl dL ) ( U I g Hb) 
AYIAW 
1 3  
1 4  
I S  
1 6  
1 7  
1 8  
1 9  
20  
2 1  





. 24 1 
. 1 96 
. 2 9 7  
. 2 7 6  
. 2 S9 
.3 26 
. 2 7 9  
. 2 7 7  
. 342  
.40 1 
After DHEA Treatment 
. 6 1 4  
. 602  
. 489  
. 4 1 8  
. S42  
. S 1 2  
. SO l  
. 608 
. SS 1  
. S l 8  
. 64 9  
. 703 
. 2 62 
. 2 63 
. 248 
. 222  
. 24S  
. 236 
. 2 42  
. 2 82 
. 2 7 2  
. 24 1  
. 307  
. 302 
9 . 47 
9 . 6S  
8 . 82 
8 . 1 6  
9 . 1 4 
9 . 7 6 
8 . 94 
9 . 86  
8 . 69 
8 . 9S  
10 . 2S 
10 . 1 3 
342 . 7 26  
337 . 6 1 7  
348 . 3 20 
337 . 02 2  
332 . 0S9  
299 . S42  
33S . 3 3 1  
3S4 . 29 7  
387 . 744  
333 . S7 2  
37 1 .03 1 
369 . 3 1 2  
1 7 . 9  
1 7 . S  
1 S . 9  
l S . S  
1 7 . 2  
18 . 0  
16 . 3  
1 8 . 3  
1 6 . 2  
1 6 . 2  
1 7 . 8  
18 . 1  
1 8 . 1 3 1 9  
1 8 . 6 1 7 2  
1 9 . 3 2 1 9  
1 7 . 7426 
1 7 . 64SS  
1 6 . 24 1 8  
18 . 3 9 18 
1 9 . 089S  
20 . 7993  
18 . 4288 
2 1 . 36SS  
20 . 66.92  
1 96 
Experiment #2 , Study 2 
Appendix Table 34 . Change in Absorbance at 340 nm , Red Blood Cell 
Count , Hemoglobin Concent rat ion and Calculated 
G6PDH Activities During DHEA Treatment for Each 
Mouse ( 90-day-olds -- (Adult s )  on 0 . 1 %  DHEA) . 
Hemo-
Genotype- RBC G6PDH globin G6PDH 







3 1  
3 2  
3 3  
34  
3 5  
3 6  
3 7  
3 8  
39  
40 















. 2 79 
. 3 7 9  
. 3 2 2  
. 3 6 6  
. 3 6 2  
. 3 8 1  
. 3 4 1  
. 3 1 6  
. 3 59  
. 407  
. 34 9  
. 3 1 8  
. 387  
. 437  
. 4 1 4  
. 3 7 3  
. 3 58 
. 302  
. 3 1 7  
. 469  
. 4 23 
. 385 
. 2 1 6  
. 2 6 2  
. 303  
. 2 8 1  
. 2 92 
. 342  
. 264  
Before DHEA Treatment 
. 6 1 7  
. 524 
. 637  
. 57 2  
. 648 
. 640 
. 67 7  
. 637 
. 582  
. 69 1  
. 73 3  
. 63 3  
. 64 1  
. 700 
. 7 99  
. 7 58 
. 697  
. 6 58 
. 627  
. 640 
. 840 
. 7 57  
. 804 
. 497  
. 269  
. 245  
. 258  
. 250  
. 282  
. 278  
. 296 
. 296 
. 266  
. 332  
. 3 26 
. 2 84 
. 3 23 
. 3 1 3  
. 36 2  
. 344 
. 3 24 
. 300 
. 3 25 
. 3 23 
. 37 1  
. 334 
. 4 1 9  
. 28 1  
8 . 96 
7 . 86 
8 . 7 5 
8 . 6 1  
8 . 85 
8 . 62 
9 . 08 
8 . 26 
7 . 99 
8 . 44 
8 � 5 3 
8 . 29  
8 . 1 3 
8 . 1 8 
8 . 87  
8 . 89 
8 . 43 
8 . 7 1  
8 . 58 
8 . 60 
9 . 1 2 
8 . 86 
8 . 1 8  
7 . 68 
During DHEA Treatment 
. 528 
. 57 5  
. 52 2  
. 5 58 
. 627 
. 5 5 1  
. 266  
. 2 7 2  
. 24 1  
. 26 6  
. 285 
. 287 
9 . 20 
9 . 1 9 
9 . 1 8  
9 . 0 1  
9 . 7 7  
8 . 98 
37 1 . 9 12 
386 . 13 5  
365 . 264  
359 . 693  
394 . 73 1  
399 . 5 1 5  
403 . 833  
443 . 923  
4 1 2 . 4 1 1 
487 . 2 94  
473 . 4 39  
424 . 384 
492 . 1 6 1  
474 . 009 
505 . 569  
47 9 . 350  
47 6 . 1 1 6 
426 . 67 7  
469 . 23 6  
465 . 264  
503 . 93 5  
466 . 99 1  
634 . 536  
453 . 25 3  
358 . 1 70 
366 . 648  
325 . 2 1 5  
365 . 7 2 3  
36 1 . 3 6 5  
395 . 9 1 4 
1 7 . 2  
1 5 . 6  
16 . 8  
1 6 . 3  
1 7 . 3  
16 . 7  
1 7 . 4  
16 . 1  
16 . 0  
1 6 . 0  
1 6 . 9  
1 6 . 4  
1 5 . 8  
1 6 . 6  
1 7 . 2  
1 6 . 7  
16 . 8  
1 7  . o  
1 6 . 9  
1 6 . 2  
18 . 1  
1 7 . 6  
16 . 5  
1 5 . 1  
1 6 . 7  
1 7 . 5  
1 7 . 0  
1 7 . 0  
1 8 . 0  
16 . 6  
1 9 . 3740 
1 9 . 4553  
1 9 . 0242 
18 . 9998  
20 . 1 929  
20 . 6 2 1 7  
2 1 . 0736  
22 . 7 7 52 
20 . 5948 
25 . 7048 
23 . 89 6 1  
2 1 . 452 1 
25 . 3 245 
23 . 3 578 
26 . 07 2 1  
25 . 5 1 7 5  
23 . 8908 
2 1 . 8609 
23 . 8228 
24 . 6992  
25 . 3 9 1 6  
23 . 508 7  
3 1 . 4 5 76  
23 . 0529  
1 9 . 7 3 1 5  
1 9 . 2542 
1 7 . 56 1 6  
19 . 3833  
1 9 . 6 1 4 1  
2 1 . 4 1 7 5  
1 9 7  
Experiment # 2 , Study 2 
Appendix Table 34 . ( cont inued ) 
Heme-
Genotype- RBC G6PDH globin G6PDH 




3 1  
3 2  
3 3  
3 4  






4 1  
4 2  
43  
44  
4 5  
4 6  
4 7  
4 8  
2 5  
2 6  




3 1  
3 2  
3 3  
34  
35  
3 6  
. 2 95  
. 3 1 5  
. 2 7 6  
. 249  
. 2 8 7  
. 2 8 7  
. 3 4 7  
. 2 5 4  
. 3 3 2  
. 305  
. 2 96 
. 266  
. 2 7 6  
. 2 84 
. 27 8  
. 2 33 
. 282  
. 2 28  
. 239  
. 2 7 2  
. 2 7 5  
. 23 9  
. 2 84 
. 2 78 
. 2 5 7  
. 269  
. 243  
. 259  
. 2 5 1 
. 2 89 
During DHEA Treatment 
. 58 1  
. 57 2  
. 5 1 6 
. 5 1 1 
. 52 1  
. 53 1  
. 639  
. 508 
. 604  
. 56 9  
. 538 
. 54 7  
. 57 3  
. 57 4  
. 554  
. 509 
. 6 52 
. 538 
. 286 
. 257  
. 240 
. 262  
. 234 
. 244  
. 292  
. 254  
. 27 2  
. 264 
. 242  
. 28 1  
. 2 97  
. 2 90 
. 2 76  
. 2 7 6  
. 3 70 
. 3 1 0 
9 . 1 1  
9 . 5 1  
8 . 7 1  
8 . 85 
8 . 84  
8 . 92 
9 . 6 6  
8 . 75 
9 . 66 
8 . 99 
8 . 79 
8 . 53 
8 . 35 
8 . 4 7  
8 . 3 2  
7 . 9 5 
8 . 1 8 
7 . 46  
After  DHEA Treatment 
. 48 1  
. 520 
. 5 1 6  
. 47 1  
. 589 
. 62 1  
. 52 1  
. 543  
. 482  
. 52 2  
. 523 
. 57 8  
. 24 2  
. 248  
. 24 1  
. 23 2  
. 305  
. 343  
. 2 64 
. 2 74 
. 2 39 
. 2 63 
. 2 72  
. 289 
9 . 2 1  
8 . 95  
9 . 59  
9 . 04 
9 . 35  
10 . 42 
9 . 33 
8 . 94 
8 . 73 
9 . 3 1  
8 . 59 
9 . 09 
388 . 905 
334 . 7 7 1  
34 1 . 34 1  
366 . 7 36 
327 . 9 13 
338 . 860 
374 . 456  
359 . 60 1  
348 . 809  
363 . 78 1  
34 1 . 053 
408 . 08 7  
440 . 62 1  
424 . 14 1  
4 1 0 . 943 
430 . 068  
560 . 330 
5 1 4 . 7 7 6  
325 . 500 
343 . 26 1  
31 1 . 3 1 1 
3 1 7 . 9 18 
404 . 09 5  
5 1 1 . 206 
350 . 524 
37 9 . 67 2  
339 . 1 40 
349 . 947  
39 2 . 258 
393 . 849 
1 6 . 
1 7 . 5  
1 6 . 7  
16 . 2  
1 7 . 1  
1 7  . o  
18 . 1  
16 . 6  
18 . 1  
16 . 7  
1 6 . 8  
1 6 . 5  
1 6 . 6  
16 . 2  
1 6 . 7  
16 . 2  
16 . 7  
1 5 . 2  
1 6 . 8  
1 6 . 9  
1 7 . 9  
16 . 9  
1 7 . 1  
1 7 . 6  
1 7 . 2  
1 6 . 8  
16 . 8  
16 . 9  
16 . 6  
16 . 7  
2 1 . 0888 
1 8 . 1 924 
1 7 . 8029 
20 . 0347 
1 6 . 95 1 8  
1 7 . 7802 
1 9 . 9848 
18 . 9549 
1 8 . 6 1 60 
1 9 . 583 2 
1 7 . 8444 
2 1 . 0969  
22 . 1 638 
22 . 1 7 58 
20 . 4733  
2 1 . 1 052 
27 . 446 1 
25 . 2647 
17 . 8444 
18 . 1 786  
16 . 6786  
1 7 . 0058 
22 . 0953 
30 . 2657  
1 9 . 0 1 3 9 
20 . 2040 
17 . 6232 
19 . 2 7 8 1  
20 . 29 8 1  
2 1 . 4 37 6 
1 99 
Experiment #2 , Study 2 
Appendix Table 35 . Change in Absorbance at 340 nm, Red Blood Cell 
Count , Hemoglobin Concent rat ion and Calculated 
G6PDH Activities During DHEA Treatment for  Each 
Mouse ( 90-day-olds -- (Adults ) on 0 . 2 %  DHEA) . 
Hemo-
Genotype- RBC G6PDH globin G6PDH 




5 1  
5 2  
5 3  
5 4  
55 
56  




6 1  
6 2  
6 3  
64  
65  
6 6  
6 7  
6 8  
69  
70  
7 1  
7 2  
49  
so  
' 5 1  
5 2  
5 3  
54  
. 356  
. 342  
. 3 7 6  
. 2 9 2  
. 3 68  
. 3 90 
. 3 59  
. 3 28 
. 2 9 7  
. 3 7 7  
. 3 8 7  
. 4 1 0  
. 384  
. 3 9 1  
. 3 23 
. 3 97 
. 402  
. 3 58 
. 3 5 1  
. 467  
. 580 
. 386  
. 4 39 
. 3 7 9  
. 2 6 9  
. 2 9 5  
. 2 34  
. 2 80 
. 2 4 1  
. 306 
Before DHEA Treatment 
. 62 1  
. 593  
. 639 
. 5 78  
. 6 53 
. 709 
. 67 1  
. 6 1 1  
. 589 
. 653 
. 679  
. 745  
. 682 
. 73 3  
. 647  
. 726  
. 7 1 4  
. 67 4  
. 656 
. 836  
. 785  
. 7 23  
. 7 58 
. 7 35 
. 26 5  
. 2 5 1  
. 26 3  
. 286  
. 285 
. 3 1 9  
. 3 1 2 
. 283 
. 2 92  
. 2 7 6  
. 292  
. 3 35  
. 2 98 
. 342  
. 3 24 
. 3 29 
. 3 1 2  
. 3 1 6  
. 305  
. 369  
. 205  
. 3 37 
. 3 1 9  
. 3 56 
8 . 53 
8 . 37 
8 . 66 
7 . 98  
8 . 59 
8 . 78 
8 . 6 7  
8 . 33 
8 . 25 
8 . 7 7 
8 . 6 1  
8 . 87 
7 . 45 
8 . 58 
8 . 58 
8 . 8 1  
8 . 50 
8 . 22 
8 . 1 4  
9 . 4 1  
8 . 66 
8 . 36  
8 . 95 
8 . 70 
During DHEA Treatment 
. 480 
. 53 1  
. 4 36 
. 523  
. 449 
. 53 5  
. 2 1 1  
. 236  
. 202  
. 24 3  
. 208 
. 2 29  
8 . 93 
8 . 9 2 
9 . 3 2  
9 . 1 7 
8 . 84 
8 . 80 
384 . 85 1  
37 1 . 48 7  
37 6 . 2 1 3 
443 . 97 5  
4 1 1 . 005  
450 . 08 2  
445 . 79 1  
420 . 85 9  
438 . 454  
389 . 85 7  
420 . 1 2 2  
467 . 86 1  
495 . 5 1 4  
493 . 78 1  
467 . 79 3  
462 . 6 1 1 
454 . 707  
47 6 . 224  
464 . 1 64  
485 . 77 2  
293 . 24 6  
499 . 36 6  
441 . 53 3  
506 . 905  
292 . 703  
327 . 7 50 
268 . 4 9 2  
328 . 2 7 1 
29 1 . 4 79  
322 . 36 5  
1 6 . 3  
1 6 . 1  
16 . 2  
1 5 . 1  
1 6 . 8  
1 6 . 5  
1 6 . 7  
1 5 . 5  
1 5 . 8  
1 7 . 0  
1 7 . 4  
1 6 . 9  
1 4 . 3  
1 7 . 3  
1 7 . 0  
1 7  . o  
1 6 . 5  
16 . 2  
1 5 . 8  
1 8 . 4  
1 6 . 7  
1 7 . 0  
1 7 . 4  
1 6 . 8  
1 6 . 2  
1 6 . 2  
1 7 . 6  
1 6 . 2  
1 6 . 2  
1 6 . 7  
20 . 1 3 9 7  
1 9 . 3 1 27 
20 . 1 1 1 1  
23 . 463 1 
2 1 . 0 1 5 1  
23 . 9498 
23 . 1 438 
22 . 6 1 78 
22 . 8940 
20 . 1 1 20  
20 . 7888 
24 . 5 5 58 
25 . 8 1 52 
24 . 4893  
23 . 6098 
23 . 97 4 1  
23 . 4243  
24 . 1 639  
23 . 9 1 3 2  
24 . 8430 
1 5 . 2066  
24 . 5 57 1 
22 . 7 1 10 
26 . 2 504 
16 . 1 348 
18 .0465 
14 . 2 1 7 9  
18 . 58 18  
1 5 . 9054 
16 . 9869 
200 
Experiment #2 , Study 2 
Appendix Table 35 . ( continued ) 
Hemo-
Genotype- RBC G6PDH globin G6PDH 









6 1  
6 2  
6 3  
6 4  
6 5  





7 1  
7 2  
49 
so  
5 1  
5 2  
5 3  







. 2 94 
. 2 26  
. 2 70 
. 3 24 
. 2 59  
. 2 74 
. 2 86 
. 2 7 1  
. 3 68 
. 1 46 
. 2 64 
. 3 1 7  
. 2 38  
. 2 93  
. 2 5 1 
. 282  
. 24 9  
. 3 1 8  
. 2 8 1  
. 2 42  
. 27 4  
. 2 3 3  
. 284 
.304 
. 2 98 
. 2 7 4  
. 2 9 6  
. 348  
. 278  
. 2 5 1  




. 567  
. 46 2  
. 48 7  
. 5 1 9  
. 57 9  
. 607  
. 37 5  
. 486 
. 56 3  
. 459  
. 5 1 8  
. 508 
. 5 1 2  
. 456  
. 56 2  
. 2 14 
. 2 28 
. 2 10 
. 243  
. 203 
. 2 13 
. 233  
. 308 
. 239  
. 229  
. 222  
. 246 
. 22 1  
. 225  
. 2 57 
. 23.0 
. 207  
. 244 
8 . 30 
8 . 30 
8 . 5 5  
8 . 8 1  
8 . 64 
8 . 45 
8 . 70 
7 . 42 
8 . 83 
6 . 8 1  
8 . 89 
8 . 99 
8 · 52 
8 . 3 1  
8 . 7 2 
8 . 63  
8 . 54  
9 . 34  
After DHEA Treatment 
. 582  
. 546  
. 5 97  
. 5 52  
. 6 60 
. 6 60 
. 664 
. 6 26  
. 642  
. 683  
. 590  
. 54 1  
. 30 1  
. 304 
. 323 
. 3 1 9  
. 3 7 6  
. 356 
. 366  
. 3 52 
. 346  
. 335  
. 3 1 2 
. 2 90 
9 . 00 
9 . 2 7 
9 . 1 1  
9 . 44 
8 . 7 3 
9 . 49 
8 . 77 
9 . 00 
9 . 20  
9 . 3 1  
9 . 1 2 
8 . 83 
3 1 9 . 3 97 
340 . 292  
304 . 263  
34 1 . 685 
29 1 . 05 7  
3 1 2 . 262  
33 1 . 7 6 6  
5 1 4 . 2 1 2 
335 . 299  
4 1 6 . 566  
309 . 348 
338 . 9 78 
3 2 1 . 3 28 
335 . 4 1 1 
36 5 . 1 00 
330 . 1 5 1  
300 . 26 7  
323 . 62 2  
41 4 . 304 
406 . 246  
439 . 2 1 8  
4 1 8 . 6 1 4 
533 . 543  
464 . 707 
5 1 6 . 984 
484 . 502 
465 . 890 
445 . 749  
423 . 795  
406 . 849 
16 . 5  
1 5 . 7  
1 6 . 2  
1 6 . 5  
1 6 . 4  
1 6 . 0  
1 6 . 3  
1 6 . 4  
1 7 . 1  
1 4 . 4  
1 7 . 1  
1 7 . 2  
1 6 . 3  
16 . 7  
1 5 . 8  
16 . 9  
15 . 8  
1 7 . 0  
1 7 . 4  
1 7 . 4  
1 7 . 9  
1 7 . 1  
1 6 . 9  
1 7 . 4  
1 7 . 2  
1 7 . 1  
1 7 . 9  
1 7 . 6  
1 7 . 7  
1 7 . 2  
1 6 . 0667  
1 7 . 9900 
1 6 . 0583 
18 . 2439  
1 5 . 3337  
1 6 . 49 1 3  
1 7 . 7078  
23 . 2 650 
1 7 . 3 140  
1 9 . 7001  
16 . 0825  
1 7 . 7 1 7 5  
16 . 7958 
16 . 6902 
20 . 1 498 
16 . 8592  
16 . 2296  
17 . 7 802 
2 1 . 4295  
2 1 . 64 3 1  
22 . 3 535  
23 . 1 095  
27 . 56 1 1 
25 . 3452  
26 . 3 602 
25 . 5001 
23 . 9452 
23 . 5 79 1. 
2 1 . 8362 
20 . 8865 
201 
Experiment #2 , Study 2 
Appendix Table 35 . ( continued ) 
Hemo-
Genotype- RBC _ G6PDH globin G6PDH 
_S_ex ____ M_o_u_se..;...._II __ Ai"'-- -A"'-f- �A;.....__(=x�1�06 I mm3 ) ( U I 1 0 1 2  RBC ) ( g I dL) ( U I g Hb ) 
6 1  








7 0  
7 1  
7 2  
. 3 6 5  
. 2 7 3  
. 2 5 1  
. 3 26 
. 2 7 6  
. 267  
. 204  
. 242  
. 266  
. 22 2  
. 1 59  
. 208 
After DHEA Treatment 
. 7 28 
. 6 1 7 
. 564 
. 695  




. 639  
. 528  
. 486 
. 5 1 2  
. 36 3  
. 344  
. 3 1 3  
. 36 9  
. 3 1 1 
. 383 
. 344  
. 3 26 
. 3 7 3  
. 306 
. 3 27 
. 304 
9 . 70 
8 . 94 
8 . 66 
9 . 07  
9 . 1 2 
8 . 98 
8 . 2 5  
8 . 72 
8 . 9 2 
8 . 84 
8 . 59 
8 . 59  
463 . 58 6  
47 6 . 6 69 
447 . 7 36  
503 . 9 82  
42 2 . 4 36  
528 . 34 6  
5 1 6 . 53 5  
463 . 1 2 3  
5 1 8 . 0 1 2  
428 . 8 10 
47 1 . 5 7 4  
438 . 405  
1 7 . 6  
1 7 . 2  
1 6 . 4  
1 7 . 4  
1 7 . 4  
16 . 9  
1 6 . 0  
1 6 . 6  
1 6 . 4  
16 . 9  
1 5 . 9  
1 6 . 0  
25 . 5499 
24 . 7 757  
23 . 6426 
26 . 2 708 
22 . 1 4 1 5  
28 .0742  
26 . 6 3 39 
24 . 32 7 9  
28 . 1 7 48 
22 . 430 1 
25 . 47 69 
23 . 5369 
202 
Experiment #2 , Study 2 
Appendix Table 36 . Change in Absorbance at 340 nm , Red Blood Cell 
Count , Hemoglobin Concentration and Calculated 
G6PDH Ac tivit ies During DHEA Treatment for Each 
Mouse ( 90-day-olds -- (Adults )  on 0 . 4 %  DHEA) . 
Heme-
Genotype- RBC G6PDH globin G6PDH 





7 5  
7 6  
7 7  
7 8  
7 9  
80  
8 1  














9 6  
7 3  
7 4  
7 5  
7 6  
7 7  
7 8  
. 3 70  
. 3 6 1 
. 329  
. 40 1  
. 3 79  
. 3 50  




. 45 1 
. 366  
. 420 
. 4 50 
. 362  
. 380 
. 428  
. 347  
. 2 7 7  
. 346  
.309 
. 346  
. 3 2 1  
. 362  
. 209  
. 246  
. 2 2 7  
. 26 7  
. 282 
. 282 
Before DHEA Treatment 
. 642 
. 642  
. 602  
. 7 1 2 




. 7 1 8 
. 699  
. 802  
. 7 1 4 
. 7 30 
. 808 
. 706 
. 687  
. 7 64 
. 660 
. • 638 
. 6 5 1  
. 6 3 1  
. 662  
. 6 1 9 
. 6 58 
. 2 7 2  
. 28 1  
. 2 73  
. 3 1 1 
. 278  
. 289 
. 3 2 1  
. 306 
. 332 
. 3 10 
. 3 5 1  
. 348 
. 3 1 0 
. 3 58 
. 344 
. 307 
. 3 36 
. 3 1 3  
. 3 6 1  
. 305 
. 3 2 2  
. 3 1 6  
. 298 
. 296 
9 . 03 
9 . 04 
8 . 6 5  
8 . 93  
8 . 34  
8 . 7 6  
6 . 83 
8 . 69 
8 . 99 
9 . 02  
9 � 05  
8 . 60 
8 . 82 
8 . 93  
8 . 30 
8 . 38 
9 . 1 8 
8 . 90 
7 . 7 1  
8 . 82 
8 . 30 
9 . 1 0 
8 . 3 7  
8 . 98 
During DHEA Treatment 
. 4 5 7  
. 4 58 
. 468 
. 530 
. 5 39 
. 5 1 0 
. 248 
. 2 1 2  
. 24 1  
. 263 
. 2 5 7  
. 2 28 
8 . 6 7  
9 . 03 
8 . 86 
8 . 9 1  
8 . 92  
8 . 7 7  
37 3 . 144  
385 . 064 
390 . 969 
431 . 424 
4 1 2 . 928 
408 . 686 
582 . 2 10 
436 . 2 1 2  
457 . 482  
425 . 746  
480 . 457  
501 . 27 5  
435 . 400 
496 . 623 
5 1 3 . 4 24 
453 . 827  
453 . 4 1 1 
435 . 662  
580 . 02 7  
428 . 378  
480 . 588  
430 . 1 7 1  
441 . 049 
408 . 330 
354 . 34 7  
290 . 833 
336 . 960 
365 . 6 57 
356 . 9 1 4 
322 . 056 
16 . 2  
16 . 8  
16 . 5  
1 6 . 6  
16 . 7  
16 . 4  
14 . 2  
16 . 3  
1 6 . 7  
1 6 . 7  
1 7 . 5  
1 5 . 9  
1 7 . 0  
1 7 . 9  
1 6 . 1  
1 6 . 5  
1 7 . 5  
1 6 . 3  
14 . 9  
1 6 . 7  
16 . 0  
1 7 . 0  
16  . o  
16 . 6  
16 . 1  
16 . 6  
16 . 1  
16 . 4  
16 . 7  
16 . 2  
20 . 7993  
20 . 7 20 1 
20 . 4962 
23 . 2085 
20 . 6 2 1 7  
2 1 . 8 298 
28 . 0035 
23 . 2 557  
24 . 6 273  
22 . 9954 
24 . 8465 
27 . 1 1 30 
22 . 5896 
24 . 7 757  
26 . 4684 
23 . 0489 
23 . 7 847  
23 . 78 7 7  
30 . 0 1 3 5 
22 . 6 245 
24 . 9305 
23 . 0268 
23 . 0724  
22 . 0892 
19 . 08 1 9  
15 . 8206 
18 . 5433 
19 . 8659 
1 9 . 0639 
1 7 . 4347  
203 
Experiment #2 , Study 2 
Appendix Table 36 . ( cont inued)  
Hemo-
Genotype- RBC G6PDH globin G6PDH 










8 6  












7 5  
7 6  








. 2 4 1  
. 1 93 
. 269  
. 26 6  
. 2 5 7  





. 3 1 6  
. 2 94  
. 2 5 1 
. 2 3 9  
. 1 98 
' . 1 92 
. 224 
. 2 1 2  
. 2 1 6  
. 2 94 
. 248  
. 3 30 
. 333  
. 3 33 
. 2 8 7  
. 2 5 6  
. 336  
. 3 5 1  
. 3 29 
. 2 69  
During DHEA Treatment 
. 4 74  
. 3 93  
. 5 1 1  
. 4 7 1 
. 480 
. 442  
. 536  
. 593  
. 6 57 
. 543  
. 569  
. 548 
. 5 1 2  
. 4 6 1  
. 439 
. 4 1 6  
. 459  
. 4 1 1 
. 233  
. 200 
. 24 2  
. 205  
. 2 23 
. 206 
. 234 
. 256  
. 308 
. 242  
. 253 
. 254  
. 2 6 1  
. 2 22  
. 24 1  
. 224  
. 235 
. 1 99 
8 . 38  
8 . 44 
8 . 5 1  
8 . 6 1  
8 . 4 1  
8 . 3 2  
9 .05  
9 . 34  
9 .48  
9 . 07  
9 . 8 1  
9 . 48  
8 . 8 1  
9 . 00 
7 . 89 
9 . 1 7 
8 . 9 1  
9 . 1 3 
After  DHEA Treatment 
. 4 98 
. 580 
. 5 56 
. 678  
. 703 
. 649 
. 6 1 3 
. 54 1  
. 6 58 
. 67 5  
. 637  
. 582  
. 282  
. 2 86 
. 308 
. 348  
. 3 70 
. 3 1 6  
. 3 26 
. 285 
. 3 22 
. 3 24 
.308 
. 3 1 3  
9 . 40 
9 . 2 1  
8 . 97 
8 . 88 
8 . 7 5 
9 . 08 
9 . 23 
8 . 74 
9 . 02  
9 . 42  
8 . 94 
8 . 95 
344 . 435 
293 . 55 1  
352 . 2 7 5  
294 . 949 
328 . 4 7 7  
306 . 7 18 
320 . 304  
339 . 538 
402 . 474  
330 . 52 5  
3 1 9 . 48 3  
331 . 9 10 
366 . 99 5  
305 . 56 7  
378 . 3 8 7  
302 . 604 
326 . 7 28 
270 . 009  
37 1 . 635 
384 . 682  
425 . 3 5 7  
485 . 469  
523 . 829  
43 1 . 1 1 9 
437 . 534 
403 . 95 1  
442 . 227  
426 . 07 9  
426 . 785  
433 . 228 
16 . 1  
1 5 . 8  
1 6 . 2  
1 6 . 6  
16 . 2  
1 6 . 1  
1 7 . 9  
1 7 . 9  
1 7 . 8  
1 7 . 3  
1 7 . 6  
1 7 . 3  
1 6 . 9  
1 6 . 2  
1 5 . 1  
1 5 . 7  
1 6 . 0  
1 6 . 1  
1 6 . 7  
1 7 . 3  
1 6 . 8  
1 7 . 0  
1 7 . 0  
1 7 . 0  
16 . 5  
1 6 . 2  
1 6 . 6  
1 7 . 7  
1 7  . 1  
1 6 . 1  
1 7 . 9 277  
1 5 . 6808 
18 . 5053 
1 5 . 2982  
1 7 . 0524 
1 5 . 8503 
16 . 1 942  
1 7 . 7 1 6 7  
2 1 . 435 1 
1 7 . 3 28 7  
1 7 . 80 7 5  
1 8 . 1 8 79  
1 9 . 1 3 1 5  
1 6 . 9 7 59 
1 9 . 7 7 1 3  
1 7 . 6744  
1 8 . 1 946 
1 5 . 3 1 1 7 
20 . 9 1 84 
20 . 4793  
22 . 7 1 10 
25 . 3586 
26 . 96 1 8  
23 . 0268 
24 . 4754  
2 1 . 7 934 
24 . 0294 
22 . 6 760 
22 . 3 1 26  
24 . 0832  
2{)4 
Experiment #2 , Study 2 
Appendix Table 36 . ( continued ) 
Hemo-
Genotype- RBC G6PDH · globin G6PDH 




8 7  







9 5  
9 6  
. 34 1  
. 330 
.384 
. 36 1 
. 328  




. 306  
. 3 3 1  
. 2 7 7  
After  DHEA Treatment 
. 639  
. 639 
. 797  
. 704 




. 67 9  
. 637  
. 650 
. 594  
. 2 98 
. 309 
. 4 1 3  
. 343 
. 3 26 
. 3 29 
. 3 36 
. 302  
. 336  
. 3 3 1  
. 3 1 9  
. 3 1 7  
9 . 2 1  
9 . 24 
9 . 45 
9 . 34 
9 . 7 7 
9 . 07 
8 . 94 
8 . 58 
9 . 2 1  
9 . 45 
8 . 70 
9 . 1 3  
400 . 823 
4 1 4 . 269  
54 1 . 395  
454 . 9 28 
4 13 . 3 5 1  
449 . 349 
465 . 583 
436 . 02 9  
45 1 . 934 
433 . 902 
454 . 2 2 1  
430 . 1 1 4 
1 7 . 6  20 . 9 749 
1 7 . 0  22 . 5 1 6 7  
1 7 . 9  28 . 5820 
1 7 . 8  23 . 8 7 1 0  
1 9 . 7  20 . 4997  
16 . 8  24 . 2595  
1 7 . 4  23 . 92 13 
16 . 2  23 . 0934  
1 7  • 6 23 • 64 9 5 
1 7 • 3 23 • 7 0 1 6  
16 . 0  24 . 6983 
17 . 7  22 . 1 8 6 1  
205 
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Appendix Table 37 . Change in Absorbance at 340 nm, Red Blood Cell 
Count , Hemoglobin Concentration and Calculated 
G6PDH Act ivities  During DHEA Treatment for Each 
Mouse ( 90-day-olds -- (Young Adults )  on 0 . 0%  
DHEA) . 
Heme-
Genotype- RBC G6PDH globin G6PDH 










1 0  
1 1  
1 2  
1 3  
1 4  
1 5  
1 6  
1 7  
1 8  
1 9  
20  
2 1  









. 23 9  
. 2 83 
. 2 7 1 
. 2 84 
. 3 1 0  
. 343  
. 223  
. 2 99 
. 1 96 
. 2 84 
. 1 66 
. 307  
. 1 58 
. 238  
. 1 97 
. 3 2 7  
. 2 7 2  
. 2 74 
. 1 5 6  
. 233  
. 1 3 1  
. 2 7 6  
. 1 8 7 
. 2 94 
. 3 87  
. 4 22  
. 3 1 7  
. 426 
. 362  
. 3 1 9  
Before DHEA Treatment 
. 5 73  
. 6 1 8 
. 574  
. 5 7 7  
. 62 1  
. 649  
. 4 7 1 










. 5 57  
. 4 9 7  
. 5 7 5  
. 5 26  




. 335  
. 303 
. 293  




. 262  
. 223 
. 2 32 
. 24 1  
. 2 9 1  
. 2 79 
. 305 
. 2 9 7  
. 337  
. 283 
. 34 1  
. 342  
. 395  
. 340 
. 349 
. 369  
6 . 2 2  
7 . 69 
7 . 50  
7 . 62  
7 . 56  
8 .2 2  
6 . 3 1  
7 . 47  
6 . 66 
7 � 0 1  
6 . 84 
7 . 49 
8 . 03 
7 . 94 
7 . 9 1  
7 . 98 
7 . 94 
8 . 30 
6 . 94 
8 . 2 5  
7 . 23 
7 . 50  
6 . 82 
8 . 2 1  
During DHEA Treatment 
. 624 
. 7 59 
. 567  
. 692  
. 633 
. 565  
. 2 37  
. 337  
. 250  
. 266  
. 2 7 1  
. 246  
8 . 50 
8 . 89 
7 . 90 
8 . 6 5  
8 . 1 6 
7 . 89 
665 . 1 99  
539 . 6 52 
500 . 469  
476 . 3 30 
509 . 606 
46 1 . 1 53  
486 . 87 5  
43 1 . 1 7 0  
487 . 330 
394 . 07 8  
420 . 1 7 2  
398 . 594  
448 . 9 24 
435 . 2 9 1  
47 7 . 6 60 
46 1 . 0 5 1  
525 . 78 1  
422 . 3 8 1  
608 . 682  
5 1 3 . 532  
676 . 7 9 1  
56 1 . 582  
633 . 9 23 
556 . 7 74 
345 . 402 
469 •595  
392 . 020  
380 . 944 
4 1 1 . 4 1 0  
386 . 237  
1 5 . 5  
16 . 8  
1 5 . 9  
1 5 . 9  
1 6 . 2  
1 6 . 6  
1 4 . 5  
1 5 . 8  
1 4 . 4  
1 5 . 2  
1 4 . 8  
1 6 . 4  
1 4 . 0  
1 5 . 7  
14 . 6  
1 6 . 3  
1 5 . 8  
1 6 . 7  
1 4 . 6  
1 6 . 8  
14 . 7  
1 5 . 8  
14 . 7  
1 6 . 8  
18 . 3  
1 6 . 7  
1 5 . 7  
1 7 . 5  
16 . 5  
1 5 . 7  
26 . 6938 
24 . 70 1 9 
23 . 6070 
22 . 8 27 9  
23 . 78 1 6  
22 . 8354 
2 1 . 1 875  
20 . 385 1 
22 . 5390 
1 8 . 1 743  
1 9 . 4 1 88 
1 8 . 2041  
25 . 7490 
22 . 0 1 4 1  
25 . 8787  
22 . 5 7 1 7 
26 . 4222  
20 . 9926 
28 . 9332 
25 . 2 1 8 1  
33 . 28 7 1  
26 . 6 574 
29 . 4 106  
27 . 2090 
1 6 . 0433 
24 . 9982 
1 9 . 7259  
18 . 8295 
20 . 346 1 
1 9 . 4 1 02 
206 
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Appendix Table 37 . ( continued ) 
Heme-
Genotype- RBC G6PDH globin G6PDH 





1 0  
1 1  
1 2  
1 3  
1 4  
1 5  
1 6  




2 1  
2 2  
2 3  










1 0  
1 1  
' 1 2  
. 3 5 2  
. 3 52  
.306 
. 2 5 5  
. 3 1 9  
. 3 5 6  
. 3 2 9  
. 3 5 2  
.00 7  
. 356  
. 380 
. 3 74  
. 2 98 
. 2 5 1  
. 3 1 1  
. 3 5 7  
. 3 5 5  
. 3 7 1  
. 306 
. 2 1 5  
. 307  
. 2 9 2  
. 338  
. 2 5 1  
. 38 1 
. 359  
. 242  
. 2 85 
. 388 
. 343  
During DHEA Treatment 
. 6 1 7  
. 6 3 2  
. 6 1 8 
. 488 
. 606  
. 6 39  
. 283 
. 634 
. 2 97  
. 6 5 1  
. 6 53 
. 6 53 
. 6 1 2  
. 5 1 6  
. 62 1  
. 659  
. 648  
. 680 
. 26 5  
. 2 80 
. 3 1 2 
. 23 3  
. 287  
. 283 
. 283 
. 2 82 
. 290 
. 295  
. 2 7 3  
. 2 7 9  
. 3 1 4  
. 2 6 5  
. 3 10 
. 302 
. 2 9 3  
. 309 
8 . 36 
8 . 23 
8 . 1 1  
8 . 0 1  
8 . 05  
8 . 53  
7 . 10 
8 . 85 
6 . 80 
8 . 93 
9 . 03 
8 . 76 
8 . 95 
8 . 1 2 ' 
8 . 4 3  
8 . 4 5 
8 . 59 
8 . 89 
After DHEA Treatment 
. 54 3  
. 459  
. 5 29  
. 509 
. 548 
. 4 54 
. 630 
. 606 
. 464  
. 528  
. 6 59 
. 5 92  
. 2 37  
. 244 
. 2 2 2  
. 2 1 7  
. 2 10 
. 203 
. 249 
. 247  
. 2 22 
. 243  
. 2 7 1  
. 249 
9 . 08 
8 . 94 
9 . 7 3 
9 . 54 
9 . 1 5  
8 . 86 
9 . 43  
8 . 84 
8 . 65 
8 . 65  
9 . 1 1  
9 . 22  
392 . 67 7  
42 1 . 4 57  
476 . 5 73  
360 . 345  
441 . 6 53 
4 1 0 . 992  
493 . 7 69 
394 . 7 3 1  
528 .305  
409 . 2 2 9  
374 . 5 1 6 
394 . 544  
434 . 6 1 3 
404 . 283 
45 5 . 543  
442 . 7 37  
42 2 . 542  
430 . 578  
323 . 339 
338 . 1 02  
282 . 64 1  
28 1 . 7 7 8  
284 . 3 1 1  
283 . 830 
327 . 1 02  
346 . 1 3 1  
3 1 7 . 93 1  
348 . 005 
368 . 508 
334 . 5 52 
1 6 . 6  
1 6 . 6  
1 6 . 4  
1 6 . 0  
1 6 . 4  
1 7 . 0  
1 1 . 7  
1 7 . 3  
10 . 9  
1 7 . 2  
1 7 . 4  
1 7 . 2  
1 7 . 3  
1 5 . 7  
1 5 . 9  
1 6 . 7  
1 7 . 6  
1 7 . 3  
1 6 . 9  
16 . 2  
1 7 . 7  
1 7 . 2  
1 7 . 3  
16 . 2  
1 7 . 9  
1 7  . 1  
1 6 . 4  
16 . 4  
18 . 0  
1 7 . 8  
1 9 . 7 7 58 
20 . 89 5 1  
23 . 56 7 1 
18 . 0398  
2 1 . 6787  
20 . 6 2 2 1  
29 . 9637  
20 . 1 929 
32 . 9585 
2 1 . 2466 
1 9 . 4 36 1  
20 . 0942 
22 . 4843 
20 . 9094 
24 . 1 5 24 
22 . 4020 
20 . 62 29 
22 . 1 263 
1 7 . 3 7 23 
18 . 6582 
1 5 . 53 73  
15 . 6288 
15 . 0373  
15 . 5 230 
1 7 . 2 3 22 
1 7 . 8935 
16 . 7 689 
18 . 3 552 
1 8 . 6 506 
1 7 . 3 29 1  
207 
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Appendix Table 37 . ( continued ) 
Hemo-
Genotype- RBC G6PDH globin G6PDH 
_S_ex ____ M_o_u_se_II __ Ai"--__ A .... t _ _ A_(=x.;...1_06 I mm3 ) ( U I 1 0  1 2  RBC ) ( g I dL) ( U I g Hb) 
AYIAW 
1 3  
1 4  
1 5  
1 6  
1 7  
1 8  
1 9  
20  
2 1  
2 2  
2 3  
2 4  
. 0 76  
.2 9 1  
. 0 7 1 
. 2 88 
. 2 93 
.349 
. 3 73  
. 304 
.34 1 
. 34 1  
.303 
. 3 29 
After DHEA Treatment 
. 3 7 1 
. 528 
. 3 58 
. 53 2  
. 608 
. 603 
. 67 2  
. 5 7 1  
. 6 1 1 
. 6 1 4  
. 60 1  
. 603 
. 2 95  
. 237  
. 287  
. 244 
. 3 1 5  
. 254  
. 2 99 
. 2 6 7  
. 2 70 
. 27 3  
. 298 
. 274  
6 . 78 
9 . 30 
7 . 07 
8 . 86 
8 . 4 5  
8 . 70 
8 . 6 1  
9 . 00 
9 . 3 1  
8 . 80 
8 . 59 
9 . 0 1  
538 . 999  
3 1 5 . 690 
502 . 8 73 
34 1 . 1 5 5  
46 1 . 7 9 5  
36 1 . 668 
430 . 1 93 
367 . 5 06 
359 . 2 6 1 
384 . 305 
429 . 7 53 
37 6 . 72 2  
1 2 . 3  
1 7 . 5  
1 2 . 6  
1 6 . 4  
1 2 . 2  
1 7 . 4  
. 1 7 . 1  
1 7 . 3  
1 7 . 4  
16 . 8  
1 7 . 3  
1 7 . 5  
29 . 7 107  
1 6 . 7 7 67 
28 . 2 1 6 7  
1 8 .4307 
3 1 . 9850 
1 8 . 0834 
2 1 . 6606 
1 9 . 1 1 88 
1 9 . 2225  
20 . 1 302 
2 1 . 3 386 
1 9 . 3 958 
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Appendix Table 38 . Change in Absorbance at 340 nm, Red Blood Cell 
Count , Hemoglobin Concent ration and Calculated 
G6PDH Activities During DHEA Treatment for Each 
Mouse ( 90-day-olds -- (Young Adults )  on 0 . 1 % 
DHEA) . 
Hemo-
Genotype- RBC G6PDH globin G6PDH 







3 1  









4 1  













.3 1 3  
. 336 
. 2 5 1 
.3 1 9  
. 248 
. 3 28 
. 1 90 
. 2 7 2  
. 2 7 3  
. 2 86 
. 2 69  
. 2 8 2  






. 22 6  
. 2 5 9  
. 422  
. 438 
. 2 7 2  
. 399  
. 322  
. 3 56 
. 3 1 6  
.33 1 
. 302 
. 3 24 
Before DHEA Treatment 
. 648 
. 638 
. 57 8  
. 620 
. 558  
. 639  
. 4 7 1 
. 53 1  
. 56 7  
. 52 2  
. 534 
. 52 9  
. 5 1 2  
. 646  
. 648 
. 688 
. 865  
. 802  
. 599 
. 64 1  
. 8 7 6  
. 895  
. 669 
. 7 7 5  
. 335  
. 302  
. 327  
. 30 1  
. 3 10 
. 3 1 1 
. 2 8 1  
. 2 59 
. 2 94 
. 2 36 
. 2 6 5  
. 247  
. 300 
. 3 2 2  
. 302  
. 386  
. 407  
. 344 
. 37 3  
. 38 2  
. 454 
. 45 7  
. 39 7  
. 3 7 6  
7 . 50 
8 . 00 
7 . 1 7  
7 . 92 
7 . 75 
8 . 1 1  
6 . 8 1  
7 . 70 
7 . 28  
7 . 98 
7 . 7 6 
8 . 3 1  
7 . 40 
8 . 2 2  
8 . 38  
8 . 00 
9 . 42  
9 . 82  
7 . 45  
7 . 79  
9 . 3 2  
9 . 29  
8 . 23 
8 . 86 
During DHEA Treatment 
. 58 7  
. 6 1 4 
. 609 
. 58 7  
. 547  
. 57 2  
. 2 6 5  
. 258 
. 293  
. 256  
. 245 
. 248 
8 . 69 
8 . 89 
8 . 46  
8 . 9 2 
8 . 65  
8 . 67 
553 . 3 24 
467 . 64 1  
564 . 969  
470 . 800  
. 495 . 5 14 
47 5 . 045 
5 1 1 . 1 58 
41 6 . 68 2  
500 . 2 78 
366 . 357  
423 . 038 
368 . 207  
502 . 2 10 
485 . 266  
446 . 435 
597 . 7 1 3  
535 . 228 
433 . 953 
620 . 223 
607 . 4 65  
603 . 442  
609 . 3 9 1  
597 . 56 7  
525 . 7 1 4 
377 . 765  
359 . 5 1 2  
429 . 035  
355 . 525  
350 . 8 70 
354 . 347  
1 5 . 6  
16 . 8  
I S  . 3  
1 6 . 6  
16 . 2  
1 6 . 4  
1 4 . 6  
1 5 . 8  
1 5 . 4  
1 6 . 1  
1 6 . 4  
1 6 . 5  
15 . 6  
16 . 9  
1 7 . 2  
16 . 4  
1 9 . 0  
1 9 . 8  
16  . o  
16 . 4  
18 . 6  
1 9 . 4  
1 7 . 4  
18 . 4  
1 6 . 7  
1 6 . 7  
16 . 3  
16 . 7  
1 6 . 3  
1 6 . 7  
26 . 602 1 
22 . 2 68 6  
· 26 . 4 7 60 
22 . 4623  
23 . 705 1 
23 . 49 1 6  
23 . 8424 
20 . 3067 
23 . 6495 
1 8 . 1 586 
20 . 0 1 6 9 
1 8 . 5442 
23 . 8228 
23 . 6029 
2 1 . 7 507 
29 . 1 567  
26 . 536 1 
2 1 . 52 23 
28 . 8792  
28 . 8 546 
30 . 2370  
29 . 1 8 1 7  
28 . 2 642  
25 . 3 143  
1 9 . 6 574 
1 9 . 1 38 1  
22 . 2677  
18 . 989 7  
18 . 6 1 98  
18 . 3963 
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Appendix Table 38 . ( cont inued ) 
Memo-
Genotype- RBC G6PDH globin G6PDH 
_S_ex ____ M_o_u_se_�-� __ A....._i __ A .. f _ _ A_.:..;;(x�1_06 lmm3 ) ( U I 1 0  1 2RBC ) (g/ dL ) ( U I g Hb) 
AYIAW 
3 1  









4 1  













3 1  
3 2  




. 338  
. 3 28 
.3 1 1  
. 268 
.336  
. 332  
. 2 5 1 
. 3 32  
. 3 54 
. 3 7 2  
. 367  
. 3 33 
. 3 1 9  
. 342  
. 363  
. 34 3  
. 4 1 0  
. 427  
. 2 94 
. 309 
. 3 23 
. 288 
. 2 9 1  
. 3 29 
. 3 7 2  
. 2 92 
. 2 8 1  
. 282  
. 2 7 9  
. 269  
During DHEA Treatment 
. 6 16 
. 647  
. 584 
. 508 
. 632  
. 637 
. 50 1  
. 59 1  
. 624  
. 6 56 
. 676  
. 629  
. 606 
. 648 
. 7 1 8  
. 678  
. 728 
. 767  
. 278  
. 3 1 9  
. 273  
. 240 
. 296 
. 305  
. 250 





. 2 87 
. 306  
. 35 5  
. 335 
. 3 1 8  
. 340  
8 . 44 
8 . 56 
8 . 4 1 
8 . 29 
8 . 49  
8 . 63 
8 . 7 1 
8 . 96 
9 . 1 4 
9 . 06 
8 . 96 
9 . 02 
8 . 46 
8 . 64 
8 . 74 
8 . 74  
9 . 59 
9 . 1 8 
After DHEA Treatment 
. 533 
. 539  
. 57 1  
. 52 1  
. 524  
. 59 1  
. 639  
. 57 1  
. 52 9  
. 5 1 7  







. 262  
. 267  




. 25 1  
9 . 03 
9 . 54 
9 . 3 1  
9 . 1 6  
8 . 88 
8 . 89 
8 . 59  
8 . 29 
8 . 34  
8 . 39  
8 . 72 
8 . 89 
408 . 035 
46 1 . 650 
402 . 1 26 
358 . 635  
43 1 . 896 
437 . 890 
355 . 564 
358 . 086 
36 5 . 943  
388 . 3 1 6  
427 . 2 1 5 
406 . 5 1 9  
420 . 249  
438 . 7 36 
503 . 1 67 
474 . 820 
4 1 0 . 7 7 5  
458 . 809 
327 . 873 
298 . 659 
329 . 988 
3 1 5 . 106  
325 . 04 1  
36 5 . 086  
385 . 047 
4 1 6 . 9 1 3 
368 . 367  
346 . 978 
33 1 . 005 
349 . 7 58 
16 . 4  
1 7  . o  
1 6 . 9  
1 5 . 9  
16 . 6  
1 6 . 9  
1 7  . o  
1 7 . 5  
1 7 . 5  
1 7 . 6  
1 7 . 3  
1 6 . 9  
1 6 . 8  
1 6 . 7  
1 6 . 8  
1 7 . 1  
1 8 . 3  
1 8 . 1  
1 6 . 6  
1 7 . 3  
1 7 . 1  
1 6 . 1  
16 . 2  
1 7 . 0  
1 7 . 0  
16 . 6  
16 . 5 
1 6 . 1  
1 6 . 2  
1 6 . 4  
20 . 9989 
23 . 2454 
20 . 0 1 1 1  
1 8 . 6986 
22 . 0892 
22 . 3568 
18 . 2 1 7 4  
18 . 3340 
1 9 . 1 1 27  
1 9 . 9895 
22 . 1 263 
2 1 . 6970 
2 1 . 1 626  
22 . 6987 
26 . 1 767  
24 . 2686 
2 1 . 5264 
23 . 2700  
1 7 . 8355 
16 . 4694 
1 7 . 9660 
1 7 . 9277  
1 7 . 8 1 7 1  
1 9 . 09 19  
1 9 . 4562 
20 . 8205 
18 . 6 1 9 3 
1 8 . 08 1 6  
1 7 . 8 1 7 1  
18 . 9594 
2 10  
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Appendix Table 38 . ( continued ) 
Hemo-
Genotype- RBC G6PDH globin G6PDH 






4 1  








. 2 96 
. 366  
. 36 1 
. 268  
. 2 74 
. 3 27  
. 3 58  
.235  
. 233  
. 3 29 
.34 1 
After DHEA Treatment 
. 603 
. 539  
. 642  
. 639  
. 525  
. 5 1 8 
. 638 
. 652 
. 527  
. 484 
. 6 1 5  
. 6 55 
. 26 1  
. 243 
. 27 6  
. 278  
. 25 7  
. 244 
. 3 1 1 
. 2 94 
. 2 92  
. 25 1  
. 286  
. 3 1 4 
8 . 9 7 
8 . 88 
9 . 07 
9 . 1 2 
8 . 33  
8 . 86 
8 . 96 
9 . 29  
9 . 43  
8 . 4 1  
9 . 22 
9 . 09  
360 . 449 
338 . 992  
37 6 . 962 
377 . 6 1 2  
382 . 1 94 
34 1 . 1 55  
429 . 980 
392 . 037 
383 . 590 
369 . 7 20 
384 . 26 5  
427 . 9 1 9  
1 6 . 9  
1 7 . 1  
1 7 . 7  
1 7 . 7  
1 5 . 9  
16 . 2  
1 7 . 0  
16 . 8  
17 . 9  
16 . 4  
1 7 . 2  
1 7 . 4  
1 9 . 1 3 1 5  
1 7 . 6038 
1 9 . 3 1 6 6  
19 . 4 56 6  
20 . 023 1 
18 . 6 58 2  
22 . 6625  
2 1 . 6 787  
20 . 208 1 
18 . 9594 
20 . 5 984 
22 . 35 5 1  
2 1 1  
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Appendix Table 39 . Change in Absorbance at 340 nm, Red Blood Cell 
Count , Hemoglobin Concent rat ion and Calculated 
G6PDH Activities  During DHEA Treatment for Each 
Mouse ( 90-day-olds -- (Young Adults )  on 0 . 2 %  
DHEA) . 
Heme-
Genotype- RBC G6PDH globin G 6PDH 
_;;;..S..;;;..ex� __ __;;,M;;..;;;o...:;;u.;:;..se�I _ _.:.;;A.._i _ __;:_;;A�f. _.......:.;;A;,._(.:..;;x;:.:l:..:...0 6 I mm3 ) ( U I 1 0  1 2RBc ) ( gl dL ) ( U I g Hb ) 
AYIAW 
49 
5 0  
5 1  
5 2  
5 3  
5 4  
5 5  
5 6  
5 7  
5 8  
59  
60  
6 1  
6 2  
6 3  
6 4  
65  
6 6  
6 7  
6 8  
6 9  
7 0  
7 1  
7 2  
49 
5 0  
5 1  
5 2  
5 3  
5 4  
. 233  
. 3 14 
. 22 1  
. 2 7 6  
. 3 1 2  
. 2 8 1  
. 283  
.3 1 2  
. 243 
. 2 23 
. 2 7 6  
. 26 9  
.30 1 
. 353  
. 290 
. 369  
. 2 7 1 
. 3 2 7  
. 1 9 1  
. 2 7 6  
. 304 
. 2 86 
.366  
. 3 50 
. 3 2 1  
. 3 4 1  
. 346  
. 3 14  
. 3 69 
. 3 1 3  
Before DHEA Treatment 
. 569  
. 633  
. 549 
. 608 
. 6 57 
. 6 1 5  
. 5 5 1  
. 593  
.490 
. 5 1 1  
. 54 1  
. 5 1 9  
. 683 
. 7 62  
. 632  
. 7 1 4  
. 556  
. 634 
. 54 1  
. 6 7 1  
. 689 
. 69 1  
. 7 74  
. 69 1  
. 336  
. 3 1 9  
. 3 28 
. 3 32 
. 345 
. 3 34 
. 268 
. 28 1  
. 247 
. 288 
. 26 5  
. 250 
. 382  
. 409 
. 342  




. 395  
. 385 
. 405  
. 408 
. 34 1  
7 . 8 1  
8 . 62 
7 . 1 9 
8 . 3 2  
7 . 6 1  
8 . 55 
7 . 56 
8 . 30 
7 . 5 1  
7 . 53 
7 . 90 
7 . 45 
8 . 00 
9 . 27 
8 . 44 
8 . 98  
8 . 1 5  
7 . 93  
6 . 98 
8 . 2 7  
8 . 1 5 
8 . 65 
8 . 42 
8 . 23 
During DHEA Treatment 
. 57 2  
. 62 7  
. 608 
. 638 
. 63 1  
. 565  
. 2 5 1  
. 286 
. 262  
. 3 24 
. 262  
. 25 2  
9 . 02 
8 . 44 
8 . 87 
8 . 72 
8 . 9 1  
8 . 68 
532 . 947 
458 . 436 
56 5 . 1 20 
494 . 3 23 
56 1 . 604 
483 . 923 
439 . 1 46 
4 1 9 . 396  
407 . 430 
473 . 7 98 
41 5 . 54 1  
4 1 5 . 699  
59 1 . 5 1 9  
546 . 562  
501 . 974 
475 . 925 
433 . 1 95 
479 . 580 
62 1 . 1 6 7  
591 . 68 1  
585 . 1 93  
580 . 009 
600 . 266  
5 1 3 . 27 5  
344 . 7 1 7  
4 1 9 . 778  
365 . 909 
460 . 282  
364 . 267  
359 . 647  
1 6 . 0  
1 6 . 9  
14 . 6  
1 6 . 5  
1 5 . 8  
1 6 . 5  
1 5 . 9  
1 6 . 7  
1 5 . 4  
1 5 . 7  
1 6 . 6  
1 5 . 1  
1 6 . 3  
1 8 . 1  
1 6 . 6  
1 7 . 5  
16 . 2  
16 . 6  
14 . 8  
1 7 . 1  
16 . 2  
1 7  . o  
1 7 . 7  
. 1 7 . 0  
1 6 . 5  
1 6 . 1  
1 6 . 8  
1 6 . 0  
1 6 . 2  
1 6 . 1  
26 . 0 145  
23 . 3830 
27 . 8302 
24 . 9258 
27 . 0494 
25 . 07 60 
20 . 880 1 
20 . 8442 
1 9 . 8688 
22 . 7242 
1 9 . 7 758 
20 . 509 7  
29 . 03 1 6  
_27 . 99 24 
25 . 52 1 9  
24 . 4 2 1 7  
2 1 . 7934 
22 . 9 100 
29 . 2956 
28 . 6 1 5 2  
29 .4402 
29 . 5 1 22 
28 . 5 550 
24 . 8486 
18 . 8445 
22 . 0057 
1 9 . 3 1 9 1  
25 . 0854 
20 . 0347 
1 9 . 3897  
2 12 
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Appendix Table 39 . ( cont inued ) 
Hemo-
Genotype- RBC G6PDH globin G6PDH 
...;;;.S...;;..ex .;;.._ __ �M=o...;;..;u...;;..se..;;:;.._I! _ ___;;,;;A ........ 1 _......;:;.;;A;.t.f._.......;;..;;A;.....__(.:.;:x�1�06 /mm3 ) (U/ 1 Q 1 2RBC ) (g/ dL) (U/ g Hb ) 
AY/AW 
55 
5 6  
5 7  





6 3  
6 4  
6 5  





7 1  
7 2  
49 
50 
5 1  





5 7  
5 8  
59  
60  
. 302  
. 3 24 
. 342  
. 3 6 1 
. 3 1 6  
. 2 84 
. 373  
.33 1 
. 36 1 
. 366  
. 334  
. 398  
. 337  
. 357  
. 343  
. 3 1 2  
.358  
. 352  
. 3 1 9  
. 2 90 
. 2 7 6  
. 2 80 
.306  
. 3 2 1  
. 3 29 
. 2 82 
. 2 5 1 
. 3 1 6  
. 3 27 
. 2 96 
During DHEA Treatment 
. 570 
. 574  
. 642  
. 66 2  
. 628  
. 570  
. 638 
. 683 
. 705  
. 64 4  
. 63 1  
. 702  
. 639  
. 660 
. 647  
. 606 
. 666  




. 30 1  
. 3 1 2  
. 286 
. 26 5  
. 3 52  
. 344  
. 2 78 
. 29 7  
. 304 
. 302  
. 303 
. 304 
. 2 94 
. 308 
. 277  
8 . 46  
9 . 02  
8 . 2 2  
8 . 7 7  
8 . 32 
8 . 1 8 
9 . 04 
8 . 78 
8 . 8 1  
9 . 4 3  
8 . 82 
8 . 39 
7 . 99 
8 . 7 2 
8 . 4 3  
8 . 1 0 
8 . 7 7 
9 . 04 
After DHEA Treatment 
. 564  
. 574  
. 535 




. 560  
. 574  
. 6 1 9  
. 627  
. 593  
. 245 
. 284 
. 259  
. 3 1 3  
. 2 92  
. 307 
. 2 9 1  
. 2 78  
. 3 23 
. 303 
. 300 
. 297  
9 . 00 
9 . 1 1  
- 9 . 3 1  
8 . 8 7  
9 . 5 7  
9 . 1 0 
9 . 27  
9 . 0 1  
8 . 76 
8 . 7 5 
8 . 93 
9 . 10 
293 . 428 
343 . 344  
452 . 1 1 1  
425 . 1 70 
464 . 544  
433 . 1 20  
363 . 1 39  
496 . 64 2  
483 . 702  
36 5 . 1 98  
4 1 7 . 1 42 
448 . 856 
468 . 226  
430 . 449 
446 . 7 26 
449 . 633 
435 . 058 
379 . 5 83 
337 . 225 
386 . 1 85 
344 . 624 
437 . 1 36 
37 7 . 978 
41 7 . 9 1 9 
388 . 8 74 
382 . 22 2  
456 . 7 66  
428 . 973  
4 1 6 . 1 6 5  
404 . 306 
1 6 . 2  
1 6 . 7  
1 6  . o  
1 7 . 2  
1 6 . 5  
1 5 . 8  
1 7 . 8  
16 . 6  
1 7  . o  
1 7 . 4  
1 7 . 2  
1 7 . 4  
1 6 . 1  
1 7 . 3  
1 7  . o  
1 6 . 1  
1 6 . 7  
1 7 . 4  
16 . 5  
16 . 8  
1 7 . 2  
16 . 4  
1 7 . 6  
1 7  . o  
1 7 . 5  
17 . 2  
17 . 6  
1 7 . 4  
17 . 3  
16 . 8  
20 . 4935  
18 . 5447  
23 . 22 7 2  
2 1 . 6787  
23 . 4 243 
22 . 4 236 
18 . 4426 
26 . 2682 
25 . 067 2 
1 9 . 792 1 
2 1 . 3906 
2 1 . 64 3 1  
23 . 2368 
2 1 . 6 966  
22 . 1 524 
22 . 6 2 1 3  
22 . 8470 
1 9 . 7 209 
18 . 3 94 1  
20 . 94 1 3  
18 . 6 538 
23 . 6426  
20 . 5 525  
22 . 3 7 10 
20 . 5992  
20 . 02 22 
22 . 7 345 
2 1 . 57 1 9  
2 1 . 48 1 8 
2 1 . 8999 
2 1 3  
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Appendix Table 39 . ( cont inued)  
Hemo-
Genotype- RBC G6PDH globin G6PDH 
_S..;;..ex .;....._ ___ M_o_u_s e..;;...._fi __ A...._i __ A ..... t _ _ A_(.:...x..;....1_0 6 I mm 3 ) ( U I 1 0  1 2  RBC )  { gl dL) { U I g Hb ) 
6 1  
6 2  
6 3  
6 4  
6 5  





7 1  
7 2  
. 3 29 
. 3 5 1 
. 3 64 
. 306  
. 2 9 6  
. 3 20 
. 253 
. 359  
. 2 68 
. 267  
. 304  
. 283  
After DHEA Treatment 
. 604  
. 670  
. 7 1 7 
. 585 
. 598 
. 6 1 8 
. 539  
. 69 1  
. 57 6  
. 566  
. 599  
. 579  
. 2 75  
. 3 1 9  
. 353 
. 2 79 
. 302  
. 298 
. 286  
. 33 2  
. 308 
. 29 9  
. 295  
. 296 
9 . 39  
9 . 1 9  
9 . 00 
8 . 94 
9 . 1 1  
8 . 73 
8 . 74 
9 . 1 1  
8 . 82 
8 . 70 
9 . 62 
9 . 5 1  
362 . 796  
430 . 002 
485 . 879 
386 . 600· 
4 1 0 . 662  
422 . 86 1  
405 . 369  
45 1 . 456  
432 . 59 1  
425 . 74 3  
379 . 8 7 7  
385 . 573  
1 7 . 5  
1 7 . 4  
1 7 . 8  
16 . 8  
1 6 . 9  
1 7 . 5  
1 6 . 6  
1 7 . 8  
16 . 7  
1 6 . 0  
1 7  . o  
17 . 0  
1 9 .4666  
2 2 . 7 1 1 0 
24 . 5 669 
20 . 5 727  
22 . 1 368 
2 1 . 0947 
2 1 . 3429  
23 . 1 054 
22 . 0470 
23 . 1 498  
2 1 . 4965  
2 1 . 5694  
2 1 4  
Experiment #2 , Study 2 
Appendix Table 40 . Change in Absorbance at 340 nm, Red Blood Cell 
Count , Hemoglobin Concent ration and Calculated 
G6PDH Ac tivities  During DHEA Treatment for Each 
Mouse ( 90-day-olds -- (Young Adult s )  on 0 . 4%  
DHEA) . 
Hemo-
Genotype- RBC G6PDH globin G6PDH 
_S_ex ____ M....;.o_;..u..;..se..;.__,I! _ ____;,Ai....__..;..;A.Lf. _ ___;;,;.A_(�x.;;;,_1_06 /mm3 ) ( U I 1 0  1 2RBC )  ( g/ dL) ( U I g Hb) 
73  
7 4  
7 5  
7 6  










8 7  
8 8  
89 
90 
9 1  




9 6  
73 
7 4  
7 5  
7 6  
7 7  
7 8  
. 1 99 
. 243  
. 2 3 1  
. 284  
. 269  
. 249  
. 248 
. 2 97 
.238  
. 223  
. 2 1 1  







. 2 9 2  
. 200 
. 1 89 
. 25 3  
. 1 73 
. 2 24 
. 3 1 9  
.3 1 7  
. 336  
.3 1 3  
.3 1 4  
. 3 1 6  
Before DHEA Treatment 
. 568 
. 54 3  




. 540  
. 602  
. 49 7  
. 4 98  
. 4 38 
. 56 9  
. 688 
. 7 74  
. 5 93  
• 7 27 
. 6 1 9  
. 65 2  
. 7 1 2 
. 5 1 6 
. 52 7  
. 584 
. 437  
. 559  
. 369  
. 300 
. 308 
. 3 1 6  
. 334 
. 3 5 9  
. 292  
. 305  
. 2 59 
. 27 5  
. 2 27 
. 298 
. 3 20 
. 340 
. 309 
. 363  
. 3 1 6 
. 2 98 
. 420 
. 3 1 6  
. 3 38 
. 3 3 1  
. 264 
. 3 1 5  
7 . 03 
7 . 98  
8 . 1 5  
7 . 83 
7 . 8 1  
8 . 1 8 
7 . 48 
7 . 39  
7 . 20 
7 . 60 
7 . 1 4 
8 . 22 
8 . 7 7  
9 . 40 
8 . 3 1  
8 . 7 6 
8 . 46  
8 . 6 2 
. 8 . 4 1  
8 . 00 
7 . 1 6 
7 . 90 
7 . 96 
7 . 92  
During DHEA Treatment 
. 597  
. 5 78  
. 6 32 
. 567  
. 604 
. 60 1  
. 2 78 
. 2 6 1 
. 2 96 
. 2 54 
. 2 90 
. 285 
9 . 2 1  
8 . 36 
8 . 22 
8 . 38 
8 . 5 1  
8 . 5 5 
650 . 230 
465 . 708 
468 . 1 54 
499 . 943 
529 . 7 75 
543 . 672  
483 . 589 
51 1 . 2 7 1 
445 . 6 1 8 
448 . 244 
393 . 843 
449 . 097  
452 . 008 
448 . 0 7 1 
460 . 63 1  
51 3 . 332  
462 . 7 14 
428 . 257  
6 1 8 . 656 
489 . 3 20 
584 . 789 
5 1 9 . 035 
4 10 . 853 
492 . 698 
373 . 922  
386 . 7 50 
446 . 083 
37 5 . 479  
422 . 1 47 
4 1 2 . 928 
1 3 . 9  
16 . 4  
1 6 . 1  
15 . 1  
1 5 . 5  
1 5 . 7  
1 5 . 3  
1 5 . 6  
1 5 . 3  
1 5 . 4  
1 5 . 6  
1 6 . 6  
17 . 8  
18 . 9  
16 . 9  
1 7 . 5  
1 7 . 2  
1 7 . 4  
16 . 6  
16 . 0  
1 5  . o  
1 5 . 8  
1 6 . 2  
1 5 . 4  
16 . 5  
1 5 . 9  
16 . 0  
16 . 1  
16 . 4  
16 . 4  
32 . 8857  
22 . 6607 
23 . 6 985 
25 . 9 242  
26 . 6 938 
28 . 3 263 
23 . 642 1 
24 . 2 1 98  
20 . 9 703 
22 . 1 2 1 1 
18 .0259  
22 . 2 384 
22 . 2 703 
22 . 2850 
22 . 6 500 
25 . 6959  
22 . 7 59 1 
2 1 . 2 160  
3 1 . 3427  
24 . 4660 
27 . 9 1 3 9  
25 . 95 1 7  
20 . 1 8 76  
25 . 3388 
20 . 8 7 1 6  
20 . 3 348 
22 . 9 1 7 5  
1 9 . 5436 
2 1 . 9053 
2 1 . 52 7 7  
2 1 5  
Experiment #2 , Study 2 
Appendix Table 40 . ( continued ) 
Heme-
Genotype- RBC G6PDH globin G6PDH 









8 6  
8 7  
8 8  
89  
90  
9 1  
9 2  
93  
9 4  
9 5  
9 6  
73  
7 4  
7 5  
7 6  
7 7  
7 8  
79  
80  




. 3 2 1  
. 346  
. 2 62 
. 3 1 4  
. 1 69 
. 2 99 
. 3 54 
. 40 1 
. 4 2 7  
. 3 52  
. 352  
. 369  




. 3 2 7  
. 3 26 
. 2 9 6  
. 3 0 2  
. 2 9 3 
. 2 9 1  
. 24 6  
. 2 66  
. 2 79 
. 2 5 1 
. 2 5 3  
. 284 
. 2 7 1 
. 2 78 
During DHEA Treatment 
. 56 9  
. 62 1  
. 507  
. 573  
. 383 
. 578  
. 62 2  
. 67 9  
. 73 2  
. 638 
. 64 1  
. 634 
. 609 
. 628  
. 6 57 
. 6 1 8  
. 6 1 2  
. 58 1  
. 248 
. 2 7 5  
. 245  
. 2 59  
. 2 1 4 
. 2 79  
. 268 
. 278  
. 305  
. 286  
. 289  
. 2 6 5 
. 2 94 
. 282  
. 27 5  
. 2 7 2  
. 285 
. 2 55  
8 . 40 
8 . 24 
7 . 84 
8 . 32 
7 . 94 
7 . 9 1  
9 . 14 
9 . 2 7  
9 . 3 5  
8 . 68 
8 . 16 
9 . 1 2 
9 . 04 
9 . 48 
9 . 60 
9 . 34  
8 . 85  
9 . 4 1  
After DHEA Treatment 
. 5 59  
. 549 
. 5 74  
. 5 58 
. 568 
. 5 1 4 
. 5 1 2  
. 50 1  
. 48 1 
. 54 1  
. 5 1 6 
. 538  
. 263  
. 247  
. 28 1  
. 2 6 7  
. 32 2  
. 248 
. 23 3  
. 2 50 
. 228 
. 2 57  
. 245  
. 2 60 
9 . 89 
9 . 28 
. 9 . 09 
8 . 3 1  
8 . 74 
8 . 8 7 
9 . 1 2 
8 . 42  
8 . 44 
8 . 50 
8 . 43  
8 . 66 
365 . 736 
4 1 3 . 42 9  
38 7 . 1 20  
385 . 63 1  
333 . 879  
436 . 94 1  
363 . 23 2  
37 1 . 502 
404 . 095  
408 . 1 7 1  
4 1 6 . 289  
359 . 954 
402 . 879  
368 . 499  
354 . 860 
360 . 7 59  
398 . 9 30 
335 . 696  
329 . 424  
329 . 7 1 9  
382 . 946  
398 . 02 1  
456 . 394  
346 . 3 5 7  
3 1 6 . 448 
367 . 8 10 
334 . 648 
374 . 5 50 
360 . 026  
37 1 . 92 1  
1 6 . 4  
1 6 . 4  
16 . 1  
1 6 . 2  
1 5 . 8  
1 5 . 9  
1 7 . 4  
18 . 0  
18 . 2  
1 7 . 2  
1 7  . o  
17 . 6  
16 . 7  
1 7 . 7  
1 7 . 6  
16 . 8  
17  . 1  
16 . 7  
1 8 . 2  
1 7  . o  
1 7  . o  
16 . 4  
1 6 . 2  
16 . 6  
16 . 7  
16 . 2  
1 6  . o  
16 . 2  
1 5 . 8  
16 . 7  
18 . 7 3 28 
20 . 7 723 
18 . 85 1 1 
19 . 8053 
16 . 7 785 
2 1 . 7 372  
1 9 . 080 1 
1 9 . 1 3 23 
20 . 7 598 
20 . 5984 
2 1 . 0593  
18 . 6 52 1  
2 1 . 8085 
1 9 . 7366 
1 9 . 3560 
20 . 0565  
20 . 6464 
18 . 9 1 56  
1 7 . 90 1 1 
1 7 . 9988 
20 . 47 64 
20 . 1 680 
24 . 6227 
1 8 . 507 1 
1 7 . 2.836 
1 9 . 1 1 70 
1 7 . 6 527 
1 9 . 6523  
1 9 . 2090 
1 9 . 2865 
2 1 6  
Experiment #2 , Study 2 
Appendix Table 40 . ( cont inued ) 
Hemo-
Genotype- RBC G6PDH globin G6PDH 
_S_ex ____ M_o_u_se_I! __ A.�,..i __ A�f _ _ A_(..:....x_1_06Jmm3 ) (U/ 1 0 1 2RBC) (g/dL ) ( U/g Hb ) 
85 
86 




9 1  





. 297  
. 3 1 2  
. 3 24 
. 3 5 2  
. 3 29 
. 2 96 
. 263  
. 298 
. 3 1 6  
. 284 
.33 1 
. 2 9 9  
After DHEA Treatment 
. 578  
. 57 9  
. 598  
. 66 1  
. 63 2  
. 536  
. 537  
. 559 
. 562  
. 57 7  
. 644  
. 562  
. 2 8 1  
. 2 67  




. 2 74 
. 2 6 1  
. 246 
. 293  
. 3 1 3  
. 2 63  
9 . 1 1  
9 . 1 9  
9 . 24 
9 . 20  
8 . 9 2  
9 . 04  
8 . 9 7  
9 . 3 9  
9 . 23  
8 . 6 5  
8 . 8 5  
9 . 24 
382 . 1 06 
359 . 908 
367 . 345  
4 1 6 . 070  
420 . 7 98  
328 . 88 1  
378 . 402  
344 . 3 27  
330 . 1 63 
4 1 9 . 6 1 1 
438 . 1 24 
352 . 598 
1 7  .o  
1 7 . 2  
1 7 . 0  
1 7 . 6  
1 6 . 9  
1 7 . 1  
16 . 4  
1 7  . 1  
1 7 . 5  
1 7  . o  
1 7 . 2  
1 7 . 7  
20 . 4764 
19 . 2300 
1 9 . 9 663 
2 1 . 749 1 
22 . 2 102  
1 7 . 38 64 
20 . 6968 
18 . 9078 
1 7 . 4 1 38 
2 1 . 3 508 
22 . 5430 
18 . 4068 
� . 
